<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/sitemap_generator/default/sitemap.xsl"?>
<!--Generated by the Simple XML Sitemap Drupal module: https://drupal.org/project/simple_sitemap.-->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
 <url>
  <loc>https://www.novartis.com/</loc>
  <lastmod>2025-03-06T11:21:09+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors/ton-buechner</loc>
  <lastmod>2025-01-17T14:27:54+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/harry-kirsch</loc>
  <lastmod>2025-01-31T08:59:33+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors/simon-moroney</loc>
  <lastmod>2025-01-17T14:27:32+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors/patrice-bula</loc>
  <lastmod>2025-01-27T13:17:08+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors/nancy-c-andrews</loc>
  <lastmod>2025-01-27T13:13:56+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors/frans-van-houten</loc>
  <lastmod>2025-01-27T13:23:48+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/karen-hale</loc>
  <lastmod>2025-01-17T14:34:51+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/klaus-moosmayer</loc>
  <lastmod>2025-01-31T08:06:06+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/lutz-hegemann</loc>
  <lastmod>2025-01-17T14:36:22+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors/elizabeth-liz-doherty</loc>
  <lastmod>2025-01-27T13:18:20+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors/charlotte-pamer-wieser</loc>
  <lastmod>2025-01-17T14:29:33+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors/bridgette-heller</loc>
  <lastmod>2025-01-17T14:28:23+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/vasant-narasimhan</loc>
  <lastmod>2025-01-31T08:02:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/steffen-lang</loc>
  <lastmod>2025-01-17T14:35:36+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/novartis-and-european-union-eu/novartis-eu-public-affairs-team/julie-chauvet</loc>
  <lastmod>2024-12-19T13:40:41+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/novartis-and-european-union-eu/novartis-eu-public-affairs-team/vincent-vanwijnsberghe</loc>
  <lastmod>2024-12-19T13:45:26+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/novartis-and-european-union-eu/novartis-eu-public-affairs-team/sarah-moundir</loc>
  <lastmod>2024-12-19T13:44:12+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/rob-kowalski</loc>
  <lastmod>2025-01-27T13:38:57+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors/daniel-hochstrasser</loc>
  <lastmod>2025-01-27T13:20:29+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors/ana-de-pro-gonzalo</loc>
  <lastmod>2025-01-17T14:28:49+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/victor-bulto</loc>
  <lastmod>2025-01-28T16:09:29+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/kees-roks</loc>
  <lastmod>2025-01-17T14:36:36+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/shreeram-aradhye</loc>
  <lastmod>2025-02-12T14:26:46+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/aharon-ronny-gal-phd</loc>
  <lastmod>2025-01-27T13:50:12+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/fiona-marshall</loc>
  <lastmod>2025-01-27T13:47:36+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors/john-d-young</loc>
  <lastmod>2025-01-27T13:28:55+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/michelle-weese</loc>
  <lastmod>2025-01-17T14:36:54+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee/patrick-horber-md</loc>
  <lastmod>2025-01-27T13:35:55+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/novartis-and-european-union-eu/novartis-eu-public-affairs-team/carine-jacquet</loc>
  <lastmod>2024-12-19T13:46:23+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors/giovanni-caforio</loc>
  <lastmod>2025-03-07T15:26:05+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors/elizabeth-mcnally</loc>
  <lastmod>2025-03-07T15:26:08+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct04174157</loc>
  <lastmod>2025-03-11T07:06:37+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct04889430</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06142357</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05147220</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06372925</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06293365</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05562466</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06345157</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct04230148</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct03040973</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct04675931</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06411626</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06470048</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05626257</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05274425</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06237062</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05921994</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05222529</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct04557462</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06267560</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05335876</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06431763</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05397496</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06075758</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05996835</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05853458</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06655896</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06517758</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05268289</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct04939610</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05666804</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05838768</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06133972</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06092879</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05870579</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct03960840</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05795140</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05634967</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct04666272</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05415072</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct04857372</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct02934568</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05868629</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05544929</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06562192</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06157086</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct04657822</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct04877522</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05943522</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05703516</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct02445222</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05110196</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05798117</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05142696</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06262919</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06379217</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06444113</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05541341</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06388941</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05900141</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06121349</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05653349</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05803941</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05648968</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05275868</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06331312</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05697146</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06287268</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05552469</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06462469</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06247995</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05285904</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05646381</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05156281</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05114746</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06053801</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05834738</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05739942</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06517719</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct04817618</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05022342</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06551519</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05639114</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05161195</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05631795</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05217810</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct03591510</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05939414</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05624749</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06148506</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct03340506</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06546670</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05293470</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05755386</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05653219</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05622708</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05726838</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05852938</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05592990</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05230537</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05935215</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05429502</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05948943</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05976243</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05362903</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct04925479</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05809986</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05252585</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05776888</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05985915</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05301907</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06517732</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06155500</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06019637</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06042478</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05682378</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05090371</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05888493</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05109728</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct04597411</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct04094311</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06236061</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06156683</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct04933552</loc>
  <lastmod>2025-03-11T07:06:37+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct04943497</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct03955445</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06444087</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct04985487</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05842954</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05621733</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06004661</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05750628</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05849298</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06581198</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct04638647</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05983198</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct04480853</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05380453</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05677451</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05126277</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05524051</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06643481</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06439082</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06335979</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06649110</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct03650114</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06606314</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06386419</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06665256</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06531499</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06733922</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06617793</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06597019</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06625333</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06659393</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06486779</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06704269</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct05067140</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06799000</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06675864</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06780670</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06006559</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06830720</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06514534</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06597006</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06744920</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/study/nct06840392</loc>
  <lastmod>2025-03-13T07:06:38+01:00</lastmod>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/manufacturing-facility-stein-ch</loc>
  <lastmod>2021-10-11T09:11:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-production-and-manufacturing-b-roll-video</loc>
  <lastmod>2024-10-29T07:52:39+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/karen-l-hale</loc>
  <lastmod>2022-04-04T07:08:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/what-non-alcoholic-steatohepatitis-nash</loc>
  <lastmod>2021-08-16T07:56:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/access-fact-sheet</loc>
  <lastmod>2021-08-16T09:06:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/healthy-family-fact-sheet</loc>
  <lastmod>2021-08-16T09:09:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/thalassemia-backgrounder</loc>
  <lastmod>2021-08-16T07:59:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/sickle-cell-disease-backgrounder</loc>
  <lastmod>2021-08-16T08:02:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/chronic-iron-overload-backgrounder</loc>
  <lastmod>2021-08-16T08:04:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/myelodysplastic-syndromes-mds-backgrounder</loc>
  <lastmod>2021-08-16T08:06:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/anaplastic-lymphoma-kinase-positive-non-small-cell-lung-cancer-interactive-media-guide</loc>
  <lastmod>2021-08-16T08:09:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/neuroendocrine-tumors-expert-media-guide</loc>
  <lastmod>2021-08-16T08:11:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/leprosy</loc>
  <lastmod>2021-08-16T08:13:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/reimagining-management-sickle-cell-disease-africa</loc>
  <lastmod>2021-08-16T08:14:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/malaria</loc>
  <lastmod>2022-03-15T09:27:38+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/chagas-disease</loc>
  <lastmod>2021-08-16T08:18:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-access-fact-sheet</loc>
  <lastmod>2021-08-03T20:09:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/chronic-myeloid-leukemia-today-and-tomorrow-visual-fact-sheet</loc>
  <lastmod>2021-08-10T19:47:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/renal-cell-carcinoma-rcc-fact-sheet</loc>
  <lastmod>2021-08-10T19:48:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/early-versus-advanced-breast-cancer-list</loc>
  <lastmod>2021-08-10T19:49:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/frontal-view-gehry-building</loc>
  <lastmod>2021-08-16T09:15:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/gehry-building-from-distance</loc>
  <lastmod>2021-08-16T09:17:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/tables-and-chairs-next-green-space</loc>
  <lastmod>2021-08-16T09:19:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/steffen-lang-phd</loc>
  <lastmod>2023-03-16T09:44:41+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-logo</loc>
  <lastmod>2021-10-19T15:46:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/frans-van-houten</loc>
  <lastmod>2024-09-04T17:24:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/charlotte-pamer-wieser-phd</loc>
  <lastmod>2024-09-04T17:31:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/elizabeth-liz-doherty</loc>
  <lastmod>2024-09-04T17:19:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/ton-buechner</loc>
  <lastmod>2024-09-04T17:15:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/nancy-c-andrews-md-phd</loc>
  <lastmod>2024-09-04T17:14:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/vasant-vas-narasimhan-md</loc>
  <lastmod>2022-04-04T07:02:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/trees-casting-shadows-along-fabrikstrasse</loc>
  <lastmod>2021-08-13T07:10:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/harry-kirsch</loc>
  <lastmod>2022-04-04T07:07:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/antimalarial-pills</loc>
  <lastmod>2021-08-16T10:49:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/antimalarial-raw-material</loc>
  <lastmod>2021-08-16T10:51:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/artemisinin-combination-therapy-act</loc>
  <lastmod>2021-08-16T10:54:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/artemisinin-extraction</loc>
  <lastmod>2021-08-16T10:58:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/farmer-harvesting-artemisia-annua</loc>
  <lastmod>2021-08-16T11:01:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/malaria-diagnostic-test</loc>
  <lastmod>2023-03-16T09:47:10+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/malaria-prevention</loc>
  <lastmod>2023-03-16T09:46:49+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/malaria-researchers-nairobi-kenya</loc>
  <lastmod>2021-08-16T11:13:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/mode-action-cgrp-receptor-blocker</loc>
  <lastmod>2021-08-16T11:28:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/patients-frozen-t-cells</loc>
  <lastmod>2021-08-16T11:39:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/sms-life</loc>
  <lastmod>2021-08-16T13:19:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/sms-life-training-session</loc>
  <lastmod>2021-08-16T13:22:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/t-cell-arrival-novartis-manufacturing-facility</loc>
  <lastmod>2021-08-16T13:23:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-fabrikstrasse-novartis-hq</loc>
  <lastmod>2021-08-16T13:24:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/worldwide-distribution-center-novartis-antimalarial-basel-switzerland</loc>
  <lastmod>2021-08-16T13:30:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/young-malaria-patient</loc>
  <lastmod>2023-03-16T09:45:27+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/cancer-2030-growing-global-crisis</loc>
  <lastmod>2021-08-16T13:35:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/sickle-cell-world-assessment-survey-sway-results</loc>
  <lastmod>2021-08-16T13:35:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/new-era-medicine</loc>
  <lastmod>2021-08-16T13:37:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/cell-and-gene-key-focus-areas</loc>
  <lastmod>2021-08-16T13:40:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/introduction-cell-and-gene-therapy</loc>
  <lastmod>2021-08-16T13:42:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-financial-results-q3-2018-infographic</loc>
  <lastmod>2021-08-16T13:44:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/klaus-moosmayer-phd</loc>
  <lastmod>2022-04-04T07:07:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-financial-results-q2-2018-infographic</loc>
  <lastmod>2021-08-12T06:34:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/impact-migraine</loc>
  <lastmod>2021-08-12T06:51:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-financial-results-q1-2018-infographic</loc>
  <lastmod>2021-08-12T07:26:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/spinal-muscular-atrophy-sma-infographic</loc>
  <lastmod>2021-08-13T13:21:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/inflammation-and-cardiovascular-risk</loc>
  <lastmod>2021-08-12T07:45:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/measuring-inflammation-and-role-hscrp</loc>
  <lastmod>2021-08-16T07:42:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/chimeric-antigen-receptor-t-cell-car-t-therapy</loc>
  <lastmod>2021-08-16T13:45:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/chronic-iron-overload-infographic</loc>
  <lastmod>2021-08-12T07:55:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/chronic-myleoid-leukemia-meet-milestones-matter-one-pager</loc>
  <lastmod>2021-08-12T07:57:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/facts-about-melanoma-infographic</loc>
  <lastmod>2021-08-12T08:03:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/chronic-iron-overload-complications-infographic</loc>
  <lastmod>2021-08-12T08:04:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/anaplastic-lymphoma-kinase-non-small-cell-lung-cancer-disease-state-infographic</loc>
  <lastmod>2021-08-12T08:09:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/about-noncommunicable-diseases-infographic</loc>
  <lastmod>2021-08-12T08:15:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/access-ncd-treatment-infographic</loc>
  <lastmod>2021-08-12T08:16:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/understanding-chronic-myeloid-leukemia-infographic</loc>
  <lastmod>2021-08-12T08:19:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/gastrointestinal-neuroendocrine-tumors-infographic</loc>
  <lastmod>2021-08-12T08:27:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/pancreatic-neuroendocrine-tumors-infographic</loc>
  <lastmod>2021-08-12T08:36:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/lung-neuroendocrine-tumors-infographic</loc>
  <lastmod>2021-08-12T08:44:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/tuberous-sclerosis-complex-patient-journey-infographic</loc>
  <lastmod>2021-08-12T08:52:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/advanced-soft-tissue-sarcoma-infographic</loc>
  <lastmod>2021-08-12T08:52:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/tuberous-sclerosis-complex-common-threads-infographic</loc>
  <lastmod>2021-08-12T09:04:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/renal-cell-carcinoma-infographic</loc>
  <lastmod>2021-08-12T09:06:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/embarking-young-adulthood-tsc-monitoring-manifestations-over-time</loc>
  <lastmod>2021-08-12T09:06:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/psychological-social-impact-advanced-breast-cancer</loc>
  <lastmod>2021-08-12T09:12:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-society-us-report-2020</loc>
  <lastmod>2021-08-12T09:14:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-society-esg-report-2020</loc>
  <lastmod>2021-08-12T09:28:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-annual-report-2020</loc>
  <lastmod>2021-08-12T09:30:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-annual-report-2019</loc>
  <lastmod>2021-08-16T08:35:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-society-us-report-2019</loc>
  <lastmod>2021-08-12T09:53:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/malaria-futures-central-africa</loc>
  <lastmod>2021-08-12T09:58:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-society-esg-report-2019</loc>
  <lastmod>2021-08-12T10:03:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/malaria-futures-asia</loc>
  <lastmod>2021-08-12T10:23:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-social-business-report-2018</loc>
  <lastmod>2021-08-12T10:29:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-society-us-report-2018</loc>
  <lastmod>2021-08-12T10:35:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-society-report-2018</loc>
  <lastmod>2022-02-01T18:02:31+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/malaria-futures-africa</loc>
  <lastmod>2021-08-12T10:46:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-annual-report-2018</loc>
  <lastmod>2021-08-12T10:50:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-annual-report-2017</loc>
  <lastmod>2021-08-12T10:50:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/healthy-family-10-year-report</loc>
  <lastmod>2021-08-12T10:54:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-access-two-year-report</loc>
  <lastmod>2021-08-12T10:59:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/corporate-responsibility-report-2017</loc>
  <lastmod>2021-08-12T10:59:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-access-one-year-report</loc>
  <lastmod>2021-08-12T11:08:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/building-trust-society-our-priorities</loc>
  <lastmod>2021-08-16T09:02:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/strengthening-our-global-health-corporate-responsibility-function</loc>
  <lastmod>2021-08-13T08:18:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/spinal-muscular-atrophy-sma-factsheet</loc>
  <lastmod>2021-08-13T08:51:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/heart-failure-hospitalization-why-moment-matters</loc>
  <lastmod>2021-08-13T08:46:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/about-migraine</loc>
  <lastmod>2021-08-13T08:55:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/diffuse-large-b-cell-lymphoma-dlbcl</loc>
  <lastmod>2021-08-13T09:01:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/acute-lymphoblastic-leukemia-all</loc>
  <lastmod>2021-08-13T09:46:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/acute-lymphoblastic-leukemia-fact-sheet</loc>
  <lastmod>2021-08-13T09:51:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/advancing-global-health</loc>
  <lastmod>2021-08-13T10:03:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/chronic-myeloid-leukemia-background-fact-sheet</loc>
  <lastmod>2021-08-12T11:55:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/science-behind-car-t-cell-therapy</loc>
  <lastmod>2023-03-16T09:47:33+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/manufacturing-car-t-cell-therapies-novartis-approach</loc>
  <lastmod>2021-08-12T13:13:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/lutz-hegemann-md-phd</loc>
  <lastmod>2024-12-02T10:13:05+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/bridgette-heller</loc>
  <lastmod>2024-09-04T17:20:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/simon-moroney-dphil</loc>
  <lastmod>2024-09-04T17:12:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/bad-sackingen-novartis-stein-switzerland</loc>
  <lastmod>2021-08-12T14:54:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/operator-culture-medium-bag</loc>
  <lastmod>2021-08-12T14:58:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-site-stein-switzerland</loc>
  <lastmod>2021-08-12T15:02:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/operators-clean-room</loc>
  <lastmod>2021-08-13T06:19:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/operator-labels-culture-plates</loc>
  <lastmod>2021-08-13T06:23:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/operator-prepares-connecting-hose</loc>
  <lastmod>2021-08-13T06:25:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/patrice-bula</loc>
  <lastmod>2024-09-04T17:17:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/people-park</loc>
  <lastmod>2021-08-13T06:31:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/break-park</loc>
  <lastmod>2021-08-13T06:33:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/operator-performs-process-operation-biosafety-cabinet</loc>
  <lastmod>2021-08-13T06:36:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/grocery-shop-staircase</loc>
  <lastmod>2021-08-13T06:40:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/staircase-fabrikstrasse-6-peter-markli</loc>
  <lastmod>2023-03-30T09:37:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/avenue-trees-along-fabrikstrasse</loc>
  <lastmod>2021-08-13T07:03:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-fabrikstrasse-6-peter-markli-trees</loc>
  <lastmod>2023-03-30T09:30:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-staircase-gehry-building</loc>
  <lastmod>2021-08-13T07:25:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/first-results-from-global-net-survey-part-1-time-diagnosis</loc>
  <lastmod>2021-08-13T07:51:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/tackling-chronic-disease-novartis-access</loc>
  <lastmod>2021-10-12T11:24:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/results-from-first-global-net-survey-part-2-net-patient-experience</loc>
  <lastmod>2021-08-13T08:32:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/what-polycythemia-vera</loc>
  <lastmod>2023-03-15T14:10:34+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/how-polycythemia-vera-diagnosed</loc>
  <lastmod>2021-08-13T07:59:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/what-are-symptoms-and-complications-polycythemia-vera</loc>
  <lastmod>2021-08-13T08:11:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/tsc-common-threads-future-outlook-tsc</loc>
  <lastmod>2021-08-13T08:18:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/tsc-common-threads-grandia-family-story</loc>
  <lastmod>2021-08-13T08:33:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/tsc-talk-did-you-know</loc>
  <lastmod>2021-08-13T08:33:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/tsc-common-threads-tsc-affects-each-person-differently</loc>
  <lastmod>2021-08-13T08:40:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/tsc-common-threads-moss-family</loc>
  <lastmod>2021-08-13T08:44:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/tsc-common-threads-life-tsc</loc>
  <lastmod>2021-08-13T08:46:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/acute-myeloid-leukemia-unique-needs-patients-and-caregivers</loc>
  <lastmod>2021-08-13T08:52:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/alk-non-small-cell-lung-cancer-patient-video-anne-marie</loc>
  <lastmod>2021-08-13T08:57:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/alk-non-small-cell-lung-cancer-patient-video-miriam-joel</loc>
  <lastmod>2021-08-13T09:06:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-access-how-well-expand-access-healthcare</loc>
  <lastmod>2021-08-13T09:12:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/experts-gather-explore-response-chronic-illness-poor-countries</loc>
  <lastmod>2021-08-13T09:12:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-and-international-red-cross-partner-provide-medicines-syrian-refugees</loc>
  <lastmod>2021-08-13T09:18:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/museum-ms</loc>
  <lastmod>2021-08-13T09:21:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/what-do-you-know-about-noncommunicable-diseases</loc>
  <lastmod>2021-08-13T09:27:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/about-erenumab-amg-334</loc>
  <lastmod>2021-09-09T10:48:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/erenumab-amg-334-key-clinical-trials-numbers</loc>
  <lastmod>2021-09-09T10:48:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/how-does-acz885-work</loc>
  <lastmod>2021-09-09T10:48:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/juliet-clinical-trial</loc>
  <lastmod>2021-09-09T10:48:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/kymriah-tisagenlecleucel-children-and-young-adults-b-cell-all-refractory-or-relapsed-least-twice</loc>
  <lastmod>2022-10-20T11:02:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/rth258-brolucizumab-clinical-trials</loc>
  <lastmod>2021-09-09T10:47:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/kymriah-tisagenlecleucel-suspension-intravenous-infusion</loc>
  <lastmod>2022-10-20T10:55:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/interleukin-17-il-17a-inflammatory-joint-disease</loc>
  <lastmod>2021-09-09T10:47:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/interleukin-17-il-17a-psoriasis</loc>
  <lastmod>2021-09-09T10:46:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/rob-kowalski</loc>
  <lastmod>2022-04-04T07:07:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/managing-tsc-transition-adult-care</loc>
  <lastmod>2021-10-06T09:33:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/nibr-basel</loc>
  <lastmod>2024-10-29T07:51:48+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/nibr-cambridge-united-states</loc>
  <lastmod>2024-10-29T07:53:36+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-animated-logo</loc>
  <lastmod>2024-10-29T07:54:06+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-forum-1-and-fabrikstrasse-novartis-campus-basel</loc>
  <lastmod>2021-12-07T14:30:18+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-fabrikstrasse-15-novartis-campus-basel</loc>
  <lastmod>2021-12-07T10:11:08+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/outside-meeting-space-novartis-campus-basel</loc>
  <lastmod>2021-12-08T09:48:37+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-asklepios-8-along-rhine-riverbank-novartis-campus-basel</loc>
  <lastmod>2021-12-07T14:29:09+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-towards-asklepios-8-and-dreirosenbruckebasel-novartis-campus-basel</loc>
  <lastmod>2021-12-07T14:37:40+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-banting-1-and-novartis-campus-basel</loc>
  <lastmod>2021-12-13T10:14:35+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-banting-1</loc>
  <lastmod>2021-12-13T10:14:45+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-novartis-campus-and-banting-1-basel</loc>
  <lastmod>2021-12-13T10:14:23+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-banting-1-and-fabrikstrasse-novartis-campus-basel</loc>
  <lastmod>2022-01-26T15:09:13+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-banting-1-and-fabrikstrasse-6-passing-cyclist-novartis-campus-basel</loc>
  <lastmod>2022-01-26T15:18:29+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-banting-1-and-fabrikstrasse-6-novartis-campus-basel</loc>
  <lastmod>2022-01-26T15:18:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-annual-report-2021</loc>
  <lastmod>2022-02-01T23:17:40+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/ana-de-pro-gonzalo</loc>
  <lastmod>2024-09-04T17:25:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/daniel-hochstrasser</loc>
  <lastmod>2024-09-04T17:23:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-novartis-campus-forum-1-banting-1-and-fabrikstrasse</loc>
  <lastmod>2022-04-05T15:44:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-pavillon-banting-1-background</loc>
  <lastmod>2022-04-05T15:45:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-pavillon-novartis-campus-and-banting-1-background</loc>
  <lastmod>2022-04-05T15:45:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-from-novartis-campus-towards-novartis-pavillon-and-basel-alongside-rhine-river</loc>
  <lastmod>2022-04-05T15:46:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-from-novartis-campus-towards-novartis-pavillon-and-basel</loc>
  <lastmod>2022-04-05T15:48:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-pavillon-located-park-south-novartis-campus</loc>
  <lastmod>2022-04-05T15:51:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/illumination-zero-energy-media-facade-novartis-pavillon-artwork-semiconductor-0</loc>
  <lastmod>2022-04-05T15:50:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/illumination-zero-energy-media-facade-novartis-pavillon-artwork-semiconductor</loc>
  <lastmod>2022-04-05T15:52:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/illumination-zero-energy-media-facade-novartis-pavillon-0</loc>
  <lastmod>2022-04-05T15:52:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/illumination-zero-energy-media-facade-novartis-pavillon</loc>
  <lastmod>2022-04-05T15:53:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/organic-solar-cell-led-core-which-builds-illuminating-skin-novartis-pavillon</loc>
  <lastmod>2022-04-05T15:54:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/schoolhub-ground-floor-novartis-pavillon</loc>
  <lastmod>2022-04-05T15:54:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/interior-view-ground-floor-novartis-pavillon</loc>
  <lastmod>2022-04-05T15:55:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/welcome-wall-and-staircase-exhibition-wonders-medicine-novartis-pavillon</loc>
  <lastmod>2022-04-05T15:56:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/welcome-wall-novartis-pavillon</loc>
  <lastmod>2022-04-05T15:56:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/content-area-fragility-life-wonders-medicine-exhibition-novartis-pavillon</loc>
  <lastmod>2022-04-05T15:57:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/victor-bulto</loc>
  <lastmod>2023-10-04T12:01:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/kees-roks</loc>
  <lastmod>2022-05-02T11:41:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/shreeram-aradhye-md</loc>
  <lastmod>2023-10-04T12:00:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/crizanlizumab-clinical-setting-from-international-managed-access-program-map</loc>
  <lastmod>2022-06-17T12:20:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/aharon-ronny-gal-phd</loc>
  <lastmod>2022-09-12T14:17:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/about-gene-therapy</loc>
  <lastmod>2022-08-12T09:29:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/gene-therapy-manufacturing-north-carolina</loc>
  <lastmod>2022-08-12T09:34:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/about-novartis-gene-therapies</loc>
  <lastmod>2022-10-03T10:34:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-gene-therapies-manufacturing-process</loc>
  <lastmod>2022-10-03T10:31:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/screen-unseen-newborn-screening-sma</loc>
  <lastmod>2022-08-12T09:22:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-aav-platform</loc>
  <lastmod>2022-10-03T10:28:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/spinal-muscular-atrophy</loc>
  <lastmod>2022-08-12T09:33:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/scientist-laboratory-banting-1-office-space-background</loc>
  <lastmod>2022-09-05T16:45:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/scientists-fermentation-hub-banting-1</loc>
  <lastmod>2022-09-05T16:45:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/fermentation-hub-banting-1-where-natural-products-and-biomolecules-can-be-produced</loc>
  <lastmod>2022-09-05T16:45:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/scientists-one-state-art-laboratories-banting-1</loc>
  <lastmod>2022-09-05T16:45:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/scientists-laboratory-banting-1-where-global-discovery-chemistry-group-based</loc>
  <lastmod>2022-09-05T16:45:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-asklepios-building-oscillation-bench-front</loc>
  <lastmod>2022-10-27T11:02:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-pavillon-located-park-south-novartis-campus-0</loc>
  <lastmod>2022-10-27T11:06:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/park-south-novartis-campus-view-novartis-pavillon</loc>
  <lastmod>2022-10-27T11:24:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/laboratory-building-virchow-6-novartis-campus</loc>
  <lastmod>2022-10-27T11:07:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/architects-map-novartis-campus-english-version</loc>
  <lastmod>2022-10-27T10:30:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-gehry-building-green-and-fabrikstrasse-novartis-campus-basel</loc>
  <lastmod>2022-10-27T11:08:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/fiona-h-marshall-phd</loc>
  <lastmod>2023-10-04T11:57:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/how-novartis-contributing-fight-against-malaria</loc>
  <lastmod>2022-11-23T07:44:14+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-annual-report-2022</loc>
  <lastmod>2023-02-02T12:55:12+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-society-integrated-report-2022</loc>
  <lastmod>2023-02-17T18:02:34+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/52-week-results-cosentyx-hidradenitis-suppurativa-summary</loc>
  <lastmod>2023-02-08T07:37:04+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/production-process-rna-therapies-schweizerhalle-switzerland</loc>
  <lastmod>2023-02-16T15:31:34+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-rna-production-schweizerhalle-switzerland</loc>
  <lastmod>2023-02-16T15:31:52+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/manufacturing-rna-therapies-schweizerhalle-switzerland</loc>
  <lastmod>2023-02-16T15:31:43+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-society-integrierter-geschaftsbericht-2022</loc>
  <lastmod>2023-02-17T18:02:26+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/john-d-young</loc>
  <lastmod>2024-09-04T17:30:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/main-entrance-novartis-pavillon</loc>
  <lastmod>2023-03-30T09:27:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/birds-eye-view-novartis-pavillon</loc>
  <lastmod>2023-03-30T09:28:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-from-kleinbasel-towards-novartis-campus-basel</loc>
  <lastmod>2023-03-30T09:32:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-novartis-pavillon-towards-dreirosenbrucke-and-city-center</loc>
  <lastmod>2023-03-30T09:27:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/view-from-hohlweg-passing-under-novartis-pavillon</loc>
  <lastmod>2023-03-30T09:28:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/wonders-medicine-exhibition-novartis-pavillon</loc>
  <lastmod>2023-03-30T09:28:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/wonders-medicine-exhibition-from-lab-patient-novartis-pavillon</loc>
  <lastmod>2023-03-30T09:28:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/wonders-medicine-exhibition-from-lab-patient-novartis-pavillon-0</loc>
  <lastmod>2023-03-30T09:28:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/wonders-medicine-exhibition-steps-through-time-novartis-pavillon</loc>
  <lastmod>2023-03-30T09:28:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/wonders-medicine-exhibition-future-healthcare-novartis-pavillon</loc>
  <lastmod>2023-03-30T09:28:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/schoolhub-novartis-pavillon</loc>
  <lastmod>2023-03-30T09:27:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/pedestrian-path-trees-novartis-campus-basel</loc>
  <lastmod>2023-03-30T09:29:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/fabrikstrasse-4-sanaa-novartis-campus-basel</loc>
  <lastmod>2023-03-30T09:29:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/fabrikstrasse-28-tadao-ando-and-artwork-richard-serra-novartis-campus-basel</loc>
  <lastmod>2023-03-30T09:29:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/fabrikstrasse-12-vittorio-magnago-lampugnani-novartis-campus-basel</loc>
  <lastmod>2023-03-30T09:29:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/banting-1-and-artwork-structure-life-claudia-comte-novartis-campus-basel</loc>
  <lastmod>2023-03-30T09:29:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-campus-basel-switzerland</loc>
  <lastmod>2024-10-29T07:54:53+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/michelle-weese</loc>
  <lastmod>2024-05-01T18:15:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/cardiovascular-disease-victorion-media-summary</loc>
  <lastmod>2023-09-12T16:34:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/cardiovascular-disease-numbers</loc>
  <lastmod>2023-09-12T16:34:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/cardiovascular-disease-orion-8-media-summary</loc>
  <lastmod>2023-09-12T16:33:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-logo-banting-1-building-novartis-campus-basel-vertical</loc>
  <lastmod>2023-10-23T13:22:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-logo-banting-1-building-from-main-gate-novartis-campus-basel-vertical</loc>
  <lastmod>2023-10-23T13:20:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-logo-banting-1-building-from-park-south-novartis-campus-basel-vertical</loc>
  <lastmod>2023-10-23T13:41:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-logo-banting-1-building-novartis-campus-basel-vertical-0</loc>
  <lastmod>2023-10-23T13:43:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-logo-banting-1-building-novartis-campus-basel-vertical-1</loc>
  <lastmod>2023-10-23T13:45:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-logo-banting-1-building-novartis-campus-basel-horizontal</loc>
  <lastmod>2023-10-23T13:46:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-logo-through-colorful-facade-forum-3-novartis-campus-basel-vertical</loc>
  <lastmod>2023-10-23T13:50:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/access-medicines-eu-member-states</loc>
  <lastmod>2023-11-23T11:49:50+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/intellectual-property-including-regulatory-data-protection-rdp</loc>
  <lastmod>2023-11-23T11:50:00+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/regulatory-framework</loc>
  <lastmod>2024-12-19T13:47:04+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/orphan-medicinal-products-pediatrics</loc>
  <lastmod>2023-11-23T11:50:21+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/security-supply</loc>
  <lastmod>2024-12-19T13:48:39+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/vasant-vas-narasimhan-md-0</loc>
  <lastmod>2023-11-28T15:42:41+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/vasant-vas-narasimhan-md-1</loc>
  <lastmod>2023-11-28T15:42:21+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/fiona-h-marshall-phd-0</loc>
  <lastmod>2023-11-28T11:24:41+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/fiona-h-marshall-phd-1</loc>
  <lastmod>2023-11-28T15:39:29+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/harry-kirsch-0</loc>
  <lastmod>2023-11-28T15:38:25+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/harry-kirsch-1</loc>
  <lastmod>2023-11-28T15:38:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/aharon-ronny-gal-phd-0</loc>
  <lastmod>2023-11-28T15:37:39+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/aharon-ronny-gal-phd-1</loc>
  <lastmod>2023-11-28T15:37:17+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/rob-kowalski-0</loc>
  <lastmod>2023-11-28T15:36:48+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/rob-kowalski-1</loc>
  <lastmod>2023-11-28T15:36:26+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/shreeram-aradhye-md-0</loc>
  <lastmod>2023-11-28T15:36:01+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/victor-bulto-0</loc>
  <lastmod>2023-11-28T15:34:45+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/victor-bulto-1</loc>
  <lastmod>2023-11-28T15:35:09+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/steffen-lang-phd-0</loc>
  <lastmod>2023-11-28T15:34:12+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/steffen-lang-phd-1</loc>
  <lastmod>2023-11-28T14:36:26+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/klaus-moosmayer-phd-0</loc>
  <lastmod>2023-11-28T14:56:56+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/klaus-moosmayer-phd-1</loc>
  <lastmod>2023-11-28T14:58:31+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/lutz-hegemann-md-phd-0</loc>
  <lastmod>2024-12-02T10:13:31+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/lutz-hegemann-md-phd-1</loc>
  <lastmod>2024-12-02T10:13:51+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/kees-roks-0</loc>
  <lastmod>2023-11-28T15:13:38+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/kees-roks-1</loc>
  <lastmod>2023-11-28T15:15:12+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/karen-l-hale-0</loc>
  <lastmod>2023-11-28T15:24:55+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/karen-l-hale-1</loc>
  <lastmod>2023-11-28T15:26:33+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/karen-l-hale-2</loc>
  <lastmod>2023-11-28T15:28:19+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/michelle-weese-0</loc>
  <lastmod>2024-05-01T18:05:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/patrick-horber-md</loc>
  <lastmod>2023-11-30T13:24:01+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/patrick-horber-md-0</loc>
  <lastmod>2023-12-05T08:22:40+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/patrick-horber-md-1</loc>
  <lastmod>2023-12-05T08:23:08+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/patrick-horber-md-2</loc>
  <lastmod>2023-12-05T08:23:25+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-society-integrated-report-2023</loc>
  <lastmod>2025-01-24T09:22:30+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-annual-report-2023</loc>
  <lastmod>2024-01-30T18:24:37+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-radioligand-therapy-rlt-manufacturing</loc>
  <lastmod>2024-02-13T08:47:54+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-society-integrierter-geschaftsbericht-2023</loc>
  <lastmod>2024-02-16T14:10:26+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/quality-control-environmental-monitoring-radioligand-therapy-rlt-manufacturing</loc>
  <lastmod>2024-03-13T08:52:33+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/specialized-equipment-manufacture-radioligand-therapy-rlt</loc>
  <lastmod>2024-03-13T08:53:34+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/refrigeration-room-novartis-radioligand-therapy-rlt-manufacturing-facility</loc>
  <lastmod>2024-03-13T08:54:18+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/radioligand-therapy-rlt-production-line</loc>
  <lastmod>2024-03-13T08:54:58+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-radioligand-therapy-rlt-manufacturing-facility</loc>
  <lastmod>2024-03-13T08:55:44+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/research-and-innovation</loc>
  <lastmod>2024-12-19T13:47:42+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-society-integrated-report-2024</loc>
  <lastmod>2025-01-30T21:35:34+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-annual-report-2024</loc>
  <lastmod>2025-01-30T23:01:36+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/novartis-society-integrierter-geschaftsbericht-2024</loc>
  <lastmod>2025-02-17T08:41:13+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/giovanni-caforio-md</loc>
  <lastmod>2025-03-07T15:26:19+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-library/elizabeth-mcnally-md-phd</loc>
  <lastmod>2025-03-07T15:26:22+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-financial-results-q2-2022</loc>
  <lastmod>2024-10-25T15:12:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-financial-results-q1-2022</loc>
  <lastmod>2024-10-25T15:13:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-financial-results-q3-2021</loc>
  <lastmod>2024-11-06T11:03:37+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-financial-results-q2-2021</loc>
  <lastmod>2024-11-06T11:01:53+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-financial-results-q1-2021</loc>
  <lastmod>2024-10-25T15:15:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-2021-financial-results</loc>
  <lastmod>2024-10-25T15:13:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-asco-and-eha-2022</loc>
  <lastmod>2024-10-25T12:00:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-ash</loc>
  <lastmod>2024-10-25T12:00:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-asco</loc>
  <lastmod>2024-10-25T12:00:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/asco-2023</loc>
  <lastmod>2024-10-25T12:00:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-financial-results-q2-2024</loc>
  <lastmod>2024-10-27T09:49:55+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-2023-financial-results</loc>
  <lastmod>2024-10-27T09:48:44+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-financial-results-q1-2024</loc>
  <lastmod>2024-10-27T09:49:23+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/jp-morgan-healthcare-conference-2024</loc>
  <lastmod>2024-10-25T15:04:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-financial-results-q2-2023</loc>
  <lastmod>2024-11-20T10:44:34+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-financial-results-q3-2023</loc>
  <lastmod>2024-10-25T15:06:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-financial-results-q1-2023</loc>
  <lastmod>2024-10-25T15:09:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-2022-financial-results</loc>
  <lastmod>2024-10-25T15:09:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-financial-results-q3-2022</loc>
  <lastmod>2024-10-25T15:11:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/world-economic-forum-2023</loc>
  <lastmod>2024-10-25T15:11:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-2020-financial-results</loc>
  <lastmod>2024-10-25T15:15:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-2016-financial-results</loc>
  <lastmod>2024-10-25T15:25:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-2017-financial-results</loc>
  <lastmod>2024-10-25T15:24:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-financial-results-q3-2020</loc>
  <lastmod>2024-10-25T15:15:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-financial-results-q1-2018</loc>
  <lastmod>2024-10-25T15:22:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-financial-results-q2-2020</loc>
  <lastmod>2024-10-25T15:18:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-financial-results-q1-2020</loc>
  <lastmod>2024-10-25T15:19:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-2019-financial-results</loc>
  <lastmod>2024-10-25T15:19:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-2018-financial-results</loc>
  <lastmod>2024-10-25T15:21:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-financial-results-q1-2019</loc>
  <lastmod>2024-10-25T15:20:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-financial-results-q2-2019</loc>
  <lastmod>2024-10-25T15:20:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-financial-results-q3-2019</loc>
  <lastmod>2024-10-25T15:19:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-financial-results-q3-2024</loc>
  <lastmod>2024-10-29T05:58:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/world-economic-forum-annual-meeting-2025</loc>
  <lastmod>2025-01-23T11:49:14+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/jp-morgan-healthcare-conference-2025</loc>
  <lastmod>2025-01-15T11:38:29+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/annual-general-meeting</loc>
  <lastmod>2025-02-04T08:42:56+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-2024-financial-results</loc>
  <lastmod>2025-01-31T13:48:52+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/eurovision-song-contest-2025</loc>
  <lastmod>2025-02-03T17:04:39+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-financial-results-q1-2025</loc>
  <lastmod>2025-01-31T09:17:24+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-financial-results-q2-2025</loc>
  <lastmod>2025-01-31T09:17:28+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events/novartis-financial-results-q3-2025</loc>
  <lastmod>2025-01-31T09:17:32+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/pandemic-has-been-reset-pharmas-reputation</loc>
  <lastmod>2021-09-10T11:48:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/moving-towards-next-normal</loc>
  <lastmod>2021-09-21T06:27:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/enabling-stable-supply-medicines-during-covid-19</loc>
  <lastmod>2021-09-21T06:31:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/overcoming-manufacturing-challenges</loc>
  <lastmod>2021-09-21T06:32:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/proactive-scenario-planning-and-supply-risk-management</loc>
  <lastmod>2021-09-21T06:34:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/supply-chain-organization-during-covid-19-pandemic</loc>
  <lastmod>2021-09-21T06:41:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/coronavirus-giving-health-and-pharma-companies-chance-woo-tech-talent</loc>
  <lastmod>2021-09-21T06:45:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/pharmas-pandemic-response-could-help-attract-tech-talent</loc>
  <lastmod>2021-09-21T06:46:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/new-era-healthcare-innovation</loc>
  <lastmod>2021-09-21T07:06:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/developing-drugs-during-pandemic</loc>
  <lastmod>2021-09-21T07:18:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/breaking-through-glass-ceiling-spring-women-artificial-intelligence</loc>
  <lastmod>2021-09-21T07:22:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/curious-advantage-curiosity-ceo-and-chief-people-and-organization-officer-perspective</loc>
  <lastmod>2021-09-21T08:04:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-pharmaceuticals-head-chief-marie-france-tschudin-rethinking-drug-launch-formula</loc>
  <lastmod>2021-09-21T08:06:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-ceo-vasant-narasimhan-building-trust-society</loc>
  <lastmod>2021-09-21T08:13:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/how-be-boss-unbossed-company</loc>
  <lastmod>2021-09-21T08:19:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/medicines-and-transformative-effect</loc>
  <lastmod>2021-09-21T08:21:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/its-time-pivot-towards-transformational-innovation</loc>
  <lastmod>2021-09-21T08:24:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-flipping-pyramid-explains-steven-baert</loc>
  <lastmod>2021-09-21T08:35:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/fortunes-most-admired-pharmaceutical-companies-2019</loc>
  <lastmod>2021-09-21T08:38:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/science-and-business-innovative-medicines</loc>
  <lastmod>2021-09-21T08:40:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/how-long-till-final-world-malaria-day</loc>
  <lastmod>2021-09-21T08:49:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-access-and-government-cameroon-sign-agreement-fight-chronic-diseases</loc>
  <lastmod>2021-09-21T08:51:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/changing-world</loc>
  <lastmod>2021-09-21T08:53:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/increasing-access-ncd-treatments-uganda</loc>
  <lastmod>2021-09-21T08:54:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-access-and-government-pakistan-sign-memorandum-understanding</loc>
  <lastmod>2021-09-21T08:56:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-access-perspective-key-fighting-chronic-disease-south-east-asia-young-people</loc>
  <lastmod>2021-09-21T09:20:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-access-perspective-how-smart-partnerships-can-help-us-fight-chronic-disease-africa</loc>
  <lastmod>2021-09-21T09:22:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/what-really-driving-malaria-control-personal-accountability-and-passion-community-health-workers</loc>
  <lastmod>2021-09-21T09:29:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/juncture-malaria-eradication</loc>
  <lastmod>2021-09-21T09:37:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/world-malaria-report-2016-keeping-momentum</loc>
  <lastmod>2021-09-21T09:39:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-access-perspectives-pharma-partners-african-countries-chronic-diseases</loc>
  <lastmod>2021-09-21T09:56:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/confronting-next-global-health-challenge</loc>
  <lastmod>2021-09-21T11:30:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/new-strategies-improving-access-lower-income-countries</loc>
  <lastmod>2021-09-21T11:32:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/tackling-chronic-disease-novartis-access</loc>
  <lastmod>2021-09-21T11:33:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/price-drugs-should-reflect-value-they-deliver</loc>
  <lastmod>2021-09-21T11:44:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-access-perspectives-making-medicines-affordable-worlds-poorest-people</loc>
  <lastmod>2021-09-21T11:53:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/reigniting-passion-science</loc>
  <lastmod>2021-09-21T12:11:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-access-perspectives-how-new-business-models-can-help-fight-chronic-diseases</loc>
  <lastmod>2021-09-21T12:27:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-access-perspectives-kenyas-new-health-care-battle</loc>
  <lastmod>2021-09-21T12:34:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/perfecting-access-through-embedded-sustainability-pooling-resources-and-consolidating-expertise</loc>
  <lastmod>2021-09-21T12:41:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/expanding-access-healthcare-what-will-it-really-take</loc>
  <lastmod>2021-09-21T13:21:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/malarias-deadly-comeback</loc>
  <lastmod>2021-09-21T13:23:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-access-perspectives-expanding-access-healthcare-what-will-it-really-take</loc>
  <lastmod>2021-09-21T13:27:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-access-hosts-second-stakeholder-dialogue</loc>
  <lastmod>2021-09-21T13:29:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-access-perspectives-fighting-africas-future-epidemics</loc>
  <lastmod>2021-09-21T13:33:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/beautiful-medicine-rediscover-power-natures-exquisite-complexity</loc>
  <lastmod>2021-09-21T13:34:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/crispr-genome-editing-fuels-cancer-drug-discovery</loc>
  <lastmod>2021-09-21T13:36:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-access-perspectives-tailoring-tactics-tackle-chronic-disease-low-income-countries</loc>
  <lastmod>2021-09-29T12:08:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/joe-jimenez-how-improve-healthcare</loc>
  <lastmod>2021-09-21T13:44:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-access-one-year-report</loc>
  <lastmod>2021-09-29T10:40:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/in-the-news/novartis-ceo-outlines-how-improve-pandemic-preparedness-warns-another-one-bound-happen</loc>
  <lastmod>2021-10-04T16:58:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/terms-use</loc>
  <lastmod>2021-09-29T14:31:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/privacy</loc>
  <lastmod>2022-05-04T13:35:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/home</loc>
  <lastmod>2025-03-06T11:21:09+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/page-not-found</loc>
  <lastmod>2024-11-20T10:00:53+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers</loc>
  <lastmod>2025-02-28T15:52:21+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/news-archive</loc>
  <lastmod>2024-07-15T12:03:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/event-calendar</loc>
  <lastmod>2025-03-07T17:59:28+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data</loc>
  <lastmod>2025-02-17T12:24:43+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/shareholder-information</loc>
  <lastmod>2025-01-28T09:19:45+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/board-directors</loc>
  <lastmod>2025-03-07T15:26:16+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/executive-committee</loc>
  <lastmod>2025-03-13T18:15:12+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/contacts</loc>
  <lastmod>2024-07-22T11:13:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/about-clinical-trials</loc>
  <lastmod>2022-01-11T11:57:49+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/glossary-clinical-trial-terms</loc>
  <lastmod>2022-11-23T17:53:29+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/healthcare-professionals/medical-congresses-and-events</loc>
  <lastmod>2024-06-05T09:20:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development/research-disease-areas</loc>
  <lastmod>2025-03-04T10:31:39+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/early-careers/us-biomedical-research-internship-programs</loc>
  <lastmod>2025-02-03T15:23:27+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/awards-and-recognition</loc>
  <lastmod>2025-03-13T16:35:35+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/company-overview/corporate-governance</loc>
  <lastmod>2025-01-30T18:40:43+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/share-data-and-analysis/share-overview</loc>
  <lastmod>2025-01-23T14:35:08+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/share-data-and-analysis/share-ownership</loc>
  <lastmod>2025-01-31T06:54:24+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/share-data-and-analysis/return-investment-calculator</loc>
  <lastmod>2024-02-09T10:18:39+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/share-data-and-analysis/dividend-information</loc>
  <lastmod>2025-03-07T12:32:50+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/shareholder-information/american-depositary-receipts-adr/adr-voting-center</loc>
  <lastmod>2025-03-11T16:46:30+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/shareholder-information/share-buy-back</loc>
  <lastmod>2024-04-23T10:02:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/annual-results</loc>
  <lastmod>2025-03-04T14:26:39+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/quarterly-results</loc>
  <lastmod>2025-02-27T15:40:48+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/share-data-and-analysis/share-monitor</loc>
  <lastmod>2024-02-09T10:16:21+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/sec-filings</loc>
  <lastmod>2024-04-11T10:12:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/product-sales</loc>
  <lastmod>2025-01-31T06:20:06+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/expected-currency-impact</loc>
  <lastmod>2025-02-17T12:26:20+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/shareholder-information/american-depositary-receipts-adr</loc>
  <lastmod>2025-01-24T10:40:33+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/novartis-and-european-union-eu/eucancerplan</loc>
  <lastmod>2021-09-30T10:53:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/novartis-and-european-union-eu/novartis-eu-public-affairs-team</loc>
  <lastmod>2025-02-10T16:13:35+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/25-years-novartis-more-250-years-innovation</loc>
  <lastmod>2021-10-19T11:08:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/healthcare-professionals/investigator-initiated-trials-studies-clinical-and-investigator-initiated-research-non-clinical</loc>
  <lastmod>2024-10-01T15:52:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/environmental-sustainability/waste</loc>
  <lastmod>2025-01-30T15:24:26+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/healthcare-professionals/novartis-external-funding</loc>
  <lastmod>2025-02-20T09:22:25+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development/chemical-biology-biomedical-research</loc>
  <lastmod>2023-10-04T14:08:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/healthcare-professionals/healthcare-professional-resources-country</loc>
  <lastmod>2024-02-08T17:29:57+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/patients-and-caregivers/novartis-commitment-patients-and-caregivers</loc>
  <lastmod>2025-02-13T16:58:39+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/environmental-sustainability/climate</loc>
  <lastmod>2025-02-05T08:58:17+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/environmental-sustainability/climate/case-study-breezhaler-carbon-footprint</loc>
  <lastmod>2022-05-13T08:50:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/environmental-sustainability/water</loc>
  <lastmod>2025-02-05T11:09:32+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development/technology-platforms/cell-therapy/car-t-cell-therapy-and-beyond/car-t-healthcare-professionals/science-car-t-cell-therapy</loc>
  <lastmod>2021-10-07T18:50:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development/technology-platforms/cell-therapy/car-t-cell-therapy-and-beyond/car-t-healthcare-professionals/process-car-t-cell-therapy</loc>
  <lastmod>2021-10-07T18:50:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/malaria</loc>
  <lastmod>2024-12-12T09:29:28+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/sickle-cell-disease</loc>
  <lastmod>2024-02-08T17:59:20+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/stay-up-to-date/subscribed</loc>
  <lastmod>2021-11-03T15:55:34+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/stay-date/subscription-cancelled</loc>
  <lastmod>2021-09-15T13:46:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/chagas-disease</loc>
  <lastmod>2025-01-28T15:41:49+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/leprosy</loc>
  <lastmod>2023-01-31T09:20:50+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development/translational-medicine-research-novartis</loc>
  <lastmod>2022-07-13T18:03:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/reporting-and-transparency-hub/patient-organization-funding</loc>
  <lastmod>2024-06-25T10:46:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/reporting-and-transparency-hub/payments-healthcare-professionals</loc>
  <lastmod>2024-07-01T13:36:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/reporting-and-transparency-hub/living-wage</loc>
  <lastmod>2025-01-28T16:20:21+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/people-and-culture/we-are-inspiring-our-people</loc>
  <lastmod>2025-01-30T17:57:48+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/people-and-culture/we-are-instilling-curiosity</loc>
  <lastmod>2024-01-30T15:56:46+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/people-and-culture/we-create-unbossed-environment</loc>
  <lastmod>2024-01-30T15:59:59+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/reporting-and-transparency-hub/public-policy</loc>
  <lastmod>2025-02-27T15:47:12+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/reporting-and-transparency-hub/safe-workplace</loc>
  <lastmod>2025-01-28T16:23:28+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/reporting-and-transparency-hub/animal-research</loc>
  <lastmod>2024-07-04T15:25:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/coronavirus/patients-and-caregivers-covid-19-information</loc>
  <lastmod>2025-02-12T16:53:37+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development/research-collaborations/novartis-global-scholars-program</loc>
  <lastmod>2024-02-13T13:55:24+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/inclusion/promoting-inclusion</loc>
  <lastmod>2025-01-30T17:57:12+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/coronavirus/can-covid-clinical-trial</loc>
  <lastmod>2021-10-07T16:42:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/inclusion/promoting-inclusion/our-equal-pay-international-coalition-epic-commitments</loc>
  <lastmod>2025-01-30T17:57:37+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/inclusion/promoting-inclusion/lgbtqi-inclusion</loc>
  <lastmod>2025-01-30T17:57:26+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/inclusion/building-belonging</loc>
  <lastmod>2025-01-30T17:57:00+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/inclusion/parental-leave</loc>
  <lastmod>2025-01-30T17:57:57+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/access/novartis-access-principles</loc>
  <lastmod>2025-01-28T15:37:36+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/access/novartis-access-principles/research-development</loc>
  <lastmod>2024-06-19T12:19:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/access/novartis-access-principles/affordability</loc>
  <lastmod>2023-01-24T11:37:54+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/access/novartis-access-principles/strengthening-healthcare-systems</loc>
  <lastmod>2023-01-30T17:46:32+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/access/patents-and-licensing</loc>
  <lastmod>2025-01-28T15:39:16+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/access/donations</loc>
  <lastmod>2024-03-14T13:59:33+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/privacy/privacy-policy</loc>
  <lastmod>2022-05-04T13:45:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/partnering/partnering-opportunities</loc>
  <lastmod>2024-12-13T09:43:46+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/privacy/novartis-binding-corporate-rules-bcr</loc>
  <lastmod>2022-05-04T13:36:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/shareholder-information/frequently-asked-questions</loc>
  <lastmod>2025-03-11T16:54:29+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/privacy/general-privacy-notice-external-stakeholders</loc>
  <lastmod>2022-05-04T13:46:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/healthcare-professionals/managed-access-programs</loc>
  <lastmod>2025-02-25T09:06:20+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/shareholder-information/general-meetings</loc>
  <lastmod>2025-03-07T17:52:15+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/novartis-directory</loc>
  <lastmod>2023-10-04T10:13:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/partnering/our-approach-partnering</loc>
  <lastmod>2024-12-13T11:16:48+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/partnering/partnering-leadership-team</loc>
  <lastmod>2024-12-05T14:54:55+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/access/creating-sustainable-business-models</loc>
  <lastmod>2023-01-31T08:58:42+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/access/creating-sustainable-business-models/novartis-access</loc>
  <lastmod>2025-01-28T15:35:50+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/access/creating-sustainable-business-models/healthy-family-programs</loc>
  <lastmod>2023-01-27T09:48:44+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/fixed-income-securities</loc>
  <lastmod>2025-02-14T18:44:31+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/clinical-trials-faqs</loc>
  <lastmod>2024-07-22T11:07:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/patients-and-caregivers</loc>
  <lastmod>2022-01-11T12:01:01+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/novartis-gene-therapies/what-cell-and-gene-therapy</loc>
  <lastmod>2023-10-04T06:38:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/novartis-gene-therapies/cell-and-gene-therapy-explained-vox-creative</loc>
  <lastmod>2023-10-04T06:35:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development/technology-platforms/cell-therapy/car-t-cell-therapy-and-beyond/car-t-healthcare-professionals</loc>
  <lastmod>2021-10-07T18:50:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/transparency</loc>
  <lastmod>2024-02-12T16:33:36+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/ethics-clinical-trials</loc>
  <lastmod>2025-02-25T09:06:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/fixed-income-securities/disclaimer</loc>
  <lastmod>2021-09-28T10:59:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/access/novartis-oncology-access</loc>
  <lastmod>2024-02-08T17:54:48+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/reporting-and-transparency-hub/reporting-archive</loc>
  <lastmod>2024-02-09T10:23:13+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/reporting-and-transparency-hub/targets</loc>
  <lastmod>2025-02-18T07:05:04+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development/research-disease-areas/global-health-disease-area-research-novartis</loc>
  <lastmod>2024-07-18T08:21:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development/collaborations</loc>
  <lastmod>2023-11-24T15:00:25+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/contacts/media-contacts</loc>
  <lastmod>2025-01-01T11:54:43+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/contacts/investor-contacts</loc>
  <lastmod>2025-02-11T09:38:26+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/early-careers/community-exploration-and-learning-lab-cell</loc>
  <lastmod>2024-02-08T18:13:30+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/ethics-risk-and-compliance/ethical-behavior/code-ethics</loc>
  <lastmod>2024-07-02T09:27:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/ethics-risk-and-compliance/ethical-behavior/speakup</loc>
  <lastmod>2024-01-12T09:56:31+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/ethics-risk-and-compliance/ethical-behavior</loc>
  <lastmod>2024-06-12T14:15:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/ethics-risk-and-compliance/compliance</loc>
  <lastmod>2024-11-01T10:04:04+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/ethics-risk-and-compliance/compliance/anti-bribery-report</loc>
  <lastmod>2024-01-30T15:46:33+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/ethics-risk-and-compliance/compliance/doing-business-ethically</loc>
  <lastmod>2023-10-31T15:48:09+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/ethics-risk-and-compliance/integrated-risk-assurance</loc>
  <lastmod>2024-11-05T11:01:43+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/bing-wang-phd</loc>
  <lastmod>2021-10-20T02:14:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-research-themes/immunology-postdoc-mentors/daniela-cipolletta-phd</loc>
  <lastmod>2021-10-11T10:53:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-research-themes/immunology-postdoc-mentors/frederic-bornancin-phd</loc>
  <lastmod>2021-10-11T10:57:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-research-themes/cancer-biology-postdoc-mentors/carlotta-costa-phd</loc>
  <lastmod>2021-10-01T08:34:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-research-themes/cancer-biology-postdoc-mentors/david-kodack-phd</loc>
  <lastmod>2021-10-01T12:13:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-research-themes/cancer-biology-postdoc-mentors/giorgio-g-galli-phd</loc>
  <lastmod>2021-10-01T13:36:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-research-themes/cancer-biology-postdoc-mentors/tobias-schmelzle-phd</loc>
  <lastmod>2021-10-01T14:38:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-research-themes/cancer-biology-postdoc-mentors/xiaomo-jiang-phd</loc>
  <lastmod>2021-10-01T14:48:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-research-themes/cancer-biology-postdoc-mentors/tony-dalessio-phd</loc>
  <lastmod>2021-10-01T14:44:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-research-themes/immunology-postdoc-mentors/martin-alexander-schneider-phd</loc>
  <lastmod>2021-10-11T11:14:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/people-and-culture/giving-matching-volunteering</loc>
  <lastmod>2024-12-03T13:03:10+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/novartis-gene-therapies/about-novartis-gene-therapies</loc>
  <lastmod>2023-10-04T06:35:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/novartis-gene-therapies/gene-therapy-manufacturing</loc>
  <lastmod>2023-10-04T06:37:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/novartis-gene-therapies/resources-rare-disorders-patient-community</loc>
  <lastmod>2023-10-04T06:38:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/ethics-risk-and-compliance/human-rights</loc>
  <lastmod>2025-01-29T10:49:26+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/ethics-risk-and-compliance/learning-and-engagement</loc>
  <lastmod>2024-02-08T17:57:42+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/heart-failure</loc>
  <lastmod>2021-10-11T11:04:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/acute-myeloid-leukemia-aml</loc>
  <lastmod>2021-10-11T13:00:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/chronic-myeloid-leukemia</loc>
  <lastmod>2024-07-02T08:33:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/multiple-myeloma</loc>
  <lastmod>2023-07-03T14:38:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/advanced-melanoma</loc>
  <lastmod>2021-10-05T15:16:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/access/value-based-pricing</loc>
  <lastmod>2024-02-08T17:54:05+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/reporting-and-transparency-hub/esg-rating-performance</loc>
  <lastmod>2025-03-13T11:00:15+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/ethics-risk-and-compliance/risk-management/external-partner-risk-management-eprm</loc>
  <lastmod>2024-01-09T10:10:52+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development/research-disease-areas/oncology-research-novartis</loc>
  <lastmod>2024-07-18T08:21:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development/research-disease-areas/cardiovascular-and-metabolic-disease-research-novartis</loc>
  <lastmod>2024-07-18T08:18:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development/research-disease-areas/immunology-disease-research-novartis</loc>
  <lastmod>2024-07-18T08:21:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/ethics-risk-and-compliance/integrated-risk-assurance/enterprise-risk-management</loc>
  <lastmod>2024-11-05T11:18:35+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/quality/audit-program</loc>
  <lastmod>2025-01-30T16:56:13+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/quality/novartis-quality-management-system-qms</loc>
  <lastmod>2024-10-09T16:56:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/quality/product-and-patient-safety-training</loc>
  <lastmod>2022-02-01T12:25:39+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/quality/regulatory-inspections</loc>
  <lastmod>2025-02-05T09:46:34+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/quality/product-recalls</loc>
  <lastmod>2025-01-31T06:07:44+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/quality/third-party-suppliers</loc>
  <lastmod>2024-07-16T16:23:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/healthcare-professionals/managed-access-programs/zolgensma-global-managed-access-program-gmap</loc>
  <lastmod>2024-08-19T09:10:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development/collaborations/academic-partnerships-and-external-innovation</loc>
  <lastmod>2023-11-30T12:16:32+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/novartis-gene-therapies/novartis-gene-therapies-request-funding</loc>
  <lastmod>2023-10-04T06:37:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development/research-disease-areas/neuroscience-research-novartis</loc>
  <lastmod>2024-07-18T08:21:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/spinal-muscular-atrophy-sma</loc>
  <lastmod>2023-08-14T09:18:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/healthcare-professionals/medical-congresses-and-events/abstract-summaries-eular</loc>
  <lastmod>2022-03-10T14:21:41+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-program-leadership/darrin-stuart-phd</loc>
  <lastmod>2021-10-06T22:36:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development/technology-platforms/cell-therapy/car-t-cell-therapy-and-beyond/car-t-cell-therapy-pioneering-cancer-therapy</loc>
  <lastmod>2022-03-11T09:21:14+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development/technology-platforms/cell-therapy/car-t-cell-therapy-and-beyond/car-t-healthcare-professionals/treatment-landscape-haematologic-malignancies</loc>
  <lastmod>2021-10-11T10:46:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/ethics-risk-and-compliance/compliance/our-commitment-ethical-and-responsible-use-artificial-intelligence-ai</loc>
  <lastmod>2024-11-01T14:58:50+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/healthcare-professionals/medical-congresses-and-events/abstract-summaries-acr</loc>
  <lastmod>2021-10-07T07:54:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/spinal-muscular-atrophy-sma/newborn-screening-spinal-muscular-atrophy-sma</loc>
  <lastmod>2023-07-06T11:08:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development/collaborations/biomedical-research-business-development-licensing</loc>
  <lastmod>2023-10-04T14:12:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development/research-disease-areas/dax-exploratory-disease-research-novartis</loc>
  <lastmod>2025-01-07T14:52:33+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development/technology-platforms/cell-therapy/car-t-cell-therapy-and-beyond/car-t-healthcare-professionals/pioneers-car-t-cell-and-gene-therapy</loc>
  <lastmod>2023-11-06T08:34:50+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development/open-source-science</loc>
  <lastmod>2023-10-13T16:27:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/cara-brocklehurst-phd</loc>
  <lastmod>2021-10-29T01:55:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/folkert-reck-phd</loc>
  <lastmod>2021-10-29T02:13:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/frederic-berst-phd</loc>
  <lastmod>2021-10-29T02:15:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/jay-larrow-phd</loc>
  <lastmod>2021-10-29T21:09:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-research-themes/chemistry-postdoc-mentors/tejas-pathak-phd</loc>
  <lastmod>2021-10-29T21:26:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-research-themes/computational-sciences-postdoc-mentors/florian-nigsch-phd</loc>
  <lastmod>2021-10-28T23:25:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-research-themes/computational-sciences-postdoc-mentors/hanneke-jansen-phd</loc>
  <lastmod>2021-10-28T23:48:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-research-themes/computational-sciences-postdoc-mentors/nicole-renaud-phd</loc>
  <lastmod>2021-10-20T04:08:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-research-themes/musculoskeletal-postdoc-mentors/mara-fornaro-phd</loc>
  <lastmod>2021-10-28T14:42:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-research-themes/musculoskeletal-postdoc-mentors/olivier-leupin-phd</loc>
  <lastmod>2021-10-28T14:43:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-research-themes/musculoskeletal-postdoc-mentors/valerie-salazar-phd</loc>
  <lastmod>2021-10-28T14:44:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-research-themes/pathways-biology-postdoc-mentors/david-rowlands-phd</loc>
  <lastmod>2021-10-20T03:46:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-research-themes/pathways-biology-postdoc-mentors/feng-cong-phd</loc>
  <lastmod>2021-10-20T03:56:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-research-themes/pathways-biology-postdoc-mentors/john-koschwanez-phd</loc>
  <lastmod>2021-10-20T04:04:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-research-themes/pathways-biology-postdoc-mentors/robert-esterberg-phd</loc>
  <lastmod>2021-10-20T04:18:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/early-careers</loc>
  <lastmod>2025-03-06T09:13:11+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/access/sub-saharan-africa</loc>
  <lastmod>2023-01-27T09:22:57+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/notice-all-applicants-us-job-openings</loc>
  <lastmod>2025-02-14T10:44:56+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/open-source</loc>
  <lastmod>2024-11-25T14:31:15+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/art-collection</loc>
  <lastmod>2023-09-05T14:45:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/prostate-cancer</loc>
  <lastmod>2023-07-03T14:54:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/multiplesclerosis</loc>
  <lastmod>2024-12-11T16:49:18+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/multiplesclerosis/types-ms-and-ms-progression</loc>
  <lastmod>2021-12-16T08:30:07+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/multiplesclerosis/ms-tools</loc>
  <lastmod>2024-12-11T16:49:10+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/multiplesclerosis/ms-treatment-options</loc>
  <lastmod>2021-12-16T08:33:26+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/migraine</loc>
  <lastmod>2021-12-16T08:24:30+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/migraine/types-migraine</loc>
  <lastmod>2021-12-16T10:58:41+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/migraine/migraine-treatment-options</loc>
  <lastmod>2021-12-16T08:18:35+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/migraine/migraine-tools</loc>
  <lastmod>2023-06-29T16:09:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-research-themes/pathways-biology-postdoc-mentors/joanne-wong-phd</loc>
  <lastmod>2022-02-23T17:06:45+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-programs/postdoc-program/postdoc-research-themes/cancer-biology-postdoc-mentors/anke-bill-phd</loc>
  <lastmod>2022-03-01T23:54:41+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/rare-kidney-diseases</loc>
  <lastmod>2024-05-02T10:38:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/rare-kidney-diseases/complement-mediated-kidney-diseases-and-their-impact</loc>
  <lastmod>2022-03-09T07:17:19+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/healthcare-professionals/novartis-medical-information</loc>
  <lastmod>2024-02-08T17:31:51+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/dry-eye-disease</loc>
  <lastmod>2022-03-28T14:59:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/privacy/privacy-notice-pharmacovigilance</loc>
  <lastmod>2022-05-04T13:46:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/global-health/avoidable-blindness</loc>
  <lastmod>2024-02-08T17:58:34+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/quarterly-results/2022-q1-transcript</loc>
  <lastmod>2024-07-24T12:11:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/privacy/general-privacy-notice-business-partners</loc>
  <lastmod>2022-05-04T13:46:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/privacy/general-privacy-notice-third-parties</loc>
  <lastmod>2022-05-04T13:46:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/elevated-lipoproteina</loc>
  <lastmod>2022-05-24T11:49:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/global-health/pandemic-preparedness</loc>
  <lastmod>2024-02-08T17:58:12+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/index/access-medicines</loc>
  <lastmod>2025-01-30T20:22:13+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/index/governance</loc>
  <lastmod>2025-01-31T11:58:29+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/index/environmental-sustainability</loc>
  <lastmod>2025-01-30T20:25:30+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/index/ethical-business-practices</loc>
  <lastmod>2025-01-30T20:27:24+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/index/human-capital</loc>
  <lastmod>2025-02-05T09:33:54+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/index/innovation</loc>
  <lastmod>2025-01-30T20:40:10+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/index/quality</loc>
  <lastmod>2025-01-30T20:20:06+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/index/supply-chain-sourcing</loc>
  <lastmod>2025-01-30T20:29:32+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/privacy/scc-c2p</loc>
  <lastmod>2022-05-24T12:08:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/privacy/scc-c2c</loc>
  <lastmod>2022-05-24T12:08:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/index/other</loc>
  <lastmod>2025-01-31T12:12:17+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/index</loc>
  <lastmod>2025-01-30T15:28:33+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development/research-collaborations</loc>
  <lastmod>2024-12-03T09:45:40+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/quarterly-results/2022-q2-transcript</loc>
  <lastmod>2024-07-24T12:09:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/sourcing-and-procurement</loc>
  <lastmod>2023-01-17T11:19:14+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/supplier-onboarding</loc>
  <lastmod>2024-06-04T14:35:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/invoicing-novartis</loc>
  <lastmod>2024-06-27T10:09:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/simple-invoice-checking</loc>
  <lastmod>2023-10-04T13:55:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/documentation</loc>
  <lastmod>2024-09-05T10:38:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/tr/sourcing-and-procurement</loc>
  <lastmod>2023-01-16T14:20:20+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/tr/supplier-onboarding</loc>
  <lastmod>2024-06-06T14:01:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/tr/invoicing-novartis</loc>
  <lastmod>2022-09-16T15:08:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/fr/sourcing-and-procurement</loc>
  <lastmod>2023-01-16T14:12:59+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/fr/supplier-onboarding</loc>
  <lastmod>2024-06-06T13:59:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/lung-cancer</loc>
  <lastmod>2023-06-12T09:16:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/es/sourcing-and-procurement</loc>
  <lastmod>2023-01-16T14:15:34+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/es/supplier-onboarding</loc>
  <lastmod>2024-06-06T13:57:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/es/invoicing-novartis</loc>
  <lastmod>2022-12-16T16:42:21+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/fr/simple-invoice-checking</loc>
  <lastmod>2023-10-04T13:56:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/es/simple-invoice-checking</loc>
  <lastmod>2023-10-04T13:57:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/tr/simple-invoice-checking</loc>
  <lastmod>2023-10-04T13:57:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/lung-cancer/sound-up</loc>
  <lastmod>2023-06-29T16:05:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/fr/invoicing-novartis</loc>
  <lastmod>2022-12-16T16:43:35+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/sandoz-spinoff</loc>
  <lastmod>2023-10-04T07:10:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/privacy/general-privacy-notice-clinical-trial-site-personnel</loc>
  <lastmod>2022-09-01T09:51:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/quarterly-results/2022-q3-transcript</loc>
  <lastmod>2024-07-24T12:12:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/therapeutic-areas/oncology/hematology</loc>
  <lastmod>2023-11-14T09:39:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/breast-cancer</loc>
  <lastmod>2022-12-06T15:09:15+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/de/sourcing-and-procurement</loc>
  <lastmod>2023-03-24T22:22:41+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/de/supplier-onboarding</loc>
  <lastmod>2024-06-06T13:56:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/de/invoicing-novartis</loc>
  <lastmod>2023-03-24T22:22:53+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/cn/sourcing-and-procurement</loc>
  <lastmod>2023-03-24T22:24:29+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/cn/supplier-onboarding</loc>
  <lastmod>2024-06-06T14:02:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/cn/invoicing-novartis</loc>
  <lastmod>2023-03-24T22:24:37+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/jp/sourcing-and-procurement</loc>
  <lastmod>2023-04-11T16:15:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/it/sourcing-and-procurement</loc>
  <lastmod>2023-03-24T22:23:18+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/jp/supplier-onboarding</loc>
  <lastmod>2024-06-06T14:03:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/jp/invoicing-novartis</loc>
  <lastmod>2023-03-24T22:25:10+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/it/supplier-onboarding</loc>
  <lastmod>2024-06-06T14:00:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/it/invoicing-novartis</loc>
  <lastmod>2023-03-24T22:23:31+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/pt/sourcing-and-procurement</loc>
  <lastmod>2023-03-24T22:23:54+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/pt/supplier-onboarding</loc>
  <lastmod>2024-06-06T14:01:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/pt/invoicing-novartis</loc>
  <lastmod>2023-03-24T22:24:09+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/cn/simple-invoice-checking</loc>
  <lastmod>2023-10-04T13:58:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/de/simple-invoice-checking</loc>
  <lastmod>2023-10-04T13:59:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/it/simple-invoice-checking</loc>
  <lastmod>2023-10-04T13:59:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/jp/simple-invoice-checking</loc>
  <lastmod>2023-10-04T13:59:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/pt/simple-invoice-checking</loc>
  <lastmod>2023-10-04T14:00:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/ru/sourcing-and-procurement</loc>
  <lastmod>2023-03-24T22:25:31+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/ru/supplier-onboarding</loc>
  <lastmod>2024-06-06T13:55:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/ru/invoicing-novartis</loc>
  <lastmod>2023-03-24T22:25:39+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal/ru/simple-invoice-checking</loc>
  <lastmod>2023-03-24T22:25:43+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-economic-forum-2023/health-systems-building-through-disruption</loc>
  <lastmod>2023-01-18T17:37:17+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/quarterly-results/2022-q4-and-full-year-results-transcript</loc>
  <lastmod>2024-07-24T12:13:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/neuroendocrine-tumors-nets</loc>
  <lastmod>2023-02-28T11:19:27+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/our-business-functions/careers-operations</loc>
  <lastmod>2024-12-13T11:13:47+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/our-business-functions/careers-global-functions</loc>
  <lastmod>2024-12-13T11:14:01+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/benefits-rewards</loc>
  <lastmod>2024-12-13T08:26:22+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/our-business-functions/careers-research-and-development</loc>
  <lastmod>2024-12-13T11:14:16+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/quarterly-results/2023-q1-transcript</loc>
  <lastmod>2024-07-24T12:10:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/partnering/partnering-event-calendar</loc>
  <lastmod>2024-12-05T14:55:19+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/healthcare-professionals/medical-congresses-and-events/asco-annual-meeting/asco-2023</loc>
  <lastmod>2024-10-29T05:32:38+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/therapeutic-areas/neuroscience</loc>
  <lastmod>2024-12-13T11:07:21+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/therapeutic-areas/immunology</loc>
  <lastmod>2025-01-14T11:38:43+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/chronic-myeloid-leukemia/innovation-cml-novartis</loc>
  <lastmod>2024-12-13T08:26:49+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/quarterly-results/2023-q2-transcript</loc>
  <lastmod>2024-07-24T12:19:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/early-careers/students</loc>
  <lastmod>2025-02-27T08:51:10+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/early-careers/graduates</loc>
  <lastmod>2025-02-27T08:49:59+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/paroxysmal-nocturnal-hemoglobinuria-pnh</loc>
  <lastmod>2023-11-27T16:47:53+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/people-and-culture/giving-volunteering/non-profit-partnering-positive-sustainable-social-change</loc>
  <lastmod>2024-03-19T14:28:38+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development/technology-platforms/radioligand-therapy/radioligand-therapy-delivering-now-building-future</loc>
  <lastmod>2024-01-08T09:21:29+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/therapeutic-areas/cardiovascular-renal-and-metabolic</loc>
  <lastmod>2025-01-14T11:38:16+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/therapeutic-areas/oncology</loc>
  <lastmod>2025-01-14T11:39:04+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/transparency/leadership</loc>
  <lastmod>2025-02-06T16:28:58+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/morphosys-acquisition</loc>
  <lastmod>2024-06-20T08:57:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/privacy/scc-p2c</loc>
  <lastmod>2024-02-07T09:28:18+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/privacy/scc-p2p</loc>
  <lastmod>2024-02-07T09:28:31+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/quarterly-results/2023-q4-and-full-year-results-transcript</loc>
  <lastmod>2024-07-24T12:18:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing/contract-manufacturing/derisk-your-mrna-program-ebook</loc>
  <lastmod>2024-12-13T08:27:42+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/events</loc>
  <lastmod>2025-03-06T11:21:52+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/iga-nephropathy</loc>
  <lastmod>2024-04-09T16:42:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/quarterly-results/2024-q1-transcript</loc>
  <lastmod>2024-05-07T11:34:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/c3-glomerulopathy</loc>
  <lastmod>2024-10-28T09:31:07+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/report</loc>
  <lastmod>2024-05-28T15:12:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/healthcare-professionals/medical-congresses-and-events/asco-annual-meeting/asco-2024</loc>
  <lastmod>2024-06-04T20:42:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/partnering/biome</loc>
  <lastmod>2024-12-13T08:32:35+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/morphosys-acquisition/voluntary-public-takeover-offer</loc>
  <lastmod>2024-08-14T17:10:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/morphosys-acquisition/delisting-purchase-offer</loc>
  <lastmod>2024-08-14T17:08:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/quarterly-results/2024-q2-transcript</loc>
  <lastmod>2024-07-24T11:39:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/quarterly-results/2024-q3-transcript</loc>
  <lastmod>2024-12-23T13:42:05+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/early-careers/early-career-professionals</loc>
  <lastmod>2025-02-27T08:49:23+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/eurovision</loc>
  <lastmod>2025-03-06T10:55:24+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/financial-data/quarterly-results/2024-q4-and-full-year-results-transcript</loc>
  <lastmod>2025-02-27T15:38:24+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/corporate-social-media-community-management-guidelines</loc>
  <lastmod>2025-03-04T11:16:52+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors</loc>
  <lastmod>2025-03-07T18:00:38+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/share-data-and-analysis</loc>
  <lastmod>2025-01-23T14:37:57+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about</loc>
  <lastmod>2025-01-31T07:22:11+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/patients-and-caregivers</loc>
  <lastmod>2025-02-13T16:57:09+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials</loc>
  <lastmod>2024-12-13T11:09:21+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/healthcare-professionals</loc>
  <lastmod>2024-12-13T11:32:22+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development</loc>
  <lastmod>2024-12-13T11:32:07+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development/technology-platforms</loc>
  <lastmod>2024-12-12T15:58:35+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases/coronavirus</loc>
  <lastmod>2024-12-13T08:28:21+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg</loc>
  <lastmod>2025-02-27T16:36:50+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news</loc>
  <lastmod>2025-02-05T09:56:10+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/company-overview</loc>
  <lastmod>2025-01-28T10:21:57+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/environmental-sustainability</loc>
  <lastmod>2025-01-30T21:39:28+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/novartis-and-european-union</loc>
  <lastmod>2025-02-10T09:54:39+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/global-health</loc>
  <lastmod>2025-01-30T20:57:55+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/partnering</loc>
  <lastmod>2024-12-13T11:11:00+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/access</loc>
  <lastmod>2025-01-28T15:33:42+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/inclusion</loc>
  <lastmod>2025-01-31T07:06:34+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/people-and-culture</loc>
  <lastmod>2025-01-30T17:55:56+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/novartis-gene-therapies</loc>
  <lastmod>2024-12-13T08:33:48+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development/technology-platforms/cell-therapy/car-t-cell-therapy-and-beyond</loc>
  <lastmod>2024-12-13T08:29:12+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/quality</loc>
  <lastmod>2024-02-02T11:51:13+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/esg/ethics-risk-and-compliance</loc>
  <lastmod>2025-01-30T20:51:49+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/diseases</loc>
  <lastmod>2024-12-13T09:23:42+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development/technology-platforms/radioligand-therapy</loc>
  <lastmod>2024-12-13T11:11:38+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development/technology-platforms/gene-therapy</loc>
  <lastmod>2024-12-13T10:58:57+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/supplier-portal</loc>
  <lastmod>2024-06-25T15:55:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development/technology-platforms/cell-therapy</loc>
  <lastmod>2024-12-13T08:33:12+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing/contract-manufacturing</loc>
  <lastmod>2025-03-03T09:03:33+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/microbial-manufacturing</loc>
  <lastmod>2023-10-31T11:36:39+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/quality-regulatory</loc>
  <lastmod>2023-10-31T11:42:52+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/manufacturing</loc>
  <lastmod>2024-12-13T11:16:32+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/healthcare-professionals-researchers</loc>
  <lastmod>2024-12-13T10:58:31+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/patients</loc>
  <lastmod>2024-12-13T10:58:14+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/novartis-trials</loc>
  <lastmod>2024-12-13T10:57:48+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/clinicaltrials/NCT05089656</loc>
  <lastmod>2022-09-22T15:02:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/therapeutic-areas</loc>
  <lastmod>2024-12-13T11:11:58+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/healthcare-professionals/medical-congresses-and-events/asco-annual-meeting</loc>
  <lastmod>2024-12-13T08:23:34+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/why-novartis</loc>
  <lastmod>2024-12-13T11:12:21+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/our-business-functions/careers-commercial-and-sales</loc>
  <lastmod>2024-10-28T15:36:34+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/our-business-functions</loc>
  <lastmod>2024-12-13T11:12:43+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-hub</loc>
  <lastmod>2024-12-13T11:13:09+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/about/therapeutic-areas/oncology/my-cancer-my-words</loc>
  <lastmod>2024-10-28T09:28:47+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/investors/reporting-and-transparency-hub</loc>
  <lastmod>2025-02-18T07:02:07+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/research-and-development/technology-platforms/radioligand-therapy/supporting-healthcare-system-readiness-rlt</loc>
  <lastmod>2024-09-12T13:50:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-afinitor-significantly-improves-progression-free-survival-advanced-nonfunctional-gastrointestinal-and-lung-net</loc>
  <lastmod>2021-10-05T11:51:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-new-heart-failure-medicine-entrestotm-recommended-chmp-eu-approval</loc>
  <lastmod>2021-10-05T11:51:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-appoints-james-e-bradner-md-president-novartis-institutes-biomedical-research-mark-fishman-retires</loc>
  <lastmod>2022-04-08T11:39:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-nomme-le-dr-james-e-bradner-president-des-instituts-novartis-pour-la-recherche-biomedicale-suite-au-prochain-depart-la-retraite-de-mark-fishman</loc>
  <lastmod>2021-10-05T11:51:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-ernennt-dr-james-e-bradner-zum-prasidenten-der-novartis-institutes-biomedical-research-da-mark-fishman-den-ruhestand-tritt</loc>
  <lastmod>2021-10-05T11:51:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-launches-novartis-access-portfolio-affordable-medicines-treat-chronic-diseases-lower-income-countries</loc>
  <lastmod>2021-10-05T11:51:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-lance-novartis-access-une-gamme-de-medicaments-prix-abordables-pour-lutter-contre-les-maladies-chroniques-dans-les-pays-faible-revenu</loc>
  <lastmod>2021-10-05T11:51:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-lanciert-novartis-access-ein-portfolio-von-erschwinglichen-medikamenten-zur-behandlung-von-chronischen-erkrankungen-landern-mit-niedrigen-einkommen</loc>
  <lastmod>2021-10-05T11:51:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/swissmedic-approves-novartis-new-heart-failure-medicine-entrestotm</loc>
  <lastmod>2021-10-05T11:51:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-foundation-healthcare-models-and-disease-elimination-programs-showcased-ectmih</loc>
  <lastmod>2021-10-05T11:51:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-eu-approval-farydak-first-its-class-anticancer-agents-approved-patients-multiple-myeloma</loc>
  <lastmod>2021-10-05T11:51:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-launches-zarxiotm-filgrastim-sndz-first-biosimilar-united-states</loc>
  <lastmod>2021-10-05T11:51:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-eu-approval-new-revolade-use-first-class-therapy-patients-severe-aplastic-anemia</loc>
  <lastmod>2021-10-05T11:51:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-global-partnership-amgen-develop-and-commercialize-pioneering-neuroscience-treatments</loc>
  <lastmod>2021-10-05T11:51:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-setzt-sich-weiter-fur-die-endgultige-ausrottung-von-lepra-ein</loc>
  <lastmod>2021-10-05T11:51:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-renouvelle-son-engagement-lapproche-de-la-derniere-ligne-droite-dans-la-lutte-visant-eradiquer-la-lepre</loc>
  <lastmod>2021-10-05T11:51:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-eu-approval-tafinlar-and-mekinist-first-combination-approved-patients-aggressive-form-melanoma</loc>
  <lastmod>2021-10-05T11:51:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-continues-commitment-go-last-mile-effort-eliminate-leprosy</loc>
  <lastmod>2021-10-05T11:51:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/das-novartis-international-biocamp-zeigt-wie-zusammenarbeit-und-vielfalt-innovationen-fordern-und-inspiriert-kunftige-wissenschaftliche-fuhrungskrafte</loc>
  <lastmod>2021-10-05T11:51:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/le-novartis-international-biocamp-souligne-le-role-de-la-collaboration-et-de-la-diversite-pour-stimuler-linnovation-et-inspirer-les-futurs-leaders-scientifiques</loc>
  <lastmod>2021-10-05T11:51:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-international-biocamp-highlights-how-collaboration-and-diversity-drive-innovation-and-inspires-future-science-leaders</loc>
  <lastmod>2021-10-05T11:51:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-expands-use-novartis-drug-promacta-include-treatment-children-ages-1-and-older-chronic-immune-thrombocytopenia</loc>
  <lastmod>2021-10-05T11:51:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-acquires-all-remaining-rights-gsks-ofatumumab-develop-treatments-ms-and-other-autoimmune-indications</loc>
  <lastmod>2021-10-05T11:51:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-odomzo-gains-eu-approval-locally-advanced-basal-cell-carcinoma-providing-new-non-invasive-therapy-patients</loc>
  <lastmod>2021-10-05T11:51:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-completes-divestiture-influenza-vaccines-business-csl-limited-usd-275-million</loc>
  <lastmod>2021-10-05T11:51:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-partners-phase-4-partners-and-institutional-investors-help-create-mereo-biopharma-group-ltd</loc>
  <lastmod>2021-10-05T11:51:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-foundation-confirms-new-members-its-board-trustees-including-new-chairman-dr-joerg-reinhardt</loc>
  <lastmod>2021-10-05T11:51:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-approves-novartis-drug-odomzo-sonidegib-locally-advanced-basal-cell-carcinoma-labcc-form-skin-cancer</loc>
  <lastmod>2021-10-05T11:51:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-combination-therapy-tafinlar-and-mekinist-achieves-important-eu-and-us-regulatory-milestones</loc>
  <lastmod>2021-10-05T11:51:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-revolade-recommended-chmp-eu-approval-treat-patients-severe-aplastic-anemia-serious-blood-disorder</loc>
  <lastmod>2021-10-05T11:51:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-solid-performance-second-quarter-strong-innovation-and-progress-new-launches</loc>
  <lastmod>2021-10-05T11:51:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-solide-performance-au-deuxieme-trimestre-grace-la-force-de-linnovation-et-aux-progres-des-nouveaux-lancements</loc>
  <lastmod>2021-10-05T11:51:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-im-zweiten-quartal-eine-solide-performance-mit-starken-innovationen-und-fortschritten-bei-neueinfuhrungen</loc>
  <lastmod>2021-10-05T11:51:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-malaria-treatment-coartem-80480mg-receives-who-prequalification-enabling-greater-access-patients</loc>
  <lastmod>2021-10-05T11:51:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-new-heart-failure-medicine-lcz696-now-called-entrestotm-approved-fda-reduce-risk-cardiovascular-death-and-heart-failure-hospitalization</loc>
  <lastmod>2021-10-05T11:52:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-receives-european-approval-pre-loaded-intraocular-lens-delivery-system-treat-patients-undergoing-cataract-surgery</loc>
  <lastmod>2021-10-05T11:52:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-pharmaceuticals-launches-first-app-visually-impaired-people-use-apple-watch-and-other-smart-watches</loc>
  <lastmod>2021-10-05T11:52:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-deepens-its-industry-leading-pipeline-acquisition-spinifex-pharmaceuticals-inc</loc>
  <lastmod>2021-10-05T11:52:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-publication-lancet-showing-sustained-efficacy-secukinumab-over-one-year-psoriatic-arthritis-patients</loc>
  <lastmod>2021-10-05T11:52:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-farydak-recommended-chmp-eu-approval-treat-multiple-myeloma-providing-patients-new-mechanism-action</loc>
  <lastmod>2021-10-05T11:52:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-us-launch-glatopatm-first-generic-competitor-copaxone-20mg</loc>
  <lastmod>2021-10-05T11:52:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-strong-innovation-momentum-its-second-meet-novartis-management-investor-day</loc>
  <lastmod>2021-10-05T11:52:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-receives-european-approval-new-trifocal-presbyopia-correcting-intraocular-lens-patients-undergoing-cataract-surgery</loc>
  <lastmod>2021-10-05T11:52:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-data-from-large-european-study-reinforcing-benefit-first-line-tasigna-newly-diagnosed-patients-cml</loc>
  <lastmod>2021-10-05T11:52:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-data-show-majority-patients-polycythemia-vera-treated-jakavi-achieved-long-term-disease-control</loc>
  <lastmod>2021-10-05T11:52:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-eha-show-increased-pfs-benefit-farydak-new-subgroup-patients-previously-treated-multiple-myeloma</loc>
  <lastmod>2021-10-05T11:52:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-arzerra-improved-median-progression-free-survival-54-patients-relapsed-chronic-lymphocytic-leukemia</loc>
  <lastmod>2021-10-05T11:52:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-reports-new-analysis-showing-xolair-improving-quality-life-78-chronic-spontaneous-urticaria-patients</loc>
  <lastmod>2021-10-05T11:52:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-gains-fda-approval-promacta-providing-new-option-children-ages-6-and-older-chronic-itp-rare-blood-disorder</loc>
  <lastmod>2021-10-05T11:52:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-data-wcd-demonstrating-significant-efficacy-cosentyx-patients-psoriasis-nails-palms-and-soles</loc>
  <lastmod>2021-10-05T11:52:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-new-one-year-results-demonstrating-sustained-secukinumab-efficacy-ankylosing-spondylitis-patients</loc>
  <lastmod>2021-10-05T11:52:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-ctl019-data-showing-its-potential-treatment-specific-types-hard-treat-non-hodgkin-lymphoma</loc>
  <lastmod>2021-10-05T11:52:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-data-asco-zykadia-and-combination-tafinlar-and-mekinist-certain-nsclc-patients-unmet-needs</loc>
  <lastmod>2021-10-05T11:52:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/combination-novartis-drugs-tafinlar-and-mekinist-shows-significant-survival-benefit-patients-metastatic-melanoma</loc>
  <lastmod>2021-10-05T11:52:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-data-21-medicines-and-11-investigational-compounds-asco-and-eha</loc>
  <lastmod>2021-10-05T11:52:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-afinitor-extended-progression-free-survival-phase-iii-trial-advanced-gastrointestinal-or-lung-neuroendocrine-tumors</loc>
  <lastmod>2021-10-05T11:52:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-two-positive-us-phase-iii-programs-copd-qva149-and-nva237</loc>
  <lastmod>2021-10-05T11:52:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-lung-cancer-drug-zykadia-gains-eu-approval-providing-new-therapy-certain-patients-alk-nsclc</loc>
  <lastmod>2021-10-05T11:52:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-phase-iii-study-arzerra-met-primary-endpoint-improved-progression-free-survival-patients-relapsed-cll</loc>
  <lastmod>2021-10-05T11:52:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-sales-growth-cc-significant-margin-expansion-cc-and-strong-innovation-q11-now-more-focused-portfolio</loc>
  <lastmod>2021-10-05T11:52:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-affiche-au-t11-une-forte-progression-de-ses-ventes-tcc-une-hausse-importante-de-sa-marge-tcc-et-une-innovation-tres-dynamique-avec-un-portefeuille-desormais-mieux-cible</loc>
  <lastmod>2021-10-05T11:52:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-im-ersten-quartal1-umsatzsteigerungen-kwk-deutlich-hohere-margen-kwk-und-beachtliche-innovationen-jetzt-mit-einem-starker-fokussierten-portfolio</loc>
  <lastmod>2021-10-05T11:52:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-celebrates-19th-annual-community-partnership-day-more-27000-associates-volunteering-their-local-communities</loc>
  <lastmod>2021-10-05T11:52:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/data-aan-showed-gilenya-high-efficacy-achieving-no-evidence-disease-activity-previously-treated-highly-active-ms-patients</loc>
  <lastmod>2021-10-05T11:52:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-fda-approval-glatopatm-first-generic-competitor-ms-therapy-copaxone-20mg</loc>
  <lastmod>2021-10-05T11:52:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-receives-fda-approval-new-multifocal-intraocular-lens-treat-cataract-patients-united-states</loc>
  <lastmod>2021-10-05T11:52:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/data-lancet-show-novartis-drug-arzerra-plus-chlorambucil-improved-median-progression-free-survival-71-cll-patients</loc>
  <lastmod>2021-10-05T11:52:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/gilenya-data-aan-highlight-novartis-leadership-innovation-new-ms-assessment-methods-benefit-patients-and-physicians</loc>
  <lastmod>2021-10-05T11:52:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-fda-approval-jadenutm-simplify-treatment-administration-patients-chronic-iron-overload</loc>
  <lastmod>2021-10-05T11:52:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-accelerates-cancer-immunotherapy-efforts-aduro-biotech-alliance-and-launch-new-immuno-oncology-research-group</loc>
  <lastmod>2021-10-05T11:52:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyxtm-two-year-data-shows-sustained-effect-and-favorable-safety-profile-psoriasis-patients</loc>
  <lastmod>2021-10-05T11:52:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-data-shows-cosentyxtm-significantly-superior-stelara-and-clears-skin-pasi-90-nearly-80-psoriasis-patients</loc>
  <lastmod>2021-10-05T11:52:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-eu-approval-jakavi-polycythemia-vera-first-targeted-therapy-approved-patients-rare-blood-cancer</loc>
  <lastmod>2021-10-05T11:52:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-present-new-late-breaking-cosentyxtm-data-aad-2015-showing-significant-patient-benefit-achieving-clear-skin</loc>
  <lastmod>2021-10-05T11:52:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-approves-first-biosimilar-zarxiotm-filgrastim-sndz-from-sandoz</loc>
  <lastmod>2021-10-05T11:52:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-completion-transactions-gsk</loc>
  <lastmod>2021-10-05T11:52:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-gibt-abschluss-von-transaktionen-mit-gsk-bekannt</loc>
  <lastmod>2021-10-05T11:52:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-annonce-la-conclusion-des-transactions-avec-gsk</loc>
  <lastmod>2021-10-05T11:52:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/positive-phase-ii-data-highlights-benefits-alcons-rth258-patients-neovascular-wet-age-related-macular-degeneration</loc>
  <lastmod>2021-10-05T11:52:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-shareholders-approve-all-resolutions-proposed-novartis-board-directors</loc>
  <lastmod>2021-10-05T11:52:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/les-actionnaires-de-novartis-approuvent-toutes-les-resolutions-proposees-par-le-conseil-dadministration</loc>
  <lastmod>2021-10-05T11:52:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/aktionare-genehmigen-alle-antrage-des-verwaltungsrats-von-novartis</loc>
  <lastmod>2021-10-05T11:52:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-lung-cancer-drug-zykadia-recommended-eu-approval-patients-alk-nsclc-previously-treated-crizotinib</loc>
  <lastmod>2021-10-05T11:52:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-fda-approval-farydak-first-hdac-inhibitor-patients-multiple-myeloma</loc>
  <lastmod>2021-10-05T11:52:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-heart-failure-medicine-lcz696-granted-fda-priority-review</loc>
  <lastmod>2021-10-05T11:52:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-receives-fda-approval-pazeotm-solution-ocular-allergy-itch-relief</loc>
  <lastmod>2021-10-05T11:52:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-study-nejm-showing-jakavi-was-superior-standard-therapy-rare-blood-cancer-polycythemia-vera</loc>
  <lastmod>2021-10-05T11:52:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-solid-sales-growth-margin-expansion-and-pipeline-progress-2014-portfolio-transformation-will-focus-company-leading-businesses</loc>
  <lastmod>2021-10-05T11:52:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-enregistre-en-2014-une-forte-augmentation-de-ses-ventes-sa-marge-et-progres-de-son-pipeline-la-transformation-du-portefeuille-concentrera-lentreprise-sur-ses-principales-activites</loc>
  <lastmod>2021-10-05T11:53:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-2014-solide-umsatzsteigerungen-hohere-margen-und-fortschritte-der-pipeline-mit-der-umgestaltung-des-portfolios-fokussiert-sich-das-unternehmen-auf-fuhrende-geschaftsbereiche</loc>
  <lastmod>2021-10-05T11:53:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-bexsero-vaccine-approved-fda-prevention-meningitis-b-leading-cause-bacterial-meningitis-us</loc>
  <lastmod>2021-10-05T11:53:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-jakavi-recommended-chmp-eu-approval-treat-adults-rare-blood-cancer-polycythemia-vera</loc>
  <lastmod>2021-10-05T11:53:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-fda-approval-first-il-17a-antagonist-cosentyxtm-secukinumab-moderate-severe-plaque-psoriasis-patients</loc>
  <lastmod>2021-10-05T11:53:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyxtm-first-il-17-inhibitor-receive-eu-approval-first-line-treatment-moderate-severe-psoriasis-patients</loc>
  <lastmod>2021-10-05T11:53:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-pharmaceuticals-announces-joint-investment-company-qualcomm-leading-innovation-digital-medicines-physicians-and-patients</loc>
  <lastmod>2021-10-05T11:53:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-robust-phase-iii-results-qva149-and-nva237-and-submits-regulatory-applications-us-fda</loc>
  <lastmod>2021-10-05T11:53:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-biosimilar-filgrastim-recommended-approval-fda-oncologic-drugs-advisory-committee</loc>
  <lastmod>2021-10-05T11:53:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-collaborates-intellia-therapeutics-and-caribou-biosciences-explore-making-medicines-and-drug-discovery-tools-crispr-genome-editing-technology</loc>
  <lastmod>2021-10-05T11:53:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-approves-sandoz-erelzitm-treat-multiple-inflammatory-diseases</loc>
  <lastmod>2021-10-05T12:04:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-convenes-experts-discuss-new-technologies-healthcare-novartis-international-biocamp</loc>
  <lastmod>2021-10-05T12:04:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/experten-diskutieren-am-novartis-international-biocamp-neue-technologien-im-gesundheitsbereich</loc>
  <lastmod>2021-10-05T12:04:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-convie-plusieurs-experts-au-novartis-international-biocamp-afin-de-discuter-des-nouvelles-technologies-en-matiere-de-sante</loc>
  <lastmod>2021-10-05T12:04:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-positive-phase-iii-results-showing-efficacy-baf312-patients-secondary-progressive-ms</loc>
  <lastmod>2021-10-05T12:04:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/six-leading-scientists-receive-prestigious-novartis-prizes-immunology-16th-international-congress-immunology</loc>
  <lastmod>2021-10-05T12:04:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cdk46-inhibitor-lee011-ribociclib-receives-fda-breakthrough-therapy-designation-first-line-treatment-hrher2-advanced-breast-cancer</loc>
  <lastmod>2021-10-05T12:04:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-achieves-us-approval-cypass-micro-stent-micro-invasive-surgical-device-treat-glaucoma</loc>
  <lastmod>2021-10-05T12:04:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-solid-q2-despite-full-quarter-us-gleevec-generic-impact-significant-positive-innovation-news-strengthens-future-growth-prospects</loc>
  <lastmod>2021-10-05T12:04:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-realise-un-2eme-trimestre-solide-malgre-limpact-sur-le-trimestre-du-generique-de-gleevec-aux-us-nouvelles-positives-importantes-de-linnovation-renforcent-les-perspectives-de-croissance</loc>
  <lastmod>2021-10-05T12:04:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-im-2-quartal-solide-ergebnisse-trotz-us-generikakonkurrenz-fur-gleevec-im-gesamten-quartal-wichtige-positive-neuigkeiten-zu-innovationen-starken-zukunftige-wachstumsperspektiven</loc>
  <lastmod>2021-10-05T12:04:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-launches-dailies-total1-multifocal-contact-lenses-first-and-only-water-gradient-lenses-designed-people-presbyopia</loc>
  <lastmod>2021-10-05T12:04:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-biosimilar-etanercept-recommended-fda-advisory-committee-approval-treat-multiple-inflammatory-diseases</loc>
  <lastmod>2021-10-05T12:04:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-data-shows-sandoz-biosimilar-etanercept-candidate-has-equivalent-efficacy-originator-product</loc>
  <lastmod>2021-10-05T12:04:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-pkc412-midostaurin-pivotal-data-published-nejm-show-60-response-rate-advanced-systemic-mastocytosis-sm</loc>
  <lastmod>2021-10-05T12:04:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/largest-global-psoriasis-survey-shows-84-people-face-discrimination-and-humiliation-because-their-skin</loc>
  <lastmod>2021-10-05T12:04:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-adds-bispecific-antibodies-its-growing-immuno-oncology-portfolio-through-collaboration-and-licensing-agreement-xencor</loc>
  <lastmod>2021-10-05T12:04:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/timely-use-novartis-entresto-could-prevent-or-postpone-over-28000-us-deaths-year-among-hfref-patients-according-expert-analysis-jama-cardiology</loc>
  <lastmod>2021-10-05T12:04:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-expands-partnership-medicines-malaria-venture-develop-next-generation-antimalarial-treatment</loc>
  <lastmod>2021-10-05T12:04:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erweitert-partnerschaft-mit-medicines-malaria-venture-zur-entwicklung-von-malariamedikamenten-der-nachsten-generation</loc>
  <lastmod>2021-10-05T12:04:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-etend-son-partenariat-avec-medicines-malaria-venture-pour-developper-la-prochaine-generation-de-traitement-antipaludeen</loc>
  <lastmod>2021-10-05T12:04:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-long-term-safety-data-revolade-adults-chronic-immune-thrombocytopenia-rare-blood-disorder</loc>
  <lastmod>2021-10-05T12:04:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-data-showing-jakavi-superior-best-available-therapy-patients-less-advanced-polycythemia-vera-pv</loc>
  <lastmod>2021-10-05T12:04:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-data-demonstrates-sandoz-etanercept-and-rituximab-biosimilar-candidates-bioequivalent-originator-products</loc>
  <lastmod>2021-10-05T12:04:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-amg-334-significantly-reduces-patients-monthly-migraine-days-phase-ii-study-chronic-migraine-prevention</loc>
  <lastmod>2021-10-05T12:04:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-scientific-evidence-cosentyx-ankylosing-spondylitis-and-psoriatic-arthritis-patients-eular-2016</loc>
  <lastmod>2021-10-05T12:04:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-combination-therapy-tafinlar-mekinist-demonstrates-overall-survival-benefit-three-year-follow-patients-advanced-melanoma</loc>
  <lastmod>2021-10-05T12:04:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-pivotal-data-tafinlar-mekinist-demonstrated-63-percent-overall-response-rate-treating-rare-form-lung-cancer</loc>
  <lastmod>2021-10-05T12:04:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-show-more-50-percent-eligible-ph-cml-patients-maintain-treatment-free-remission-tfr-after-stopping-tasigna</loc>
  <lastmod>2021-10-05T12:04:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-afinitor-receives-eu-approval-treat-certain-types-advanced-gastrointestinal-gi-and-lung-neuroendocrine-tumors-net</loc>
  <lastmod>2021-10-05T12:04:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-its-strong-foundation-long-term-sustainable-growth-third-meet-novartis-management-event</loc>
  <lastmod>2021-10-05T12:04:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-biosimilar-rituximab-regulatory-submission-accepted-european-medicines-agency</loc>
  <lastmod>2021-10-05T12:04:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-entresto-given-strong-class-i-recommendation-both-us-and-eu-heart-failure-guidelines-less-year-after-regulatory-approvals</loc>
  <lastmod>2021-10-05T12:04:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-investment-fortihfy-clinical-program-entresto-and-heart-failure</loc>
  <lastmod>2021-10-05T12:04:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-present-pivotal-data-hematologic-and-solid-tumor-cancers-2016-asco-annual-meeting</loc>
  <lastmod>2021-10-05T12:04:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/monaleesa-2-trial-novartis-lee011-ribociclib-stopped-due-positive-efficacy-results-interim-analysis-hrher2-advanced-breast-cancer</loc>
  <lastmod>2021-10-05T12:05:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-focuses-pharmaceuticals-division-creating-two-business-units-novartis-pharmaceuticals-and-novartis-oncology-appoints-leaders-executive-committee-novartis</loc>
  <lastmod>2021-10-05T12:05:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-renforce-la-division-pharmaceuticals-par-la-creation-de-deux-unites-daffaires-novartis-pharmaceuticals-et-novartis-oncology-et-nomme-de-nouveaux-dirigeants-son-comite-de-direction</loc>
  <lastmod>2021-10-05T12:05:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-fokussiert-ihre-division-pharmaceuticals-durch-schaffung-der-geschaftseinheiten-novartis-pharmaceuticals-und-novartis-oncology-und-beruft-deren-leiter-die-geschaftsleitung-von-novartis</loc>
  <lastmod>2021-10-05T12:05:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-foundation-and-partners-launch-innovative-hypertension-program-vietnam</loc>
  <lastmod>2021-10-05T12:05:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/major-study-published-nejm-confirms-novartis-ultibro-breezhaler-superiority-over-seretide-preventing-copd-exacerbations</loc>
  <lastmod>2021-10-05T12:05:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-afinitor-recommended-chmp-european-union-approval-treat-select-gi-and-lung-neuroendocrine-tumors</loc>
  <lastmod>2021-10-05T12:05:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-three-fda-breakthrough-therapy-designations-ilaris-treat-rare-types-periodic-fever-syndromes</loc>
  <lastmod>2021-10-05T12:05:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-solid-q1-despite-gleevec-loss-exclusivity-investing-behind-new-launches-long-term-growth</loc>
  <lastmod>2021-10-05T12:05:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-im-ersten-quartal-trotz-verlust-der-exklusivrechte-gleevec-solide-ergebnisse-und-investiert-neueinfuhrungen-zugunsten-langfristigen-wachstums</loc>
  <lastmod>2021-10-05T12:05:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-enregistre-un-premier-trimestre-solide-malgre-la-perte-dexclusivite-de-gleevec-et-investi-dans-de-nouveaux-lancements-pour-soutenir-la-croissance-long-terme</loc>
  <lastmod>2021-10-05T12:05:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-afinitor-significantly-reduces-seizures-phase-iii-study-patients-tuberous-sclerosis-complex</loc>
  <lastmod>2021-10-05T12:05:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-ec-approval-subcutaneous-route-administration-biosimilar-binocrits-nephrology-indication</loc>
  <lastmod>2021-10-05T12:05:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-eu-approval-revolade-first-class-therapy-children-aged-1-year-and-above-chronic-itp</loc>
  <lastmod>2021-10-05T12:05:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-analyses-show-novartis-entrestotm-reduced-cardiovascular-death-or-hospitalization-heart-failure-consistently-benefitting-patients-reduced-ejection-fraction-regardless</loc>
  <lastmod>2021-10-05T12:05:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-publishes-updated-2015-segment-financials-reflecting-new-division-structure</loc>
  <lastmod>2021-10-05T12:05:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-superior-stelara-delivering-long-lasting-skin-clearance-pasi-90-psoriasis-patients-52-weeks</loc>
  <lastmod>2021-10-05T12:05:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-approves-new-indication-novartis-drug-afinitor-progressive-nonfunctional-gi-and-lung-neuroendocrine-tumors-net</loc>
  <lastmod>2021-10-05T12:05:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-shareholders-approve-all-resolutions-proposed-board-directors</loc>
  <lastmod>2021-10-05T12:05:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/les-actionnaires-de-novartis-approuvent-toutes-les-resolutions-proposees-par-le-conseil-dadministration-0</loc>
  <lastmod>2021-10-05T12:05:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-aktionare-genehmigen-alle-antrage-des-verwaltungsrats</loc>
  <lastmod>2021-10-05T12:05:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-pkc412-midostaurin-receives-breakthrough-therapy-designation-from-fda-newly-diagnosed-flt3-mutated-acute-myeloid-leukemia-aml</loc>
  <lastmod>2021-10-05T12:05:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-expands-leadership-position-treating-glaucoma-through-acquisition-transcend-medical-inc</loc>
  <lastmod>2021-10-05T12:05:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-strengthens-its-biosimilars-portfolio-acquisition-pfizers-biosimilar-infliximab-eea</loc>
  <lastmod>2021-10-05T12:05:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-advances-its-biosimilars-program-ema-acceptance-regulatory-submission-biosimilar-pegfilgrastim</loc>
  <lastmod>2021-10-05T12:05:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-foundation-commemorates-world-leprosy-day-its-continued-efforts-go-last-mile-toward-elimination</loc>
  <lastmod>2021-10-05T12:05:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-strong-sales-growth-and-core-margin-expansion-cc1-2015-announces-plans-accelerate-growth-alcon-streamline-group-operations</loc>
  <lastmod>2021-10-05T12:05:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-enregistre-en-2015-une-forte-croissance-des-ventes-et-une-hausse-de-sa-marge-core-tcc1-et-annonce-des-plans-pour-accelerer-la-croissance-dalcon-et-rationaliser-les-operations-du-groupe</loc>
  <lastmod>2021-10-05T12:05:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-2015-eine-kraftige-steigerung-des-umsatzes-und-der-kern-gewinnmarge-kwk1-plane-zur-wachstumsbeschleunigung-bei-alcon-und-zur-straffung-der-konzernaktivitaten-bekannt-gegeben</loc>
  <lastmod>2021-10-05T12:05:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-two-new-fda-approvals-cosentyx-treat-patients-ankylosing-spondylitis-and-psoriatic-arthritis-us</loc>
  <lastmod>2021-10-05T12:05:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-continues-grow-immuno-oncology-pipeline-through-collaboration-and-licensing-agreement-surface-oncology</loc>
  <lastmod>2021-10-05T12:05:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-pharmaceuticals-collaborates-qualcomm-digital-innovation-breezhalertm-inhaler-device-treat-copd</loc>
  <lastmod>2021-10-05T12:05:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-nejm-publication-two-major-trials-showing-significant-efficacy-cosentyx-ankylosing-spondylitis-patients</loc>
  <lastmod>2021-10-05T12:05:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/300-million-child-friendly-antimalarial-treatments-supplied-without-profit-novartis</loc>
  <lastmod>2021-10-05T12:05:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-advances-its-biosimilars-program-european-medicines-agency-ema-acceptance-regulatory-submission-biosimilar-etanercept</loc>
  <lastmod>2021-10-05T12:05:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-new-ctl019-phase-ii-data-demonstrating-93-complete-remission-pediatric-patients-rr-all</loc>
  <lastmod>2021-10-05T12:05:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/phase-iii-data-shows-sandoz-proposed-biosimilar-pegfilgrastim-has-similar-safety-and-efficacy-reference-product</loc>
  <lastmod>2021-10-05T12:05:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-pkc412-midostaurin-improves-overall-survival-23-global-phase-iii-study-aml-patients-flt3-mutations</loc>
  <lastmod>2021-10-05T12:05:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-new-ctl019-study-data-demonstrating-overall-response-adult-patients-certain-types-lymphoma</loc>
  <lastmod>2021-10-05T12:05:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-phase-iii-studies-jakavi-show-disease-improvement-patients-myelofibrosis-and-polycythemia-vera</loc>
  <lastmod>2021-10-05T12:05:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-data-targeted-combination-therapy-sabcs-reinforcing-commitment-breast-cancer-patients</loc>
  <lastmod>2021-10-05T12:05:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-clinical-advances-ash-2015-underscoring-leadership-hematology-research</loc>
  <lastmod>2021-10-05T12:05:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-heart-failure-medicine-entrestotm-receives-eu-approval</loc>
  <lastmod>2021-10-05T12:05:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-two-landmark-european-approvals-cosentyx-treat-patients-ankylosing-spondylitis-and-psoriatic-arthritis</loc>
  <lastmod>2021-10-05T12:05:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-pharmaceuticals-corporation-finalizes-settlement-agreement-resolving-civil-suit-filed-us-attorneys-office-southern-district-new-york</loc>
  <lastmod>2021-10-05T12:05:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/regulatory-submission-sandoz-proposed-biosimilar-pegfilgrastim-accepted-fda</loc>
  <lastmod>2021-10-05T12:05:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/flame-study-shows-superiority-novartis-ultibro-breezhaler-over-seretide-reducing-copd-exacerbations</loc>
  <lastmod>2021-10-05T12:05:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-introduces-contoura-vision-first-personalized-lasik-procedure-american-academy-ophthalmology-annual-meeting</loc>
  <lastmod>2021-10-05T12:05:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-two-year-data-cosentyx-showing-no-progression-joint-damage-84-psoriatic-arthritis-patients</loc>
  <lastmod>2021-10-05T12:05:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-two-year-data-novartis-cosentyx-show-sustained-response-and-no-progression-spinal-damage-shown-x-ray-80-patients-ankylosing-spondylitis</loc>
  <lastmod>2021-10-05T12:05:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-nominating-elizabeth-doherty-and-ton-buechner-board-directors</loc>
  <lastmod>2021-10-05T12:05:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-foundation-and-partners-launch-new-hypertension-program-ghana</loc>
  <lastmod>2021-10-05T12:05:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-strong-core-margin-expansion-cc-and-continued-strengthen-pipeline-q3-track-full-year-guidance</loc>
  <lastmod>2021-10-05T12:06:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-realise-au-troisieme-trimestre-une-forte-hausse-de-sa-marge-core-tcc-et-continue-de-renforcer-son-pipeline-confirmant-ainsi-ses-previsions-pour-lexercice</loc>
  <lastmod>2021-10-05T12:06:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-steigert-die-kerngewinnmarge-kwk-im-dritten-quartal-kraftig-starkt-erneut-die-pipeline-und-ist-auf-kurs-fur-die-jahresprognose</loc>
  <lastmod>2021-10-05T12:06:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-first-il-17a-inhibitor-cosentyxtm-treat-ankylosing-spondylitis-and-psoriatic-arthritis</loc>
  <lastmod>2021-10-05T12:06:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-broadens-immuno-oncology-pipeline-acquisition-admune-therapeutics-and-licensing-agreements-xoma-and-palobiofarma</loc>
  <lastmod>2021-10-05T12:06:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/kenya-first-country-launch-novartis-access-expanding-affordable-treatment-options-against-chronic-diseases</loc>
  <lastmod>2021-10-05T12:06:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-data-showing-majority-patients-are-able-maintain-clear-or-almost-clear-skin-cosentyx-across-3-years</loc>
  <lastmod>2021-10-05T12:06:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/long-term-efficacy-gilenya-reinforced-new-no-evidence-disease-activity-neda-4-analysis-ms-patients-over-seven-years</loc>
  <lastmod>2021-10-05T12:06:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-receives-fda-approval-pre-loaded-intraocular-lens-delivery-system-treat-patients-undergoing-cataract-surgery</loc>
  <lastmod>2021-10-05T12:06:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-accepts-sandoz-regulatory-submission-proposed-biosimilar-etanercept</loc>
  <lastmod>2021-10-05T12:06:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-nejm-publication-secukinumab-phase-iii-data-confirming-significant-efficacy-patients-psoriatic-arthritis</loc>
  <lastmod>2021-10-05T12:06:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/patients-aggressive-form-melanoma-lived-more-two-years-average-when-taking-novartis-therapies-tafinlar-mekinist</loc>
  <lastmod>2021-10-05T12:06:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-next-generation-car-t-cell-therapy-ctl119-combined-ibrutinib-shows-high-rate-responses-cll-patients</loc>
  <lastmod>2021-10-05T12:08:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-fda-approval-expanded-use-zykadia-first-line-alk-positive-metastatic-non-small-cell-lung-cancer-nsclc</loc>
  <lastmod>2021-10-05T12:08:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-new-analyses-reinforce-potential-ultibro-breezhaler-copd-patients-historically-treated-steroids</loc>
  <lastmod>2021-10-05T12:08:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-first-line-use-zykadia-alk-positive-advanced-non-small-cell-lung-cancer-nsclc</loc>
  <lastmod>2021-10-05T12:08:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-asco-icml-and-eha-meetings-demonstrate-meaningful-advancements-cancer-care</loc>
  <lastmod>2021-10-05T12:08:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-foundation-and-partners-launch-initiative-tackle-hypertension-and-its-root-causes-low-income-urban-communities</loc>
  <lastmod>2021-10-05T12:08:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-celebrates-21st-annual-community-partnership-day-over-24500-associates-volunteering-their-local-communities</loc>
  <lastmod>2021-10-05T12:08:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-exercises-exclusive-option-agreement-conatus-treatment-nash</loc>
  <lastmod>2021-10-05T12:08:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-fda-approval-rydapt-newly-diagnosed-flt3-mutated-acute-myeloid-leukemia-aml-and-three-types-systemic-mastocytosis-sm</loc>
  <lastmod>2021-10-05T12:08:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-announces-eu-launch-cypass-micro-stent-micro-invasive-glaucoma-surgical-device-lower-intraocular-pressure-iop-patients-primary-open-angle-glaucoma</loc>
  <lastmod>2021-10-05T12:08:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-sales-growth-across-all-divisions-cc1-growth-drivers-including-cosentyx-and-entresto-more-offset-generic-erosion-innovation-momentum-continued</loc>
  <lastmod>2021-10-05T12:08:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-ventes-en-progression-tcc1-dans-toutes-ses-divisions-les-moteurs-de-croissance-cosentyx-et-entresto-inclus-compensent-lerosion-due-aux-generiques-linnovation-toujours-en-plein-essor</loc>
  <lastmod>2021-10-05T12:08:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-umsatzsteigerungen-allen-divisionen-kwk1-wobei-wachstumstreiber-wie-cosentyx-und-entresto-die-einbussen-durch-generika-mehr-als-wettmachen-innovationsdynamik-setzt-sich-fort</loc>
  <lastmod>2021-10-05T12:08:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-expands-global-collaboration-amgen-commercialize-first-class-amg-334-erenumab-program-migraine-prevention-us-and-canada</loc>
  <lastmod>2021-10-05T12:08:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-real-world-data-aan-confirms-benefit-gilenya-four-key-measures-disease-activity-relapsing-ms</loc>
  <lastmod>2021-10-05T12:08:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-proposed-biosimilars-rituximab-and-etanercept-recommended-approval-europe</loc>
  <lastmod>2021-10-05T12:08:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/nih-study-nejm-shows-novartis-drug-eltrombopag-first-line-therapy-standard-treatment-improves-responses-severe-aplastic-anemia</loc>
  <lastmod>2021-10-05T12:08:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-expands-development-programs-nash-through-clinical-collaboration-allergan</loc>
  <lastmod>2021-10-05T12:08:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-car-t-cell-therapy-ctl019-receives-fda-breakthrough-therapy-designation-treatment-adult-patients-rr-dlbcl</loc>
  <lastmod>2021-10-05T12:08:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-strengthen-rd-pipeline-licensing-ecf843-ophthalmic-indications</loc>
  <lastmod>2021-10-05T12:08:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-combination-tafinlar-mekinist-receives-eu-approval-braf-v600-positive-advanced-non-small-cell-lung-cancer-nsclc</loc>
  <lastmod>2021-10-05T12:08:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-first-car-t-cell-therapy-bla-pediatric-and-young-adult-patients-rr-b-cell-all-granted-fda-priority-review</loc>
  <lastmod>2021-10-05T12:08:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-receives-us-fda-approval-new-acrysof-iq-restor-25-multifocal-toric-iol-activefocustm-design-uncompromised-distance-vision-and-presbyopia-correction</loc>
  <lastmod>2021-10-05T12:08:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-phase-iii-study-rlx030-serelaxin-patients-acute-heart-failure</loc>
  <lastmod>2021-10-05T12:08:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-first-and-only-il-17a-inhibitor-potentially-modify-course-psoriasis</loc>
  <lastmod>2021-10-05T12:08:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-analysis-shows-novartis-entresto-improves-glycemic-control-reduced-ejection-fraction-heart-failure-patients-diabetes</loc>
  <lastmod>2021-10-05T12:08:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-ribociclib-lee011-receives-fda-approval-first-line-treatment-hrher2-metastatic-breast-cancer-combination-any-aromatase-inhibitor</loc>
  <lastmod>2021-10-05T12:08:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-winners-inaugural-healthcare-access-challenge-sandoz-hack</loc>
  <lastmod>2021-10-05T12:08:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-shows-almost-all-psoriasis-patients-rapidly-regain-skin-clearance-following-treatment-pause</loc>
  <lastmod>2021-10-05T12:08:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-data-demonstrate-sandoz-proposed-biosimilar-adalimumab-has-equivalent-efficacy-reference-medicine</loc>
  <lastmod>2021-10-05T12:08:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-aktionare-genehmigen-der-ordentlichen-generalversammlung-alle-antrage-des-verwaltungsrats</loc>
  <lastmod>2021-10-05T12:08:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-shareholders-approve-all-resolutions-proposed-board-directors-annual-general-meeting</loc>
  <lastmod>2021-10-05T12:08:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/les-actionnaires-de-novartis-approuvent-toutes-les-resolutions-proposees-par-le-conseil-dadministration-lors-de-lassemblee-generale-annuelle</loc>
  <lastmod>2021-10-05T12:08:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-tafinlar-mekinist-braf-positive-non-small-cell-lung-cancer-nsclc-patients</loc>
  <lastmod>2021-10-05T12:08:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-zykadia-receives-fda-priority-review-first-line-use-patients-alk-metastatic-nsclc</loc>
  <lastmod>2021-10-05T12:08:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-pharmaceuticals-ag-recu-la-certification-top-employer-suisse-2017</loc>
  <lastmod>2021-10-05T12:08:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-pharmaceuticals-ag-als-top-arbeitgeber-schweiz-2017-ausgezeichnet</loc>
  <lastmod>2021-10-05T12:08:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-votubia-receives-eu-approval-treat-refractory-partial-onset-seizures-patients-tsc</loc>
  <lastmod>2021-10-05T12:08:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-progress-towards-access-and-environmental-goals-2016-corporate-responsibility-performance-report</loc>
  <lastmod>2021-10-05T12:08:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-launches-new-trifocal-toric-intraocular-lens-patients-astigmatism-undergoing-cataract-surgery</loc>
  <lastmod>2021-10-05T12:08:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-solid-2016-performance-growth-products1-absorbing-gleevec-us-loe-innovation-momentum-continued-announces-share-buyback</loc>
  <lastmod>2021-10-05T12:08:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-solide-performance-en-2016-les-produits-de-croissance1-absorbant-la-perte-dexclusivite-de-gleevec-aux-usa-dynamique-continue-dinnovation-rachat-dactions-annonce</loc>
  <lastmod>2021-10-05T12:08:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-2016-solide-ergebnisse-wobei-die-wachstumsprodukte1-den-verlust-der-exklusivrechte-fur-gleevec-den-usa-wettmachen-innovationsdynamik-halt-aktienruckkauf-angekundigt</loc>
  <lastmod>2021-10-05T12:08:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-invests-next-generation-therapies-reduce-cardiovascular-risk-patients-underlying-lipid-disorders</loc>
  <lastmod>2021-10-05T12:08:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-bolsters-ophthalmology-pipeline-through-acquisition-encore-vision-inc</loc>
  <lastmod>2021-10-05T12:08:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-exclusive-option-collaboration-and-license-agreement-conatus-develop-new-oral-treatments-chronic-liver-diseases</loc>
  <lastmod>2021-10-05T12:08:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-recommendation-ilaris-treat-rare-diseases-adults-and-children-called-periodic-fever-syndromes</loc>
  <lastmod>2021-10-05T12:08:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-votubia-recommended-chmp-eu-approval-treat-refractory-partial-onset-seizures-patients-tsc</loc>
  <lastmod>2021-10-05T12:08:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-bolsters-innovative-dermatology-portfolio-through-acquisition-ziarco-group-limited</loc>
  <lastmod>2021-10-05T12:08:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-launches-sms-life-20-nigeria-help-improve-access-essential-medicines</loc>
  <lastmod>2021-10-05T12:08:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-lance-sms-life-20-au-nigeria-pour-aider-ameliorer-lacces-aux-medicaments-essentiels</loc>
  <lastmod>2021-10-05T12:08:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-fuhrt-sms-life-20-nigeria-ein-um-den-zugang-zu-unentbehrlichen-arzneimitteln-zu-verbessern</loc>
  <lastmod>2021-10-05T12:08:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-pegpleranib-phase-iii-clinical-trial-program-patients-neovascular-age-related-macular-degeneration-namd-or-wet-amd</loc>
  <lastmod>2021-10-05T12:08:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-lee011-ribociclib-plus-letrozole-analyses-show-superior-pfs-across-broad-spectrum-patients-first-line-hrher2-advanced-breast-cancer-versus-letrozole</loc>
  <lastmod>2021-10-05T12:08:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-ultibro-breezhaler-improved-lung-function-and-copd-symptoms-after-direct-switch-from-previous-treatment</loc>
  <lastmod>2021-10-05T12:08:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-lucentis-received-eu-approval-new-indication-lucentis-only-treatment-available-wide-range-cnv-conditions</loc>
  <lastmod>2021-10-05T12:08:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-zykadia-first-line-study-results-showing-166-month-progression-free-survival-patients-alk-advanced-nsclc</loc>
  <lastmod>2021-10-05T12:08:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-shows-treatment-free-remission-rates-are-consistently-above-50-regardless-reason-switch-tasigna-from-glivec</loc>
  <lastmod>2021-10-05T12:09:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-survey-uncovers-real-world-burden-myeloproliferative-neoplasms-rare-blood-cancers-daily-activity-and-ability-work</loc>
  <lastmod>2021-10-05T12:09:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-interim-data-demonstrate-sandoz-proposed-biosimilar-rituximab-has-equivalent-efficacy-reference-product</loc>
  <lastmod>2021-10-05T12:09:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-results-from-first-global-registration-trial-ctl019-pediatric-and-young-adult-patients-rr-b-all</loc>
  <lastmod>2021-10-05T12:09:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-seg101-crizanlizumab-formerly-selg1-significantly-reduces-frequency-sickle-cell-pain-crises-phase-ii-study</loc>
  <lastmod>2021-10-05T12:09:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-access-communique-son-bilan-un-et-annonce-la-signature-dun-protocole-daccord-avec-le-rwanda</loc>
  <lastmod>2021-10-05T12:09:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-access-shares-one-year-learnings-and-announces-memorandum-understanding-rwanda</loc>
  <lastmod>2021-10-05T12:09:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-access-informiert-uber-erfahrungen-im-ersten-jahr-und-gibt-memorandum-understanding-mit-ruanda-bekannt</loc>
  <lastmod>2021-10-05T12:09:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-acquires-selexys-pharmaceuticals-corporation-and-selg1-antibody-reduction-pain-crises-sickle-cell-disease-scd</loc>
  <lastmod>2021-10-05T12:09:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-commends-publication-major-report-which-recommends-broad-use-dual-bronchodilators-treat-copd</loc>
  <lastmod>2021-10-05T12:09:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/innovative-study-three-treatment-switches-confirms-sandoz-biosimilar-etanercept-has-equivalent-efficacy-originator</loc>
  <lastmod>2021-10-05T12:09:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-amg-334-significantly-reduces-monthly-migraine-days-second-pivotal-phase-iii-episodic-migraine-study</loc>
  <lastmod>2021-10-05T12:09:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-ash-and-sabcs-showcase-latest-innovations-development-patients-blood-disorders-and-breast-cancer</loc>
  <lastmod>2021-10-05T12:09:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-analysis-novartis-entresto-data-shows-long-term-benefits-heart-failure-readmissions-and-total-cardiovascular-deaths</loc>
  <lastmod>2021-10-05T12:09:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-pkc412-midostaurin-granted-fda-priority-review-newly-diagnosed-flt3-mutated-aml-and-advanced-systemic-mastocytosis</loc>
  <lastmod>2021-10-05T12:09:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-cosentyx-data-showing-long-lasting-efficacy-psoriatic-arthritis-over-3-years-including-patient-reported-pain</loc>
  <lastmod>2021-10-05T12:09:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-improves-ranking-2016-access-medicine-index</loc>
  <lastmod>2021-10-05T12:09:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-lee011-ribociclib-granted-fda-priority-review-first-line-treatment-hrher2-advanced-breast-cancer</loc>
  <lastmod>2021-10-05T12:09:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-wins-two-prestigious-prix-galien-foundation-awards-gleevec-recognized-discovery-decade-best-pharmaceutical-product-cosentyx-best-biotechnology-product</loc>
  <lastmod>2021-10-05T12:09:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-solid-third-quarter-growth-products1-offsetting-gleevec-patent-expiration-several-positive-readouts-potential-blockbusters</loc>
  <lastmod>2021-10-05T12:09:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-im-dritten-quartal-solide-ergebnisse-wobei-die-wachstumsprodukte1-den-verlust-des-patents-fur-gleevec-wettmachen-mehrere-positive-daten-fur-potenzielle-blockbuster</loc>
  <lastmod>2021-10-05T12:09:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-realise-un-troisieme-trimestre-solide-les-produits-de-croissance1-ayant-compense-lexpiration-du-brevet-de-glivec-plusieurs-resultats-positifs-concernant-des-blockbusters-potentiels</loc>
  <lastmod>2021-10-05T12:09:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-launches-cypass-micro-stent-american-academy-ophthalmology-aao-2016-annual-meeting</loc>
  <lastmod>2021-10-05T12:09:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-alk-metastatic-nsclc-therapy-zykadia-extends-progression-free-survival-beyond-18-months-phase-ii-study</loc>
  <lastmod>2021-10-05T12:09:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-tafinlar-dabrafenib-mekinist-trametinib-demonstrate-superior-overall-survival-benefit-advanced-melanoma-patients-three-year-follow</loc>
  <lastmod>2021-10-05T12:09:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-breakthrough-therapy-lee011-plus-letrozole-demonstrates-superior-progression-free-survival-first-line-treatment-hrher2-advanced-breast-cancer-compared-standard-care</loc>
  <lastmod>2021-10-05T12:09:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-reports-over-half-psoriasis-patients-do-not-reach-achievable-treatment-goal-clear-skin-largest-global-survey</loc>
  <lastmod>2021-10-05T12:09:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-late-breaking-data-show-cosentyx-delivers-high-and-long-lasting-skin-clearance-over-4-years-psoriasis-patients</loc>
  <lastmod>2021-10-05T12:09:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-phase-iii-study-shows-amg-334-significantly-reduces-monthly-migraine-days-people-episodic-migraine</loc>
  <lastmod>2021-10-05T12:09:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-invites-young-entrepreneurs-enter-sandoz-hack-global-competition-help-solve-healthcare-access-challenges</loc>
  <lastmod>2021-10-05T12:10:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-three-new-fda-approvals-expanded-use-ilaris-treating-rare-periodic-fever-syndrome-conditions</loc>
  <lastmod>2021-10-05T12:10:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-positive-top-line-results-from-ascend-4-phase-iii-trial-zykadia-untreated-adult-alk-nsclc-patients</loc>
  <lastmod>2021-10-05T12:10:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novel-novartis-malaria-compound-shows-potential-be-effective-against-infections-resistant-all-currently-available-antimalarial-drugs</loc>
  <lastmod>2021-10-05T12:10:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/important-new-analysis-shows-novartis-entresto-associated-higher-relative-health-related-quality-life-scores-among-hfref-patients</loc>
  <lastmod>2021-10-05T12:10:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-baf312-reduces-risk-disability-progression-pivotal-phase-iii-study-secondary-progressive-ms-patients</loc>
  <lastmod>2021-10-05T12:10:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-data-presented-ectrims-show-benefit-gilenya-patient-disability-progression-10-years</loc>
  <lastmod>2021-10-05T12:10:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-positive-data-ehmtic-showing-amg-334-significantly-reduces-monthly-migraine-days-chronic-migraine</loc>
  <lastmod>2021-10-05T12:10:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-foundation-showcases-progress-leprosy-elimination-programs-19th-international-leprosy-congress</loc>
  <lastmod>2021-10-05T12:10:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-point-care-nijitm-system-may-provide-earlier-diagnosis-severe-allergic-asthma-and-faster-treatment-decisions</loc>
  <lastmod>2021-10-05T12:10:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-launches-ngenuity-3d-visualization-system-designed-further-enhance-retinal-surgeon-experience</loc>
  <lastmod>2021-10-05T12:10:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-ultibro-breezhaler-consistently-more-effective-seretide-reducing-copd-flare-ups-across-different-patient-groups</loc>
  <lastmod>2021-10-05T12:10:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/airflusal-forspiro-showed-superiority-12-months-over-seretide-diskus1-persistence-treatment</loc>
  <lastmod>2021-10-05T12:10:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-new-data-reinforces-superiority-cosentyx-versus-stelara-achieving-skin-clearance-psoriasis-patients</loc>
  <lastmod>2021-10-05T12:36:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-regulatory-submission-proposed-biosimilar-adalimumab-accepted-fda</loc>
  <lastmod>2021-10-05T12:36:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-appoints-elizabeth-barrett-oncology-head</loc>
  <lastmod>2021-10-05T12:36:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-ernennt-elizabeth-barrett-zur-chefin-onkologie</loc>
  <lastmod>2021-10-05T12:36:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-advances-head-head-superiority-trials-cosentyx-versus-humira-and-proposed-biosimilar-adalimumab</loc>
  <lastmod>2021-10-05T12:36:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-promacta-receives-fda-breakthrough-therapy-designation-first-line-use-severe-aplastic-anemia-saa</loc>
  <lastmod>2021-10-05T12:36:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-received-fda-breakthrough-therapy-designation-initial-endocrine-based-treatment-premenopausal-women-hrher2-advanced-breast-cancer</loc>
  <lastmod>2021-10-05T12:36:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-tasigna-approved-fda-first-and-only-cml-therapy-treatment-free-remission-data-its-label</loc>
  <lastmod>2021-10-05T12:36:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-combination-therapy-tafinlar-mekinist-granted-fda-priority-review-adjuvant-treatment-stage-iii-braf-v600-mutation-positive-melanoma</loc>
  <lastmod>2021-10-05T12:36:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-oncology-head-retire</loc>
  <lastmod>2021-10-05T12:36:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-gibt-rucktritt-des-onkologie-chefs-bekannt</loc>
  <lastmod>2021-10-05T12:36:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-crizanlizumab-shown-prolong-time-patients-first-sickle-cell-pain-crisis-subgroup-analysis-sustain-study</loc>
  <lastmod>2021-10-05T12:36:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/primary-analysis-results-from-novartis-pivotal-juliet-trial-show-kymriahtm-tisagenlecleucel-sustained-complete-responses-six-months-adults-rr-dlbcl-difficult-treat-cancer</loc>
  <lastmod>2021-10-05T12:36:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-new-phase-i-data-showing-proposed-biosimilar-pegfilgrastim-matches-reference-medicine</loc>
  <lastmod>2021-10-05T12:36:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-tender-offer-advanced-accelerator-applications-commences</loc>
  <lastmod>2021-10-05T12:36:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/kisqali-first-and-only-cdk46-inhibitor-show-superior-efficacy-vs-oral-endocrine-therapy-1l-treatment-randomized-phase-iii-trial-premenopausal-women-hrher2-advanced-breast-cancer</loc>
  <lastmod>2021-10-05T12:36:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-first-biologic-show-long-term-efficacy-nail-and-palmoplantar-psoriasis-which-can-impact-90-psoriasis-patients</loc>
  <lastmod>2021-10-05T12:36:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-phase-iii-strive-data-published-nejm-demonstrating-significant-and-sustained-efficacy-erenumab-amg334-migraine-prevention</loc>
  <lastmod>2021-10-05T12:36:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-ultibro-breezhaler-significantly-improved-copd-patients-lung-function-after-direct-switch-from-seretide</loc>
  <lastmod>2021-10-05T12:36:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-tasigna-nilotinib-secures-eu-approval-first-and-second-line-treatment-ph-cml-cp-children</loc>
  <lastmod>2021-10-05T12:36:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-ascp-and-acs-join-forces-fight-cancer-ethiopia-uganda-and-tanzania</loc>
  <lastmod>2021-10-05T12:36:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-data-sabcs-across-broad-range-breast-cancer-patient-populations-combination-treatments-and-lines-therapy</loc>
  <lastmod>2021-10-05T12:36:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-data-reinforces-clinical-basis-switching-sandoz-biosimilar-medicines</loc>
  <lastmod>2021-10-05T12:36:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-canakinumab-acz885-reduced-cardiovascular-risk-25-subgroup-cantos-phase-iii-trial-participants</loc>
  <lastmod>2021-10-05T12:36:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-its-differentiated-late-stage-pipeline-rd-update-and-investor-event</loc>
  <lastmod>2021-10-05T12:36:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-entresto-real-world-evidence-data-shows-beneficial-impact-quality-life-people-living-heart-failure</loc>
  <lastmod>2021-10-05T12:36:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/punjab-province-pakistan-signs-agreement-novartis-access-against-chronic-diseases</loc>
  <lastmod>2021-10-05T12:36:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-brolucizumab-rth258-demonstrates-superiority-versus-aflibercept-key-secondary-endpoint-measures-disease-activity-namd-leading-cause-blindness</loc>
  <lastmod>2021-10-05T12:36:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-reports-positive-results-from-phase-iii-trial-kisqali-ribociclib-combination-therapy-premenopausal-women-hrher2-advanced-or-metastatic-breast-cancer</loc>
  <lastmod>2021-10-05T12:36:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-study-data-demonstrating-cosentyx-reduced-signs-and-symptoms-psoriatic-arthritis-while-inhibiting-progression-joint-structural-damage</loc>
  <lastmod>2021-10-05T12:36:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-seeks-leadership-cosentyx-showing-no-radiographic-progression-ankylosing-spondylitis-4-years</loc>
  <lastmod>2021-10-05T12:36:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-reaches-another-regulatory-milestone-ctl019-tisagenlecleucel-submission-its-maa-ema-children-young-adults-rr-b-cell-all-and-adult-patients-rr-dlbcl</loc>
  <lastmod>2021-10-05T12:36:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-amgen-announce-expanded-collaboration-banner-alzheimers-institute-pioneering-prevention-program</loc>
  <lastmod>2021-10-05T12:36:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-data-ash-patients-serious-blood-disorders-lymphoma-leukemia-and-sickle-cell-disease</loc>
  <lastmod>2021-10-05T12:37:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-submits-application-fda-kymriahtm-tisagenlecleucel-adult-patients-rr-dlbcl-seeking-second-indication-first-ever-fda-approved-car-t-therapy</loc>
  <lastmod>2021-10-05T12:37:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-present-first-its-kind-evidence-cosentyx-potential-maintain-mobility-patients-and-psa</loc>
  <lastmod>2021-10-05T12:37:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-planned-acquisition-advanced-accelerator-applications-strengthen-oncology-portfolio</loc>
  <lastmod>2021-10-05T12:37:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-paradigms-data-show-children-and-adolescents-ms-had-82-lower-relapse-rate-gilenya-vs-interferon-beta-1a</loc>
  <lastmod>2021-10-05T12:37:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-proposed-biosimilar-pegfilgrastim-accepted-ema-regulatory-review</loc>
  <lastmod>2021-10-05T12:37:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-confirms-leadership-multiple-sclerosis-ms-scientific-advancements-and-new-data-presented-ectrims</loc>
  <lastmod>2021-10-05T12:37:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-growth-top-and-bottom-line-all-divisions-q3</loc>
  <lastmod>2021-10-05T12:37:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-au-troisieme-trimestre-croissance-du-chiffre-daffaires-et-du-resultat-dans-toutes-les-divisions</loc>
  <lastmod>2021-10-05T12:37:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-steigert-im-dritten-quartal-umsatz-und-gewinn-allen-divisionen</loc>
  <lastmod>2021-10-05T12:37:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-combination-adjuvant-therapy-tafinlar-mekinist-receives-fda-breakthrough-therapy-designation-stage-iii-braf-v600-mutation-positive-melanoma-patients</loc>
  <lastmod>2021-10-05T12:37:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-revolade-shows-long-term-disease-control-chronicpersistent-immune-thrombocytopenia-itp</loc>
  <lastmod>2021-10-05T12:37:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-receives-ce-mark-first-its-kind-autonometm-preloaded-intraocular-lens-iol-delivery-system-clareon-iol</loc>
  <lastmod>2021-10-05T12:37:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-introduces-new-innovations-cataract-surgery-european-society-cataract-refractive-surgeons-2017-annual-congress</loc>
  <lastmod>2021-10-05T12:37:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-uc-berkeley-collaborate-tackle-undruggable-disease-targets</loc>
  <lastmod>2021-10-05T12:37:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-max-foundation-transform-pioneering-cancer-access-program-people-lower-income-countries</loc>
  <lastmod>2021-10-05T12:37:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-rydapt-midostaurin-receives-eu-approval-newly-diagnosed-flt3-mutated-acute-myeloid-leukemia-aml-and-three-types-advanced-systemic-mastocytosis-sm</loc>
  <lastmod>2021-10-05T12:37:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-xolair-confirms-re-treatment-efficacy-chronic-spontaneous-urticaria-patients-after-treatment-interruption</loc>
  <lastmod>2021-10-05T12:37:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-proposed-biosimilar-adalimumab-matches-reference-biologic-terms-efficacy-and-safety-long-term-study</loc>
  <lastmod>2021-10-05T12:37:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-sets-new-benchmark-psoriasis-robust-5-year-sustained-phase-iii-efficacy-and-safety-data</loc>
  <lastmod>2021-10-05T12:37:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-proposed-biosimilar-rituximab-accepted-review-fda</loc>
  <lastmod>2021-10-05T12:37:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-phase-iii-study-demonstrates-adjuvant-tafinlar-mekinist-reduced-risk-disease-recurrence-53-patients-resected-braf-v600-mutation-positive-melanoma</loc>
  <lastmod>2021-10-05T12:37:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-analysis-demonstrating-amg-334-erenumab-significantly-reduced-monthly-migraine-days-patients-who-failed-previous-preventive-therapies</loc>
  <lastmod>2021-10-05T12:37:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-landmark-phase-iii-trial-shows-fingolimod-significantly-reduces-relapses-children-and-adolescents-ms</loc>
  <lastmod>2021-10-05T12:37:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-ceo-joseph-jimenez-retire-from-novartis-2018-vasant-narasimhan-appointed-ceo-effective-february-1-2018</loc>
  <lastmod>2021-10-05T12:37:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-first-ever-fda-approval-car-t-cell-therapy-kymriahtm-ctl019-children-and-young-adults-b-cell-all-refractory-or-has-relapsed-least-twice</loc>
  <lastmod>2021-10-05T12:37:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-analysis-published-lancet-showing-acz885-reduced-lung-cancer-mortality-77-cantos-study-further-studies-planned</loc>
  <lastmod>2021-10-05T12:37:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-phase-iii-cantos-study-demonstrates-targeting-inflammation-acz885-reduces-cardiovascular-risk</loc>
  <lastmod>2021-10-05T12:37:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-appoints-bertrand-bodson-chief-digital-officer</loc>
  <lastmod>2021-10-05T12:37:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-ribociclib-receives-eu-approval-first-line-treatment-hrher2-locally-advanced-or-metastatic-breast-cancer-combination-any-aromatase-inhibitor</loc>
  <lastmod>2021-10-05T12:37:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-et-medicines-malaria-venture-lancent-une-etude-clinique-en-afrique-pour-kaf156-un-candidat-medicament-novateur-contre-le-paludisme-multiresistant</loc>
  <lastmod>2021-10-05T12:37:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-medicines-malaria-venture-launch-patient-trial-africa-kaf156-novel-compound-against-multidrug-resistant-malaria</loc>
  <lastmod>2021-10-05T12:37:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-und-medicines-malaria-venture-starten-afrika-eine-patientenstudie-mit-kaf156-einem-neuartigen-wirkstoff-gegen-multiresistente-malaria</loc>
  <lastmod>2021-10-05T12:37:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-expands-partnership-world-child-cancer-help-children-access-treatment-four-developing-countries</loc>
  <lastmod>2021-10-05T12:37:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-rydapt-midostaurin-newly-diagnosed-flt3-mutated-acute-myeloid-leukemia-aml-and-three-types-advanced-systemic-mastocytosis-sm</loc>
  <lastmod>2021-10-05T12:37:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/die-ergebnisse-im-zweiten-quartal-bestatigen-die-jahresprognosen-starke-forschungs-und-entwicklungsresultate-untermauern-das-potenzial-einiger-hoch-innovativer-produkte</loc>
  <lastmod>2021-10-05T12:37:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/les-resultats-du-t2-confirment-les-previsions-de-lexercice-2017-les-tres-bons-resultats-du-pipeline-etayent-le-potentiel-de-plusieurs-produits-hautement-novateurs</loc>
  <lastmod>2021-10-05T12:37:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/q2-results-confirm-full-year-guidance-strong-pipeline-results-underpin-potential-several-highly-innovative-products</loc>
  <lastmod>2021-10-05T12:37:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-confirms-5-year-data-first-and-only-fully-human-il-17a-inhibitor-cosentyx-reinforcing-sustained-efficacy-and-safety-profile-psoriasis</loc>
  <lastmod>2021-10-05T12:37:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-car-t-cell-therapy-ctl019-unanimously-10-0-recommended-approval-fda-advisory-committee-treat-pediatric-young-adult-rr-b-cell-all</loc>
  <lastmod>2021-10-05T12:38:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-approval-eu-cosentyx-label-update-includes-long-term-superiority-data-versus-stelara-psoriasis</loc>
  <lastmod>2021-10-05T12:38:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-eu-approval-first-line-use-zykadia-alk-positive-advanced-non-small-cell-lung-cancer-nsclc</loc>
  <lastmod>2021-10-05T12:38:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-approval-europe-erelzi-biosimilar-etanercept-treat-multiple-inflammatory-diseases</loc>
  <lastmod>2021-10-05T12:38:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/nejm-publishes-full-analysis-rydapt-midostaurin-phase-iii-ratify-trial-newly-diagnosed-flt3-mutated-acute-myeloid-leukemia-aml</loc>
  <lastmod>2021-10-05T12:38:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-ribociclib-receives-positive-chmp-opinion-first-line-treatment-hrher2-locally-advanced-or-metastatic-breast-cancer-combination-any-aromatase-inhibitor</loc>
  <lastmod>2021-10-05T12:38:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-shows-half-eligible-ph-cml-cp-patients-remain-treatment-free-remission-nearly-two-years-after-stopping-tasigna</loc>
  <lastmod>2021-10-05T12:38:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-pivotal-ctl019-6-month-follow-data-show-durable-remission-rates-children-young-adults-rr-b-cell-all</loc>
  <lastmod>2021-10-05T12:38:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-combination-targeted-therapy-tafinlar-mekinist-receives-fda-approval-braf-v600e-mutant-metastatic-non-small-cell-lung-cancer-nsclc</loc>
  <lastmod>2021-10-05T12:38:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-phase-iii-study-shows-acz885-canakinumab-reduces-cardiovascular-risk-people-who-survived-heart-attack</loc>
  <lastmod>2021-10-05T12:38:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-achieves-important-regulatory-milestone-amg-334-erenumab-migraine-prevention-ema-filing-acceptance</loc>
  <lastmod>2021-10-05T12:38:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-rth258-brolucizumab-demonstrates-robust-visual-gains-namd-patients-majority-12-week-injection-interval</loc>
  <lastmod>2021-10-05T12:38:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-real-world-study-shows-almost-half-chronic-urticaria-patients-are-not-receiving-any-treatment-despite-significant-disease-burden</loc>
  <lastmod>2021-10-05T12:38:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-approval-europe-rixathon-biosimilar-rituximab-treat-blood-cancers-and-immunological-diseases</loc>
  <lastmod>2021-10-05T12:38:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-international-ag-new-patient-survey-highlights-need-more-action-help-severe-asthma-patients-gain-control-their-disease</loc>
  <lastmod>2021-10-05T12:38:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-accepts-sandoz-regulatory-submission-generic-version-advair-diskus</loc>
  <lastmod>2021-10-05T12:38:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-shows-sustained-improvements-signs-and-symptoms-both-and-psa-80-patients-3-years</loc>
  <lastmod>2021-10-05T12:38:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-data-demonstrating-efficacy-amg-334-erenumab-migraine-prevention-american-headache-society-annual-meeting</loc>
  <lastmod>2021-10-05T12:38:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-interim-results-from-global-pivotal-ctl019-trial-show-durable-complete-responses-adults-rr-dlbcl</loc>
  <lastmod>2021-10-05T12:38:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-tasigna-receives-eu-approval-inclusion-treatment-free-remission-tfr-data-product-label</loc>
  <lastmod>2021-10-05T12:38:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-clinical-collaboration-bristol-myers-squibb-evaluate-potential-treatments-metastatic-colorectal-cancer</loc>
  <lastmod>2021-10-05T12:38:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-ground-breaking-collaboration-ibm-watson-health-outcomes-based-care-advanced-breast-cancer</loc>
  <lastmod>2021-10-05T12:38:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-landmark-study-tafinlar-mekinist-demonstrates-durable-survival-benefit-five-years-patients-braf-mutation-positive-metastatic-melanoma</loc>
  <lastmod>2021-10-05T12:38:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-updated-data-reinforce-efficacy-and-safety-kisqali-ribociclib-plus-letrozole-first-line-option-hrher2-advanced-or-metastatic-breast-cancer</loc>
  <lastmod>2021-10-05T12:38:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/progress-reported-global-fight-against-diarrheal-disease-cryptosporidiosis</loc>
  <lastmod>2021-10-05T12:38:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-proposed-biosimilars-adalimumab-and-infliximab-accepted-regulatory-review-european-medicines-agency</loc>
  <lastmod>2021-10-05T12:38:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/meet-novartis-management-investor-event-novartis-highlights-focus-innovation-and-productivity-expects-next-growth-phase-begin-2018</loc>
  <lastmod>2021-10-05T12:38:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-ernennt-dr-klaus-moosmayer-zum-chief-ethics-risk-and-compliance-officer</loc>
  <lastmod>2021-10-05T12:39:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-marks-new-era-migraine-patients-eu-approval-aimovig-first-its-kind-treatment-specifically-designed-migraine-prevention</loc>
  <lastmod>2021-10-05T12:39:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-european-commission-approval-biosimilar-hyrimoz-adalimumab</loc>
  <lastmod>2021-10-05T12:39:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-combination-tafinlar-mekinist-receives-positive-chmp-opinion-adjuvant-treatment-braf-v600-mutation-positive-melanoma</loc>
  <lastmod>2021-10-05T12:39:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-renews-drug-donation-egaten-triclabendazole-until-2022-reaffirming-its-commitment-fight-against-liver-fluke</loc>
  <lastmod>2021-10-05T12:39:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-demonstrates-commitment-lead-immuno-dermatology-licensing-il-17c-compound-atopic-dermatitis</loc>
  <lastmod>2021-10-05T12:39:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-now-first-and-only-cdk46-inhibitor-indicated-us-first-line-therapy-specifically-premenopausal-women-and-initial-therapy-fulvestrant-postmenopausal-women</loc>
  <lastmod>2021-10-05T12:39:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivers-solid-growth-second-quarter-and-continues-transformation-focused-medicines-company</loc>
  <lastmod>2021-10-05T12:39:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-realise-une-solide-croissance-au-deuxieme-trimestre-et-poursuit-sa-transformation-en-une-entreprise-axee-sur-les-medicaments</loc>
  <lastmod>2021-10-05T12:39:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-im-zweiten-quartal-ein-solides-wachstum-und-setzt-die-transformation-zu-einem-fokussierten-arzneimittelunternehmen-fort</loc>
  <lastmod>2021-10-05T12:39:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-kymriah-treating-two-aggressive-blood-cancers-marking-important-medical-advance-patients-europe</loc>
  <lastmod>2021-10-05T12:39:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erhalt-positive-chmp-stellungnahme-fur-kymriah-zur-behandlung-zweier-aggressiver-blutkrebsarten-ein-wichtiger-medizinischer-fortschritt-fur-patientinnen-und-patienten-europa</loc>
  <lastmod>2021-10-05T12:39:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-intention-seek-shareholder-approval-100-spinoff-alcon-eye-care-devices-business-initiates-share-buyback-usd-5-bn</loc>
  <lastmod>2021-10-05T12:39:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-gibt-absicht-bekannt-die-genehmigung-der-aktionare-fur-einen-100igen-spin-des-geschafts-mit-ophthalmologischen-produkten-von-alcon-einzuholen-und-leitet-gleichzeitig-einen-aktienruck</loc>
  <lastmod>2021-10-05T12:39:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-annonce-son-intention-de-solliciter-lapprobation-des-actionnaires-pour-la-scission-100-dalcon-sa-division-de-produits-ophtalmologiques-et-initie-un-rachat-dactions-hauteur-dusd</loc>
  <lastmod>2021-10-05T12:39:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-data-demonstrating-long-term-efficacy-safety-and-tolerability-aimovig-erenumab-patients-chronic-and-episodic-migraine</loc>
  <lastmod>2021-10-05T12:39:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-international-ag-global-study-novartis-and-european-migraine-and-headache-alliance-reveals-60-employed-people-severe-migraine-miss-average-week-work-month</loc>
  <lastmod>2021-10-05T12:39:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-clear-about-psoriasis-survey-data-highlights-challenges-psoriasis-patients-face-achieve-goal-clear-skin</loc>
  <lastmod>2021-10-05T12:39:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-international-ag-alcon-acrysof-iq-panoptix-trifocal-intraocular-lens-shows-superior-visual-performance-head-head-trial-post-cataract-surgery</loc>
  <lastmod>2021-10-05T12:39:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-juliet-trial-kymriah-demonstrates-more-one-year-durability-responses-adults-relapsed-or-refractory-dlbcl</loc>
  <lastmod>2021-10-05T12:39:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-survey-uncovers-real-world-impact-immune-thrombocytopenia-or-itp-rare-blood-disease-patients-quality-life</loc>
  <lastmod>2021-10-05T12:39:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-study-real-world-data-concludes-jakavi-associated-reduction-risk-death-and-dangerous-blood-clots-patients-rare-blood-cancer</loc>
  <lastmod>2021-10-05T12:39:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-presents-new-long-term-and-switching-data-biosimilars-zessly-infliximab-and-erelzi-etanercept-rheumatoid-arthritis</loc>
  <lastmod>2021-10-05T12:39:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-data-advance-understanding-role-il-17a-and-reinforce-cosentyx-leadership-spondyloarthritis</loc>
  <lastmod>2021-10-05T12:39:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-jco-publication-lutathera-netter-1-data-showing-significantly-longer-time-deterioration-key-quality-life-measures-patients-progressive-midgut-nets</loc>
  <lastmod>2021-10-05T12:39:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-schullabor-empfangt-hunderttausendsten-besucher</loc>
  <lastmod>2021-10-05T12:39:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/third-novartis-phase-iii-trial-shows-kisqali-combination-therapy-significantly-improves-pfs-hrher2-advanced-breast-cancer</loc>
  <lastmod>2021-10-05T12:39:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-data-presented-asco-find-nearly-half-cml-patients-treated-tasigna-remain-remission-almost-three-years-after-stopping-therapy</loc>
  <lastmod>2021-10-05T12:39:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-completes-sale-stake-consumer-healthcare-joint-venture-gsk-usd130-billion</loc>
  <lastmod>2021-10-05T12:40:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-positive-chmp-opinion-proposed-biosimilar-adalimumab</loc>
  <lastmod>2021-10-05T12:40:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-aimovig-erenumab-prevention-migraine</loc>
  <lastmod>2021-10-05T12:40:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-expedites-review-novartis-drug-promacta-first-line-severe-aplastic-anemia-saa</loc>
  <lastmod>2021-10-05T12:40:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-international-ag-patient-reported-outcomes-tool-revealed-significant-improvement-symptom-frequency-and-quality-life-domains-entresto</loc>
  <lastmod>2021-10-05T12:40:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-european-commission-approval-zessly-infliximab-gastroenterological-rheumatological-and-dermatological-diseases</loc>
  <lastmod>2021-10-05T12:40:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-amgen-announce-fda-approval-aimovigtm-erenumab-novel-treatment-developed-specifically-migraine-prevention</loc>
  <lastmod>2021-10-05T12:40:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-asco-and-eha-reinforce-companys-commitment-reimagining-cancer</loc>
  <lastmod>2021-10-05T12:40:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kundigt-veranderungen-der-geschaftsleitung</loc>
  <lastmod>2021-10-05T12:40:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/meet-novartis-management-investor-event-novartis-highlights-strategy-focus-company-and-drive-sustainable-growth</loc>
  <lastmod>2021-10-05T12:40:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-changes-executive-committee</loc>
  <lastmod>2021-10-05T12:40:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-successfully-completes-acquisition-avexis-inc</loc>
  <lastmod>2021-10-05T12:40:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-arrow-trial-assess-mechanistic-superiority-direct-il-17a-inhibition-cosentyx-over-il-23-inhibition-tremfya</loc>
  <lastmod>2021-10-05T12:40:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-completes-tender-offer-all-outstanding-shares-avexis-inc</loc>
  <lastmod>2021-10-05T12:40:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-fda-approval-gilenya-first-disease-modifying-therapy-pediatric-relapsing-multiple-sclerosis</loc>
  <lastmod>2021-10-05T12:40:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-cares-project-100-commits-reducing-cataract-blindness-globally</loc>
  <lastmod>2021-10-05T12:40:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-complete-response-letter-from-us-fda-proposed-biosimilar-rituximab</loc>
  <lastmod>2021-10-05T12:40:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/kymriah-tisagenlecleucel-first-class-car-t-therapy-from-novartis-receives-second-fda-approval-treat-appropriate-rr-patients-large-b-cell-lymphoma</loc>
  <lastmod>2021-10-05T12:40:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-proposed-acquisition-avexis</loc>
  <lastmod>2021-10-05T12:40:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-fda-approval-tafinlar-mekinist-adjuvant-treatment-braf-v600-mutant-melanoma</loc>
  <lastmod>2021-10-05T12:40:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-phase-iii-data-brolucizumab-demonstrate-reliability-12-week-treatment-interval</loc>
  <lastmod>2021-10-05T12:40:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-launches-focalview-app-providing-opportunity-patients-participate-ophthalmology-clinical-trials-from-home</loc>
  <lastmod>2021-10-05T12:40:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-analyses-aan-show-siponimods-efficacy-disability-and-cognition-secondary-progressive-ms-patients</loc>
  <lastmod>2021-10-05T12:40:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-appoints-john-tsai-head-global-drug-development-and-chief-medical-officer</loc>
  <lastmod>2021-10-05T12:40:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-strong-first-quarter-and-acted-become-more-focused-medicines-company</loc>
  <lastmod>2021-10-05T12:40:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-realise-une-bonne-performance-au-premier-trimestre-et-agi-pour-devenir-une-entreprise-plus-centree-sur-les-medicaments</loc>
  <lastmod>2021-10-05T12:40:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-verzeichnet-ein-starkes-erstes-quartal-und-ergreift-schritte-um-ein-starker-fokussiertes-arzneimittelunternehmen-zu-werden</loc>
  <lastmod>2021-10-05T12:40:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-signs-agreement-pear-therapeutics-develop-and-commercialize-prescription-digital-therapeutics-patients-substance-use-disorder-and-opioid-use-disorders</loc>
  <lastmod>2021-10-05T12:40:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-first-its-kind-evidence-aan-reinforcing-robust-and-consistent-efficacy-aimovigtm-erenumab-migraine-patients-multiple-treatment-failures</loc>
  <lastmod>2021-10-05T12:40:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-renews-commitment-malaria-elimination-investing-usd-100-million-research-and-develop-next-generation-antimalarials</loc>
  <lastmod>2021-10-05T12:40:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-bekraftigt-engagement-zur-eliminierung-von-malaria-und-investiert-usd-100-millionen-die-erforschung-und-entwicklung-der-nachsten-generation-von-malariamedikamenten</loc>
  <lastmod>2021-10-05T12:40:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-renouvelle-son-engagement-afin-deliminer-le-paludisme-en-investissant-100-millions-de-dollars-dans-la-recherche-et-le-developpement-dantipaludiques-de-nouvelle-generation</loc>
  <lastmod>2021-10-05T12:40:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-tender-offer-avexis-commences</loc>
  <lastmod>2021-10-05T12:40:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-new-analysis-demonstrating-entresto-helped-preserve-kidney-function-patients-chronic-heart-failure-especially-those-diabetes</loc>
  <lastmod>2021-10-05T12:40:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-enters-agreement-acquire-avexis-inc-usd-87-bn-transform-care-sma-and-expand-position-gene-therapy-and-neuroscience-leader</loc>
  <lastmod>2021-10-05T12:40:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-schliesst-vereinbarung-zum-erwerb-von-avexis-inc-fur-usd-87-mrd-ab-um-therapie-der-sma-zu-transformieren-und-position-als-fuhrendes-gentherapie-und-neuroscience-unternehmen-auszubauen</loc>
  <lastmod>2021-10-05T12:40:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-outlines-plans-next-healthcare-access-challenge-hack-support-local-digital-innovation</loc>
  <lastmod>2021-10-05T12:40:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-jama-cardiology-publication-data-showing-entresto-improves-physical-and-social-activity-hfref-patients-versus-enalapril</loc>
  <lastmod>2021-10-05T12:40:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-present-predictability-data-brolucizumab-namd-from-pivotal-hawk-and-harrier-trials-arvo</loc>
  <lastmod>2021-10-05T12:40:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-sell-stake-consumer-healthcare-joint-venture-gsk-usd130-billion-focus-strategic-priorities</loc>
  <lastmod>2021-10-05T12:40:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-verkauft-beteiligung-consumer-healthcare-joint-venture-fur-usd-13-milliarden-gsk-um-sich-auf-strategische-prioritaten-zu-konzentrieren</loc>
  <lastmod>2021-10-05T12:40:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-positive-chmp-opinion-proposed-biosimilar-infliximab</loc>
  <lastmod>2021-10-05T12:40:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/phase-iii-data-lancet-show-novartis-siponimod-significantly-improves-outcomes-patients-secondary-progressive-ms</loc>
  <lastmod>2021-10-05T12:40:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-drug-tasigna-approved-fda-treat-children-rare-form-leukemia</loc>
  <lastmod>2021-10-05T12:40:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-teams-harvard-develop-next-generation-biomaterial-systems-deliver-immunotherapies</loc>
  <lastmod>2021-10-05T12:40:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-changes-executive-committee-support-strategic-priorities</loc>
  <lastmod>2021-10-05T12:40:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kundigt-veranderungen-der-geschaftsleitung-zur-unterstutzung-strategischer-prioritaten</loc>
  <lastmod>2021-10-05T12:40:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-annonce-des-changements-au-sein-de-son-comite-de-direction-afin-de-soutenir-ses-priorites-strategiques</loc>
  <lastmod>2021-10-05T12:41:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-expands-alliance-science-37-advance-virtual-clinical-trials-program</loc>
  <lastmod>2021-10-05T12:41:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-xolair-recommended-new-global-chronic-urticaria-guideline</loc>
  <lastmod>2021-10-05T12:41:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-shareholders-approve-all-resolutions-proposed-board-directors-annual-general-meeting-0</loc>
  <lastmod>2021-10-05T12:41:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/les-actionnaires-de-novartis-approuvent-toutes-les-resolutions-proposees-par-le-conseil-dadministration-lors-de-lassemblee-generale</loc>
  <lastmod>2021-10-05T12:41:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-aktionare-genehmigen-der-ordentlichen-generalversammlung-alle-antrage-des-verwaltungsrats-0</loc>
  <lastmod>2021-10-05T12:41:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-pear-therapeutics-develop-digital-therapeutics-patients-schizophrenia-and-multiple-sclerosis</loc>
  <lastmod>2021-10-05T12:41:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/treatment-novartis-ultibro-breezhaler-improved-cardiac-function-copd-patients-lung-hyperinflation</loc>
  <lastmod>2021-10-05T12:41:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-new-data-show-cosentyx-improved-quality-life-over-5-years-two-thirds-patients-moderate-severe-plaque-psoriasis</loc>
  <lastmod>2021-10-05T12:41:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-new-cosentyx-data-confirms-robust-efficacy-and-quality-life-improvements-scalp-psoriasis</loc>
  <lastmod>2021-10-05T12:41:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-forms-alliance-develop-medicines-treating-infectious-diarrheal-disease</loc>
  <lastmod>2021-10-05T12:41:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-us-fda-approval-and-launch-glatopa-40-mgml-three-times-week-generic-option-relapsing-forms-multiple-sclerosis</loc>
  <lastmod>2021-10-05T12:41:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-fda-approval-cosentyx-label-update-include-moderate-severe-scalp-psoriasis</loc>
  <lastmod>2021-10-05T12:41:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-completes-subsequent-offering-period-tender-offer-advanced-accelerator-applications-sa</loc>
  <lastmod>2021-10-05T12:41:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-nejm-publication-updated-analysis-from-eliana-trial-showing-longer-term-durable-remissions-kymriahtm-children-young-adults-rr-all</loc>
  <lastmod>2021-10-05T12:41:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/advanced-accelerator-applications-receives-fda-approval-lutathera-treatment-gastroenteropancreatic-neuroendocrine-tumors</loc>
  <lastmod>2021-10-05T12:41:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-exclusively-licenses-first-ophthalmology-gene-therapy-all-markets-outside-us-milestone-patients-rare-inherited-vision-loss</loc>
  <lastmod>2021-10-05T12:41:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-good-operational-performance-and-landmark-innovation-2017-entering-our-next-growth-phase</loc>
  <lastmod>2021-10-05T12:41:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-enregistre-en-2017-une-belle-performance-operationnelle-et-des-innovations-majeures-entrant-ainsi-dans-une-nouvelle-phase-de-croissance</loc>
  <lastmod>2021-10-05T12:41:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-2017-eine-gute-operative-performance-sowie-wegweisende-innovationen-und-ist-gut-gerustet-fur-die-nachste-wachstumsphase</loc>
  <lastmod>2021-10-05T12:41:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-reports-erenumab-met-all-primary-and-secondary-endpoints-unique-phase-iiib-study-episodic-migraine-patients-who-have-failed-multiple-prior-preventive-treatments</loc>
  <lastmod>2021-10-05T12:41:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-completes-tender-offer-advanced-accelerator-applications-sa-and-announces-commencement-subsequent-offering-period</loc>
  <lastmod>2021-10-05T12:41:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-exclusive-global-collaboration-biocon-next-generation-biosimilars</loc>
  <lastmod>2021-10-05T12:41:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-granted-us-fda-priority-review-kymriahtm-tisagenlecleucel-formerly-ctl019-adults-rr-dlbcl</loc>
  <lastmod>2021-10-05T12:41:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/europe-africa-partnership-spearheads-development-next-generation-antimalarial-drug</loc>
  <lastmod>2023-07-03T16:44:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-drives-differentiated-portfolio-deal-commercialize-new-treatment-opioid-induced-constipation-key-european-countries</loc>
  <lastmod>2021-10-05T12:42:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-continues-transformation-leading-medicines-company-completion-alcon-spin</loc>
  <lastmod>2021-10-05T12:42:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-updates-migraine-collaboration-amgen</loc>
  <lastmod>2021-10-05T12:42:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-resubmits-biosimilar-pegfilgrastim-application-us-fda</loc>
  <lastmod>2021-10-05T12:42:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-first-class-cosentyx-approved-china-psoriasis-patients</loc>
  <lastmod>2021-10-05T12:42:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-expands-world-leading-gene-therapy-manufacturing-capacity-purchase-advanced-biologics-therapy-manufacturing-campus-longmont-colorado</loc>
  <lastmod>2021-10-05T12:42:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-adds-clinical-and-preclinical-anti-inflammatory-programs-portfolio-acquisition-ifm-tre</loc>
  <lastmod>2021-10-05T12:42:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-fda-approval-mayzent-siponimod-first-oral-drug-treat-secondary-progressive-ms-active-disease</loc>
  <lastmod>2021-10-05T12:42:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-plans-alcon-spin-april-9-2019</loc>
  <lastmod>2021-10-05T12:43:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-announces-acquisition-powervision-inc</loc>
  <lastmod>2021-10-05T12:43:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-joins-global-chagas-disease-coalition-and-also-announces-first-multinational-prospective-randomized-study-people-chronic-chagas-cardiomyopathy</loc>
  <lastmod>2021-10-05T12:43:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-change-sandoz-leadership</loc>
  <lastmod>2021-10-05T12:43:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/three-winners-2019-sandoz-healthcare-access-challenge-hack-are-announced-sxsw</loc>
  <lastmod>2021-10-05T12:43:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-shows-superior-improvements-psoriasis-patients-quality-life-versus-janssens-il-23-stelara</loc>
  <lastmod>2021-10-05T12:43:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-confirm-rapid-response-and-high-efficacy-cosentyx-psoriasis-patients-first-time-china</loc>
  <lastmod>2021-10-05T12:43:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-shareholders-approve-all-resolutions-proposed-board-directors-annual-general-meeting-1</loc>
  <lastmod>2021-10-05T12:43:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/die-aktionare-von-novartis-heissen-der-generalversammlung-alle-antrage-des-verwaltungsrates-gut</loc>
  <lastmod>2021-10-05T12:43:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/les-actionnaires-de-novartis-approuvent-toutes-les-resolutions-proposees-par-le-conseil-dadministration-lors-de-lassemblee-generale-0</loc>
  <lastmod>2021-10-05T12:43:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-issues-summary-financial-information-alcon-eye-care-business-ahead-shareholder-vote-proposed-spin</loc>
  <lastmod>2021-10-05T12:43:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-pursue-transformational-therapy-reduce-risk-cardiovascular-disease-people-living-elevated-levels-inherited-lipoproteina</loc>
  <lastmod>2021-10-05T12:43:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-fda-approval-egaten-treatment-fascioliasis-neglected-tropical-disease</loc>
  <lastmod>2021-10-05T12:43:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-strong-sales-growth-core-margin-expansion-built-leading-advanced-therapy-platforms-and-focused-company-2018</loc>
  <lastmod>2021-10-05T12:43:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/en-2018-novartis-enregistre-une-forte-croissance-de-ses-ventes-avec-une-expansion-de-sa-marge-core-developpe-des-plates-formes-leaders-de-traitements-de-pointe-et-recentre-lentreprise</loc>
  <lastmod>2021-10-05T12:43:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-2018-ein-kraftiges-umsatzwachstum-bei-gleichzeitiger-steigerung-der-kerngewinnmarge-baut-wegweisende-therapieplattformen-auf-und-fokussiert-das-unternehmen</loc>
  <lastmod>2021-10-05T12:43:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-investigational-therapy-crizanlizumab-seg101-receives-fda-breakthrough-therapy-designation-prevention-vaso-occlusive-crises-sickle-cell-disease</loc>
  <lastmod>2021-10-05T12:43:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-and-pear-therapeutics-announce-us-launch-reset-otm-help-treat-opioid-use-disorder</loc>
  <lastmod>2021-10-05T12:43:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-successfully-completes-acquisition-endocyte</loc>
  <lastmod>2021-10-05T12:43:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-european-commission-ec-approval-expanded-indication-kisqali-ribociclib</loc>
  <lastmod>2021-10-05T12:43:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-offer-acquire-cellforcure-expand-manufacturing-capacity-innovative-cell-and-gene-therapies</loc>
  <lastmod>2021-10-05T12:43:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-new-ceo-oncology-business-unit</loc>
  <lastmod>2021-10-05T12:43:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-enters-commercialization-and-supply-agreement-insulin-biosimilars-anticipating-growing-demand-diabetes-burden-rises</loc>
  <lastmod>2021-10-05T12:43:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-announces-acquisition-tear-film-innovations-inc</loc>
  <lastmod>2021-10-05T12:43:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-european-commission-approval-self-administration-xolair-across-all-indications</loc>
  <lastmod>2021-10-05T12:43:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-inc-and-pear-therapeutics-obtain-fda-clearance-reset-otm-treat-opioid-use-disorder</loc>
  <lastmod>2021-10-05T12:43:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-demonstrates-consistent-efficacy-and-tolerability-kisqali-combination-therapy-hrher2-advanced-breast-cancer-patients-difficult-treat-visceral-disease</loc>
  <lastmod>2021-10-05T12:43:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-investigational-byl719-alpelisib-plus-fulvestrant-consistently-improved-pfs-patients-pik3ca-mutated-hrher2-advanced-breast-cancer-new-solar-1-analyses</loc>
  <lastmod>2021-10-05T12:43:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-advances-ligelizumab-qge031-urticaria-phase-iii-basis-strong-phase-ii-head-head-data</loc>
  <lastmod>2021-10-05T12:43:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-fda-filing-acceptance-and-priority-review-avxs-101-one-time-treatment-designed-address-genetic-root-cause-sma-type-1</loc>
  <lastmod>2021-10-05T12:44:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/real-world-data-show-novartis-drug-revolade-improves-outcomes-itp-patients-compared-other-second-line-therapies</loc>
  <lastmod>2021-10-05T12:44:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-longer-term-analyses-from-pivotal-kymriah-trials-showed-durable-responses-are-maintained-patients-advanced-blood-cancers</loc>
  <lastmod>2021-10-05T12:44:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-new-crizanlizumab-seg101-data-analysis-sickle-cell-disease-and-investment-sentry-clinical-program</loc>
  <lastmod>2021-10-05T12:44:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-eu-approval-gilenya-children-and-adolescents-ms-making-it-first-and-only-oral-disease-modifying-treatment-these-patients-europe</loc>
  <lastmod>2021-10-05T12:44:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-eighth-european-commission-approval-biosimilar-ziextenzo-pegfilgrastim</loc>
  <lastmod>2021-10-05T12:44:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-highlight-its-vision-strategy-and-benefits-standalone-company-investors-and-analysts-new-york-and-london</loc>
  <lastmod>2021-10-05T12:44:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-landmark-eu-approval-one-time-gene-therapy-luxturna-restore-vision-people-rare-inherited-retinal-disease</loc>
  <lastmod>2021-10-05T12:44:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-rises-second-place-2018-access-medicine-index</loc>
  <lastmod>2021-10-05T12:44:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-and-pear-therapeutics-announce-launch-reset-treatment-patients-substance-use-disorder</loc>
  <lastmod>2021-10-05T12:44:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-approves-novartis-drug-promacta-first-line-saa-and-grants-breakthrough-therapy-designation-additional-new-indication</loc>
  <lastmod>2021-10-05T12:44:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-expand-kisqali-combination-therapy-all-women-hrher2-locally-advanced-or-metastatic-breast-cancer</loc>
  <lastmod>2021-10-05T12:44:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-files-initial-form-20-f-registration-statement-sec-proposed-spinoff-plans-investor-days-new-york-and-london</loc>
  <lastmod>2021-10-05T12:44:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-study-supports-entresto-foundational-hfref-therapy-and-hospital-initiation-appropriate-stabilized-heart-failure-patients</loc>
  <lastmod>2021-10-05T12:44:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-rd-update-highlights-industry-leading-development-pipeline-including-potential-blockbusters-and-advanced-therapy-platforms</loc>
  <lastmod>2021-10-05T12:44:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-decides-not-pursue-us-biosimilar-rituximab-will-focus-robust-biosimilar-portfolio-unmet-access-and-sustainability-needs</loc>
  <lastmod>2021-10-05T12:44:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-ash-and-sabcs-show-strength-pipeline-and-portfolio-hematology-and-oncology</loc>
  <lastmod>2021-10-05T12:44:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-us-fda-approval-biosimilar-hyrimoztm-adalimumab-adaz</loc>
  <lastmod>2021-10-05T12:44:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-clinical-collaboration-pfizer-advance-treatment-nash</loc>
  <lastmod>2021-10-05T12:44:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/two-year-data-novartis-brolucizumab-reaffirm-superiority-versus-aflibercept-reducing-retinal-fluid-patients-namd</loc>
  <lastmod>2021-10-05T12:44:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-approval-cosentyx-label-update-europe-include-dosing-flexibility-psoriatic-arthritis</loc>
  <lastmod>2021-10-05T12:44:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-develop-smart-suite-digital-health-platform-cataract-surgery</loc>
  <lastmod>2021-10-05T12:44:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-lancet-publication-pioneering-study-migraine-prevention-showing-efficacy-aimovig-where-other-treatments-have-failed</loc>
  <lastmod>2021-10-05T12:44:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-combi-ad-study-tafinlar-mekinist-continues-demonstrate-relapse-free-survival-benefit-patients-braf-v600-mutant-stage-iii-melanoma</loc>
  <lastmod>2021-10-05T12:44:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-investigational-byl719-alpelisib-plus-fulvestrant-nearly-doubles-median-pfs-patients-pik3ca-mutated-hrher2-advanced-breast-cancer-compared-fulvestrant-alone</loc>
  <lastmod>2021-10-05T12:44:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-phase-ii-geometry-mono-1-trial-investigational-medicine-capmatinib-inc280-shows-positive-results-patients-met-mutated-advanced-nsclc</loc>
  <lastmod>2021-10-05T12:44:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-presentation-new-lutathera-netter-1-data-esmo-demonstrating-significant-improvement-pfs-regardless-baseline-liver-tumor-burden</loc>
  <lastmod>2021-10-05T12:44:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-planned-acquisition-endocyte-expand-expertise-radiopharmaceuticals-and-build-commitment-transformational-therapeutic-platforms</loc>
  <lastmod>2021-10-05T12:44:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-strong-growth-and-innovation-during-third-quarter-including-progressing-advanced-therapy-platforms-drive-future-growth</loc>
  <lastmod>2021-10-05T12:44:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-enregistre-au-troisieme-trimestre-une-forte-croissance-et-fait-preuve-dune-innovation-dynamique-incluant-des-plateformes-therapeutiques-avancees-pour-soutenir-la-croissance-future</loc>
  <lastmod>2021-10-05T12:44:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-im-dritten-quartal-starkes-wachstum-und-treibt-innovationen-wie-fortschrittliche-therapieplattformen-voran-um-das-zukunftige-wachstum-zu-beschleunigen</loc>
  <lastmod>2021-10-05T12:44:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-5-year-data-psoriatic-arthritis-and-ankylosing-spondylitis-reinforces-cosentyx-leadership-spondyloarthritis</loc>
  <lastmod>2021-10-05T12:44:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-global-resolution-biosimilar-adalimumab-patent-disputes-securing-patient-access</loc>
  <lastmod>2021-10-05T12:44:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-new-data-from-first-direct-head-head-trial-demonstrate-superior-efficacy-gilenya-over-copaxone-patients-relapsing-remitting-multiple-sclerosis</loc>
  <lastmod>2021-10-05T12:44:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/breadth-data-ectrims-underpins-novartis-relentless-commitment-decoding-science-multiple-sclerosis-ms-and-decreasing-patient-burden</loc>
  <lastmod>2021-10-05T12:44:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-analysis-shows-crizanlizumab-seg101-increased-number-patients-free-sickle-cell-pain-crises-vs-placebo-during-sustain-study</loc>
  <lastmod>2021-10-05T12:44:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-fda-and-ema-filing-acceptance-siponimod-first-and-only-drug-shown-meaningfully-delay-disability-progression-typical-spms-patients</loc>
  <lastmod>2021-10-05T12:44:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-healthcare-access-challenge-hack-returns-seeking-digital-solutions-local-healthcare-access-challenges</loc>
  <lastmod>2021-10-05T12:44:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-licenses-three-novel-anti-infective-programs-boston-pharmaceuticals</loc>
  <lastmod>2021-10-05T12:44:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-five-grant-recipients-excellence-ophthalmology-vision-award-xova-nonprofit-sustainable-eye-health-initiatives</loc>
  <lastmod>2021-10-05T12:45:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-file-new-lucentis-ranibizumab-indication-retinopathy-prematurity-rop-rare-disease-premature-infants-often-leads-blindness</loc>
  <lastmod>2021-10-05T12:45:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-analysis-novartis-phase-iii-brolucizumab-rth258-data-reinforces-superior-reduction-retinal-fluid-key-marker-disease-activity-namd</loc>
  <lastmod>2021-10-05T12:45:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-positive-chmp-opinion-proposed-biosimilar-pegfilgrastim</loc>
  <lastmod>2021-10-05T12:45:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-gilenya-treatment-children-and-adolescents-ms-marking-major-medical-advance-young-ms-patients-europe</loc>
  <lastmod>2021-10-05T12:45:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-positive-chmp-opinion-one-time-gene-therapy-luxturna-treat-children-and-adults-rare-inherited-retinal-disease</loc>
  <lastmod>2021-10-05T12:45:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/worlds-largest-alzheimers-survey-reveals-most-adults-believe-cure-will-be-developed-their-lifetime</loc>
  <lastmod>2021-10-05T12:45:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/launch-alcon-experience-academy-reinforces-commitment-training-and-education-eye-care-professionals</loc>
  <lastmod>2021-10-05T12:45:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-real-world-evidence-confirms-efficacy-and-safety-benefits-cosentyx-daily-life-psoriasis-patients</loc>
  <lastmod>2021-10-05T12:45:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-nejm-publication-landmark-paradigms-study-demonstrating-significant-benefit-gilenya-children-and-adolescents-ms</loc>
  <lastmod>2021-10-05T12:45:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-survey-shows-psoriasis-patients-want-treatment-effect-beyond-clear-skin</loc>
  <lastmod>2021-10-05T12:45:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-confirms-commitment-switzerland-ahead-proposed-spinoff-from-novartis</loc>
  <lastmod>2021-10-05T12:45:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-bestatigt-vor-dem-vorgeschlagenen-spin-von-novartis-das-engagement-der-schweiz</loc>
  <lastmod>2021-10-05T12:45:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-confirme-son-engagement-envers-la-suisse-en-perspective-de-la-scission-proposee-avec-novartis</loc>
  <lastmod>2021-10-05T12:45:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-divest-sandoz-us-dermatology-business-and-generic-us-oral-solids-portfolio-aurobindo</loc>
  <lastmod>2021-10-05T12:45:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/european-commission-approves-novartis-combination-therapy-tafinlar-mekinist-adjuvant-treatment-braf-v600-mutation-positive-melanoma</loc>
  <lastmod>2021-10-05T12:45:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/alcon-announces-voluntary-global-market-withdrawal-cypass-micro-stent-surgical-glaucoma</loc>
  <lastmod>2021-10-05T12:45:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-european-commission-approval-its-car-t-cell-therapy-kymriah-tisagenlecleucel</loc>
  <lastmod>2021-10-05T12:45:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erhalt-die-zulassung-fur-seine-car-t-zell-therapie-kymriah-tisagenlecleucel-von-der-europaischen-kommission</loc>
  <lastmod>2021-10-05T12:45:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-new-data-show-entresto-sacubitrilvalsartan-can-be-initiated-early-safely-hospitalized-patients-after-acute-heart-failure-episode</loc>
  <lastmod>2021-10-05T12:45:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/solar-1-trial-novartis-investigational-alpha-specific-pi3k-inhibitor-byl719-alpelisib-meets-primary-endpoint-hrher2-advanced-breast-cancer-pik3ca-mutation</loc>
  <lastmod>2021-10-05T12:45:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-appoints-dr-klaus-moosmayer-chief-ethics-risk-and-compliance-officer</loc>
  <lastmod>2021-10-05T12:45:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-breadth-data-2019-ash-demonstrates-commitment-reimagining-medicine-hematology-through-innovative-therapeutic-platforms</loc>
  <lastmod>2021-10-05T12:50:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-acquire-medicines-company-usd-97-bn-adding-inclisiran-potentially-transformational-investigational-cholesterol-lowering-therapy-address-leading-global-cause-death</loc>
  <lastmod>2021-10-05T12:50:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-launches-innovation-prize-assistive-tech-encourage-new-technologies-address-unmet-needs-multiple-sclerosis-community</loc>
  <lastmod>2021-10-05T12:50:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-paragon-hf-analyses-suggest-entresto-benefit-beyond-hfref</loc>
  <lastmod>2021-10-05T12:50:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-medicine-adakveo-crizanlizumab-approved-fda-reduce-frequency-pain-crises-individuals-living-sickle-cell-disease</loc>
  <lastmod>2021-10-05T12:50:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-mayzent-siponimod-treatment-adult-patients-active-secondary-progressive-multiple-sclerosis-spms</loc>
  <lastmod>2021-10-05T12:50:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-new-strategy-provide-innovative-medicines-more-patients-sub-saharan-africa</loc>
  <lastmod>2021-10-05T12:50:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-presents-real-world-data-showing-effectiveness-erelzi-etanercept-szzs-rheumatic-disease-treatment</loc>
  <lastmod>2021-10-05T12:50:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-prevent-data-show-cosentyx-delivers-early-relief-axial-spondyloarthritis</loc>
  <lastmod>2021-10-05T12:50:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-show-tropifexor-ljn452-significantly-improves-several-key-biomarkers-nash-patients-moderate-severe-fibrosis</loc>
  <lastmod>2021-10-05T12:50:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-agreement-acquire-aspens-japanese-operations-and-associated-assets-strengthening-position-worlds-third-largest-generics-market</loc>
  <lastmod>2021-10-05T12:50:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-us-fda-approval-long-acting-oncology-supportive-care-biosimilar-ziextenzotm-pegfilgrastim-bmez</loc>
  <lastmod>2021-10-05T12:50:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-shows-encouraging-results-versus-humira-from-first-its-kind-head-head-trial-psoriatic-arthritis</loc>
  <lastmod>2021-10-05T12:50:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-avxs-101-intrathecal-study-update</loc>
  <lastmod>2021-10-05T12:50:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-approval-cosentyx-label-update-europe-include-dosing-flexibility-ankylosing-spondylitis</loc>
  <lastmod>2021-10-05T12:50:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-another-strong-quarter-double-digit-sales-growth-and-core1-margin-expansion-2019-sales-and-profit-guidance-raised-beovu-launched-us</loc>
  <lastmod>2021-10-05T12:50:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-verzeichnet-ein-weiteres-starkes-quartal-mit-zweistelligem-umsatz-wachstum-und-hoherer-kerngewinnmarge1-umsatz-und-gewinnerwartung-fur-2019-angehoben-us-einfuhrung-von-beovu</loc>
  <lastmod>2021-10-05T12:50:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-encore-un-fort-trimestre-croissance-deux-chiffres-des-ventes-et-expansion-de-la-marge-core1-hausse-des-previsions-de-chiffre-daffaires-et-de-resultat-en-2019-beovu-lance-aux-usa</loc>
  <lastmod>2021-10-05T12:50:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-jakavi-ruxolitinib-meets-primary-endpoint-phase-iii-study-acute-graft-versus-host-disease</loc>
  <lastmod>2021-10-05T12:50:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-show-cosentyx-treatment-results-rapid-and-sustained-resolution-signs-and-symptoms-psoriatic-arthritis-patients-and-without-enthesitis</loc>
  <lastmod>2021-10-05T12:50:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-real-world-evidence-confirms-high-efficacy-long-term-response-and-favorable-safety-profile-cosentyx-clinical-practice</loc>
  <lastmod>2021-10-05T12:50:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-show-more-patients-are-completely-symptom-free-from-chronic-spontaneous-urticaria-ligelizumab-qge031-xolair-300-mg</loc>
  <lastmod>2021-10-05T12:50:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-fda-approval-beovu-offering-wet-amd-patients-vision-gains-and-greater-fluid-reductions-vs-aflibercept</loc>
  <lastmod>2021-10-05T12:50:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-presents-updated-strong-data-wms</loc>
  <lastmod>2021-10-05T12:50:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-positive-52-week-prevent-data-confirm-cosentyx-efficacy-addressing-entire-axspa-spectrum</loc>
  <lastmod>2021-10-05T12:50:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-microsoft-announce-collaboration-transform-medicine-artificial-intelligence</loc>
  <lastmod>2021-10-05T12:50:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-positive-results-from-phase-iii-palladium-study-inhaled-combination-qmf149-patients-uncontrolled-asthma</loc>
  <lastmod>2021-10-05T12:50:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-positive-results-from-phase-iii-iridium-study-inhaled-combination-qvm149-patients-uncontrolled-asthma</loc>
  <lastmod>2021-10-05T12:50:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-delivers-consistently-superior-overall-survival-monaleesa-3-trial-demonstrates-more-life-postmenopausal-hrher2-advanced-breast-cancer-patients</loc>
  <lastmod>2021-10-05T12:50:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-presents-new-data-epns-continuing-show-significant-therapeutic-benefit-zolgensma-prolonging-event-free-survival-now-5-years-age-patients-spinal-muscular-atrophy-sma-type-1</loc>
  <lastmod>2021-10-05T12:50:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/positive-results-from-novartis-five-year-verify-study-type-2-diabetes-demonstrate-long-term-clinical-benefits-early-combination-treatment-galvus-and-metformin</loc>
  <lastmod>2021-10-05T12:50:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-positive-16-week-prevent-results-advance-potential-new-indication-patients-axial-spondyloarthritis</loc>
  <lastmod>2021-10-05T12:50:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-phase-iii-asclepios-trials-demonstrate-robust-efficacy-ofatumumab-patients-relapsing-multiple-sclerosis</loc>
  <lastmod>2021-10-05T12:50:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-data-show-neuronal-and-glial-filaments-biomarkers-disease-activity-have-potential-support-decision-making-management-multiple-sclerosis-ms-patient</loc>
  <lastmod>2021-10-05T12:50:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-data-show-mayzent-can-help-preserve-mobility-longer-patients-secondary-progressive-multiple-sclerosis-spms</loc>
  <lastmod>2021-10-05T12:50:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-ectrims-highlight-innovative-approach-reimagining-care-people-living-multiple-sclerosis-ms</loc>
  <lastmod>2021-10-05T12:50:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-confirm-long-term-efficacy-and-safety-aimovig-majority-patients-episodic-migraine</loc>
  <lastmod>2021-10-05T12:50:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-investigational-lung-cancer-therapy-capmatinib-inc280-granted-fda-breakthrough-therapy-designation-patients-met-mutated-advanced-non-small-cell-lung-cancer</loc>
  <lastmod>2021-10-05T12:50:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-study-shows-migraine-support-workplace-can-improve-employee-quality-life</loc>
  <lastmod>2021-10-05T12:50:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-global-deal-commercialize-proposed-biosimilar-natalizumab-key-multiple-sclerosis-medicine</loc>
  <lastmod>2021-10-05T12:51:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/entresto-improved-measures-heart-structure-and-function-hfref-patients-new-novartis-study-additional-data-complement-findings</loc>
  <lastmod>2021-10-05T12:51:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-paragon-hf-trial-suggests-entresto-benefit-hfpef-patients-narrowly-misses-primary-endpoint</loc>
  <lastmod>2021-10-05T12:51:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-ofatumumab-demonstrates-superiority-versus-aubagio-two-head-head-phase-iii-multiple-sclerosis-studies</loc>
  <lastmod>2021-10-05T12:51:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-present-new-entresto-hfpef-and-hfref-data-esc-congress-2019</loc>
  <lastmod>2021-10-05T12:51:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-will-appeal-district-court-new-jersey-ruling-biosimilar-erelzi-etanercept-szzs-us-patent-case</loc>
  <lastmod>2021-10-05T12:51:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-stands-behind-zolgensma-onasemnogene-abeparvovec-xioi-treatment-children-less-2-years-age-spinal-muscular-atrophy</loc>
  <lastmod>2021-10-05T12:51:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-significantly-prolongs-life-women-hrher2-advanced-breast-cancer-now-two-distinct-phase-iii-trials</loc>
  <lastmod>2021-10-05T12:51:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-phase-iii-paragon-hf-trial-heart-failure-patients-preserved-ejection-fraction-hfpef</loc>
  <lastmod>2021-10-05T12:51:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-lucentis-treatment-preterm-infants-retinopathy-prematurity-rop-disease-causing-visual-impairment-and-blindness</loc>
  <lastmod>2021-10-05T12:51:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-first-patient-enrolled-clinical-study-proposed-biosimilar-denosumab-osteoporosis</loc>
  <lastmod>2021-10-05T12:51:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-key-multiple-sclerosis-product-gilenya-approved-china</loc>
  <lastmod>2021-10-05T12:51:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivers-strong-sales-double-digit-core-operating-income-growth-and-launches-zolgensma-and-piqray-second-quarter-sales-and-profit-guidance-increased</loc>
  <lastmod>2021-10-05T12:51:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-au-2e-trimestre-fortes-ventes-croissance-deux-chiffres-du-resultat-operationnel-core-et-lancements-de-zolgensma-et-de-piqray-prevision-des-ventes-et-du-resultat-revue-la-hausse</loc>
  <lastmod>2021-10-05T12:51:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-im-zweiten-quartal-starke-umsatze-eine-zweistellige-steigerung-des-operativen-kernergebnisses-und-lanciert-zolgensma-und-piqray-anhebung-der-umsatz-und-gewinnerwartung</loc>
  <lastmod>2021-10-05T12:51:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-accepts-file-and-accelerates-review-novartis-sickle-cell-disease-medicine-crizanlizumab-seg101</loc>
  <lastmod>2021-10-05T12:51:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-amgen-and-banner-alzheimers-institute-discontinue-clinical-program-bace-inhibitor-cnp520-alzheimers-prevention</loc>
  <lastmod>2021-10-05T12:51:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-launches-oncology-generic-gefitinib-13-eu-countries-loss-market-exclusivity-expanding-access-essential-medicine</loc>
  <lastmod>2021-10-05T12:51:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-cognition-data-secondary-progressive-multiple-sclerosis-spms</loc>
  <lastmod>2021-10-05T12:51:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-successfully-completes-acquisition-xiidra-bolstering-ophthalmic-portfolio</loc>
  <lastmod>2021-10-05T12:51:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-show-aimovig-cuts-acute-migraine-medication-days-half-patients-who-failed-prior-preventive-therapies</loc>
  <lastmod>2021-10-05T12:51:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-underpin-long-term-efficacy-aimovig-where-other-treatments-have-failed</loc>
  <lastmod>2021-10-05T12:51:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-new-publication-showing-il-17a-antibody-cosentyx-improves-inflammation-and-rapidly-suppresses-il-23-plaque-psoriasis</loc>
  <lastmod>2021-10-05T12:51:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-phase-2b-encore-lf-trial-nash-cirrhosis</loc>
  <lastmod>2021-10-05T12:51:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-analysis-novartis-data-confirms-cosentyx-demonstrates-durable-comprehensive-treatment-across-psoriatic-disease</loc>
  <lastmod>2021-10-05T12:51:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-sandoz-biosimilar-adalimumab-data-confirms-switching-from-reference-biologic-has-no-impact-safety-or-efficacy</loc>
  <lastmod>2021-10-05T12:51:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-continues-innovate-cml-long-term-treatment-free-remission-results-following-tasigna-use-and-promising-combination-data-investigational-compound-asciminib-abl001</loc>
  <lastmod>2021-10-05T12:51:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/three-quarters-people-living-axial-spondyloarthritis-struggle-find-job-imas-survey-shows</loc>
  <lastmod>2021-10-05T12:51:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/cosentyx-provides-long-lasting-inhibition-radiographic-progression-psoriatic-arthritis-new-novartis-data-show</loc>
  <lastmod>2021-10-05T12:51:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-first-show-efficacy-all-key-manifestations-psoriatic-arthritis</loc>
  <lastmod>2021-10-05T12:51:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-new-leader-pharmaceuticals-business-unit</loc>
  <lastmod>2021-10-05T12:51:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-stellt-neue-leiterin-der-pharmaceuticals-business-unit-vor</loc>
  <lastmod>2021-10-05T12:51:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/advanced-accelerator-applications-receives-positive-chmp-opinion-lysakare</loc>
  <lastmod>2021-10-05T12:51:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-first-its-kind-histology-data-iscalimab-cfz533-suggesting-extended-survival-transplanted-organs-may-be-possible</loc>
  <lastmod>2021-10-05T12:51:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/long-term-survival-benefit-shown-metastatic-melanoma-patients-treated-novartis-tafinlar-mekinist</loc>
  <lastmod>2021-10-05T12:51:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-shows-growing-strength-lung-cancer-innovation-new-capmatinib-investigational-data-and-novel-canakinumab-clinical-trials</loc>
  <lastmod>2021-10-05T12:51:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/xolair-omalizumab-significantly-reduced-nasal-polyps-and-congestion-symptoms-adults-chronic-rhinosinusitis-nasal-polyps-two-phase-iii-studies</loc>
  <lastmod>2021-10-05T12:51:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-significantly-extends-life-women-hrher2-advanced-breast-cancer-monaleesa-7-trial</loc>
  <lastmod>2021-10-05T12:51:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-phase-iii-quartz-study-new-investigational-inhaled-combination-treatment-qmf149-meets-primary-and-key-secondary-endpoints-patients-inadequately-controlled-asthma</loc>
  <lastmod>2021-10-05T12:51:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-approves-novartis-piqray-first-and-only-treatment-specifically-patients-pik3ca-mutation-hrher2-advanced-breast-cancer</loc>
  <lastmod>2021-10-05T12:51:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-announces-innovative-zolgensma-gene-therapy-access-programs-us-payers-and-families</loc>
  <lastmod>2021-10-05T12:51:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-receives-fda-approval-zolgensma-first-and-only-gene-therapy-pediatric-patients-spinal-muscular-atrophy-sma</loc>
  <lastmod>2021-10-05T12:51:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-company-transformation-catalyst-rich-pipeline-and-strong-progress-strategy-meet-novartis-management-investor-event</loc>
  <lastmod>2021-10-05T12:51:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-phase-ii-data-new-inhaled-combination-treatment-qvm149-demonstrates-significant-improvements-over-current-standard-care-inhaled-treatment</loc>
  <lastmod>2021-10-05T12:51:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-asco-and-eha-demonstrate-novel-approaches-reimagining-medicine-cancer-and-serious-blood-disorders</loc>
  <lastmod>2021-10-05T12:51:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-aan-show-gilenya-first-and-only-disease-modifying-therapy-proven-superiority-versus-glatiramer-acetate-relapsing-remitting-ms</loc>
  <lastmod>2021-10-05T12:51:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-demonstrates-strategic-focus-china-first-kind-generic-approval-under-quality-consistency-evaluation-system</loc>
  <lastmod>2021-10-05T12:51:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-acquire-xiidra-expanding-front-eye-portfolio-and-strengthening-leadership-eye-care</loc>
  <lastmod>2021-10-05T12:51:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-aan-show-mayzents-positive-impact-cognitive-processing-speed-core-element-cognitive-function-people-living-secondary-progressive-ms</loc>
  <lastmod>2021-10-05T12:52:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-avexis-data-aan-showed-long-term-durability-zolgensma-patients-spinal-muscular-atrophy-sma-type-1</loc>
  <lastmod>2021-10-05T12:52:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-first-its-kind-algorithm-based-tool-help-ms-patients-and-physicians-evaluate-and-discuss-early-signs-progression-secondary-progressive-ms</loc>
  <lastmod>2021-10-05T12:52:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-presented-robust-data-aan-demonstrating-efficacy-zolgensma-broad-spectrum-spinal-muscular-atrophy-sma-patients</loc>
  <lastmod>2021-10-05T12:52:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlight-extensive-long-term-safety-and-efficacy-data-aimovig-across-spectrum-migraine-aan</loc>
  <lastmod>2021-10-05T12:52:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-data-aan-reinforce-novartis-commitment-transforming-lives-people-all-ages-who-live-neurological-conditions</loc>
  <lastmod>2021-10-05T12:52:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-enters-agreement-proposed-trastuzumab-biosimilar-currently-phase-iii-development-treat-selected-her2-positive-cancer-tumors</loc>
  <lastmod>2021-10-05T12:52:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-starts-2019-strong-sales-and-double-digit-core1-operating-income-growth-mayzent-launch-and-alcon-spin-profit-guidance-upgraded</loc>
  <lastmod>2021-10-05T12:52:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-entame-2019-avec-une-forte-croissance-des-ventes-et-une-hausse-deux-chiffres-du-resultat-operationnel-core1-le-lancement-de-mayzent-et-le-spin-dalcon-profit-annuel-revu-la-hausse</loc>
  <lastmod>2021-10-05T12:52:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-startet-2019-mit-starken-umsatzen-und-einer-zweistelligen-steigerung-des-operativen-kernergebnisses1-einfuhrung-von-mayzent-sowie-abspaltung-von-alcon-gewinnprognose-angehoben</loc>
  <lastmod>2021-10-05T12:52:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-data-reinforce-effectiveness-zolgensma-treating-spinal-muscular-atrophy-sma-type-1</loc>
  <lastmod>2021-10-05T12:52:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-fda-filing-acceptance-and-priority-review-brolucizumab-rth258-patients-wet-amd</loc>
  <lastmod>2021-10-05T12:52:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-post-hoc-analysis-shows-high-dose-enerzair-breezhaler-reduces-asthma-exacerbations-versus-medium-dose-complementing-key-pivotal-iridium-study-findings</loc>
  <lastmod>2021-10-05T14:27:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-nejm-publication-pivotal-study-tabrectatm-patients-metex14-metastatic-non-small-cell-lung-cancer</loc>
  <lastmod>2021-10-05T14:27:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-collaboration-between-novartis-and-africa-medical-supplies-platform-facilitate-supply-covid-19-related-medicines</loc>
  <lastmod>2021-10-05T14:27:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-ambitious-esg-targets-increase-access-medicines-and-achieve-full-carbon-neutrality</loc>
  <lastmod>2021-10-05T14:27:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-new-analysis-shows-high-consistency-lowering-ldl-c-individual-response-investigational-inclisiran</loc>
  <lastmod>2021-10-05T14:27:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-positive-results-from-phase-ii-study-lnp023-patients-paroxysmal-nocturnal-hemoglobinuria-pnh</loc>
  <lastmod>2021-10-05T14:27:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-investigational-novel-stamp-inhibitor-asciminib-abl001-meets-primary-endpoint-phase-iii-chronic-myeloid-leukemia-study</loc>
  <lastmod>2021-10-05T14:27:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-phase-iii-study-evaluating-investigational-spartalizumab-pdr001-combination-tafinlar-mekinist-advanced-melanoma</loc>
  <lastmod>2021-10-05T14:27:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-approves-novartis-kesimpta-ofatumumab-first-and-only-self-administered-targeted-b-cell-therapy-patients-relapsing-multiple-sclerosis</loc>
  <lastmod>2021-10-05T14:27:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-us-district-court-district-delaware-upholds-validity-gilenya-fingolimod-dosage-regimen-patent</loc>
  <lastmod>2021-10-05T14:27:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-ec-approval-new-xolair-indication-treat-severe-chronic-rhinosinusitis-nasal-polyps</loc>
  <lastmod>2021-10-05T14:27:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-nejm-publication-phase-iii-asclepios-trials-demonstrating-superior-efficacy-ofatumumab-patients-relapsing-multiple-sclerosis</loc>
  <lastmod>2021-10-05T14:27:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-kymriah-meets-primary-endpoint-interim-analysis-pivotal-study-follicular-lymphoma</loc>
  <lastmod>2021-10-05T14:27:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-receives-eu-approval-first-line-systemic-treatment-pediatric-psoriasis</loc>
  <lastmod>2021-10-05T14:27:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-piqray-approval-europe-first-and-only-targeted-medicine-hrher2-advanced-breast-cancer-pik3ca-mutation</loc>
  <lastmod>2021-10-05T14:27:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-plans-joint-investment-help-strengthen-future-antibiotics-manufacturing-europe</loc>
  <lastmod>2021-10-05T14:27:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-analysis-shows-wet-amd-patients-achieved-sustained-fluid-control-faster-beovu-versus-aflibercept</loc>
  <lastmod>2021-10-05T14:27:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-adakveo-receives-positive-chmp-opinion-prevention-recurrent-vaso-occlusive-crises-patients-sickle-cell-disease</loc>
  <lastmod>2021-10-05T14:27:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-phase-iii-study-jakavi-chronic-graft-versus-host-disease-met-primary-and-key-secondary-endpoints</loc>
  <lastmod>2021-10-05T14:27:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-strong-h1-performance-fy-2020-guidance-confirmed-higher-end-core-operating-income-and-lower-end-sales</loc>
  <lastmod>2021-10-05T14:27:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielte-im-ersten-halbjahr-eine-starke-performance-die-jahresprognose-2020-fur-das-operative-kernergebnis-bzw-den-umsatz-wurde-am-oberen-bzw-unteren-ende-fruherer-voraussagen-bestatigt</loc>
  <lastmod>2021-10-05T14:27:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-realise-une-excellente-performance-au-s1-previsions-pour-2020-confirmees-dans-le-haut-de-la-fourchette-pour-le-resultat-operationnel-core-et-dans-le-bas-pour-le-chiffre-daffaires</loc>
  <lastmod>2021-10-05T14:27:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-launches-first-its-kind-not-profit-portfolio-medicines-symptomatic-treatment-covid-19</loc>
  <lastmod>2021-10-05T14:27:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-phase-iii-iridium-data-lancet-respiratory-medicine-show-benefit-enerzair-breezhaler-qvm149-first-class-inhaled-labalamaics-combination-uncontrolled-asthma</loc>
  <lastmod>2021-10-05T14:27:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-ec-approval-enerzair-breezhaler-including-first-digital-companion-sensor-and-app-can-be-prescribed-alongside-treatment-uncontrolled-asthma-eu</loc>
  <lastmod>2021-10-05T14:27:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-resolves-legacy-litigation-matters-finalizing-settlement-speaker-program-litigation-government-us-and-positioning-company-future-fully-scaling-its-next-generation-digital-engagement-technologies</loc>
  <lastmod>2021-10-05T14:27:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-reviewing-options-after-federal-circuit-upholds-lower-court-ruling-biosimilar-erelzi-case</loc>
  <lastmod>2021-10-05T14:27:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-met-inhibitor-tabrectatm-approved-japan-advanced-non-small-cell-lung-cancer-metex14</loc>
  <lastmod>2021-10-05T14:27:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-simultaneous-approval-five-new-products-from-japanese-ministry-health-labour-and-welfare-offering-japanese-patients-broad-range-novel-treatment-options</loc>
  <lastmod>2021-10-05T14:27:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-gains-positive-chmp-opinion-pediatric-psoriasis-reinforcing-established-efficacy-and-safety-profile</loc>
  <lastmod>2021-10-05T14:27:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-new-xolair-indication-treat-severe-chronic-rhinosinusitis-nasal-polyps</loc>
  <lastmod>2021-10-05T14:27:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-resolves-legacy-fcpa-investigations</loc>
  <lastmod>2021-10-05T14:28:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-winners-innovation-prize-assistive-tech-rewarding-new-technologies-could-improve-mobility-and-independence-people-living-multiple-sclerosis</loc>
  <lastmod>2021-10-05T14:28:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-research-shows-technology-talent-increasingly-drawn-pharma-industry-covid-19-solve-healthcare-challenges</loc>
  <lastmod>2021-10-05T14:28:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-discontinues-hydroxychloroquine-clinical-trial-based-slow-enrollment-remains-committed-pandemic-research-efforts</loc>
  <lastmod>2021-10-05T14:28:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-expands-africa-sickle-cell-disease-program-uganda-and-tanzania</loc>
  <lastmod>2021-10-05T14:28:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-receives-fda-approval-new-indication-treat-active-non-radiographic-axial-spondyloarthritis</loc>
  <lastmod>2021-10-05T14:28:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/us-fda-approves-updated-novartis-beovu-label-include-additional-safety-information</loc>
  <lastmod>2021-10-05T14:28:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-phase-iiib-argon-study-meets-primary-endpoint-comparison-enerzair-breezhaler-qvm149-versus-free-combination-two-existing-inhaled-treatments-uncontrolled-asthma</loc>
  <lastmod>2021-10-05T14:28:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-prevent-data-show-cosentyx-helps-patients-realize-early-and-lasting-relief-axial-spondyloarthritis</loc>
  <lastmod>2021-10-05T14:28:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-fda-review-ofatumumab-self-administered-targeted-b-cell-therapy-patients-relapsing-multiple-sclerosis</loc>
  <lastmod>2021-10-05T14:28:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-long-term-relapse-free-survival-benefit-high-risk-stage-iii-melanoma-patients-treated-tafinlar-mekinist-following-surgery</loc>
  <lastmod>2021-10-05T14:28:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-piqray-receives-positive-chmp-opinion-treat-hrher2-advanced-breast-cancer-pik3ca-mutation</loc>
  <lastmod>2021-10-05T14:28:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-highlight-benefit-early-treatment-initiation-patients-secondary-progressive-multiple-sclerosis-spms</loc>
  <lastmod>2021-10-05T14:28:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-shows-overall-survival-benefit-hrher2-advanced-breast-cancer-consistent-findings-patients-more-aggressive-disease</loc>
  <lastmod>2021-10-05T14:28:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-new-late-breaking-ofatumumab-data-ean-demonstrating-robust-efficacy-and-safety-treatment-relapsing-forms-multiple-sclerosis-rms</loc>
  <lastmod>2021-10-05T14:28:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-study-reveals-migraine-support-workspace-can-significantly-decrease-impact-disease-affected-employees</loc>
  <lastmod>2021-10-05T14:28:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-receives-ec-approval-and-activates-day-one-access-program-zolgensma-only-gene-therapy-spinal-muscular-atrophy-sma</loc>
  <lastmod>2021-10-05T14:28:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-asco-and-eha-showcase-bold-approaches-reimagine-cancer-and-blood-disorders-through-multiple-therapeutic-platforms</loc>
  <lastmod>2021-10-05T14:28:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-fda-approval-met-inhibitor-tabrectatm-metastatic-non-small-cell-lung-cancer-metex14</loc>
  <lastmod>2021-10-05T14:28:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-chmp-positive-opinion-enerzair-breezhaler-qvm149-potential-first-class-inhaled-labalamaics-combination-uncontrolled-asthma</loc>
  <lastmod>2021-10-05T14:28:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-gains-fourth-indication-eu-first-class-approval-axial-spondyloarthritis-spectrum</loc>
  <lastmod>2021-10-05T14:28:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-maintains-strong-operational-performance-q1-confirms-fy-2020-guidance-time-and-advances-broad-range-efforts-support-global-response-covid-19</loc>
  <lastmod>2021-10-05T14:28:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-setzt-im-1-quartal-die-starke-operative-performance-fort-bestatigt-derzeit-die-prognose-2020-und-fordert-verschiedenste-aktivitaten-um-globale-massnahmen-gegen-covid-19-zu-unterstutzen</loc>
  <lastmod>2021-10-05T14:28:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-conserve-une-forte-performance-operationnelle-au-1er-trimestre-confirme-ce-stade-les-previsions-pour-2020-et-fournit-de-grands-efforts-pour-contribuer-la-reponse-mondiale-au-covid-19</loc>
  <lastmod>2021-10-05T14:28:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-data-showing-jakavi-ruxolitinib-more-effective-best-available-therapy-acute-graft-versus-host-disease</loc>
  <lastmod>2021-10-05T14:28:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kymriah-receives-fda-regenerative-medicine-advanced-therapy-designation-follicular-lymphoma</loc>
  <lastmod>2021-10-05T14:28:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-new-mayzent-siponimod-data-show-sustained-effect-delaying-disability-five-years-patients-secondary-progressive-multiple-sclerosis-spms</loc>
  <lastmod>2021-10-05T14:28:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-sponsor-large-clinical-trial-hydroxychloroquine-hospitalized-covid-19-patients</loc>
  <lastmod>2021-10-05T14:28:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-acquires-amblyotech-pursuing-novel-digital-therapy-children-and-adult-patients-lazy-eye</loc>
  <lastmod>2021-10-05T14:28:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-data-neurology-reinforcing-real-world-and-long-term-effectiveness-and-safety-aimovig-preventive-treatment-across-full-spectrum-migraine</loc>
  <lastmod>2021-10-05T14:28:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-plan-initiate-clinical-study-jakavi-severe-covid-19-patients-and-establish-international-compassionate-use-program</loc>
  <lastmod>2021-10-05T14:28:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-mutual-agreement-terminate-sale-sandoz-us-generic-oral-solids-dermatology-portfolio-aurobindo</loc>
  <lastmod>2021-10-05T14:28:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-new-analysis-further-shows-durable-and-potent-ldl-c-reduction-inclisiran-investigational-first-class-sirna-cholesterol-lowering-treatment</loc>
  <lastmod>2021-10-05T14:28:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-gains-positive-chmp-opinion-new-indication-axial-spondyloarthritis-spectrum</loc>
  <lastmod>2021-10-05T14:28:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-receives-positive-chmp-opinion-zolgensma-only-gene-therapy-spinal-muscular-atrophy-sma</loc>
  <lastmod>2021-10-05T14:28:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-life-sciences-companies-commit-expertise-and-assets-fight-against-covid-19-pandemic-alongside-bill-melinda-gates-foundation</loc>
  <lastmod>2021-10-05T14:28:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/zolgensma-data-shows-rapid-significant-clinically-meaningful-benefit-sma-including-prolonged-event-free-survival-motor-milestone-achievement-and-durability-now-5-years-post-dosing</loc>
  <lastmod>2021-10-05T14:28:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-presents-avxs-101-it-data-demonstrating-remarkable-increases-hfmse-scores-and-consistent-clinically-meaningful-response-older-patients-sma-type-2</loc>
  <lastmod>2021-10-05T14:28:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-commits-donate-130-million-doses-hydroxychloroquine-support-global-covid-19-pandemic-response</loc>
  <lastmod>2021-10-05T14:29:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-approval-from-japanese-ministry-health-labour-and-welfare-zolgensma-only-gene-therapy-patients-spinal-muscular-atrophy-sma</loc>
  <lastmod>2021-10-05T14:29:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-nejm-publication-three-pivotal-trials-showing-durable-and-potent-efficacy-inclisiran-investigational-first-class-sirna-cholesterol-lowering-therapy</loc>
  <lastmod>2021-10-05T14:29:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-broad-range-initiatives-respond-covid-19-pandemic-creates-usd-20-million-global-fund-support-impacted-communities</loc>
  <lastmod>2021-10-05T14:29:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/international-research-partnership-and-edctp-invest-eu44m-next-generation-antimalarials-combat-drug-resistant-malaria-africa</loc>
  <lastmod>2021-10-05T14:29:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-resolves-generic-drug-antitrust-investigation-us</loc>
  <lastmod>2021-10-05T14:29:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-shareholders-approve-all-resolutions-proposed-board-directors-annual-general-meeting-2</loc>
  <lastmod>2021-10-05T14:29:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/les-actionnaires-de-novartis-approuvent-toutes-les-resolutions-proposees-par-le-conseil-dadministration-lassemblee-generale-annuelle</loc>
  <lastmod>2021-10-05T14:29:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-dndi-collaborate-development-new-oral-drug-treat-visceral-leishmaniasis</loc>
  <lastmod>2021-10-05T14:29:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-fda-and-ema-filing-acceptance-ofatumumab-novel-b-cell-therapy-patients-relapsing-forms-multiple-sclerosis-rms</loc>
  <lastmod>2021-10-05T14:29:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-ec-approval-beovu-next-generation-anti-vegf-treatment-wet-amd-leading-cause-blindness-worldwide</loc>
  <lastmod>2021-10-05T14:29:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-met-inhibitor-capmatinib-inc280-first-potential-treatment-metex14-mutated-advanced-non-small-cell-lung-cancer-granted-priority-fda-review</loc>
  <lastmod>2021-10-05T14:29:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-completes-acquisition-aspens-japanese-operations-strengthening-its-position-worlds-third-largest-market-generics-and-patent-medicines</loc>
  <lastmod>2021-10-05T14:29:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-builds-its-axspa-leadership-us-label-update-dosing-flexibility-ankylosing-spondylitis</loc>
  <lastmod>2021-10-05T14:29:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-strong-sales-growth-margin-expansion-and-breakthrough-innovation-launching-five-nmes-2019</loc>
  <lastmod>2021-10-05T14:29:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-2019-ein-starkes-umsatzwachstum-margen-steigerungen-und-bahnbrechende-innovationen-mit-der-markteinfuhrung-funf-neuer-wirkstoffe</loc>
  <lastmod>2021-10-05T14:29:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-realise-en-2019-une-forte-croissance-de-son-chiffre-daffaires-une-augmentation-de-sa-marge-et-une-percee-dans-linnovation-en-lancant-cinq-nouvelles-entites-moleculaires</loc>
  <lastmod>2021-10-05T14:29:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-eu-approval-mayzent-siponimod-adult-patients-secondary-progressive-multiple-sclerosis-spms-active-disease</loc>
  <lastmod>2021-10-05T14:29:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-ligelizumab-qge031-more-effective-xolair-inhibiting-immunoglobulin-e-pathway-responsible-chronic-spontaneous-urticaria</loc>
  <lastmod>2021-10-05T14:29:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-successfully-completes-acquisition-medicines-company-adding-potentially-first-class-investigational-cholesterol-lowering-therapy-inclisiran</loc>
  <lastmod>2021-10-05T14:29:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-completes-tender-offer-all-outstanding-shares-medicines-company</loc>
  <lastmod>2021-10-05T14:29:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-luster-phase-iii-studies-patients-uncontrolled-gina-45-asthma</loc>
  <lastmod>2021-10-05T14:29:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-beovu-brolucizumab-treatment-wet-amd</loc>
  <lastmod>2021-10-05T14:29:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-data-show-superior-overall-survival-compared-fulvestrant-and-consistent-efficacy-across-advanced-breast-cancer-patient-subgroups-monaleesa-3</loc>
  <lastmod>2021-10-05T14:29:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kymriah-demonstrates-consistent-efficacy-and-safety-outcomes-us-patients-when-used-real-world-setting</loc>
  <lastmod>2021-10-05T14:29:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-global-survey-uncovers-profound-and-often-under-reported-effects-sickle-cell-disease-patients</loc>
  <lastmod>2021-10-05T14:29:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-phase-iii-data-new-inhaled-dual-combination-qmf149-show-significant-improvement-across-key-asthma-outcomes-versus-monotherapy</loc>
  <lastmod>2021-10-05T14:29:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-tender-offer-medicines-company-commences</loc>
  <lastmod>2021-10-05T14:29:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-investigational-oral-therapy-iptacopan-lnp023-shows-benefit-monotherapy-treatment-naive-patients-rare-and-life-threatening-blood-disorder-paroxysmal-nocturnal-hemoglobinuria</loc>
  <lastmod>2021-10-05T14:32:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-new-interim-analysis-phase-ii-data-iptacopan-rare-kidney-disease-c3-glomerulopathy-c3g</loc>
  <lastmod>2021-10-05T14:32:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-iptacopan-met-phase-ii-study-primary-endpoint-rare-kidney-disease-iga-nephropathy-igan</loc>
  <lastmod>2021-10-05T14:32:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-tabrecta-first-published-overall-survival-and-updated-overall-response-data-patients-metex14-metastatic-nsclc</loc>
  <lastmod>2021-10-05T14:32:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-investigational-checkpoint-inhibitor-tislelizumab-met-primary-endpoint-overall-survival-pivotal-phase-iii-trial-esophageal-cancer-after-systemic-therapy</loc>
  <lastmod>2021-10-05T14:32:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-reports-clinically-relevant-improvement-median-overall-survival-data-final-analysis-pivotal-netter-1-study-targeted-radioligand-therapy-lutathera</loc>
  <lastmod>2021-10-05T14:32:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-177lu-psma-617-significantly-improves-overall-survival-and-radiographic-progression-free-survival-men-metastatic-castration-resistant-prostate-cancer-phase-iii-vision-study</loc>
  <lastmod>2021-10-05T14:32:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kymriah-pivotal-trial-demonstrates-strong-response-rates-and-remarkable-safety-profile-relapsed-or-refractory-follicular-lymphoma</loc>
  <lastmod>2021-10-05T14:32:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-reports-longest-median-overall-survival-postmenopausal-hrher2-metastatic-breast-cancer-patients</loc>
  <lastmod>2021-10-05T14:32:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-positive-phase-iii-results-from-junipera-study-supporting-cosentyx-potential-treatment-jia-population-eular-2021</loc>
  <lastmod>2021-10-05T14:32:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-receives-fda-approval-treatment-children-and-adolescents-moderate-severe-plaque-psoriasis</loc>
  <lastmod>2021-10-05T14:32:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-reports-one-year-results-phase-iii-merlin-study-evaluating-beovu-every-four-week-dosing-and-provides-update-beovu-clinical-program</loc>
  <lastmod>2021-10-05T14:32:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-molecular-partners-announce-start-empathy-clinical-trial-ensovibep-treatment-covid-19</loc>
  <lastmod>2021-10-05T14:32:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-unveil-new-data-asco-and-eha-from-its-robust-portfolio-including-overall-survival-prostate-and-breast-cancer</loc>
  <lastmod>2021-10-05T14:32:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-plans-further-strengthen-its-antibiotics-manufacturing-setup-europe</loc>
  <lastmod>2021-10-05T14:32:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-reaches-milestone-delivery-1-billion-courses-antimalarial-treatment</loc>
  <lastmod>2021-10-05T14:32:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/us-supreme-court-denies-sandoz-petition-review-biosimilar-erelzi-etanercept-szzs-case</loc>
  <lastmod>2021-10-05T14:32:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-confirms-late-stage-clinical-development-plans-proposed-biosimilar-aflibercept-key-ophthalmology-medicine</loc>
  <lastmod>2021-10-05T14:32:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-phase-iii-beovu-data-show-potential-fluid-resolution-more-diabetic-macular-edema-patients-fewer-injections-versus-aflibercept</loc>
  <lastmod>2021-10-05T14:32:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-key-growth-drivers-and-launches-continue-momentum-q1-maintaining-confidence-growth-group-guidance-fy-2021-confirmed</loc>
  <lastmod>2021-10-05T14:32:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-moteurs-cles-de-la-croissance-et-lancements-poursuivent-leur-essor-au-1er-trimestre-maintenant-la-confiance-dans-la-croissance-confirmation-des-previsions-pour-le-groupe-pour-2021</loc>
  <lastmod>2021-10-05T14:32:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/wichtige-wachstumstreiber-und-neueinfuhrungen-von-novartis-setzen-ihre-dynamik-im-ersten-quartal-fort-und-erhalten-das-vertrauen-das-wachstum-konzernprognose-fur-2021-bestatigt</loc>
  <lastmod>2021-10-05T14:32:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-initiate-smart-phase-3b-global-study-zolgensma-children-21-kg-building-real-world-experience</loc>
  <lastmod>2021-10-05T14:32:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/kesimpta-ofatumumab-data-aan-showed-reduction-disability-progression-independent-relapse-activity-newly-diagnosed-patients-rms</loc>
  <lastmod>2021-10-05T14:32:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-signs-initial-agreement-reserve-capacity-and-implement-technology-transfer-production-active-pharmaceutical-ingredient-roches-actemraroactemra</loc>
  <lastmod>2021-10-05T14:32:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-eu-approval-kesimpta-ofatumumab-first-and-only-self-administered-targeted-b-cell-therapy-adult-patients-relapsing-multiple-sclerosis</loc>
  <lastmod>2021-10-05T14:32:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-expands-targeted-radioligand-therapy-pipeline-license-compounds-targeting-fibroblast-activation-protein-fap</loc>
  <lastmod>2021-10-05T14:32:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-positive-result-phase-iii-study-radioligand-therapy-177lu-psma-617-patients-advanced-prostate-cancer</loc>
  <lastmod>2021-10-05T14:32:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-appoints-karen-hale-chief-legal-officer</loc>
  <lastmod>2021-10-05T14:32:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-zolgensma-data-demonstrate-age-appropriate-development-when-used-early-real-world-benefit-older-children-and-durability-5-years-post-treatment</loc>
  <lastmod>2021-10-05T14:32:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-phase-iii-study-evaluating-canakinumab-acz885-second-or-third-line-treatment-combination-chemotherapy-non-small-cell-lung-cancer</loc>
  <lastmod>2021-10-05T14:32:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-change-executive-committee</loc>
  <lastmod>2021-10-05T14:32:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-signs-initial-agreement-curevac-manufacture-covid-19-vaccine-candidate</loc>
  <lastmod>2021-10-05T14:32:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-shareholders-approve-all-resolutions-proposed-board-directors-annual-general-meeting-3</loc>
  <lastmod>2021-10-05T14:32:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/die-aktionare-von-novartis-heissen-der-generalversammlung-alle-antrage-des-verwaltungsrats-gut</loc>
  <lastmod>2021-10-05T14:32:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/les-actionnaires-de-novartis-approuvent-toutes-les-resolutions-proposees-par-le-conseil-dadministration-lors-de-lassemblee-generale-annuelle-0</loc>
  <lastmod>2021-10-05T14:32:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-strengthens-oncology-pipeline-successful-closing-tislelizumab-licensing</loc>
  <lastmod>2021-10-05T14:32:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-gains-eu-label-update-first-its-kind-maximise-data-axial-manifestations-psoriatic-arthritis</loc>
  <lastmod>2021-10-05T14:32:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-bill-melinda-gates-foundation-collaborate-discover-and-develop-accessible-vivo-gene-therapy-sickle-cell-disease</loc>
  <lastmod>2021-10-05T14:32:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-entresto-granted-expanded-indication-chronic-heart-failure-fda</loc>
  <lastmod>2021-10-05T14:32:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-show-multiple-sclerosis-patients-and-nurses-prefer-kesimpta-ofatumumab-sensoready-autoinjector-pen</loc>
  <lastmod>2021-10-05T14:32:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-agreement-acquire-gsks-cephalosporin-antibiotics-business-reinforcing-its-leading-global-position-antibiotics</loc>
  <lastmod>2021-10-05T14:32:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-fda-breakthrough-therapy-designations-investigational-stamp-inhibitor-asciminib-abl001-chronic-myeloid-leukemia</loc>
  <lastmod>2021-10-05T14:32:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-kesimpta-ofatumumab-self-administered-treatment-adult-patients-relapsing-multiple-sclerosis</loc>
  <lastmod>2021-10-05T14:32:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-signs-initial-agreement-provide-manufacturing-capacity-pfizer-biontech-covid-19-vaccine</loc>
  <lastmod>2021-10-05T14:32:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-renews-who-medicine-donation-pledge-aim-ending-leprosy</loc>
  <lastmod>2021-10-05T14:32:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-sales-growth-and-margin-expansion-continued-progress-its-next-wave-medicines-2020</loc>
  <lastmod>2021-10-05T14:32:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-hat-2020-umsatz-und-margen-gesteigert-und-die-nachste-welle-von-medikamenten-weiter-vorangetrieben</loc>
  <lastmod>2021-10-05T14:32:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/en-2020-novartis-enregistre-une-croissance-de-son-chiffre-daffaires-et-de-sa-marge-il-continue-de-faire-progresser-sa-prochaine-vague-de-medicaments</loc>
  <lastmod>2021-10-05T14:33:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-gsk-announce-collaboration-support-scientific-research-genetic-diversity-africa</loc>
  <lastmod>2021-10-05T14:33:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-ligelizumab-qge031-receives-fda-breakthrough-therapy-designation-patients-chronic-spontaneous-urticaria-csu</loc>
  <lastmod>2021-10-05T14:33:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-expands-oncology-pipeline-licensing-tislelizumab-from-beigene</loc>
  <lastmod>2021-10-05T14:33:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-complete-response-letter-from-us-fda-inclisiran</loc>
  <lastmod>2021-10-05T14:33:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-builds-commitment-addressing-need-neuropsychiatric-disorders-cadent-therapeutics-acquisition</loc>
  <lastmod>2021-10-05T14:33:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-investigational-oral-therapy-iptacopan-lnp023-receives-fda-breakthrough-therapy-designation-pnh-and-rare-pediatric-disease-designation-c3g</loc>
  <lastmod>2021-10-05T14:33:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-positive-fda-advisory-committee-recommendation-use-entresto-treat-patients-hfpef</loc>
  <lastmod>2021-10-05T14:33:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-reports-positive-topline-results-from-second-phase-iii-trial-beovu-patients-diabetic-macular-edema</loc>
  <lastmod>2021-10-05T14:33:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-ruxcovid-study-ruxolitinib-hospitalized-patients-covid-19</loc>
  <lastmod>2021-10-05T14:33:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-eu-approval-leqvio-inclisiran-first-class-sirna-lower-cholesterol-two-doses-year</loc>
  <lastmod>2021-10-05T14:33:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-data-demonstrate-superior-benefit-across-main-intrinsic-subtypes-metastatic-breast-cancer</loc>
  <lastmod>2021-10-05T14:33:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-demonstrates-nearly-five-years-median-overall-survival-metastatic-breast-cancer</loc>
  <lastmod>2021-10-05T14:33:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-investigational-stamp-inhibitor-asciminib-abl001-shows-superior-mmr-rate-bosulif-chronic-myeloid-leukemia-trial</loc>
  <lastmod>2021-10-05T14:33:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-analyses-confirm-benefit-kymriah-clinically-meaningful-rates-complete-response-seen-patients-certain-advanced-lymphomas</loc>
  <lastmod>2021-10-05T14:33:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-first-data-from-reach3-trial-showing-jakavi-ruxolitinib-significantly-improved-outcomes-patients-steroid-resistantdependent-chronic-gvhd</loc>
  <lastmod>2021-10-05T14:33:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-confidence-growing-sales-margin-expansion-fueled-market-brands-and-rich-pipeline-annual-meet-management-investor-event</loc>
  <lastmod>2021-10-05T14:33:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-secures-exclusive-rights-potential-acute-respiratory-distress-syndrome-cell-therapy</loc>
  <lastmod>2021-10-05T14:33:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-data-ash-reinforce-breadth-novartis-hematology-portfolio-across-multiple-blood-cancers-and-serious-hematologic-diseases</loc>
  <lastmod>2021-10-05T14:33:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-set-achieve-100-renewable-electricity-its-european-operations</loc>
  <lastmod>2021-10-05T14:33:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/results-from-real-world-data-and-post-hoc-analysis-novartis-beovu-pivotal-trials-presented-aao-2020</loc>
  <lastmod>2021-10-05T14:33:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-analyses-investigational-inclisiran-demonstrate-consistently-effective-and-sustained-ldl-c-reduction-month-17-regardless-age-and-gender</loc>
  <lastmod>2021-10-05T14:33:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-can-covid-trial-hospitalized-patients-covid-19-pneumonia-and-cytokine-release-syndrome-crs</loc>
  <lastmod>2021-10-05T14:33:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-shows-early-synovitis-reduction-patients-psoriatic-arthritis-first-its-kind-study</loc>
  <lastmod>2021-10-05T14:33:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-positive-results-from-phase-iv-study-showing-superior-tolerability-and-efficacy-aimovig-erenumab-compared-topiramate-migraine-prevention</loc>
  <lastmod>2021-10-05T14:33:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-sickle-cell-medicine-adakveo-approved-europe-prevent-recurrent-vaso-occlusive-crises</loc>
  <lastmod>2021-10-05T14:33:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-expands-kymriah-manufacturing-footprint-first-ever-approved-site-commercial-car-t-cell-therapy-manufacturing-asia</loc>
  <lastmod>2021-10-05T14:33:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-latest-phase-iii-data-reinforcing-cosentyx-first-line-systemic-treatment-pediatric-psoriasis</loc>
  <lastmod>2021-10-05T14:33:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-acquires-vedere-bio-adding-novel-optogenetic-gene-therapy-technology-treating-blindness</loc>
  <lastmod>2021-10-05T14:33:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-collaboration-molecular-partners-develop-two-darpin-therapies-designed-potential-use-against-covid-19</loc>
  <lastmod>2021-10-05T14:33:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivers-solid-q3-performance-11-core-operating-income-growth-net-sales-line-prior-year-strong-pipeline-progression-upgrades-full-year-core-operating-income-guidance</loc>
  <lastmod>2021-10-05T14:33:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-im-3-qu-mit-solider-performance-operatives-kernergebnis-steigt-um-11-nettoumsatz-auf-vorjahresniveau-starke-pipeline-fortschritte-jahresprognose-fur-operatives-kernergebnis-angehoben</loc>
  <lastmod>2021-10-05T14:33:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-au-t3-performance-solide-croissance-de-11-du-resultat-operationnel-core-chiffre-daffaires-net-proche-de-lan-dernier-pipeline-en-fort-progres-hausse-du-resultat-operationnel-core-prevu</loc>
  <lastmod>2021-10-05T14:33:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-promising-interim-phase-ii-data-potential-first-class-oral-therapy-iptacopan-lnp023-rare-renal-disease-c3-glomerulopathy-c3g</loc>
  <lastmod>2021-10-05T14:33:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-european-medicines-agency-ema-has-granted-orphan-drug-designation-iptacopan-lnp023-iga-nephropathy-igan</loc>
  <lastmod>2021-10-05T14:34:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-us-food-and-drug-administration-fda-orphan-drug-designation-branaplam-lmi070-huntingtons-disease-hd</loc>
  <lastmod>2021-10-05T14:34:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-leqvio-inclisiran-potential-first-class-sirna-treatment-high-cholesterol</loc>
  <lastmod>2021-10-05T14:34:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-received-european-medicines-agency-ema-prime-designation-iptacopan-lnp-c3-glomerulopathy-c3g</loc>
  <lastmod>2021-10-05T14:34:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-phase-iii-analysis-demonstrates-novartis-beovu-showed-improvement-best-corrected-visual-acuity-wet-amd-patients-early-persistent-fluid</loc>
  <lastmod>2021-10-05T14:34:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/zolgensma-data-including-patients-more-severe-sma-baseline-further-demonstrate-therapeutic-benefit-including-prolonged-event-free-survival-increased-motor-function-and-milestone-achievement</loc>
  <lastmod>2021-10-05T14:34:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-avxs-101-intrathecal-clinical-development-program</loc>
  <lastmod>2021-10-05T14:34:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-receives-highest-rating-any-cdk46-inhibitor-esmo-magnitude-clinical-benefit-scale</loc>
  <lastmod>2021-10-05T14:34:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-piqray-data-show-survival-benefit-patients-hrher2-advanced-breast-cancer-pik3ca-mutation</loc>
  <lastmod>2021-10-05T14:34:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-reports-late-breaking-data-from-phase-iii-combi-i-trial-spartalizumab-pdr001-tafinlar-and-mekinist-advanced-melanoma</loc>
  <lastmod>2021-10-05T14:34:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-tafinlar-mekinist-demonstrates-long-term-relapse-free-survival-benefit-high-risk-stage-iii-melanoma-patients-study-published-nejm</loc>
  <lastmod>2021-10-05T14:34:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-reinforces-commitment-patient-access-pricing-eur-185-billion-sustainability-linked-bond</loc>
  <lastmod>2021-10-05T14:34:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/european-medicines-agency-ema-approves-safety-label-update-novartis-beovu</loc>
  <lastmod>2021-10-05T14:34:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-reports-positive-topline-results-from-first-phase-iii-trial-beovu-versus-aflibercept-patients-diabetic-macular-edema-dme</loc>
  <lastmod>2021-10-05T14:34:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-show-early-treatment-mayzent-siponimod-delays-disability-progression-and-show-benefits-cognitive-performance-patients-secondary-progressive-multiple-sclerosis-spms</loc>
  <lastmod>2021-10-05T14:34:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-data-actrims-ectrims-kesimpta-ofatumumab-newly-diagnosed-treatment-naive-adults-relapsing-multiple-sclerosis</loc>
  <lastmod>2021-10-05T14:34:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-actrims-ectrims-highlight-strength-leading-multiple-sclerosis-ms-portfolio-life-changing-therapies-people-across-ms-spectrum</loc>
  <lastmod>2021-10-05T14:34:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-community-statement-global-managed-access-program-avxs-101</loc>
  <lastmod>2021-10-06T12:17:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-community-statement-coronavirus-disease-covid-19</loc>
  <lastmod>2021-10-06T12:17:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-community-statement-global-managed-access-program-avxs-101-0</loc>
  <lastmod>2021-10-06T12:17:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-statement-changes-senior-leadership-team</loc>
  <lastmod>2021-10-06T12:17:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-statement-access-zolgensma-onasemnogene-abeparvovec-xioi</loc>
  <lastmod>2021-10-06T12:17:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-reports-first-quarter-2018-financial-and-operating-results</loc>
  <lastmod>2021-10-06T12:17:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-announces-first-patient-dosed-phase-3-trial-avxs-101-pre-symptomatic-sma-types-1-2-and-3</loc>
  <lastmod>2021-10-06T12:17:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-presents-initial-data-from-pivotal-us-trial-sma-type-1-and-24-month-follow-data-from-phase-1-trial-avxs-101-sma-type-1-annual-meeting-american-academy-neurology</loc>
  <lastmod>2021-10-06T12:18:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-present-avxs-101-data-annual-meeting-american-academy-neurology</loc>
  <lastmod>2021-10-06T12:18:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-gene-therapy-awarded-sakigake-designation-spinal-muscular-atrophy-type-1</loc>
  <lastmod>2021-10-06T12:18:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-enters-licensing-agreement-genethon</loc>
  <lastmod>2021-10-06T12:18:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-reports-fourth-quarter-and-full-year-2017-financial-and-operating-results</loc>
  <lastmod>2021-10-06T12:18:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-report-fourth-quarter-and-full-year-2017-financial-and-operating-results</loc>
  <lastmod>2021-10-06T12:18:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-initiate-screening-remaining-patients-pivotal-trial-avxs-101-sma-type-1-following-review-preliminary-data-from-first-three-patients</loc>
  <lastmod>2021-10-06T12:18:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-announces-closing-public-offering-common-stock-and-full-exercise-underwriters-option-purchase-additional-shares</loc>
  <lastmod>2021-10-06T12:18:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-announces-pricing-public-offering-common-stock</loc>
  <lastmod>2021-10-06T12:18:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-announces-proposed-public-offering-common-stock</loc>
  <lastmod>2021-10-06T12:18:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-announces-expanded-clinical-development-program-avxs-101-spinal-muscular-atrophy</loc>
  <lastmod>2021-10-06T12:18:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/regenxbio-and-avexis-announce-expansion-relationship-through-amended-license-agreement-development-and-commercialization-treatments-spinal-muscular-atrophy</loc>
  <lastmod>2021-10-06T12:18:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/avexis-announces-alignment-fda-next-steps-toward-bla-submission-avxs-101-sma-type-1</loc>
  <lastmod>2021-10-06T12:18:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-expects-sustain-long-term-growth-robust-pipeline-25-potential-blockbusters-highlighted-rd-day</loc>
  <lastmod>2021-10-06T17:07:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-present-broad-range-portfolio-data-ectrims-reinforcing-long-standing-commitment-people-living-multiple-sclerosis</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-resolves-legacy-federal-government-civil-investigation-us-regarding-generic-drugs</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-show-rapid-and-effective-disease-activity-control-remibrutinib-lou064-patients-chronic-spontaneous-urticaria</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-accelerates-efforts-toward-esg-targets-increase-access-medicines-improve-health-equity-and-achieve-net-zero-carbon-emissions</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-medicines-malaria-venture-report-positive-results-phase-2b-study-novel-ganaplacidelumefantrine-combination-children-malaria</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-data-reinforce-efficacy-and-convenience-novartis-cosentyx-secukinumab-300-mg-autoinjector-adults-psoriasis</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-show-achieving-complete-control-chronic-spontaneous-urticaria-csu-improves-overall-quality-life-reported-patients</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-acquires-arctos-medical-expanding-optogenetics-portfolio-bring-gene-therapies-patients-severe-vision-loss</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-acquiert-arctos-medical-elargissant-ainsi-son-portefeuille-doptogenetique-afin-de-proposer-des-therapies-geniques-aux-patients-souffrant-dune-severe-perte-de-la-vision</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-ubernimmt-arctos-medical-und-erweitert-damit-ihr-optogenetik-portfolio-um-patientinnen-und-patienten-mit-einem-schwerem-verlust-des-sehvermogens-gentherapien-anbieten-zu-konnen</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-collaboration-harmonia-phase-iii-head-head-trial-evaluating-kisqali-vs-ibrance-patients-hrher2-advanced-breast-cancer</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-kisqali-data-showing-longest-median-overall-survival-ever-reported-hrher2-advanced-breast-cancer</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-findings-from-real-world-study-alpelisib-demonstrating-clinical-benefit-people-pik3ca-related-overgrowth-spectrum-pros</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-reports-positive-health-related-quality-life-data-177lu-psma-617-radioligand-therapy-patients-advanced-prostate-cancer-esmo-2021</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-first-fda-filing-acceptance-anti-pd-1-antibody-tislelizumab-people-esophageal-cancer</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-strengthens-pipeline-entering-agreement-biosimilar-bevacizumab-key-oncology-medicine</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-findings-ers-reinforcing-efficacy-enerzair-breezhaler-highlighting-its-digital-companion-well-showcasing-commitment-low-carbon-footprint-asthma-solutions</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/world-first-agreement-between-novartis-and-nhs-enables-broad-and-rapid-access-first-class-cholesterol-lowering-medicine-leqvio-vinclisiran</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-leqvio-inclisiran-analyses-show-effective-and-sustained-ldl-c-reduction-two-sub-populations-patients-ascvd</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-important-overall-survival-and-quality-life-results-across-solid-tumor-portfolio-among-other-key-data-esmo</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-belinda-study-investigating-kymriah-second-line-treatment-aggressive-b-cell-non-hodgkin-lymphoma</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-secures-new-approval-china-cosentyx-secukinumab-pediatric-psoriasis</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-positive-results-from-phase-iii-trials-beovu-diabetic-macular-edema-including-dosing-intervals-16-weeks</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-lift-partial-clinical-trial-hold-and-plans-initiate-new-pivotal-phase-3-study-intrathecal-oav-101-older-patients-sma</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivered-strong-q2-performance-driven-momentum-key-growth-brands-fy-2021-guidance-unchanged</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-forte-performance-au-deuxieme-trimestre-soutenue-par-la-dynamique-des-marques-cles-de-croissance-previsions-pour-lexercice-2021-inchangees</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-hat-im-zweiten-quartal-dank-der-dynamik-wichtiger-wachstums-marken-eine-starke-performance-erzielt-prognose-fur-2021-unverandert</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-pledges-10-year-commitment-morehouse-school-medicine-26-historically-black-colleges-universities-medical-schools-and-other-leading-organizations-co-create-effective-measurable-solutions-health-equity</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-nejm-publication-positive-phase-iii-reach3-data-jakavi-chronic-gvhd</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-appoints-rob-kowalski-chief-people-organization-officer</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-eu-launch-ready-dilute-generic-pemetrexed-treat-most-prevalent-form-lung-cancer</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/positive-survival-data-novartis-investigational-radioligand-therapy-177lu-psma-617-published-new-england-journal-medicine</loc>
  <lastmod>2021-12-02T12:33:04+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-hewlett-packard-enterprise-join-forces-advance-novartis-global-health-efforts</loc>
  <lastmod>2021-12-02T18:33:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/kesimpta-ofatumumab-data-show-long-term-preservation-iggigm-levels-and-no-increased-risk-serious-infections-people-living-multiple-sclerosis</loc>
  <lastmod>2021-12-03T22:33:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-zolgensma-data-demonstrate-age-appropriate-development-when-used-presymptomatically-and-rapid-clinically-meaningful-efficacy-symptomatic-children-even-those-severe-sma-baseline</loc>
  <lastmod>2021-12-04T11:03:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-completes-acquisition-gsks-cephalosporin-business-reinforcing-leading-global-position-antibiotics</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-fda-and-ema-filing-acceptances-beovu-patients-diabetic-macular-edema</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/kesimpta-ofatumumab-data-ectrims-highlights-preservation-igg-levels-and-safety-experience-over-extended-exposure-35-years-people-living-relapsing-multiple-sclerosis</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/global-heart-hub-and-novartis-partner-tackle-ascvd-global-health-crisis-and-worlds-1-killer</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-signs-new-initial-agreement-biontech-support-fill-and-finish-mrna-pfizer-biontech-covid-19-vaccine</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-top-line-results-canopy-1-phase-iii-study-support-further-evaluation-canakinumab-lung-cancer</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivers-solid-q3-results-strong-growth-innovative-medicines-announces-strategic-review-sandoz</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-realise-de-solides-resultats-au-3e-trimestre-avec-une-forte-croissance-dinnovative-medicines-et-annonce-un-examen-strategique-de-sandoz</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-im-dritten-quartal-solide-ergebnisse-mit-starkem-wachstum-bei-innovative-medicines-das-unternehmen-kundigt-eine-strategische-uberprufung-von-sandoz</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-priority-review-us-fda-and-filing-acceptance-ema-kymriah-treat-patients-relapsed-or-refractory-follicular-lymphoma</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-approves-novartis-scemblix-asciminib-novel-mechanism-action-treatment-chronic-myeloid-leukemia</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-sell-its-roche-stake-bilateral-transaction-roche</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-verkauft-ihre-roche-beteiligung-einer-bilateralen-transaktion-roche</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-data-ash-spotlight-novartis-recently-approved-scemblix-next-generation-car-t-platform-and-expanding-hematology-portfolio</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-iptacopan-meets-primary-endpoints-phase-ii-study-rare-kidney-disease-c3-glomerulopathy-c3g</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/leqvio-inclisiran-reduced-ldl-c-people-who-are-overweight-or-obese</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-new-publication-cephalalgia-data-showcasing-superior-tolerability-and-efficacy-aimovig-erenumab-compared-topiramate-migraine-prevention</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-positive-phase-iii-results-cosentyx-children-active-enthesitis-related-arthritis-era-and-juvenile-psoriatic-arthritis-jpsa-acr-2021</loc>
  <lastmod>2021-12-02T12:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-rd-day-spotlights-attractive-growth-profile-underpinned-strong-market-brands-20-potential-high-value-pipeline-assets-and-technology-platforms</loc>
  <lastmod>2021-12-06T17:48:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/bilateral-transaction-between-novartis-and-roche-successfully-closed</loc>
  <lastmod>2021-12-06T17:48:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-kisqali-data-shows-consistent-overall-survival-benefit-across-genomic-and-clinical-subtypes-interest-hrher2-metastatic-breast-cancer</loc>
  <lastmod>2021-12-08T15:33:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-positive-results-from-year-two-phase-iii-trial-beovu-diabetic-macular-edema</loc>
  <lastmod>2021-12-09T16:48:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-highlight-efficacy-piqray-hrher2-metastatic-breast-cancer-pik3ca-driver-mutation-immediately-post-cdk46i</loc>
  <lastmod>2021-12-10T14:03:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kymriah-demonstrates-strong-responses-high-risk-patients-relapsed-or-refractory-follicular-lymphoma-extended-study-follow</loc>
  <lastmod>2021-12-11T18:03:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-scemblix-demonstrates-sustained-response-rate-48-week-follow-patients-chronic-myeloid-leukemia</loc>
  <lastmod>2021-12-11T22:03:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-t-chargetm-next-generation-car-t-platform-first-human-data-ash-2021</loc>
  <lastmod>2021-12-13T20:48:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-initiates-new-usd-15-billion-share-buyback-highlighting-confidence-growth-and-pipeline</loc>
  <lastmod>2021-12-16T07:03:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-phase-iii-ligelizumab-qge031-studies-chronic-spontaneous-urticaria-csu</loc>
  <lastmod>2021-12-20T07:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-strengthens-immunotherapy-pipeline-option-collaboration-and-license-agreement-beigene-tigit-inhibitor-ociperlimab</loc>
  <lastmod>2021-12-20T12:18:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-submits-biologics-license-application-proposed-biosimilar-trastuzumab-us-fda</loc>
  <lastmod>2021-12-20T22:18:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-submits-marketing-authorization-application-proposed-biosimilar-trastuzumab-ema</loc>
  <lastmod>2021-12-22T07:18:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-acquire-gyroscope-therapeutics-adding-one-time-gene-therapy-could-transform-care-geographic-atrophy-leading-cause-blindness</loc>
  <lastmod>2021-12-22T08:03:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-approves-novartis-leqvio-inclisiran-first-class-sirna-lower-cholesterol-and-keep-it-low-two-doses-year</loc>
  <lastmod>2021-12-22T22:18:04+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-receives-fda-approval-treatment-children-and-adolescents-enthesitis-related-arthritis-and-psoriatic-arthritis</loc>
  <lastmod>2021-12-23T00:03:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-shareholders-approve-all-resolutions-proposed-board-directors-annual-general-meeting-4</loc>
  <lastmod>2022-03-03T13:19:05+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/les-actionnaires-de-novartis-approuvent-toutes-les-resolutions-proposees-par-le-conseil-dadministration-lors-de-lassemblee-generale-annuelle-1</loc>
  <lastmod>2022-03-03T13:19:05+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-entresto-granted-expanded-indication-chronic-heart-failure-fda-0</loc>
  <lastmod>2022-03-03T13:19:05+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-peer-reviewed-research-shows-no-increased-risk-serious-covid-19-infections-kesimpta-ofatumumab-treated-adults-multiple-sclerosis</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-targets-growth-opportunities-respiratory-and-complex-generics-through-acquisition-respiratory-device-company-coalesce</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-again-demonstrate-age-appropriate-development-when-zolgensma-used-presymptomatically-and-post-hoc-data-reveal-sma-type-1-patients-could-speak-swallow-and-maintain-airway-protection</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-signs-initial-agreement-carisma-therapeutics-manufacturing-her-2-targeted-car-m-cell-therapy</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/nejm-publication-novartis-kisqali-data-shows-longest-median-overall-survival-ever-reported-hrher2-advanced-breast-cancer</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-voyager-therapeutics-reach-license-option-agreement-next-generation-gene-therapy-vectors-neurological-diseases</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-shareholders-approve-all-resolutions-proposed-board-directors-annual-general-meeting-5</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/les-actionnaires-de-novartis-approuvent-toutes-les-resolutions-proposees-par-le-conseil-dadministration-lors-de-lassemblee-generale-ordinaire</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/aktionarinnen-und-aktionare-von-novartis-heissen-der-ordentlichen-generalversammlung-alle-antrage-des-verwaltungsrats-gut</loc>
  <lastmod>2022-06-29T02:04:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-peer-reviewed-safety-and-tolerability-data-further-strengthens-kesimptas-ofatumumab-favorable-benefit-risk-profile-patients-relapsing-multiple-sclerosis</loc>
  <lastmod>2022-06-30T00:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-launches-generic-lenalidomide-19-countries-across-europe-expanding-access-essential-oncology-medicine</loc>
  <lastmod>2022-06-30T00:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivers-mid-single-digit-sales-growth-margin-expansion-and-advancement-robust-pipeline-2021</loc>
  <lastmod>2022-06-30T00:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-enregistre-en-2021-une-croissance-du-chiffre-daffaires-net-un-chiffre-dans-le-milieu-de-la-fourchette-une-expansion-de-la-marge-et-une-avancee-du-robuste-pipeline</loc>
  <lastmod>2022-06-30T00:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-2021-ein-umsatzwachstum-im-mittleren-einstelligen-bereich-verbessert-die-margen-und-treibt-die-solide-pipeline-voran</loc>
  <lastmod>2022-06-30T00:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-molecular-partners-report-positive-topline-data-from-phase-2-study-ensovibep-mp0420-darpin-antiviral-therapeutic-covid-19</loc>
  <lastmod>2022-06-30T00:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-collaboration-alnylam-explore-targeted-therapy-restore-liver-function</loc>
  <lastmod>2022-06-30T00:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-us-court-appeals-federal-circuit-cafc-upholds-validity-gilenya-fingolimod-dosage-regimen-patent</loc>
  <lastmod>2022-06-30T00:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-pluvictotm-approved-fda-first-targeted-radioligand-therapy-treatment-progressive-psma-positive-metastatic-castration-resistant-prostate-cancer</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-jakavi-treat-acute-and-chronic-graft-versus-host-disease</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-kymriah-car-t-cell-therapy-adult-patients-relapsed-or-refractory-follicular-lymphoma-europe</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-european-commission-approval-beovu-people-living-diabetic-macular-edema</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-new-organizational-structure-accelerate-growth-strengthen-pipeline-and-increase-productivity</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-gibt-neue-organisationsstruktur-bekannt-fur-schnelleres-wachstum-eine-starkere-pipeline-und-hohere-produktivitat</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-four-year-data-efficacy-and-safety-kesimpta-ofatumumab-people-living-relapsing-multiple-sclerosis</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-expands-zolgensma-manufacturing-capacity-approval-multi-product-north-carolina-facility</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-approves-novartis-vijoice-alpelisib-first-and-only-treatment-select-patients-pik3ca-related-overgrowth-spectrum-pros</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-extends-collaboration-agreement-drive-cutting-edge-digital-solutions-global-fight-against-antimicrobial-resistance-amr</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-anti-pd-1-tislelizumab-accepted-ema-regulatory-review-esophageal-and-lung-cancers</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-early-clinical-data-unique-krasg12c-inhibitor-american-association-cancer-research-annual-meeting</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-launches-generic-brimonidine-tartratetimolol-maleate-eyedrop-us-patients-ocular-hypertension-expanding-leading-ophthalmic-portfolio</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-tabrecta-patients-metex14-advanced-non-small-cell-lung-cancer</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivers-solid-sales-and-profit-growth-strong-performance-market-brands-supports-confidence-mid-term-growth-outlook</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-solide-croissance-du-chiffre-daffaires-et-du-benefice-la-forte-performance-des-marques-existantes-soutient-la-confiance-dans-les-previsions-de-croissance-moyen-terme</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-ein-solides-umsatz-und-gewinnwachstum-die-starke-performance-auf-dem-markt-befindlicher-marken-stutzt-das-vertrauen-die-mittelfristigen-wachstumsaussichten</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-tislelizumab-plus-chemotherapy-significantly-improved-overall-survival-first-line-treatment-advanced-esophageal-cancer-phase-iii-study</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kymriah-receives-ec-approval-first-car-t-cell-therapy-adults-relapsed-or-refractory-follicular-lymphoma</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-data-demonstrate-only-kisqali-offers-more-life-first-line-setting-postmenopausal-hrher2-advanced-breast-cancer-patients</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-european-commission-approval-jakavi-be-first-post-steroid-treatment-acute-and-chronic-graft-versus-host-disease</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-production-radioligand-therapy-medicines</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-asco-and-eha-showcase-latest-oncology-research-and-innovation-including-breast-and-prostate-cancer</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-secukinumab-receives-positive-chmp-opinion-expanded-use-childhood-arthritic-conditions</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-appoints-new-board-representative-global-amr-industry-alliance</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-approves-novartis-kymriah-car-t-cell-therapy-adult-patients-relapsed-or-refractory-follicular-lymphoma</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-new-global-act4biosimilars-initiative-improve-patient-access-and-increase-adoption-least-30-30-countries-2030</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-partnership-american-society-hematology-fight-sickle-cell-disease-sub-saharan-africa</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-cdk46i-data-asco-reinforce-novartis-kisqali-only-drug-class-consistently-proven-overall-survival-benefit-hrher2-metastatic-breast-cancer</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-data-show-piqray-effectiveness-across-key-biomarkers-patients-hrher2-metastatic-breast-cancer</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-tafinlar-dabrafenib-mekinist-trametinib-demonstrates-unprecedented-efficacy-pediatric-patients-braf-v600-low-grade-gliomas-phase-iiiii-study</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-scemblix-novel-mechanism-action-shows-superior-long-term-efficacy-and-consistent-tolerability-96-week-follow-chronic-myeloid-leukemia-trial</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-five-year-kymriah-data-show-durable-remission-and-long-term-survival-maintained-children-and-young-adults-advanced-b-cell-all</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-research-reveals-critical-actions-needed-ensure-covid-19-driven-surge-virtual-health-and-care-drives-health-access-and-equity</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-application-proposed-biosimilar-adalimumabs-high-concentration-formulation-accepted-ema</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-nature-medicine-publication-zolgensma-data-demonstrating-age-appropriate-milestones-when-treating-children-sma-presymptomatically</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-plans-petition-us-court-appeals-federal-circuit-further-review-uphold-validity-gilenya-fingolimod-dosing-regimen-patent</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-european-commission-approval-tabrecta-treatment-metex14-skipping-advanced-non-small-cell-lung-cancer</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-tafinlar-mekinist-receives-fda-approval-first-tumor-agnostic-indication-braf-v600e-solid-tumors</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-renews-commitment-neglected-tropical-disease-and-malaria-elimination-investing-usd-250-million-over-five-years-research-and-develop-new-treatments</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-scemblix-novel-treatment-adult-patients-chronic-myeloid-leukemia</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-extension-phase-data-show-nearly-80-rms-patients-treated-kesimpta-ofatumumab-had-no-evidence-disease-activity-neda-3</loc>
  <lastmod>2022-06-30T07:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/cosentyx-secukinumab-receives-expanded-approvals-eu-use-childhood-arthritic-conditions</loc>
  <lastmod>2022-06-28T21:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-maintains-growth-momentum-and-confirms-fy22-group-guidance</loc>
  <lastmod>2022-12-05T17:19:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-investigational-oral-monotherapy-iptacopan-demonstrates-clinically-meaningful-superiority-over-anti-c5-treatment-phase-iii-apply-pnh-study</loc>
  <lastmod>2022-12-05T17:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-pluvicto-patients-progressive-psma-positive-metastatic-castration-resistant-prostate-cancer</loc>
  <lastmod>2022-12-05T17:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-unveils-new-focused-strategy-underpinned-eight-potential-multi-billion-dollar-peak-sales-brands-deep-pipeline-meet-management-event</loc>
  <lastmod>2022-12-05T17:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-plans-petition-us-supreme-court-uphold-validity-gilenya-fingolimod-dosing-regimen-patent</loc>
  <lastmod>2022-12-05T17:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-further-progress-its-biosimilar-pipeline-release-positive-results-denosumab-integrated-phase-iiii-clinical-trial</loc>
  <lastmod>2022-12-05T17:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-statement-regarding-competition-authority-investigation-assertion-patent</loc>
  <lastmod>2022-12-05T17:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-invests-early-technical-development-capabilities-next-generation-biotherapeutics</loc>
  <lastmod>2022-12-05T17:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-tislelizumab-demonstrated-efficacy-and-tolerability-first-line-advanced-liver-cancer-phase-iii-trial</loc>
  <lastmod>2022-12-05T17:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-shows-clinically-meaningful-symptom-improvements-patients-hidradenitis-suppurativa-pivotal-phase-iii-trials</loc>
  <lastmod>2022-12-05T17:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-adds-one-more-year-survival-benefit-broadest-set-patients-including-those-aggressive-hrher2-advanced-breast-cancer</loc>
  <lastmod>2022-12-05T17:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-depth-immunology-pipeline-novel-data-key-upcoming-international-congresses</loc>
  <lastmod>2022-12-05T17:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-appoints-fiona-marshall-phd-president-novartis-institutes-biomedical-research-jay-bradner-md-steps-down-from-executive-committee-novartis</loc>
  <lastmod>2022-12-05T17:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-data-breast-and-prostate-cancer-esmo</loc>
  <lastmod>2022-12-05T17:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-scemblix-novel-mechanism-action-approved-european-commission-adult-patients-chronic-myeloid-leukemia</loc>
  <lastmod>2022-12-05T17:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-intention-separate-sandoz-business-create-standalone-company-way-100-spin</loc>
  <lastmod>2022-12-05T17:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-provides-update-phase-iii-canopy-study-evaluating-canakinumab-adjuvant-treatment-non-small-cell-lung-cancer</loc>
  <lastmod>2022-12-05T17:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/applications-proposed-first-kind-multiple-sclerosis-biosimilar-natalizumab-accepted-us-fda-and-ema</loc>
  <lastmod>2022-12-05T17:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-supplemental-biologics-license-application-accepted-us-fda-biosimilar-hyrimoz-adalimumab-adaz-high-concentration-formulation-hcf</loc>
  <lastmod>2022-12-05T17:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivers-continued-strong-momentum-key-growth-brands-progress-strategic-initiatives-and-confirms-fy22-group-guidance</loc>
  <lastmod>2022-12-05T17:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-phase-iii-data-show-novartis-tislelizumab-significantly-extended-median-overall-survival-more-6-months-first-line-advanced-esophageal-cancer-combination-chemotherapy</loc>
  <lastmod>2022-12-05T17:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-resumes-production-and-delivery-radioligand-therapy-medicines-ahead-schedule</loc>
  <lastmod>2022-12-05T17:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-further-investment-key-manufacturing-facility-austria-support-increased-global-demand-essential-antibiotics</loc>
  <lastmod>2022-12-05T17:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-long-term-leqvio-inclisiran-data-from-novartis-show-sustained-efficacy-and-safety-over-four-years</loc>
  <lastmod>2022-12-05T17:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-scientific-advances-kisqali-iptacopan-scemblix-and-ytb323-data-sabcs-and-ash</loc>
  <lastmod>2022-12-05T17:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-medicines-malaria-venture-announce-decision-move-phase-3-study-novel-ganaplacidelumefantrine-sdf-combination-adults-and-children-malaria</loc>
  <lastmod>2022-12-05T17:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-setzt-die-wachstumsdynamik-fort-und-bestatigt-die-konzernprognose-fur-das-geschaftsjahr-2022</loc>
  <lastmod>2023-01-18T11:07:06+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-will-das-sandoz-geschaft-durch-eine-hundertprozentige-ausgliederung-als-eigenstandiges-unternehmen-abspalten</loc>
  <lastmod>2023-01-18T11:07:09+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-eine-anhaltend-starke-dynamik-der-wichtigsten-wachstumsmarken-sowie-fortschritte-bei-strategischen-initiativen-und-bestatigt-die-konzernprognose-fur-das-geschaftsjahr-2022</loc>
  <lastmod>2023-01-18T11:07:11+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-maintient-sa-dynamique-de-croissance-et-confirme-les-previsions-de-lexercice-2022-pour-le-groupe</loc>
  <lastmod>2023-01-18T11:07:14+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-continue-le-fort-elan-des-principales-marques-de-croissance-progresse-dans-ses-initiatives-strategiques-et-confirme-les-previsions-de-lexercice-2022-pour-le-groupe</loc>
  <lastmod>2023-01-18T11:07:16+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-announces-appointment-chairman-designate-sandoz-board-directors</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-biologics-license-application-proposed-biosimilar-denosumab-accepted-us-fda</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/patients-hidradenitis-suppurativa-experienced-sustained-efficacy-and-symptom-improvement-one-year-when-treated-novartis-cosentyx</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-continues-grow-further-core-margin-expansion-and-achieves-important-innovation-milestones</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-poursuit-sa-croissance-avec-une-nouvelle-expansion-de-sa-marge-core-et-franchit-des-etapes-importantes-dans-linnovation</loc>
  <lastmod>2023-06-02T01:34:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-setzt-wachstumskurs-mit-weiterer-steigerung-der-kerngewinnmarge-fort-und-erreicht-wichtige-innovations-meilensteine</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-positive-chmp-opinion-citrate-free-high-concentration-formulation-adalimumab-biosimilar</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-agreement-acquire-leading-antifungal-agent-mycamine-from-astellas-reinforcing-hospital-offering-and-leading-anti-infectives-portfolio</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-pivotal-phase-iii-apply-pnh-data-ash-demonstrating-investigational-oral-monotherapy-iptacopan-superiority-over-anti-c5</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-european-commission-approval-pluvicto-first-targeted-radioligand-therapy-treatment-progressive-psma-positive-metastatic-castration-resistant-prostate-cancer</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-investigational-iptacopan-provides-clinically-meaningful-increases-hemoglobin-levels-complement-inhibitor-naive-patients-pnh</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-prolonged-pfs-benefit-pre-and-perimenopausal-patients-aggressive-hrher2-metastatic-breast-cancer-compared-chemotherapy</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-pluvictotm-shows-statistically-significant-and-clinically-meaningful-radiographic-progression-free-survival-benefit-patients-psma-positive-metastatic-castration-resistant-prostate-cancer</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-shareholders-approve-all-resolutions-proposed-board-directors-annual-general-meeting-6</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/les-actionnaires-de-novartis-approuvent-toutes-les-resolutions-proposees-par-le-conseil-dadministration-lors-de-lassemblee-generale-ordinaire-0</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/aktionarinnen-und-aktionare-von-novartis-heissen-der-ordentlichen-generalversammlung-alle-antrage-des-verwaltungsrats-gut-0</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-signs-memorandum-understanding-build-new-biologics-production-plant-slovenia-support-increasing-global-demand-biosimilar-medicines</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-tafinlar-mekinist-approved-fda-pediatric-patients-braf-v600e-low-grade-glioma-most-common-pediatric-brain-cancer</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-shares-zolgensma-long-term-data-demonstrating-sustained-durability-75-years-post-dosing-100-achievement-all-assessed-milestones-children-treated-prior-sma-symptom-onset</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-us-fda-approval-biosimilar-hyrimoz-adalimumab-adaz-high-concentration-formulation</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-phase-iii-natalee-trial-meets-primary-endpoint-interim-analysis-demonstrating-clinically-meaningful-benefit-broad-population-patients-early-breast-cancer</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-entresto-receives-positive-chmp-opinion-pediatric-heart-failure</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-approval-european-commission-hyrimoz-adalimumab-high-concentration-formulation</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-five-year-data-disability-outcomes-and-safety-kesimpta-ofatumumab-people-living-relapsing-multiple-sclerosis</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivers-strong-sales-growth-robust-margin-expansion-and-major-innovation-milestones-raises-fy-guidance</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-realise-une-croissance-forte-de-son-chiffre-daffaires-une-expansion-robuste-de-sa-marge-des-etapes-majeures-de-linnovation-et-rehausse-ses-previsions-pour-lexercice-2023</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-kraftige-umsatzsteigerungen-eine-robuste-margenerhohung-und-wichtige-innovationsmeilensteine-erhohung-der-jahresprognose</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-phase-iii-appoint-pnh-trial-shows-investigational-oral-monotherapy-iptacopan-improves-hemoglobin-near-normal-levels-leading-transfusion-independence-all-treatment-naive-pnh-patients</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-present-new-data-across-oncology-portfolio-including-kisqali-phase-iii-natalee-trial-early-breast-cancer-asco</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-cosentyx-gains-positive-chmp-opinion-hidradenitis-suppurativa</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-exclusively-commercialize-six-products-us-reinforcing-global-leadership-position-patent-medicines</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-strengthens-pipeline-expansion-through-partnership-develop-and-manufacture-multiple-biosimilars</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-feature-new-pnh-and-cml-scientific-data-from-broad-hematology-portfolio-european-hematology-association-annual-meeting</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-sandoz-board-directors-appointed</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-marketing-authorization-applications-proposed-biosimilar-denosumab-accepted-ema</loc>
  <lastmod>2023-06-01T07:49:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-european-approval-cosentyx-first-and-only-il-17a-inhibitor-hidradenitis-suppurativa</loc>
  <lastmod>2023-12-03T09:04:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-plans-move-new-central-basel-headquarters-mid-2024-following-proposed-spin-standalone-company</loc>
  <lastmod>2023-12-12T09:19:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-significantly-reduced-risk-recurrence-25-across-broad-population-patients-early-breast-cancer-clinically-meaningful-benefit-was-consistent-across-subgroups</loc>
  <lastmod>2023-12-03T09:04:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-presents-compelling-investment-proposition-standalone-company-capital-markets-day</loc>
  <lastmod>2023-12-03T09:04:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-unveils-results-from-global-patient-and-physician-survey-disrupting-notion-cml-solved-disease</loc>
  <lastmod>2023-12-03T09:04:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-bolsters-innovative-medicines-strategy-and-renal-pipeline-agreement-acquire-chinook-therapeutics-usd-32bn-upfront-usd-40-share</loc>
  <lastmod>2023-12-03T09:04:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-introduces-act4biosimilars-action-plan-accelerate-patient-access-biosimilar-medicines</loc>
  <lastmod>2023-12-03T09:04:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-signs-agreement-divest-front-eye-ophthalmology-assets-line-focused-strategy</loc>
  <lastmod>2023-12-03T09:04:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-publishes-new-five-year-efficacy-data-kesimpta-ofatumumab-treatment-relapsing-multiple-sclerosis</loc>
  <lastmod>2023-12-13T14:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-launch-hyrimoz-adalimumab-adaz-high-concentration-formulation-marking-sandoz-entrance-us-immunology-space</loc>
  <lastmod>2023-12-02T22:04:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-will-appeal-us-court-appeals-uphold-validity-entresto-combination-patent-maintains-2023-guidance-and-mid-term-outlook</loc>
  <lastmod>2023-12-02T22:04:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-builds-neuroscience-pipeline-and-xrna-platform-capabilities-acquisition-dtx-pharma</loc>
  <lastmod>2023-12-02T18:49:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivers-strong-sales-growth-robust-margin-expansion-and-raises-guidance-announces-usd-15-billion-share-buyback-and-board-endorses-sandoz-spin-off12</loc>
  <lastmod>2023-12-02T17:04:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-realise-une-forte-croissance-de-son-chiffre-daffaires-et-de-sa-marge-releve-ses-previsions-et-annonce-un-rachat-dactions-dusd-15-milliards1-le-conseil-dadministration-approuve-le-spin-de-sandoz2</loc>
  <lastmod>2023-12-02T18:49:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-kraftige-umsatz-und-margensteigerungen-und-erhoht-die-prognose-aktienruckkaufprogramm-von-usd-15-milliarden-angekundigt-der-verwaltungsrat-unterstutzt-den-spin-von-sandoz12</loc>
  <lastmod>2023-12-02T18:49:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-plans-build-biosimilar-technical-development-center-slovenia-support-future-growth-biosimilar-pipeline</loc>
  <lastmod>2023-12-02T17:04:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-positive-chmp-opinion-multiple-sclerosis-biosimilar-natalizumab</loc>
  <lastmod>2023-12-02T17:04:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-remibrutinib-phase-iii-trials-met-their-primary-endpoints-and-showed-rapid-symptom-control-chronic-spontaneous-urticaria</loc>
  <lastmod>2023-12-02T17:04:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-completes-acquisition-chinook-therapeutics</loc>
  <lastmod>2023-12-02T17:04:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-positive-results-from-mylight-phase-lll-study-biosimilar-aflibercept</loc>
  <lastmod>2023-12-02T14:04:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-issues-egm-invitation-and-shareholder-information-brochure-sandoz-publishes-listing-prospectus-ahead-proposed-spin-vote</loc>
  <lastmod>2023-12-02T14:04:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-publiziert-einladung-und-aktionarsbroschure-zur-ausserordentlichen-generalversammlung-sandoz-veroffentlicht-den-kotierungsprospekt-im-vorfeld-der-abstimmung-zum-vorgeschlagenen-spin</loc>
  <lastmod>2023-12-02T14:04:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-publie-linvitation-lage-et-la-brochure-dinformation-aux-actionnaires-sandoz-publie-le-prospectus-de-cotation-avant-le-vote-sur-la-proposition-de-scission</loc>
  <lastmod>2023-12-02T14:04:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-fda-approval-tyruko-natalizumab-sztn-first-and-only-fda-approved-biosimilar-relapsing-forms-multiple-sclerosis</loc>
  <lastmod>2023-12-02T14:04:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-completes-acquisition-leading-antifungal-agent-mycamine-from-astellas-reinforcing-leading-global-anti-infectives-portfolio</loc>
  <lastmod>2023-12-02T14:04:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-long-term-leqvio-inclisiran-data-demonstrating-consistent-efficacy-and-safety-beyond-six-years</loc>
  <lastmod>2023-12-02T07:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-publishes-supplement-listing-prospectus-including-sandoz-h1-2023-financial-statements</loc>
  <lastmod>2023-12-02T06:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-publie-un-supplement-au-prospectus-de-cotation-comprenant-les-etats-financiers-de-sandoz-au-premier-semestre-2023</loc>
  <lastmod>2023-12-02T07:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-veroffentlicht-nachtrag-zum-kotierungsprospekt-einschliesslich-finanzabschluss-von-sandoz-fur-das-1-halbjahr-2023</loc>
  <lastmod>2023-12-02T07:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-appoints-patrick-horber-md-president-international-marie-france-tschudin-president-innovative-medicines-international-and-chief-commercial-officer-steps-down-from-executive-committee-novartis</loc>
  <lastmod>2023-12-01T23:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-ernennt-dr-patrick-horber-zum-president-international-da-marie-france-tschudin-president-innovative-medicines-international-und-chief-commercial-officer-aus-der-geschaftsleitung-von-novartis-ausscheidet</loc>
  <lastmod>2023-12-02T06:04:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-nomme-patrick-horber-docteur-en-medecine-au-poste-de-president-international-alors-que-marie-france-tschudin-president-innovative-medicines-international-et-chief-commercial-officer-quitte-le-comite-executif-de-novartis</loc>
  <lastmod>2023-12-02T06:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-announces-exclusive-deal-commercialize-biosimilar-ustekinumab-further-reinforcing-growing-pipeline-and-immunology-patient-offering</loc>
  <lastmod>2023-12-01T23:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-reduced-risk-cancer-recurrence-while-maintaining-quality-life-patients-diagnosed-early-breast-cancer</loc>
  <lastmod>2023-12-01T23:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-shareholders-approve-proposed-100-spin-sandoz</loc>
  <lastmod>2023-12-01T05:04:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/les-actionnaires-de-novartis-approuvent-le-projet-de-scission-100-de-sandoz</loc>
  <lastmod>2023-12-01T08:04:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/aktionarinnen-und-aktionare-von-novartis-stimmen-dem-geplanten-100-igen-spin-von-sandoz-zu</loc>
  <lastmod>2023-12-01T23:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-positive-chmp-opinion-breast-and-gastric-cancer-biosimilar-trastuzumab</loc>
  <lastmod>2023-12-01T18:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-radioligand-therapy-lutathera-demonstrated-statistically-significant-and-clinically-meaningful-progression-free-survival-first-line-advanced-gastroenteropancreatic-neuroendocrine-tumors-gep-nets</loc>
  <lastmod>2023-12-01T18:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-confirms-sandoz-spin-october-4-2023</loc>
  <lastmod>2023-12-01T10:19:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/sandoz-receives-european-commission-approval-tyruko-natalizumab-first-and-only-biosimilar-multiple-sclerosis-europe</loc>
  <lastmod>2023-12-01T18:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-completes-divestment-front-eye-ophthalmology-assets</loc>
  <lastmod>2023-12-01T10:19:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-investigational-iptacopan-phase-iii-study-demonstrates-clinically-meaningful-and-highly-statistically-significant-proteinuria-reduction-patients-iga-nephropathy-igan</loc>
  <lastmod>2023-12-01T18:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-executes-sandoz-spin-completing-strategic-transformation-leading-focused-innovative-medicines-company</loc>
  <lastmod>2023-12-01T18:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-present-new-oncology-data-esmo-2023-demonstrating-practice-changing-innovation-advanced-prostate-and-early-breast-cancer</loc>
  <lastmod>2023-12-01T18:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-natalee-analysis-reinforces-consistent-reduction-risk-recurrence-across-key-subgroups-patients-early-breast-cancer</loc>
  <lastmod>2023-12-01T18:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-pluvictotm-shows-clinically-meaningful-and-highly-statistically-significant-rpfs-benefit-patients-psma-positive-metastatic-castration-resistant-prostate-cancer-pre-taxane-setting</loc>
  <lastmod>2023-12-01T18:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivers-12-sales-and-21-core-operating-income-growth-from-continuing-operations-cc1-executes-sandoz-spin-achieves-important-innovation-milestones-and-raises-fy-2023-guidance</loc>
  <lastmod>2023-12-01T18:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-hausse-de-12-du-chiffre-daffaires-et-de-21-du-resultat-operationnel-core-tcc1-spin-de-sandoz-etapes-importantes-de-linnovation-hausse-des-previsions-pour-2023</loc>
  <lastmod>2023-12-01T18:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-steigert-umsatz-um-12-und-operatives-kernergebnis-um-21-fortzufuhrende-geschaftsbereiche-kwk1-sandoz-abgespalten-wichtige-innovationsmeilensteine-erreicht-und-prognose-2023-erhoht</loc>
  <lastmod>2023-12-01T07:04:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-confirms-unconstrained-supply-pluvicto-and-continues-significantly-expand-number-treatment-centers</loc>
  <lastmod>2023-12-01T18:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-investigational-atrasentan-phase-iii-study-demonstrates-clinically-meaningful-and-highly-statistically-significant-proteinuria-reduction-patients-iga-nephropathy-igan</loc>
  <lastmod>2023-12-01T10:19:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-approves-novartis-cosentyx-first-new-biologic-treatment-option-hidradenitis-suppurativa-patients-nearly-decade</loc>
  <lastmod>2023-12-01T18:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-show-potential-remibrutinib-oral-treatment-chronic-spontaneous-urticaria-providing-significant-symptom-improvement-early-week-2</loc>
  <lastmod>2023-12-01T18:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-showcases-significant-data-updates-from-kisqali-iptacopan-and-scemblix-sabcs-and-ash</loc>
  <lastmod>2023-12-01T18:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-upgrades-mid-term-sales-growth-guidance-showcases-its-differentiated-innovative-medicines-strategy-and-robust-pipeline-rd-day</loc>
  <lastmod>2023-12-01T18:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-investigational-iptacopan-phase-iii-study-demonstrates-clinically-meaningful-and-statistically-significant-proteinuria-reduction-patients-c3-glomerulopathy-c3g</loc>
  <lastmod>2024-05-06T02:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-48-week-results-from-phase-iii-apply-pnh-trial-showing-sustained-efficacy-and-long-term-safety-fabhalta-iptacopan-adults-paroxysmal-nocturnal-hemoglobinuria-pnh</loc>
  <lastmod>2024-05-06T02:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/latest-novartis-kisqali-natalee-analysis-reinforces-25-reduction-risk-recurrence-across-broad-population-patients-early-breast-cancer-supports-regulatory-submissions</loc>
  <lastmod>2024-05-06T02:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-fda-approval-fabhalta-iptacopan-offering-superior-hemoglobin-improvement-absence-transfusions-first-oral-monotherapy-adults-pnh</loc>
  <lastmod>2024-05-06T02:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-expands-production-pluvictotm-addition-its-largest-and-most-advanced-radioligand-therapy-manufacturing-facility-indianapolis</loc>
  <lastmod>2024-05-06T02:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-scemblix-shows-superior-major-molecular-response-mmr-rates-vs-standard-care-tkis-phase-iii-trial-newly-diagnosed-patients-chronic-myeloid-leukemia</loc>
  <lastmod>2024-05-06T02:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-lutathera-significantly-reduced-risk-disease-progression-or-death-72-first-line-treatment-patients-advanced-gastroenteropancreatic-neuroendocrine-tumors</loc>
  <lastmod>2024-04-30T22:34:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivers-strong-full-year-performance-10-net-sales-and-18-core-operating-income-growth-cc1-margin-expansion-continuing-innovation-momentum-multiple-positive-ph3-readouts</loc>
  <lastmod>2024-05-02T17:04:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-forte-performance-en-2023-hausse-de-10-du-chiffre-daffaires-net-et-de-18-du-resultat-operationnel-core-tcc1-expansion-de-la-marge-innovation-nombreux-resultats-positifs-de-phase-iii</loc>
  <lastmod>2024-01-31T09:27:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/starkes-jahresergebnis-novartis-steigert-den-nettoumsatz-um-10-das-operative-kernergebnis-um-18-kwk1-sowie-die-margen-weitere-innovationsdynamik-mit-mehreren-positiven-phase-3-ergebnissen</loc>
  <lastmod>2024-02-05T22:48:49+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-strengthen-oncology-pipeline-agreement-acquire-morphosys-ag-eur-68-share-or-aggregate-eur-27bn-cash</loc>
  <lastmod>2024-02-05T22:48:45+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-new-data-safety-and-efficacy-zolgensma-including-maintained-and-improved-motor-milestones-older-and-heavier-children-sma</loc>
  <lastmod>2024-03-04T07:19:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-shareholders-approve-all-resolutions-proposed-board-directors-annual-general-meeting-7</loc>
  <lastmod>2024-03-05T15:34:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/les-actionnaires-de-novartis-approuvent-toutes-les-resolutions-proposees-par-le-conseil-dadministration-lors-de-lassemblee-generale-ordinaire-1</loc>
  <lastmod>2024-03-05T15:34:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/aktionarinnen-und-aktionare-von-novartis-heissen-der-ordentlichen-generalversammlung-alle-antrage-des-verwaltungsrats-gut-1</loc>
  <lastmod>2024-05-02T14:04:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-fabhalta-iptacopan-receives-positive-chmp-opinion-first-oral-monotherapy-adult-patients-paroxysmal-nocturnal-hemoglobinuria-pnh</loc>
  <lastmod>2024-03-22T12:34:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-data-show-early-addition-twice-yearly-leqvio-inclisiran-following-maximally-tolerated-statin-therapy-significantly-reduces-ldl-c-ascvd-patients-real-world-setting</loc>
  <lastmod>2024-05-03T14:49:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-tender-offer-morphosys-ag-commences</loc>
  <lastmod>2024-05-04T09:49:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-fabhalta-iptacopan-data-show-clinically-meaningful-and-statistically-significant-proteinuria-reduction-383-versus-placebo-patients-iga-nephropathy-igan</loc>
  <lastmod>2024-05-02T20:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kesimpta-six-year-efficacy-data-show-substantial-benefits-recently-diagnosed-treatment-naive-people-relapsing-multiple-sclerosis</loc>
  <lastmod>2024-04-17T14:34:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-delivers-double-digit-sales-growth-and-core-margin-expansion-q1-fy-2024-guidance-raised</loc>
  <lastmod>2024-07-08T10:20:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-au-premier-trimestre-croissance-deux-chiffres-du-chiffre-daffaires-et-expansion-de-la-marge-core-hausse-des-previsions-pour-2024</loc>
  <lastmod>2024-04-23T08:03:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-im-ersten-quartal-ein-zweistelliges-umsatzwachstum-und-steigert-die-kerngewinnmarge-prognose-fur-das-geschaftsjahr-2024-erhoht</loc>
  <lastmod>2024-04-23T08:03:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-radioligand-therapy-lutathera-fda-approved-first-medicine-specifically-pediatric-patients-gastroenteropancreatic-neuroendocrine-tumors</loc>
  <lastmod>2024-04-23T19:49:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-enters-agreement-acquire-mariana-oncology-strengthening-radioligand-therapy-pipeline</loc>
  <lastmod>2024-11-04T07:04:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-and-medicines-malaria-venture-announce-positive-efficacy-and-safety-data-novel-treatment-babies</loc>
  <lastmod>2024-11-04T07:04:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-pioneering-innovation-cml-data-from-scemblix-phase-iii-asc4first-study-newly-diagnosed-patients-asco-and-eha</loc>
  <lastmod>2024-11-04T07:04:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-meets-all-tender-offer-conditions-acquire-morphosys-ag-eur-68-share-cash</loc>
  <lastmod>2024-11-04T07:04:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-presents-latest-phase-iii-fabhalta-iptacopan-data-c3-glomerulopathy-c3g-showing-clinically-meaningful-and-statistically-significant-351-proteinuria-reduction-vs-placebo</loc>
  <lastmod>2024-11-04T07:04:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-atrasentan-phase-iii-data-show-clinically-meaningful-proteinuria-reduction-further-advancing-companys-iga-nephropathy-igan-portfolio</loc>
  <lastmod>2024-11-04T07:04:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-phase-iii-data-confirm-sustained-efficacy-and-long-term-safety-oral-remibrutinib-chronic-spontaneous-urticaria</loc>
  <lastmod>2024-11-04T07:04:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-scemblix-phase-iii-data-first-show-superior-efficacy-favorable-safety-and-tolerability-profile-vs-standard-care-tkis-adults-newly-diagnosed-cml</loc>
  <lastmod>2024-11-04T07:04:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/latest-analysis-novartis-natalee-study-shows-kisqali-reduces-risk-cancer-recurrence-early-breast-cancer-patients-high-risk-node-negative-disease</loc>
  <lastmod>2024-11-04T07:04:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-continues-deliver-strong-sales-growth-and-core-margin-expansion-q2-raises-fy-2024-bottom-line-guidance</loc>
  <lastmod>2024-11-04T07:04:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-poursuivi-au-t2-la-forte-croissance-de-son-chiffre-daffaires-et-lexpansion-de-sa-marge-core-hausse-des-previsions-de-son-resultat-operationnel-core-pour-2024</loc>
  <lastmod>2024-11-04T07:04:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-erzielt-im-zweiten-quartal-weiterhin-kraftige-umsatzsteigerungen-und-erhoht-die-kerngewinnmarge-gewinnprognose-fur-das-geschaftsjahr-2024-angehoben</loc>
  <lastmod>2024-11-04T07:04:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-scemblix-granted-fda-priority-review-treatment-adults-newly-diagnosed-cml</loc>
  <lastmod>2024-11-04T07:04:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-fda-accelerated-approval-fabhalta-iptacopan-first-and-only-complement-inhibitor-reduction-proteinuria-primary-iga-nephropathy-igan</loc>
  <lastmod>2024-11-04T07:04:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-twice-yearly-leqvio-demonstrated-clinically-meaningful-statistically-significant-ldl-c-lowering-monotherapy-patients-low-or-moderate-ascvd-risk</loc>
  <lastmod>2024-11-04T07:04:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-shows-deepening-benefit-new-analysis-reducing-risk-recurrence-285-broad-population-patients-early-breast-cancer</loc>
  <lastmod>2024-11-04T07:04:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/fda-approves-novartis-kisqali-reduce-risk-recurrence-people-hrher2-early-breast-cancer</loc>
  <lastmod>2024-11-04T07:04:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-novartis-data-relapsing-ms-reinforce-benefits-kesimpta-first-line-and-switch-patients</loc>
  <lastmod>2024-11-04T07:04:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-receives-positive-chmp-opinion-kisqali-help-reduce-risk-recurrence-people-hrher2-early-breast-cancer</loc>
  <lastmod>2024-11-04T07:04:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-ribociclib-kisqali-recognized-category-1-preferred-breast-cancer-adjuvant-treatment-nccn-clinical-practice-guidelines-oncology-nccn-guidelines</loc>
  <lastmod>2024-11-19T14:04:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-oral-fabhalta-iptacopan-sustained-clinically-meaningful-results-one-year-phase-iii-c3-glomerulopathy-c3g-trial</loc>
  <lastmod>2024-11-04T07:04:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-continues-strong-momentum-q3-10-sales-growth-20-core-operating-income-growth-and-important-innovation-milestones-raises-fy-2024-guidance</loc>
  <lastmod>2024-11-04T07:04:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-setzt-die-starke-dynamik-im-dritten-quartal-fort-mit-steigerungen-beim-umsatz-10-und-operativen-kernergebnis-20-sowie-wichtigen-innovationsmeilensteinen-prognose-fur-2024-angehoben</loc>
  <lastmod>2024-11-04T07:04:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-scemblix-fda-approved-newly-diagnosed-cml-offering-superior-efficacy-and-favorable-safety-and-tolerability-profile</loc>
  <lastmod>2024-11-04T07:04:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-ranks-first-2024-access-medicine-index</loc>
  <lastmod>2024-11-25T07:19:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-upgrades-mid-term-guidance-and-highlights-deep-pipeline-core-therapeutic-areas-drive-long-term-growth</loc>
  <lastmod>2024-11-21T07:04:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-highlights-new-96-week-results-from-phase-iii-scemblix-asc4first-trial-ash-and-late-breaking-analysis-from-phase-iii-kisqali-natalee-trial-sabcs</loc>
  <lastmod>2024-11-25T07:19:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-kisqali-receives-european-commission-approval-broad-population-patients-hrher2-early-breast-cancer-high-risk-recurrence</loc>
  <lastmod>2024-11-27T13:03:29+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/new-phase-iiib-data-shows-novartis-fabhalta-improved-hemoglobin-levels-adult-patients-paroxysmal-nocturnal-hemoglobinuria-who-switched-from-anti-c5-therapy</loc>
  <lastmod>2024-12-06T07:19:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/longer-term-data-novartis-scemblix-reinforce-superior-efficacy-favorable-safety-and-tolerability-profile-adults-newly-diagnosed-cml</loc>
  <lastmod>2024-12-08T18:34:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/longer-term-novartis-kisqali-natalee-data-show-durable-reduction-distant-recurrence-broad-population-patients-early-breast-cancer</loc>
  <lastmod>2024-12-10T15:04:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-intrathecal-onasemnogene-abeparvovec-phase-iii-study-meets-primary-endpoint-children-and-young-adults-sma</loc>
  <lastmod>2025-01-10T12:49:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-entresto-us-patent-upheld-us-court-appeals</loc>
  <lastmod>2025-01-13T07:19:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-continues-strong-momentum-sales-growth-margin-expansion-reaches-key-innovation-milestones-2024</loc>
  <lastmod>2025-01-31T07:34:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-setzt-die-starke-umsatzdynamik-mit-margenerhohungen-fort-und-erreicht-2024-wichtige-meilensteine-bei-innovationen</loc>
  <lastmod>2025-01-31T07:34:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-bolsters-late-stage-cardiovascular-pipeline-agreement-acquire-anthos-therapeutics-usd-925-million-upfront</loc>
  <lastmod>2025-02-11T07:19:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-oral-fabhalta-iptacopan-receives-positive-chmp-opinion-treatment-adults-living-c3-glomerulopathy-c3g</loc>
  <lastmod>2025-02-28T13:49:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-data-presentations-aaaai-and-aad-underscore-commitment-advancing-treatment-hidradenitis-suppurativa-hs-and-chronic-spontaneous-urticaria-csu</loc>
  <lastmod>2025-02-28T15:04:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/novartis-shareholders-approve-all-resolutions-proposed-board-directors-2025-annual-general-meeting</loc>
  <lastmod>2025-03-07T15:19:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/media-releases/aktionare-von-novartis-heissen-der-generalversammlung-2025-alle-antrage-des-verwaltungsrats-gut</loc>
  <lastmod>2025-03-07T15:19:02+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-inaugurates-innovative-watershed-project-india-increase-water-availability</loc>
  <lastmod>2024-06-07T12:57:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-cancer-day-2021</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/global-health-corporate-responsibility</loc>
  <lastmod>2024-07-08T09:55:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/achieving-100-renewable-electricity</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-appoints-marc-boutin-global-head-patient-engagement-advocacy</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-provides-update-use-and-safety-beovu-patients-wet-amd</loc>
  <lastmod>2021-09-14T13:02:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/avexis-data-integrity-updates</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/epis-explores-how-covid-19-shaping-future-digital-engagement-within-healthcare</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-ranks-second-2021-access-medicine-index</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/highlights-from-co-creating-impact-summit-2020</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-chagas-disease-day-2021</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/bold-advocates-blood-cancers-and-blood-disorders</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/blood-cancer-awareness-month-cutting-edge-innovation-hematology</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/solar-1-nejm-publication</loc>
  <lastmod>2021-10-07T09:00:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/mission-transform-planetary-health</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-announces-flexible-return-office-and-site-field-activities-starting-may-11-2020</loc>
  <lastmod>2021-10-13T09:18:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-completes-safety-review-and-initiates-update-beovu-prescribing-information-worldwide</loc>
  <lastmod>2021-09-09T09:50:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-announces-first-european-donation-hydroxychloroquine-switzerland</loc>
  <lastmod>2021-09-09T09:51:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-coronavirus-update-supply-chain-response-measures-efpia-rd-call</loc>
  <lastmod>2021-10-14T08:01:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/expanding-car-t-manufacturing-australia</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/why-healthcares-digital-moment-now</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/avexis-renamed-novartis-gene-therapies-signifying-growing-importance-gene-therapy-novartis-corporate-strategy</loc>
  <lastmod>2021-10-07T09:12:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/ruxcovid-clinical-trial</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/study-suggests-there-may-be-two-stages-fatal-lung-disease-covid-19</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/choice-responsibility-reimagining-how-we-work</loc>
  <lastmod>2022-12-05T08:13:49+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/international-womens-day-2020</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-sight-day-2020</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/standing-racial-equity-and-justice-one-novartis</loc>
  <lastmod>2021-09-09T09:49:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-update-following-who-solidarity-trial-announcement</loc>
  <lastmod>2021-09-09T09:49:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-announces-plan-initiate-clinical-trial-canakinumab-patients-covid-19-pneumonia</loc>
  <lastmod>2021-09-09T09:50:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/leading-performance-sustainability</loc>
  <lastmod>2024-10-29T05:40:13+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-heart-day-2020-from-our-heart-yours</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/50-climate-leaders</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/new-report-shows-how-ai-health-critical-covid-19-response-and-recovery</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-coronavirus-update-remote-working-business-travel-restrictions</loc>
  <lastmod>2021-09-14T13:02:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/expanding-car-t-manufacturing-europe-serve-more-patients</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/committed-increasing-access</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/pride-novartis-2020-inspired-make-difference</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-sickle-cell-day-2020</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/pride-novartis-2019</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-chagas-disease-day-2020</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-covid-19-response-fund-provides-support-healthcare-workers-and-communities</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-esmo</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/day-african-child-2020</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-cancer-day-2020</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-world-economic-forum-annual-meeting-davos-2020</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/sustaining-momentum-toward-universal-health-coverage-africa</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/discussing-innovative-solutions-address-unmet-healthcare-needs-asia</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-joins-accelerating-covid-19-therapeutic-interventions-and-vaccines-activ-initiative</loc>
  <lastmod>2021-09-09T09:50:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-announces-further-steps-protect-and-support-its-associates-during-covid-19-pandemic</loc>
  <lastmod>2021-09-14T12:59:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-ranks-4-patientviews-2019-corporate-reputation-survey-patient-organizations</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/behind-research-driving-our-data-medical-conferences</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/uncovering-profound-and-under-reported-effects-people-living-sickle-cell-disease</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/amazon-web-services-aws-announces-strategic-collaboration-novartis-accelerate-digital-transformation-its-business-operations</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-opens-facility-innovative-cell-and-gene-therapies-switzerland</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-sight-day-2019</loc>
  <lastmod>2022-02-10T11:47:38+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-and-microsoft-announce-collaboration-transform-medicine-artificial-intelligence</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/health-experts-explore-response-chronic-illness-poor-countries</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-malaria-day-2019</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/global-equal-parental-leave-policy-all-novartis-parents</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-moves-address-superbug-threat</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/celebrating-community-partnership-day</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-recognized-global-leader-sustainable-water-and-climate-management</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/biosimilar-drugs-have-potential-save-more-usd-54-billion</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-foundation-joins-global-partnership-zero-leprosy</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-sickle-cell-day-2019</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/exploring-future-access-healthcare-lower-income-countries</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/alcon-survey-reveals-people-are-happier-and-more-satisfied-their-lives-after-cataract-surgery</loc>
  <lastmod>2021-08-23T10:08:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/car-t-therapies-are-manufactured-each-individual-patient</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/asthma-and-exercise-why-patients-can-and-should-stay-active</loc>
  <lastmod>2021-07-28T14:09:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/beyond-pill-precision-medicine-practice</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/improving-diabetes-awareness-and-treatment-adherence-india</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/how-digital-technologies-are-creating-new-normal-people-living-copd</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/when-innovation-draws-new-future-patient-treatments</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/taking-action-psoriasis-patients-who-psoriasis-resolution</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-medikidz-and-copd-foundation-partnership-superhero-proportions</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/innovation-practice-how-we-form-partnerships-pharma</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-evolving-business-practices-better-educate-medical-community</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/medical-researchers-using-new-tools-turn-science-fiction-science-fact</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/students-take-challenges-digital-medicine</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/fighting-high-blood-pressure-vietnam</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-asthma-day-2021</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/nurturing-next-generation-scientists</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-and-red-cross-partner-tackle-chronic-diseases-refugee-populations</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/essential-consultants-updates</loc>
  <lastmod>2021-10-14T09:40:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/avxs-101-managed-access-program</loc>
  <lastmod>2021-10-13T11:51:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-malaria-day-2021</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-dialogue-explore-solutions-rise-chronic-diseases-developing-world</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-host-stakeholder-dialogue-ways-improve-access-healthcare-lower-income-countries</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/european-patient-innovation-summit-recommends-increasing-impact-digital-technologies</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/alcon-becomes-separately-traded-standalone-company</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-rd-day</loc>
  <lastmod>2022-12-15T11:16:56+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-jp-morgan-2020</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/co-creating-impact-summit-society-and-planet</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/life-science-companies-and-bill-melinda-gates-foundation-joint-communique</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/european-patient-innovation-summit-publishes-call-action-ensure-greater-patient-involvement-digital-health-solution-development</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-research-shows-technology-talent-increasingly-drawn-pharma-industry-covid-19</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-malaria-day-2020</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/impact-measurement-and-valuation</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/ai-nurse-set-transform-standards-care-heart-failure-patients-china</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/meet-novartis-management-2020</loc>
  <lastmod>2023-12-06T10:37:20+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-announces-discontinuation-cirrus-1-study-cfz533-iscalimab-kidney-transplant-patients</loc>
  <lastmod>2021-10-04T08:25:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-receives-fda-fast-track-designation-lna043-osteoarthritis-knee</loc>
  <lastmod>2021-10-04T08:28:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-sabatolimab-receives-orphan-drug-designation-from-european-commission-myelodysplastic-syndromes</loc>
  <lastmod>2021-10-14T13:31:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/fda-accelerates-review-novartis-stamp-inhibitor-asciminib-abl001-patients-chronic-myeloid-leukemia-cml</loc>
  <lastmod>2021-10-04T08:26:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-receives-fda-orphan-drug-designation-nis793-pancreatic-cancer</loc>
  <lastmod>2021-10-04T08:28:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-announces-complete-response-resubmission-inclisiran-new-drug-application</loc>
  <lastmod>2021-10-04T08:26:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-receives-fda-breakthrough-therapy-designation-investigational-177lu-psma-617-patients-metastatic-castration-resistant-prostate-cancer-mcrpc</loc>
  <lastmod>2023-04-11T16:10:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-entresto-indicated-treatment-hypertension-china</loc>
  <lastmod>2021-10-04T08:25:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-receives-fda-fast-track-designation-sabatolimab-mbg453-myelodysplastic-syndromes</loc>
  <lastmod>2021-10-04T08:28:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/industry-and-academia-collaborating-innovate-patients</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/fda-grants-priority-review-investigational-targeted-radioligand-therapy-177lu-psma-617-patients-metastatic-castration-resistant-prostate-cancer-mcrpc</loc>
  <lastmod>2021-10-14T10:02:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/one-billion-antimalarial-treatments-delivered-extraordinary-partnership-journey</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/asia-pacific-patient-innovation-summit-examines-capability-building-gaps-patient-organizations</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/enabling-our-associates-work-safely-our-sites</loc>
  <lastmod>2021-10-07T13:13:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/beacon-hope-addressing-health-disparities-through-holistic-community-based-collective-action</loc>
  <lastmod>2021-10-11T12:14:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-hematology-relentless-pursuit-cure</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/two-decades-pioneering-innovation-cml-and-beyond</loc>
  <lastmod>2023-03-13T10:41:16+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/covid-19-news-archive</loc>
  <lastmod>2023-07-03T16:14:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-sight-day-2021</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/sound-up</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/raising-awareness-prostate-cancer-during-movember</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-receives-fda-fast-track-designation-branaplam-lmi070-treatment-huntingtons-disease</loc>
  <lastmod>2021-12-16T10:00:12+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/2021-global-managed-access-program-community-update</loc>
  <lastmod>2022-01-31T14:36:51+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-co-creating-impact-summit-2021</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-announces-european-patent-office-orders-grant-european-gilenya-fingolimod-05mg-daily-dose-patent</loc>
  <lastmod>2022-02-15T10:02:38+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-condemns-war-ukraine-and-commits-supporting-humanitarian-efforts</loc>
  <lastmod>2022-03-15T08:49:19+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-expands-humanitarian-efforts-ukraine-through-donation-essential-medicines</loc>
  <lastmod>2022-03-08T16:49:12+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-condemns-war-ukraine-update-march-22</loc>
  <lastmod>2022-03-22T08:11:41+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-provides-more-usd-25-million-medical-aid-patients-ukraine-and-bordering-countries</loc>
  <lastmod>2022-04-19T14:32:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-resumes-business-ukraine</loc>
  <lastmod>2022-07-28T12:22:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/from-the-heart</loc>
  <lastmod>2022-11-07T09:58:07+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/zolgensma-acute-liver-failure-update</loc>
  <lastmod>2022-08-16T17:30:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/branaplam-vibrant-hd-study-update</loc>
  <lastmod>2022-08-25T16:01:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-hematology-working-help-ensure-patients-are-getting-access-they-need</loc>
  <lastmod>2022-10-25T09:27:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/world-sight-day-2022</loc>
  <lastmod>2022-10-13T09:44:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/creating-positive-social-change-through-volunteering</loc>
  <lastmod>2022-11-29T13:07:09+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/zolgensma-global-managed-access-program-2023</loc>
  <lastmod>2023-01-09T08:36:49+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-shares-strategy-insights-and-highlights-key-pipeline-catalysts-jp-morgan-healthcare-conference-2023</loc>
  <lastmod>2023-01-09T17:18:36+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-provides-update-phase-iii-stand-trial-assessing-crizanlizumab</loc>
  <lastmod>2023-02-01T12:36:05+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-announces-support-people-affected-earthquake-turkey-and-syria</loc>
  <lastmod>2023-02-07T19:10:01+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-releases-emergency-funding-usd-1-million-people-turkey-and-syria-and-launches-employee-donation-and-volunteering-programs</loc>
  <lastmod>2023-02-09T16:14:57+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-unwavering-support-one-year-from-start-war-ukraine</loc>
  <lastmod>2023-02-28T17:30:32+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-completes-fda-filing-approval-millburn-facility-support-pluvicto-launch</loc>
  <lastmod>2023-03-03T08:56:35+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/fda-approves-novartis-millburn-facility-us-commercial-production-pluvicto</loc>
  <lastmod>2023-04-21T17:17:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/chmp-recommends-revoking-conditional-marketing-authorization-adakveo-crizanlizumab</loc>
  <lastmod>2023-05-26T14:28:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/european-commission-ec-adopts-decision-endorsing-chmp-recommendation-revoke-conditional-marketing-authorization-adakveo-crizanlizumab</loc>
  <lastmod>2023-08-04T14:29:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-statement-about-entresto-sacubitrilvalsartan-selection-medicare-drug-price-negotiation-program</loc>
  <lastmod>2023-08-29T14:51:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-statement-filing-inflation-reduction-act-lawsuit</loc>
  <lastmod>2023-09-01T20:47:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-giving-volunteering-wins-accps-2023-corporate-social-impact-team-year-award</loc>
  <lastmod>2023-10-11T14:26:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/gt005-ppy988-development-program-geographic-atrophy</loc>
  <lastmod>2023-09-11T16:14:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-provides-support-moroccan-earthquake-victims</loc>
  <lastmod>2023-09-13T15:52:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-statement-collaboration-and-license-agreement-tislelizumab-beigene-ltd</loc>
  <lastmod>2023-09-19T14:36:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-condemns-terrorist-actions-against-people-israel-and-loss-innocent-lives</loc>
  <lastmod>2023-10-13T13:31:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/violence-against-innocent-people-runs-counter-our-work-improve-human-health</loc>
  <lastmod>2023-10-19T07:57:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/our-next-era</loc>
  <lastmod>2024-10-28T09:23:26+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-shares-strategy-and-growth-update-jp-morgan-healthcare-conference-2024</loc>
  <lastmod>2024-01-08T17:33:04+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-appoints-sloan-simpson-global-head-investor-relations</loc>
  <lastmod>2024-02-29T08:59:50+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-confirms-plans-file-pluvicto-pre-taxane-label-expansion-h2-2024-based-latest-data-from-phase-iii-psmafore-study</loc>
  <lastmod>2024-04-04T15:27:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-implements-manufacturing-adjustments-ribociclib-ensure-alignment-latest-regulatory-standards-ebc-end-q2</loc>
  <lastmod>2024-04-09T22:26:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-receives-fda-breakthrough-therapy-designation-scemblix-1l-cml</loc>
  <lastmod>2024-12-02T14:42:01+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-statement-maximum-fair-price-entresto</loc>
  <lastmod>2024-08-15T14:50:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-employs-creative-deal-structure-establish-borealis-biosciences-divests-legacy-chinook-site-invests-form-new-company-and-engages-rd-collaboration</loc>
  <lastmod>2024-08-22T13:53:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/official-partner-eurovision-song-contest-2025</loc>
  <lastmod>2024-10-31T11:19:44+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-bolsters-neuroscience-pipeline-licensing-ptc518-huntingtons-disease</loc>
  <lastmod>2024-12-02T12:59:50+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/news/novartis-presentation-jp-morgan-healthcare-conference-2025</loc>
  <lastmod>2025-01-14T09:56:21+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/artificial-intelligence-decodes-cancer-pathology-images</loc>
  <lastmod>2022-02-10T13:40:05+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/african-experts-call-renewed-global-drive-beat-malaria</loc>
  <lastmod>2021-10-12T14:51:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/10-big-questions-dissect-science-papers</loc>
  <lastmod>2021-10-18T14:17:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/abcdes-melanoma-prevention-and-detection</loc>
  <lastmod>2021-10-18T07:50:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/challenging-young-scientist-focus-patients</loc>
  <lastmod>2021-10-14T07:38:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/biological-battle-bulge</loc>
  <lastmod>2021-10-07T10:20:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/building-boot-camps-immune-cells-near-tumors</loc>
  <lastmod>2021-10-08T14:58:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/bringing-gene-therapy-focus</loc>
  <lastmod>2022-02-11T14:53:34+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/can-we-unlock-bodys-ability-regenerate-lost-hearing</loc>
  <lastmod>2021-10-07T10:28:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/building-collaborations-fight-pandemic</loc>
  <lastmod>2021-10-07T12:27:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/breaking-vicious-cycle-inflammation</loc>
  <lastmod>2021-10-07T15:54:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/bringing-real-change-people</loc>
  <lastmod>2021-10-07T12:17:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/cancer-cocktails-abl001-hitting-one-target-twice</loc>
  <lastmod>2021-10-07T10:25:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/cancer-cocktails-come-age</loc>
  <lastmod>2021-10-07T10:25:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/bringing-science-and-medicine-together-help-patients-cancer</loc>
  <lastmod>2021-10-08T14:54:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/cancer-cocktails-lee011-popular-combination-partner</loc>
  <lastmod>2021-09-14T11:23:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/cancer-cocktails-ljm716-closing-common-release-valve</loc>
  <lastmod>2021-09-14T12:38:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/cancer-researchers-ready-aim-cures</loc>
  <lastmod>2021-10-07T07:10:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/chan-zuckerberg-initiative-friends-novartis-scientist-mission-conquer-disease</loc>
  <lastmod>2021-10-15T13:20:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/clinical-trial-comes-together-weeks-address-coronavirus</loc>
  <lastmod>2021-10-15T13:51:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/cellular-drama-heart-researchers-family</loc>
  <lastmod>2021-10-15T12:06:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/clinical-trials-make-move-toward-mice</loc>
  <lastmod>2021-10-15T13:48:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/close-look-cryo-electron-microscopy</loc>
  <lastmod>2021-10-15T14:00:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/collaborating-explore-new-gene-regulation-therapies</loc>
  <lastmod>2021-10-18T14:29:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/collaborating-unlock-secrets-microbiome</loc>
  <lastmod>2021-10-08T06:30:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/compound-designed-fight-alzheimers-disease-shows-promise-lab</loc>
  <lastmod>2021-10-07T14:27:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/compounds-spur-insulin-producing-cells-replicate-lab</loc>
  <lastmod>2021-10-15T15:20:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/combination-therapies-seeking-block-cancers-pathways-growth</loc>
  <lastmod>2021-10-15T14:43:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/counting-combos-complex-liver-diseases</loc>
  <lastmod>2022-06-08T10:16:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/confidence-led-researcher-swim-against-current</loc>
  <lastmod>2021-10-11T11:47:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/covid-19-answering-your-top-questions</loc>
  <lastmod>2021-10-01T06:28:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/data42-program-shows-novartis-intent-go-big-data-and-digital</loc>
  <lastmod>2021-10-11T14:30:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/could-umbilical-cords-yield-more-stem-cells-life-saving-transplants</loc>
  <lastmod>2021-10-15T15:31:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/digital-health-ecosystem-gets-boost-novartis-biome</loc>
  <lastmod>2022-01-07T09:15:56+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/embracing-big-data-understand-complex-diseases</loc>
  <lastmod>2021-10-18T14:31:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/decades-long-journey-blood-cancer-research</loc>
  <lastmod>2021-10-15T15:46:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/drug-development-gets-big-data-analytics-boost</loc>
  <lastmod>2021-10-07T10:45:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/evolution-scientist</loc>
  <lastmod>2021-10-07T10:43:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/experimental-gene-therapy-discovered-house-enters-clinical-testing</loc>
  <lastmod>2021-10-18T14:37:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/experimental-treatment-clears-malaria-infections-small-clinical-study</loc>
  <lastmod>2021-10-15T16:01:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/exploring-longstanding-questions-about-heart-disease</loc>
  <lastmod>2021-10-07T08:08:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/eye-fastest-muscle-human-body</loc>
  <lastmod>2021-07-21T14:12:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/dna-encoded-molecules-provide-new-edge-cancer-drug-hunts</loc>
  <lastmod>2021-10-01T06:43:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/factory-foreman-keeps-livers-line-workers-task</loc>
  <lastmod>2021-10-07T08:39:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/eyewitness-healer-pursues-new-treatments-patients</loc>
  <lastmod>2021-10-18T14:42:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/fresh-look-fighting-glaucoma</loc>
  <lastmod>2021-10-07T08:40:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/from-patient-patient-advocate-how-cancer-diagnosis-fueled-new-career-path</loc>
  <lastmod>2021-10-01T07:13:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/getting-down-roots-alzheimers-disease</loc>
  <lastmod>2021-10-07T14:25:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/going-global-meet-local-needs-china</loc>
  <lastmod>2024-07-08T09:34:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/how-love-sport-led-scientific-breakthrough</loc>
  <lastmod>2021-10-07T08:59:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/heart-failure-leading-cause-hospitalizations-it-doesnt-have-be</loc>
  <lastmod>2023-04-11T16:04:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/eye-patients-mind-innovation</loc>
  <lastmod>2021-10-01T07:09:42+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/helping-clinical-trial-patients-during-lockdown</loc>
  <lastmod>2021-10-18T09:37:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/how-scientists-aim-expand-immunotherapy-options-cancer-patients</loc>
  <lastmod>2022-06-07T17:03:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/immuno-oncology-researchers-seek-build-smart-drug-combos</loc>
  <lastmod>2021-10-18T14:45:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/innovating-trusted-class-antibiotics-attack-superbugs</loc>
  <lastmod>2021-10-18T09:55:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/investigating-myopia-mystery</loc>
  <lastmod>2022-06-21T15:35:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/it-takes-rd-village-fight-pandemic</loc>
  <lastmod>2021-10-18T14:47:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/intractable-tumor-cells-crippled</loc>
  <lastmod>2021-10-18T10:15:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/keeping-heart-patients-heart-everything-we-do</loc>
  <lastmod>2023-07-04T14:59:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/let-there-be-sight</loc>
  <lastmod>2021-10-07T09:08:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/loss-friend-liver-cancer-sharpens-focus-experimental-therapy</loc>
  <lastmod>2021-09-29T07:49:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/killing-three-diseases-one-stone-lab</loc>
  <lastmod>2021-09-29T08:11:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/leveraging-livers-ability-heal-scarred-tissue</loc>
  <lastmod>2021-10-18T12:01:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/making-possible-stepping-toward-future-cell-and-gene-therapy</loc>
  <lastmod>2022-01-14T16:58:56+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/meet-achim-leading-data42-program</loc>
  <lastmod>2021-10-07T09:14:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/mutant-protein-spreads-through-neural-circuit-huntingtons-disease</loc>
  <lastmod>2021-10-07T09:49:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/moving-from-speculation-science-during-pandemic</loc>
  <lastmod>2021-10-01T08:06:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/not-your-grandparents-nuclear-medicine</loc>
  <lastmod>2022-01-11T09:30:42+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/machine-learning-poised-accelerate-drug-discovery</loc>
  <lastmod>2022-06-21T17:07:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/neuroscientists-restore-cell-cell-signaling-and-sociability-autism-models</loc>
  <lastmod>2021-10-07T14:50:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/new-drug-manufacturing-tools-change-pharma-chemistry</loc>
  <lastmod>2021-10-07T09:54:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/new-recruit-has-big-dreams-cancer-immunotherapy</loc>
  <lastmod>2021-10-18T15:02:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/new-hope-treating-inflammatory-diseases-kidney</loc>
  <lastmod>2022-01-11T09:27:11+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/novartis-and-pfizer-join-forces-upend-oncology-dogma</loc>
  <lastmod>2021-10-18T15:13:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/novartis-cancer-researchers-advance-precision-medicine</loc>
  <lastmod>2021-10-18T15:59:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/novartis-researches-smas-genetic-roots</loc>
  <lastmod>2021-10-07T10:05:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/open-science-demystified</loc>
  <lastmod>2021-10-19T08:44:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/novartis-scientists-target-resistance-threat-malaria</loc>
  <lastmod>2021-10-07T10:09:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/organic-dealmaker-drug-discovery</loc>
  <lastmod>2021-10-11T11:55:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/open-resources-novartis-help-drive-innovation</loc>
  <lastmod>2022-01-14T15:56:41+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/physician-scientist-donald-ganem-takes-reins-infectious-disease</loc>
  <lastmod>2021-10-07T10:21:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/potential-weight-loss-treatment-takes-shape-help-from-patients</loc>
  <lastmod>2021-10-19T08:56:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/predictive-analytics-could-bring-medicines-patients-faster</loc>
  <lastmod>2021-10-19T09:01:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/reaping-cancer-clues-from-blood</loc>
  <lastmod>2021-09-28T11:25:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/rare-speed-rare-disease</loc>
  <lastmod>2021-10-19T09:23:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/researchers-overcome-hurdles-test-experimental-malaria-drug</loc>
  <lastmod>2021-10-07T14:36:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/researchers-aim-beat-trick-play-tumors-drug-combo</loc>
  <lastmod>2021-10-19T09:28:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/quest-new-measure-mental-health</loc>
  <lastmod>2021-10-19T09:04:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/researcher-races-find-new-treatment-his-progressive-disease</loc>
  <lastmod>2021-10-18T08:18:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/researchers-phd-leads-medical-breakthrough-rare-skin-disease</loc>
  <lastmod>2021-10-07T10:40:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/researcher-seeks-roots-plants-healing-power</loc>
  <lastmod>2021-10-19T09:32:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/respiratory-clinical-trials-putting-patients-heart-research</loc>
  <lastmod>2023-07-04T16:27:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/rewriting-playbook-clinical-testing-rare-disease</loc>
  <lastmod>2021-10-07T10:42:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/saving-tumor-suppressors-from-shredder</loc>
  <lastmod>2021-10-07T10:44:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/shaping-future-sickle-cell-disease</loc>
  <lastmod>2021-10-07T10:46:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/search-differences-make-difference</loc>
  <lastmod>2021-10-07T10:45:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/specter-malaria-resists-treatment</loc>
  <lastmod>2021-10-07T10:49:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/stepping-toward-regenerative-medicine-diabetes</loc>
  <lastmod>2021-10-18T08:21:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/small-viruses-could-accelerate-cell-and-gene-therapy-research</loc>
  <lastmod>2021-10-18T15:24:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/stopping-alzheimers-disease-it-starts</loc>
  <lastmod>2021-10-07T10:52:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/stifling-danger-signals-rheumatoid-arthritis</loc>
  <lastmod>2021-10-07T10:51:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/tackling-common-denominator-liver-disease</loc>
  <lastmod>2021-10-07T10:55:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/systematically-exposing-vulnerabilities-cancer-cells</loc>
  <lastmod>2022-01-11T09:33:46+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/taking-clinical-trials-next-level-through-technology</loc>
  <lastmod>2021-10-07T10:59:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/taking-obesity</loc>
  <lastmod>2021-10-18T15:26:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/tracking-patients-progress-radio-signals-and-machine-learning</loc>
  <lastmod>2024-07-08T09:45:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/talking-bruno-strigini-why-were-entering-transformative-time-cancer-care</loc>
  <lastmod>2021-10-07T11:26:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/teaming-academia-discover-medicines</loc>
  <lastmod>2021-10-07T11:28:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/turning-research-advances-innovative-medicines</loc>
  <lastmod>2021-11-23T16:15:54+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-cathryn-clary</loc>
  <lastmod>2021-10-19T06:42:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/visualizing-immuno-oncology-research</loc>
  <lastmod>2023-04-11T15:58:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-kristen-harrington-smith</loc>
  <lastmod>2021-10-07T11:42:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-annie-martin</loc>
  <lastmod>2021-10-07T11:39:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-mimi-huizinga</loc>
  <lastmod>2021-10-07T11:56:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-hannah-mosca</loc>
  <lastmod>2021-10-19T06:34:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-lauren-abrey</loc>
  <lastmod>2021-10-07T11:43:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-sandrine-piret-gerard</loc>
  <lastmod>2021-10-07T11:58:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-renee-rodgers</loc>
  <lastmod>2021-10-07T11:57:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-lilli-petruzzelli</loc>
  <lastmod>2021-10-07T11:45:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-shilpa-shah-mehta</loc>
  <lastmod>2021-09-28T12:36:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-shannon-campbell</loc>
  <lastmod>2021-10-07T11:59:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-susanne-schaffert</loc>
  <lastmod>2021-10-07T12:00:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-medy-attalla</loc>
  <lastmod>2021-10-07T11:51:41+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/word-street-what-cell-and-gene-therapy</loc>
  <lastmod>2021-10-07T12:03:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-tania-small</loc>
  <lastmod>2021-10-07T12:02:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/3-d-printing-scientists-reinvent-research-tools</loc>
  <lastmod>2021-10-07T12:05:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-virginia-lazala</loc>
  <lastmod>2021-10-18T14:39:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/bringing-virtual-reality-lab</loc>
  <lastmod>2022-01-11T09:54:21+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/brain-dish-researchers-take-neurological-disorders</loc>
  <lastmod>2021-10-07T12:08:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/5-tips-making-smart-decisions-research-projects</loc>
  <lastmod>2021-10-07T12:06:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/building-brain-organoids-shed-light-disease</loc>
  <lastmod>2021-10-07T12:09:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/cancer-spies-find-drug-beating-covert-cells</loc>
  <lastmod>2021-07-21T14:55:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/can-we-edit-our-genes-fight-disease</loc>
  <lastmod>2021-09-13T11:20:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/chemical-genetics-sleuthing-behind-modern-drug-discovery</loc>
  <lastmod>2021-10-07T12:14:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/could-digital-technology-drive-clinical-research-africa</loc>
  <lastmod>2021-10-07T12:15:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/disease-pathways-key-new-drug-discovery</loc>
  <lastmod>2021-10-07T12:18:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/electrical-brainstorms-traced-genetic-mutations</loc>
  <lastmod>2021-10-07T12:43:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/crispr-genome-editing-fuels-cancer-drug-discovery</loc>
  <lastmod>2021-10-18T09:44:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/countering-genome-reprogramming-cancer-cells</loc>
  <lastmod>2021-10-18T08:26:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/eye-disease-tracked-glitch-starburst-cells</loc>
  <lastmod>2021-10-07T12:45:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/five-things-look-scientific-mentor</loc>
  <lastmod>2021-10-07T12:48:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/hooked-science-jay-bradner-becomes-top-researcher-novartis</loc>
  <lastmod>2021-10-07T13:02:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/hardwiring-future</loc>
  <lastmod>2021-10-07T13:01:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/giraffes-have-high-blood-pressure-why-dont-they-drop-dead</loc>
  <lastmod>2021-10-07T13:00:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/fixing-whats-lost-translation</loc>
  <lastmod>2021-10-07T12:59:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/how-address-culture-gap-between-academia-and-industry-biomedicine</loc>
  <lastmod>2021-10-07T14:46:10+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/improving-science-communication-3-easy-steps</loc>
  <lastmod>2021-10-07T13:07:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/mhealth-revolution-healthcare</loc>
  <lastmod>2021-10-07T13:09:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/how-i-built-mini-gut-next-no-biology-training</loc>
  <lastmod>2021-10-07T13:05:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/how-zika-infects-growing-brain</loc>
  <lastmod>2021-10-07T13:06:08+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/minion-challenges-assumptions-about-genome</loc>
  <lastmod>2021-10-07T13:10:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/molecular-glue-kills-cancer-cells-mice</loc>
  <lastmod>2022-01-07T09:04:45+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/letters-my-younger-self-female-scientists-share-their-wisdom</loc>
  <lastmod>2021-10-07T13:08:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/neuroscientists-target-alzheimers-silent-stage</loc>
  <lastmod>2021-10-07T13:12:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/nurturing-life-science-ecosystem</loc>
  <lastmod>2021-10-07T13:14:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/opening-chemistry-education-world</loc>
  <lastmod>2021-10-07T13:15:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/rebuilding-blood</loc>
  <lastmod>2021-10-07T13:16:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/rediscovering-power-natures-exquisite-complexity</loc>
  <lastmod>2021-10-07T13:17:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/reigniting-passion-science</loc>
  <lastmod>2021-10-07T13:17:40+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/reimagining-protein-sequencing</loc>
  <lastmod>2021-10-07T13:16:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/robots-speed-pace-modern-drug-discovery</loc>
  <lastmod>2022-01-07T08:53:12+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/stopping-free-radicals-their-source</loc>
  <lastmod>2021-10-18T10:44:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/novartis-antibody-increases-muscle-growth-mice-and-human-cell-cultures</loc>
  <lastmod>2021-10-18T08:13:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/surfing-wave-big-data-analytics</loc>
  <lastmod>2021-10-18T15:31:43+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/three-lessons-ive-learned-industry-postdoc</loc>
  <lastmod>2021-10-07T11:12:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/turning-heat-tumors</loc>
  <lastmod>2021-10-07T11:21:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/visual-tour-scientific-strategies-combating-coronavirus</loc>
  <lastmod>2022-01-10T09:20:55+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/vision-hacker</loc>
  <lastmod>2021-10-07T11:28:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/tuning-drugs-succeed-cells-surface</loc>
  <lastmod>2021-10-18T10:16:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-alexandra-bach-weidmuller</loc>
  <lastmod>2024-07-08T09:47:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/what-goes-wrong-window-soul-glaucoma</loc>
  <lastmod>2021-10-18T10:23:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/when-tiny-brains-are-best-brain-research</loc>
  <lastmod>2021-10-07T11:33:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-jean-silveri</loc>
  <lastmod>2024-07-08T09:46:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-cyndy-grosskreutz</loc>
  <lastmod>2024-07-08T09:43:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/turning-power-nuclear-technology-medical-force</loc>
  <lastmod>2021-11-25T16:08:34+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-jennifer-allport-anderson</loc>
  <lastmod>2024-07-08T09:33:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/young-talent-emerging-technologies-come-together-biocamp</loc>
  <lastmod>2021-10-07T12:52:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/2-million-kids-receive-malaria-medicine</loc>
  <lastmod>2021-11-16T11:53:01+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-wendy-winckler</loc>
  <lastmod>2021-10-11T15:39:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-marjorie-eiref</loc>
  <lastmod>2024-07-08T09:48:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/ai-changing-face-healthcare</loc>
  <lastmod>2021-10-07T12:57:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/asian-health-experts-call-final-push-wipe-out-deadliest-form-malaria</loc>
  <lastmod>2023-07-03T17:16:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/bringing-chagas-disease-peoples-attention</loc>
  <lastmod>2021-10-13T08:24:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/bringing-modern-medicine-rural-vietnam</loc>
  <lastmod>2022-06-08T10:29:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/cancer-didnt-stop-covid-19</loc>
  <lastmod>2021-10-18T11:08:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/collaboration-strengthening-care-chronic-illness-ethiopia</loc>
  <lastmod>2021-10-07T13:11:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/chagas-disease-breaking-silence</loc>
  <lastmod>2021-10-07T13:12:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/confronting-global-spread-chronic-disease</loc>
  <lastmod>2021-10-07T13:06:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/tackling-rare-disease-working-toward-treatment-sma</loc>
  <lastmod>2021-10-07T10:56:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/sleuths-use-hi-tech-sensors-fight-pharmaceutical-crime</loc>
  <lastmod>2021-10-18T10:49:49+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/dealing-spread-chronic-disease-africa</loc>
  <lastmod>2021-10-07T13:02:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/fighting-malaria-africa</loc>
  <lastmod>2022-06-10T10:21:56+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/ensuring-medicine-supply-patients-during-covid-19</loc>
  <lastmod>2021-10-13T09:10:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/fighting-respiratory-disease-source</loc>
  <lastmod>2021-10-07T12:54:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/delivering-access-first-launch-kenya</loc>
  <lastmod>2023-07-04T12:04:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/health-collaboration-russia-helped-reduce-blood-pressure-deaths</loc>
  <lastmod>2021-10-18T11:32:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/fighting-pneumonia-biggest-killer-young-children</loc>
  <lastmod>2021-10-07T12:55:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/kenya-confronts-chronic-diseases-building-progress-against-aids</loc>
  <lastmod>2021-10-13T10:25:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/helping-people-sickle-cell-disease-painful-and-life-threatening-blood-disorder</loc>
  <lastmod>2021-10-07T11:53:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/helping-syrian-refugees-manage-chronic-diseases</loc>
  <lastmod>2021-10-07T11:52:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/improving-lives-through-community-based-care</loc>
  <lastmod>2023-04-11T16:06:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/sight-savers-jet-rescue</loc>
  <lastmod>2021-10-14T12:13:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/streamlining-systems-respond-covid-19</loc>
  <lastmod>2021-10-14T12:21:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/tailoring-tactics-tackle-chronic-disease-low-income-countries</loc>
  <lastmod>2021-10-14T12:39:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/talking-ann-aerts-head-novartis-foundation</loc>
  <lastmod>2023-07-04T16:34:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/life-dedicated-fighting-malaria</loc>
  <lastmod>2021-11-17T15:28:51+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/living-breast-cancer-uganda</loc>
  <lastmod>2021-10-13T11:00:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/living-hypertension-cameroon-few-dollars-day</loc>
  <lastmod>2021-09-28T14:41:19+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/malaria-fighter-rides-bicycle-battle-disease</loc>
  <lastmod>2021-10-13T12:26:09+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/malaria-still-disrupting-lives-despite-progress</loc>
  <lastmod>2021-10-13T13:19:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/talking-juergen-brokatzky-geiger-global-head-corporate-responsibility-novartis</loc>
  <lastmod>2021-10-11T13:40:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/talking-patrice-matchaba-global-head-corporate-responsibility-novartis</loc>
  <lastmod>2021-10-07T10:49:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/telemedicine-taking-health-care-worlds-far-corners</loc>
  <lastmod>2022-05-24T16:12:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/text-messages-africa-help-fight-malaria</loc>
  <lastmod>2021-11-18T16:25:22+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/treating-cataracts-leading-cause-preventable-blindness-worldwide</loc>
  <lastmod>2021-10-07T10:46:15+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/women-science-fionnuala-doyle</loc>
  <lastmod>2021-10-07T10:44:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/fighting-ms-through-innovation</loc>
  <lastmod>2021-10-11T13:33:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/from-melanoma-survivor-front-line-nurse</loc>
  <lastmod>2021-09-29T07:18:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/ai-nurse-evolving-heart-failure-patients-china</loc>
  <lastmod>2021-12-14T12:32:41+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/body-painter-captures-anguish-those-who-suffer-from-psoriasis</loc>
  <lastmod>2023-07-04T09:30:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/changing-landscape-cancer-treatment</loc>
  <lastmod>2023-07-04T11:43:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/caring-someone-heart-failure</loc>
  <lastmod>2023-07-24T13:42:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/choosing-right-care</loc>
  <lastmod>2021-10-07T10:22:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/conversations-patient-advocates-ron-hollander-president-inca</loc>
  <lastmod>2021-10-07T10:21:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/coping-eye-disease-and-fading-vision-late-life</loc>
  <lastmod>2021-10-07T10:07:58+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/meet-manuel-cobos-transplant-surgeon-and-researcher</loc>
  <lastmod>2021-10-13T14:51:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/creative-ways-help-kids-understand-rare-diseases</loc>
  <lastmod>2021-10-11T13:15:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/dealing-psoriasis</loc>
  <lastmod>2022-02-14T15:53:07+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/debunking-myths-about-multiple-sclerosis</loc>
  <lastmod>2021-10-07T10:03:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/digital-innovation-looks-set-dominate-2021-healthcare-agenda</loc>
  <lastmod>2023-07-04T12:08:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/digital-health-providing-opportunities-advocacy-groups-and-community-patients</loc>
  <lastmod>2021-10-07T10:02:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/meet-martin-grobusch-malaria-fighter</loc>
  <lastmod>2021-10-13T15:53:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/experts-call-new-approach-patient-and-physician-management-type-2-diabetes</loc>
  <lastmod>2021-10-07T09:59:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/giving-small-community-big-voice</loc>
  <lastmod>2021-10-15T15:57:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/fitness-trainer-strives-keep-his-mothers-mind-limber</loc>
  <lastmod>2021-10-11T11:48:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/from-nurse-patient-facing-aggressive-blood-cancer</loc>
  <lastmod>2021-10-18T06:19:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/glaucoma-silently-steals-sight</loc>
  <lastmod>2021-10-15T15:53:20+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/meet-visionary-who-beat-odds-realize-his-vision-inclusive-eye-care</loc>
  <lastmod>2023-07-04T15:38:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/groundskeeper-tackles-cancer-several-ways</loc>
  <lastmod>2021-10-15T15:50:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/heart-failure-coping-one-worlds-biggest-killers</loc>
  <lastmod>2021-10-15T15:45:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/importance-caregivers</loc>
  <lastmod>2021-10-15T15:39:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/inside-cancer-diagnosis</loc>
  <lastmod>2021-10-15T14:51:02+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/patients-perspective-biomarker-testing</loc>
  <lastmod>2021-10-15T11:46:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/led-steven-taylor-sjogrens-syndrome-foundation-raising-awareness-little-known-autoimmune-disease</loc>
  <lastmod>2021-10-08T10:39:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/lessons-from-blind-chef</loc>
  <lastmod>2022-01-07T09:19:03+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/living-heart-failure</loc>
  <lastmod>2021-10-15T11:45:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/living-hfpef-patients-story</loc>
  <lastmod>2021-11-17T17:37:31+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/longevity-vitality-japanese-elders-provide-examples-healthy-aging</loc>
  <lastmod>2021-10-15T12:09:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/lung-cancer-test-or-not-test</loc>
  <lastmod>2021-10-14T14:28:13+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/meet-tj-sharpe</loc>
  <lastmod>2023-07-04T15:36:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/most-europeans-have-limited-awareness-about-heart-failure</loc>
  <lastmod>2022-01-07T09:11:28+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/migraine-one-worlds-most-common-diseases</loc>
  <lastmod>2021-10-14T14:11:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/new-years-resolution-copd</loc>
  <lastmod>2021-10-14T13:51:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/no-longer-living-fear</loc>
  <lastmod>2021-10-15T12:22:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/one-boys-quest-battle-cancer</loc>
  <lastmod>2023-07-04T16:05:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/parenting-child-rare-disease</loc>
  <lastmod>2023-07-04T16:10:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/patient-advocacy-work-one-mans-contributions-copd-community</loc>
  <lastmod>2021-10-14T13:01:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/psoriasis-story-hidden-condition</loc>
  <lastmod>2021-10-11T11:09:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/putting-patients-first</loc>
  <lastmod>2022-02-14T11:58:04+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/rare-every-day-experiences-challenges-and-victories-rare-disease-community</loc>
  <lastmod>2021-09-30T09:08:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/protecting-our-tomorrows-portraits-meningococcal-disease</loc>
  <lastmod>2021-10-14T11:41:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/realities-living-premenopausal-metastatic-breast-cancer</loc>
  <lastmod>2021-11-17T11:46:58+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/reimagining-asthma-care-how-data-and-digital-could-bring-asthma-management-goals-within-reach</loc>
  <lastmod>2023-07-04T16:15:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/surviving-heart-failure</loc>
  <lastmod>2022-06-21T15:49:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/speaking-cml</loc>
  <lastmod>2021-09-29T10:00:07+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/targeting-roots-sjogrens-syndrome</loc>
  <lastmod>2021-09-29T10:18:29+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/tj-sharpe-why-clinical-trials-matter</loc>
  <lastmod>2023-07-04T16:36:55+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/visionary-silke-mader-has-vision-care-premature-infants-and-their-parents</loc>
  <lastmod>2021-10-11T10:30:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/why-research-rare-diseases-matters</loc>
  <lastmod>2021-08-25T13:31:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/turning-sound-patient-voices-lung-cancer-research-and-development</loc>
  <lastmod>2021-10-01T07:49:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/flexibility-novartis-ana-graf</loc>
  <lastmod>2021-09-29T11:17:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/enabling-130000-employees-grow-organization-committed-continuous-learning</loc>
  <lastmod>2021-09-29T10:38:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/your-genes-your-melanoma</loc>
  <lastmod>2021-09-29T10:27:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/flexibility-novartis-deepti-mittal</loc>
  <lastmod>2021-09-29T11:20:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/flexibility-novartis-christine-sturchler-and-aileen-wrynn</loc>
  <lastmod>2021-10-14T07:23:16+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/flexibility-novartis-janneke-van-der-kamp</loc>
  <lastmod>2021-09-29T11:22:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/flexibility-novartis-peter-canavan</loc>
  <lastmod>2021-10-14T06:37:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/flexibility-novartis-linda-karpiak</loc>
  <lastmod>2021-09-29T11:23:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/flexibility-novartis-robert-gschwentner-and-stefan-lackner</loc>
  <lastmod>2021-10-14T06:27:54+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/going-extra-mile-keep-clinical-trials-track-during-covid-19-pandemic</loc>
  <lastmod>2021-09-29T12:37:53+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/flexibility-novartis-shamsah-kazani</loc>
  <lastmod>2021-11-16T11:15:40+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/novartis-social-business-careers-improving-health-lower-income-countries</loc>
  <lastmod>2022-01-07T09:00:43+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/oncology-careers-life-changing-purpose</loc>
  <lastmod>2021-09-29T12:46:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/parental-leave-novartis-alfreds-story</loc>
  <lastmod>2022-05-24T16:23:14+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/parental-leave-novartis-michaels-story</loc>
  <lastmod>2021-11-23T16:50:24+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/nudging-bias-out-organization</loc>
  <lastmod>2021-09-23T11:39:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/qa-new-nibr-cio-dimitris-agrafiotis</loc>
  <lastmod>2021-09-30T14:50:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/reimagining-cancer-workplace</loc>
  <lastmod>2021-09-29T12:52:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/teaching-daughter-power-purpose</loc>
  <lastmod>2021-10-14T10:09:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/two-decades-volunteering-novartis</loc>
  <lastmod>2021-10-11T10:18:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/making-healthcare-sustainable-developing-world</loc>
  <lastmod>2021-10-06T07:37:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/positive-gains-are-needed-accelerate-change-women-lung-disease</loc>
  <lastmod>2021-10-01T10:03:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/new-drugs-could-offer-hope-malaria-patients</loc>
  <lastmod>2021-10-03T16:01:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/partnering-improved-cancer-care-around-globe</loc>
  <lastmod>2021-10-07T11:03:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/pioneering-business-approach-expands-healthcare-indian-villages</loc>
  <lastmod>2021-10-14T11:57:33+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/novartis-joins-pharma-wide-effort-meet-global-demand-covid-19-vaccines</loc>
  <lastmod>2022-05-20T15:35:45+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/new-orbis-flying-eye-hospital-helps-fight-blindness-china</loc>
  <lastmod>2021-10-14T08:54:03+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/novartis-access-impact-evaluation-progress-update-our-work-boston-university</loc>
  <lastmod>2021-10-01T10:07:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/novartis-invites-scrutiny-effort-improve-access-medicine</loc>
  <lastmod>2022-06-07T17:08:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/artificial-intelligence-decodes-cancer-pathology-images-without-image-gallery</loc>
  <lastmod>2021-08-24T11:51:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/can-data-from-heart-disease-trial-lead-potential-cancer-treatment</loc>
  <lastmod>2021-09-30T14:48:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/cancer-research-drives-breast-cancer-treatment-forward</loc>
  <lastmod>2021-09-30T09:47:34+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/discovery-gives-cystic-fibrosis-researchers-new-direction</loc>
  <lastmod>2021-10-11T10:39:37+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/guidance-system-lights-path-drug-discovery</loc>
  <lastmod>2021-10-18T09:03:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/need-new-heart-disease-medicines-drives-wave-potential-therapies</loc>
  <lastmod>2021-09-30T11:20:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/researchers-boost-understanding-t-cell-therapy-blood-cancer</loc>
  <lastmod>2021-09-30T11:41:44+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/novartis-and-uc-berkeley-take-undruggable-proteins-new-collaboration</loc>
  <lastmod>2022-05-24T16:17:59+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/striving-vanquish-leukemia</loc>
  <lastmod>2021-09-27T11:08:05+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/sourcing-innovation-strategically</loc>
  <lastmod>2021-09-30T12:12:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/take-visual-tour-medicines-target-rna</loc>
  <lastmod>2022-06-21T17:13:21+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/toward-improving-health-and-longevity-transplanted-organs</loc>
  <lastmod>2021-09-30T15:13:47+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/using-super-resolution-microscopy-see-neurodegeneration</loc>
  <lastmod>2021-09-30T15:30:39+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/visualizing-molecular-glues</loc>
  <lastmod>2021-09-30T15:43:23+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/advancing-medicine-through-collaboration</loc>
  <lastmod>2021-09-30T16:00:24+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/how-19th-century-technology-speeding-drug-discovery</loc>
  <lastmod>2021-09-30T16:13:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/seeing-through-knees-quest-alleviate-osteoarthritis</loc>
  <lastmod>2021-09-30T16:17:25+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/why-novartis-scouts-disruptive-technology</loc>
  <lastmod>2021-09-30T16:30:01+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/future-chronic-myeloid-leukemia-evolving</loc>
  <lastmod>2021-10-15T16:05:57+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/inspiring-daughter-make-her-own-path</loc>
  <lastmod>2021-10-15T12:05:00+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/being-and-becoming-data-science-company</loc>
  <lastmod>2021-09-30T14:30:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/doing-right-thing-good-business</loc>
  <lastmod>2021-10-11T08:41:26+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/discover-how-inflammation-could-fan-flames-cancer</loc>
  <lastmod>2021-10-11T10:42:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/your-neighborhood-community-based-approach-health-equity-us</loc>
  <lastmod>2021-10-26T16:09:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/search-new-options-patients-lung-cancer</loc>
  <lastmod>2021-10-01T12:27:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/toward-regrowing-cartilage</loc>
  <lastmod>2023-07-04T16:46:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/blood-cancer-patients-long-road-diagnosis</loc>
  <lastmod>2021-10-15T12:02:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/photographer-captures-patients-around-world-persevering-itp</loc>
  <lastmod>2021-10-08T08:09:48+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/expanding-new-digital-healthcare-solution-across-chronic-heart-disease-management</loc>
  <lastmod>2021-10-11T08:39:32+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/restoring-vision-and-hope-thousands-southeast-asia</loc>
  <lastmod>2023-02-06T10:13:26+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/demystifying-science-myelodysplastic-syndromes</loc>
  <lastmod>2023-02-06T10:13:06+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/breaking-down-barriers-patients-sickle-cell-disease</loc>
  <lastmod>2023-02-06T10:12:35+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/make-difference-start-patients</loc>
  <lastmod>2023-02-06T10:12:51+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/solving-puzzle-immunotherapy</loc>
  <lastmod>2023-04-11T15:57:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/stopping-coronavirus-and-next-one</loc>
  <lastmod>2023-02-06T10:11:58+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/art-drug-design-technological-age</loc>
  <lastmod>2024-07-08T09:23:22+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/when-it-comes-cancer-theres-power-good-partner</loc>
  <lastmod>2023-02-06T10:11:08+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/prioritizing-needs-patients</loc>
  <lastmod>2023-02-06T10:10:30+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/understanding-hidradenitis-suppurativa-through-jasmines-eyes</loc>
  <lastmod>2022-03-25T10:27:19+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/tackling-health-toll-climate-change</loc>
  <lastmod>2022-04-06T15:38:18+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/staying-one-step-ahead-malaria-parasite</loc>
  <lastmod>2022-04-19T18:16:06+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/boosting-access-cancer-care-where-its-needed-most</loc>
  <lastmod>2022-06-13T09:30:28+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/how-emilys-act-bravery-inspired-wave-continued-innovation</loc>
  <lastmod>2023-02-06T10:09:32+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/prostate-cancer-collective-commitment-serving-underserved-communities</loc>
  <lastmod>2022-06-13T09:12:51+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/shared-mission-take-impossible-cancer-research</loc>
  <lastmod>2025-01-30T15:41:42+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/sickle-cell-screening-urged-newborns-africa</loc>
  <lastmod>2023-02-06T09:22:58+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/renewing-our-commitment-neglected-tropical-disease-and-malaria-elimination</loc>
  <lastmod>2022-06-23T07:30:04+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/lets-talk-about-c-word-navigating-cancer-diagnosis-and-life-beyond-it-leanne-pero</loc>
  <lastmod>2022-10-12T16:02:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/neuroscience-inflection-point-knowledge-and-technology</loc>
  <lastmod>2022-10-13T22:47:12+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/scientist-from-start-qa-nibr-president-fiona-marshall</loc>
  <lastmod>2022-11-01T12:41:44+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/prostate-cancer-and-support-care-partner-carl-and-arlenes-story</loc>
  <lastmod>2023-02-16T15:34:10+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/compassionate-use-providing-access-much-needed-treatments</loc>
  <lastmod>2023-02-06T09:19:07+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/when-you-think-word-cancer-what-are-first-words-spring-mind</loc>
  <lastmod>2023-04-24T15:44:38+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/qa-addressing-unmet-needs-people-living-pnh-rare-and-chronic-blood-disorder</loc>
  <lastmod>2023-08-29T14:32:50+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/future-medicine-here</loc>
  <lastmod>2023-05-30T09:55:27+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/treatments-blood-cancers-and-serious-blood-disorders-are-advancing-rapidly-novartis-helping-lead-way</loc>
  <lastmod>2023-09-08T15:13:36+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/how-i-found-my-true-purpose-novartis</loc>
  <lastmod>2023-11-28T08:16:01+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/belonging-here-how-novartis-helped-me-come-out-transgender-woman</loc>
  <lastmod>2023-11-28T08:16:49+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/mentoring-matters-how-we-grow-together-novartis</loc>
  <lastmod>2023-11-28T08:14:32+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/beacon-hope-lights-way-more-equitable-future</loc>
  <lastmod>2023-11-30T18:38:42+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/shoulder-to-shoulder</loc>
  <lastmod>2023-12-08T17:10:45+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/innovation-fueled-compassion</loc>
  <lastmod>2023-12-14T09:16:07+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/balancing-family-life-legal-career</loc>
  <lastmod>2024-02-07T13:56:41+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/facing-fear-breast-cancer-recurrence</loc>
  <lastmod>2024-02-05T10:04:04+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/partnership-against-epilepsy</loc>
  <lastmod>2024-02-05T10:10:58+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/water-project-revives-rural-community-india</loc>
  <lastmod>2024-02-05T09:59:30+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/giving-voice-people-misunderstood-disease</loc>
  <lastmod>2024-02-05T10:08:14+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/cancer-patient-gets-new-lease-life</loc>
  <lastmod>2024-01-29T15:21:43+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/empowering-next-generation-healthcare-leaders</loc>
  <lastmod>2024-01-29T15:23:04+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/going-upstream-improve-heart-health-philadelphia</loc>
  <lastmod>2024-01-26T11:32:14+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/colombia-researcher-works-against-devastating-disease</loc>
  <lastmod>2024-01-26T11:32:56+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/how-collaboration-can-enhance-your-science-career</loc>
  <lastmod>2024-02-08T09:23:38+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/listening-cml-patient-community</loc>
  <lastmod>2024-02-14T08:13:45+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/drug-delivery-service-delivery-and-future-cancer-care</loc>
  <lastmod>2024-05-06T16:40:52+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/from-black-holes-ai-driven-drug-discovery-collaboration-wins-day</loc>
  <lastmod>2024-04-30T09:58:46+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/personal-journey-full-circle-from-curiosity-about-life-earth-transformative-therapies-novartis</loc>
  <lastmod>2024-10-07T14:35:31+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/legacy-blood-cancer-innovation</loc>
  <lastmod>2024-09-13T13:22:35+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/diversity-equity-and-inclusion-dei-really-important</loc>
  <lastmod>2024-10-07T14:33:30+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/every-number-has-story-my-journey-novartis-refugee</loc>
  <lastmod>2024-10-07T14:42:17+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/negative-impact-ira-patient-access-innovative-treatments</loc>
  <lastmod>2024-10-07T14:38:11+02:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/my-journey-novartis-finding-my-purpose-and-passion</loc>
  <lastmod>2025-02-27T15:30:19+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/addressing-unmet-needs-inherited-neuromuscular-diseases</loc>
  <lastmod>2024-11-21T12:58:31+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/biologist-head-hunter</loc>
  <lastmod>2025-02-05T17:28:48+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/stories/parental-leave-leadership-opportunity</loc>
  <lastmod>2025-02-28T15:51:39+01:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>1.0</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10022538-it-strategic-business-partner-usi-salesforce</loc>
  <lastmod>2024-10-01T15:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10002027-production-operator-de-de</loc>
  <lastmod>2024-11-04T08:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/395252br-analyst-sfe-products-de-de</loc>
  <lastmod>2024-11-04T08:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10006282-contracts-manager-ldc-solutions-design-manager-de-de</loc>
  <lastmod>2024-12-04T01:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10008960-equipment-operator-de-de</loc>
  <lastmod>2024-11-04T08:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10008887-scm-sourcing-officer-de-de</loc>
  <lastmod>2024-12-02T18:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10015785-tax-manager-de-de</loc>
  <lastmod>2025-01-22T08:31:04+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10019758-refs-key-account-business-relationship-manager-de-de</loc>
  <lastmod>2024-11-04T08:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023764-legal-trainee-rechtsreferendar-mfd-der-rechtsanwaltsstation-oder-im-pflichtwahlpraktikum-de-de</loc>
  <lastmod>2024-11-18T06:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10025495-duales-studium-bachelor-bwl-industrie-de-de</loc>
  <lastmod>2024-11-18T06:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026273-tax-manager-mwd-de-de</loc>
  <lastmod>2025-01-09T15:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023658-quality-control-staff-de-de</loc>
  <lastmod>2024-11-04T08:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023734-chemical-expert-fire-brigade-de-de</loc>
  <lastmod>2025-02-24T13:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/395252br-analyst-sfe-products-sl-si</loc>
  <lastmod>2024-11-04T08:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023658-quality-control-staff-sl-si</loc>
  <lastmod>2024-11-04T08:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028282-rechtsreferendar-legal-mwd-de-de</loc>
  <lastmod>2024-11-18T06:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10015658-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2024-11-29T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023471-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2024-11-29T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023664-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2024-11-29T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026865-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2024-11-29T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028158-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2024-11-29T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028262-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2024-11-29T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031384-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2024-11-29T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031928-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10015658-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2024-11-29T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023471-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2024-11-29T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023664-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2024-11-29T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026865-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2024-11-29T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028158-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2024-11-29T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028262-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2024-11-29T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031384-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2024-11-29T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031928-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026344-process-expert-mfd-part-time-50-de-de</loc>
  <lastmod>2024-12-02T15:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032125-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032125-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032713-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2024-12-13T10:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032713-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2024-12-13T10:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032299-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2024-12-05T17:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032299-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2024-12-05T17:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032849-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2024-12-06T04:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032851-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2024-12-06T04:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032849-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2024-12-06T04:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032851-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2024-12-06T04:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/395252br-analyst-sfe-products-ru-ru</loc>
  <lastmod>2024-12-06T13:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023521-key-account-manager-ru-ru</loc>
  <lastmod>2024-12-06T13:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023658-quality-control-staff-ru-ru</loc>
  <lastmod>2024-12-06T13:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10015658-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2024-12-06T13:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023471-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2024-12-06T13:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023664-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2024-12-06T13:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026865-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2024-12-06T13:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028158-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2024-12-06T13:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028262-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2024-12-06T13:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031384-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2024-12-06T13:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031928-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032125-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032713-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2024-12-13T10:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032299-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2024-12-06T13:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032849-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2024-12-06T13:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032851-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2024-12-06T13:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032586-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2024-12-08T09:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032586-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2024-12-08T09:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032586-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2024-12-08T09:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032428-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2024-12-09T13:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032426-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2024-12-09T13:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032428-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2024-12-09T13:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032426-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2024-12-09T13:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032428-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2024-12-09T13:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032426-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2024-12-09T13:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/395252br-analyst-sfe-products-it-it</loc>
  <lastmod>2024-12-15T01:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023658-quality-control-staff-it-it</loc>
  <lastmod>2024-12-15T01:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10015658-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2024-12-15T01:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023471-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2024-12-15T01:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023664-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2024-12-15T01:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026865-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2024-12-15T01:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028158-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2024-12-15T01:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028262-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2024-12-15T01:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031384-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2024-12-15T01:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031928-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032125-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032713-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2024-12-15T01:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032299-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2024-12-15T01:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032849-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2024-12-15T01:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032851-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2024-12-15T01:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032586-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2024-12-15T01:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032428-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2024-12-15T01:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032426-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2024-12-15T01:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034511-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2024-12-18T03:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034511-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2024-12-18T03:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034511-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2024-12-18T03:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034511-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2024-12-18T03:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031941-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2024-12-18T11:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032427-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2024-12-18T11:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031941-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2024-12-18T11:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032427-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2024-12-18T11:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031941-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2024-12-18T11:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032427-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2024-12-18T11:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031941-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2024-12-18T11:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032427-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2024-12-18T11:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034168-vzorcevalec-mzd-sl-si</loc>
  <lastmod>2025-01-24T12:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10000472-site-equipment-cqv-lead</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/393470br-new-products-strategic-pricing-partner-0</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/393466br-patient-access-lead-0</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/393064br-territory-business-executive-0</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10001635-sr-spec-ddit-ies-netsec-engg</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10001018-sr-spec-ddit-ies-cloud-engineering</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/394168br-assoc-dir-ddit-isc-ent-arch-digit-sec-0</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/388900br-assoc-dir-ddit-isc-vulnsvcs-role-0</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/393453br-sr-bus-analyst-ddit-usi-cpm-0</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/392477br-sr-spec-ddit-isc-secops-iam-0</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10000175-sr-spec-ddit-ies-nw-engineering</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/391900br-snrspec-ddit-apd-sol-del-visualization</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/394054br-sr-specialist-ddit-apd-erp-platformtech</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10003000-spec-ddit-ies-cloud-engineering</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10003964-medical-science-liaison-allergy-derm-mn-wi-nd-sd-remote</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10002668-head-quality</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10003845-analyst</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10002321-principal-scientist-pathology</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10004425-maintenance-calibration-technician-2nd-shift</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10004819-analyst</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10004652-senior-automation-engineer</loc>
  <lastmod>2025-02-11T16:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10005078-analyst</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10003290-sr-process-team-lead</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/393040br-senior-analyst-0</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/393921br-clinical-data-specialist-0</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/394227br-sr-spec-ddit-isc-secops-cyber-tools-0</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10001856-spec-ddit-ies-cloud-engineering</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/389449br-senior-analyst-apld-0</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10002575-sr-spec-ddit-ies-cloud-engineering</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10005272-sr-spec-ddit-ies-cloud-engineering</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10003332-data-analyst</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/391150br-assoc-dir-ddit-apd-erp-platformtech-se</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10006524-regulatory-affairs-manager</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/391465br-snr-spec-ddit-isc-ies-0</loc>
  <lastmod>2025-02-10T13:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10005588-business-data-migration-expert-manufacturing</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10001167-principal-scientific-writer</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10006558-clinical-laboratory-scientist-generalist</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10003737-manager-advanced-analytics</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/392841br-hire-retire-services-specialist</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10006270-analyst-patient-oriented-programs</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/395252br-analyst-sfe-products</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/392790br-senior-vendor-program-manager-0</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/381169br-senior-clinical-development-medical-director-rheumatology</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10005560-sr-spec-ddit-isc-ies</loc>
  <lastmod>2025-02-10T13:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/392425br-senior-analyst-data-products</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/383281br-hse-facilities-maintenances-specialist</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10006976-global-clinical-publishing-associate</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10006588-s4hana-abap-technical-expert</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10009172-analyst</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/394060br-sourcing-manager-rd-drug-development-0</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10008072-p2p-te-specialist-japanese-speaker</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/389390br-principal-rwe-research-analyst-0</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10009609-assoc-dir-ddit-apd-erp-commercials-and-cross-functional</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10006027-sr-sales-executive-oph</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10010751-s2p-business-partner</loc>
  <lastmod>2025-01-20T09:31:12+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10010584-automation-engineer</loc>
  <lastmod>2025-02-11T16:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10011709-ecompliance-manager</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/392838br-global-digital-fra-automation-lead-0</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10008985-ad-product-manager-drug-candidate-selection-software-applications</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10005048-expert-gmp-auditor</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10007992-ta-strategy-lead-hematology</loc>
  <lastmod>2025-01-13T13:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10010471-senior-gcppv-auditor</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10013372-ast-expert-quality-operations</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10013378-qa-compliance-expert-reg-cmc-facilitator</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10007757-senior-clinical-development-medical-director-cardio-renal-metabolism</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/385231br-therapeutic-data-strategy-director-0</loc>
  <lastmod>2025-01-09T16:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10013733-specialist-product-complaints-qop</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10014638-ra-cmc-manager</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10013034-specialist-resource-management</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10011406-specialist-master-batch-record-mbr-design</loc>
  <lastmod>2025-02-11T16:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/365068br-public-affairs-manager-mfd</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/377387br-senior-public-affairs-manager-mfd</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/388168br-engineer-project</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10015033-associate-manager-mst</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10015150-rlt-analytical-product-project-leader-mfd</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10014979-veeva-crm-architect</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10015460-specialist-master-batch-record-mbr-design</loc>
  <lastmod>2025-02-11T16:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10008379-global-program-clinical-head</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10014236-srspecialist-wireless-network-engineering</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10014239-network-specialist</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10014238-network-specialist</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10015462-expert-regulatory-writer</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/390890br-erp-assurance-senior-consultant</loc>
  <lastmod>2025-02-25T08:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10015156-specialist-quality-operations</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10015176-specialist-quality-operations</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10015901-specialist-quality-operations</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10015308-laboratory-asset-maintenance-and-calibration-engineer</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10016094-associate-sales-manager</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10015387-mechanical-engineering-executive</loc>
  <lastmod>2025-02-27T14:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10013814-patent-paralegal</loc>
  <lastmod>2025-02-25T19:31:03+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10006001-principal-scientist-2-preclinical-safety</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10011968-junior-engineer-conferencing-ar-vr-platforms</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10010209-validation-expert</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10016313-cq-engineer-senior-executive</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10016358-ldc-it-planning-manager</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10014923-project-manager</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10008890-r2r-specialist-inventory</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10009309-team-leader</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10012692-visji-specialist-proizvodno-informacijskih-sistemov-senior-specialist-it-mes</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10016994-elektroniker-mwd-der-fachrichtung-betriebstechnik-im-bereich-facility-management</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10016992-mechaniker-mwd-im-bereich-facility-management</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10017920-sr-automation-engineer</loc>
  <lastmod>2025-02-11T16:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10011229-associate-director-biostatistics</loc>
  <lastmod>2025-01-27T18:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10016179-senior-principal-data-scientist</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10011228-senior-principal-pharmacometrics</loc>
  <lastmod>2025-01-27T18:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10013609-associate-director-pharmacometrics</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/391682br-assoc-dir-ddit-dev-gco-tech-design-technical-business-analyst</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10018383-spec-sol-delivery-trd-labs</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10018690-associate-director-m365-platform-design-delivery</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10006523-real-world-evidence-research-analyst</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10018830-assoc-director-technical-solution-delivery-global-clinical-operations</loc>
  <lastmod>2025-03-10T11:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10018839-assoc-director-business-analyst-technical-research-development-trd</loc>
  <lastmod>2025-01-27T11:31:21+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10018843-business-analyst-ddit-dev-technical-research-development-trd</loc>
  <lastmod>2025-01-27T11:31:21+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10018835-snr-specialist-it-business-analyst-technical-design-regulatory-affairs</loc>
  <lastmod>2025-01-27T11:31:21+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10018685-project-controller</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10018194-qc-analyst-iv-analytical</loc>
  <lastmod>2025-03-13T10:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10018653-associate-analyst-master-data-management</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10000550-fra-technical-accounting-special-projects-apma</loc>
  <lastmod>2025-02-27T10:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10018840-associate-director-business-analyst-ddit-dev-technical-research-development-trd</loc>
  <lastmod>2025-01-27T11:31:21+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10019896-business-planning-and-analysis-manager-novartis-technical-operations</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10019441-associate-manager-quality-operations</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/393543br-buyer-german-0</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10018949-associate-director-veeva-crm-architect</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10020319-ra-cmc-senior-manager</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10019209-sr-spec-ddit-ies-database-services</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10007443-salesforce-marketing-cloud-architect-mcp-or-mci-data-cloud</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10006266-customer-engagement-solution-partner</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10003320-labortechniker-qc-analyst-ii-mwd-tirol-osterreich</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10020711-intake-specialist</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10019211-specialist-quality-operations</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10020392-ra-cmc-associate-manager-ii</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10019592-engagement-services-senior-expert</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10019582-senior-process-unit-maintenance-engineer</loc>
  <lastmod>2025-01-16T13:31:10+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10013346-manager-data-science</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10018078-allergy-territory-account-specialist-kansas-city-mo-remote</loc>
  <lastmod>2025-03-13T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10013345-manager-data-science</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10014929-financial-analyst-sod-ops</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/386692br-sasayamamanagerfinance-business-planning-and-analysis</loc>
  <lastmod>2025-02-25T04:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10012004-functional-lead-compliance-analytics-and-reporting</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/393548br-clinical-development-medical-director-renal-80-100</loc>
  <lastmod>2025-03-04T16:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10003153-global-program-clinical-head-renal</loc>
  <lastmod>2025-03-04T16:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10020276-associate-director-it-project-manager-ma</loc>
  <lastmod>2025-02-26T10:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10018439-senior-manager-erp-assurance</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023039-s2p-business-partner</loc>
  <lastmod>2025-01-06T09:31:04+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10020334-associate-director-clinical-qa</loc>
  <lastmod>2025-01-10T03:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10020409-hpc-infrastructure-services-specialist</loc>
  <lastmod>2025-03-12T14:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023687-sr-specialist-ddit-isc-csoc-engineering</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10022170-associate-director-ddit-isc-detection-response</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10021325-clinical-development-medical-director-renal</loc>
  <lastmod>2025-03-12T16:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10021326-clinical-development-medical-director-renal</loc>
  <lastmod>2025-03-11T18:31:16+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10016328-automation-coordinator</loc>
  <lastmod>2025-01-23T13:31:18+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10022544-sourcing-manager-mro</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023942-director-ddit-usi-product-management-medical-eng</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10022549-global-category-manager-mro</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023038-associate-director-ddit-isc-csoc-engineering</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10024277-validation-lead</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10019347-sr-spec-ddit-ies-solution-delivery</loc>
  <lastmod>2025-02-04T18:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10011232-senior-principal-biostatistician</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023406-senior-specialist-detection-response-ddit-isc</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10022779-content-education-specialist</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10019462-r2r-specialist-gl-reporting</loc>
  <lastmod>2025-01-06T05:31:05+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10025442-civil-architectural-structural-executive</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10025273-security-solutions-architect-mergers-acquisitions</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10025274-senior-medical-advisor-radioligand-therapy</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10025244-ldc-data-business-manager-operations</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10021691-qc-specialist-ii</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10022120-technology-product-manager</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10025733-process-expert-comecer-lines</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10022534-qa-operations-expert</loc>
  <lastmod>2025-01-22T15:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10022850-therapeutic-area-head-hematology-region-lacan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10022508-regional-procurement-category-manager-real-estate</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10025243-r2r-specialist-gl-reporting</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10020584-produktionsmitarbeiter-mwd-schaftenau-tirol-austria</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026403-senior-principal-clinical-data-standards-specialist</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023658-quality-control-staff</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10022271-specialist-kontrole-kakovosti-ii-specialist-laboratorijske-opreme-mzd-ljubljana-menges</loc>
  <lastmod>2025-01-15T10:31:38+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026095-production-manager</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10018425-director-delivery-excellence</loc>
  <lastmod>2025-03-06T21:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10015312-lab-operational-technology-engineer</loc>
  <lastmod>2025-03-12T20:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10025576-ldc-data-business-workstream-lead-material-master</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026731-tactical-planner-clinical-supply-plant-planner</loc>
  <lastmod>2025-01-29T07:31:22+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026406-associate-director-data-engineering-lead</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10025916-key-account-manager-ns-gene-therapies-bucharest</loc>
  <lastmod>2025-02-20T11:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026181-zvo-poslovni-partner-platforma-mzd-hse-business-partner-platform-mfd</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10027219-hire-retire-services-expert</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10027859-scm-expert</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10027926-sr-manager-manager-global-program-regulatory-manager-gprm-japan</loc>
  <lastmod>2025-01-21T05:31:06+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028216-manufacturing-operations-specialist</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026927-site-hse-head-cluster-lead</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/394015br-clinical-development-medical-director-0</loc>
  <lastmod>2025-02-21T01:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10012574-assoc-dir-platform-analytics-architecture</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10027832-process-expert</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028542-associate-director-biostatistics-early-development</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028570-senior-principal-biostatistician-early-development</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028472-supervisor-qc-chemistry</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028797-data-architect-intern</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10027284-global-head-statistical-programming</loc>
  <lastmod>2025-02-24T13:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10024987-head-quality-operations-legal</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10014378-senior-principal-scientistassociate-director-oncology-drug-discovery-small-molecules-biology</loc>
  <lastmod>2025-03-05T01:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10022468-business-data-migration-expert-sales-management</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10009349-principal-clinical-data-scientist</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028470-associate-director-manufacturing-operations</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10009744-sr-operational-scheduler</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028361-facilities-engineer</loc>
  <lastmod>2025-03-04T19:31:04+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10008278-tax-team-lead</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028162-globalni-ekspert-za-varnost-global-safety-expert</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028508-assoc-director-ddit-ops-data-analytics-dsai</loc>
  <lastmod>2025-01-21T08:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10027086-medical-field-trainer</loc>
  <lastmod>2025-01-13T13:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/388561br-brand-manager-oncology-st</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028960-sr-spec-ddit-ies-db-mw-services-operations</loc>
  <lastmod>2025-01-16T12:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10029370-qa-operations-specialist</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026067-elektriker-mwd-schaftenau-tirol</loc>
  <lastmod>2025-03-04T13:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10004198-technikermechatronikermechanikerelektrikerschlosser-mfd-kundl-schaftenau</loc>
  <lastmod>2025-03-10T07:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026554-sr-ecompliance-specialist</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10029120-medical-science-liaison-oncology-breast-cancer</loc>
  <lastmod>2025-01-08T07:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10029967-medical-science-liaison-msl-onc-prostate-radioligand-therapies-az-nm-nv-remote</loc>
  <lastmod>2025-02-24T19:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10029772-qa-compliance-specialist</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10029763-senior-document-control-specialist</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10013708-chief-financial-officer-manufacturing-targu-mures</loc>
  <lastmod>2025-02-14T15:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10029535-sr-specialist-ddit-isc-qnova-computer-system-validation</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030320-app-business-insight-strategy-analyst</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030316-stg-business-insight-strategy-analyst</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028820-ad-access-reimbursement-rlt-portland-or-remote</loc>
  <lastmod>2025-02-18T20:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10024800-senior-medical-science-liaison-rheumatology</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023531-manager-fcc</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10029378-ra-cmc-senior-manager</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030411-ra-cmc-manager</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023901-associate-director-data-digital-it-development</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10029595-associate-director-labor-rights-emea</loc>
  <lastmod>2025-01-28T10:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030811-product-steward-product-life-cycle-owner</loc>
  <lastmod>2025-01-22T15:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10029467-r2r-specialist-inventory</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030031-data-scientist</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030688-aseptic-process-expert</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031028-tl-operational-expert</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030151-engineering-expert-pharmaceutical-equipment</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10027994-senior-specialist-infrastructure-services-o365-collab-engineer</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10003807-solution-delivery-sap-subject-matter-expert-btp-cpi</loc>
  <lastmod>2025-01-27T17:31:26+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10029404-site-qc-head-associate-director</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030827-production-technician</loc>
  <lastmod>2025-02-04T16:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031536-associate-director-forensics-ddit-isc</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10014324-head-occupational-health-and-safety-governance</loc>
  <lastmod>2025-01-23T15:31:23+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031024-radioligand-therapy-product-manager</loc>
  <lastmod>2025-03-13T05:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031838-it-administrator-laboratorijskih-racunalniskih-sistemov-mzd-ljubljana-menges</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10025079-laboratorijski-analitik-v-medfazni-analitiki-mzd</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10002986-senior-msl-manager-rlt</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10015658-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10019839-senior-china-program-head</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10020243-medical-advisor-hema</loc>
  <lastmod>2025-02-24T08:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10020080-associate-clinical-development-medical-director</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023471-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10025594-medical-advisor-ophtha</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023664-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026540-expert-science-technology-ii-senior-expert-science-technology-i-material-science</loc>
  <lastmod>2025-02-12T11:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026865-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10027190-new-product-launch-lead</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028051-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028054-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028053-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028122-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028158-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028262-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10029113-gaojidaqujingli</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10029114-gaojidaqujingli</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10029468-senior-group-pv-head-safety-physicianpv-physician</loc>
  <lastmod>2025-03-06T08:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030206-senior-qa-operations-specialist-rlt-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030464-equipment-engineer-ii</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030459-utility-engineer</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030203-qc-specialist-ii-micro</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030705-maintenance-lead</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030467-supply-operations-lead</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030465-commissioning-qualification-engineer</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031384-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031612-brand-manager</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031928-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031005-qc-chemist</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10013680-sr-sales-executive-solid-tumor</loc>
  <lastmod>2024-12-29T15:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031699-hematology-area-manager</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10029989-senior-clinical-data-scientistmultiple-rolessenior-clinical-data-manager</loc>
  <lastmod>2025-02-27T05:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026956-vodja-ekipe-za-mednarodno-trgovino-mzd-international-trade-team-lead-mfd</loc>
  <lastmod>2025-02-12T14:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031063-solution-design-expert-manufacturing-data-analytics</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032125-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031345-computational-medicinal-chemist</loc>
  <lastmod>2025-03-12T22:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030968-trial-vendor-senior-manager-tvsm</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10004374-senior-molecular-imaging-expert-senior-principal-scientist</loc>
  <lastmod>2025-01-10T21:31:03+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10011616-global-regulatory-publishing-associate</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10027047-global-regulatory-publishing-associate</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032323-medical-science-liaison-immunology</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10012035-data-engineer-data42</loc>
  <lastmod>2025-02-12T09:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/389522br-inzenir-tehnicnih-storitev-za-scada-sisteme-mzd-ts-engineer-scada-systemsmfd</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031862-chef-de-produit-hematologie-en-stage</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032343-senior-principal-statistical-programmer</loc>
  <lastmod>2025-01-21T11:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032347-principal-statistical-programmer</loc>
  <lastmod>2025-01-21T16:31:03+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032713-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031544-sourcing-manager-refs-real-estate-facilities-services</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028533-trial-vendor-senior-manager</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028514-sr-specialist-ddit-ops-data-analytics-dsai</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032677-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10011626-regulatory-publishing-specialist</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10010696-sourcing-manager-rd</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10009803-tehnik-v-proizvodnji-bioloskih-ucinkovin-mzd</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028143-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032299-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032849-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032851-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033015-senior-principal-data-scientist-cadd</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031373-adopt-apmajc-process-lead-tcm</loc>
  <lastmod>2025-01-28T09:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032565-center-operation-manager</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028007-operational-scheduler</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032327-collaboration-manager</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030184-r2r-tax-reporting-lead</loc>
  <lastmod>2025-02-06T13:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032586-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032674-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032780-gaojiquyushichangjingli</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10011226-director-hta-biostatistics-medical-affairs</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028790-rd-quality-manager</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031731-country-head-comms-patient-advocacy</loc>
  <lastmod>2025-01-24T16:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032428-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032426-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032730-computer-aided-drug-design-ai-project-lead</loc>
  <lastmod>2025-03-12T22:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10029490-tehnolog-proizvodnih-procesov-analitik-mzd-process-expert-analyst-mfd</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026458-global-program-safety-lead-immunology</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030751-medical-director-clinical-pharmacology</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032838-gaojiquyushichangjingli</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031773-sales-representative</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033206-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033179-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033278-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033217-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033207-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033270-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033205-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033275-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033273-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033268-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033272-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033276-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033202-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033200-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033216-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033263-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028597-trial-vendor-associate-director</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026484-sr-spec-ddit-usi-solution-delivery-medical</loc>
  <lastmod>2025-01-28T17:31:17+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031000-manager-marketing-cloud-intelligence</loc>
  <lastmod>2025-02-04T11:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10007430-tehnik-inzeniringa-lokacije-mzd</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031868-qa-operations-specialist</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032642-vodja-kontrole-kakovosti-mzd-qc-lead-mfd-menges</loc>
  <lastmod>2025-01-08T09:31:06+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033335-qa-operations-expert-pmo-support-microbial-projects</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10015153-rlt-analytical-expert-mfd</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10011931-network-security-engineer-firewall-services</loc>
  <lastmod>2025-03-13T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10020967-comos-superuser</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033221-csa-architectural-sr-executive</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10009312-gen-ai-developer</loc>
  <lastmod>2025-02-28T16:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033908-global-program-regulatory-manager-lcm</loc>
  <lastmod>2025-02-20T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033577-priority-therapeutic-area-head</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033089-sc-data-analyst-mwd-tirol-schaftenau-befristet-teilzeit</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033479-tco-physician</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034185-gsoc-incident-monitoring-communications-lead</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030438-global-head-oncology-chemistry</loc>
  <lastmod>2025-03-12T22:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10001508-mst-expansion-lead-rlt-sasayama</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10027956-senior-brand-manager</loc>
  <lastmod>2025-01-24T15:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033878-team-head-clinical-supply-project-leadership</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032445-purchase-officer</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034233-head-cadd-computer-aided-drug-discovery</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032310-qa-operations-expert</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034511-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034364-pop-governance-manager</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031941-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032427-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034488-business-excell-execution-im-head-ar</loc>
  <lastmod>2025-01-08T17:31:12+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030437-translational-medicine-site-lead-united-kingdom-uk</loc>
  <lastmod>2025-03-05T01:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034351-sr-spec-ddit-gf-soldel-hcm</loc>
  <lastmod>2025-01-08T07:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034407-assoc-dir-ddit-gf-soldel-ta</loc>
  <lastmod>2025-01-08T07:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034657-strategic-assistant-country-president</loc>
  <lastmod>2025-02-19T15:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033208-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034685-principal-rwe-research-analyst</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033180-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033796-data-engineering-tech-lead</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028716-assistant-manager-sod-ops</loc>
  <lastmod>2025-01-30T10:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033794-data-engineer</loc>
  <lastmod>2025-02-12T15:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10004520-tehnik-elektro-vzdrzevanja-mzd</loc>
  <lastmod>2025-02-07T08:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034224-laboratorijski-analitik-mzd</loc>
  <lastmod>2025-02-04T12:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033274-tehnik-v-proizvodnji-bioloskih-ucinkovin-mzd</loc>
  <lastmod>2025-02-07T13:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031252-validation-expert</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031709-validatie-engineer-packaging-automation</loc>
  <lastmod>2025-02-20T17:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034329-specialist-mst</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032249-key-account-manager-immunology</loc>
  <lastmod>2025-02-06T16:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10022507-customer-insights-product-manager-mwd-rare-diseases-portfolio</loc>
  <lastmod>2025-02-06T16:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/395252br-analyst-sfe-products-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023658-quality-control-staff-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10006766-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10015658-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10022493-senior-msl-manager-lc-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023471-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023664-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026528-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026346-sr-medical-advisor-lc-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026486-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026854-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026865-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10027929-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028059-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028158-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028148-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028262-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028396-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028919-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10029440-medical-advisor-bc-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10029106-medical-science-liaison-zh-cn</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10029441-msl-manager-bc-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030049-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-02-20T10:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030686-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030868-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031026-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031184-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031233-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031190-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031358-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031384-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031245-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031364-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031462-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031637-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031388-senior-medical-advisor-rlt-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031763-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031764-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031928-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031923-gaojidequjingli-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031947-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032125-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032102-gaojidequjingli-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028488-marketing-manager-zh-cn</loc>
  <lastmod>2025-01-10T09:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032344-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032501-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032496-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10022145-global-clinical-operations-finance-specialist-zh-cn</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032137-global-clinical-operations-study-start-cra-zh-cn</loc>
  <lastmod>2025-03-10T06:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032530-xianyuzhurenxianyuzhuguan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032589-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032554-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032619-gaojidequjingli-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032293-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032644-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032648-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032739-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032660-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032713-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032620-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032077-gaojidaqujingli-zh-cn</loc>
  <lastmod>2025-02-24T10:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032811-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032494-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032801-xianyuzhurenxianyuzhuguan-zh-cn</loc>
  <lastmod>2025-01-01T08:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032493-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032833-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10027895-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032299-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032195-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032053-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032828-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032849-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032847-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032851-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033019-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033118-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031925-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031403-gaojidequjingli-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032586-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032084-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033185-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031915-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033006-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032569-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-lingshou-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030218-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032428-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031036-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032107-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033114-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032426-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033188-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10027982-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032775-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033189-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10027678-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032285-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033187-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033254-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033242-gaojidequjingli-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033437-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10029498-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033448-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033440-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033465-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033424-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033452-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033676-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033430-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032787-medical-advisor-cardio-zh-cn</loc>
  <lastmod>2024-12-23T10:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033873-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033874-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033702-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033767-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034038-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033673-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033426-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034159-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034179-gaojiquyushichangjingli-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033690-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033876-qa-compliance-senior-specialist-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034511-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033667-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031941-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032427-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033513-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034088-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032857-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033243-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034690-sr-heor-access-strategy-manager-zh-cn</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034716-xianyuzhurenxianyuzhuguan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034718-xianyuzhurenxianyuzhuguan-zh-cn</loc>
  <lastmod>2024-12-23T09:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034015-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034305-gaojiquyushichangjingli-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034514-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034814-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034788-xianyuzhurenxianyuzhuguan-zh-cn</loc>
  <lastmod>2024-12-21T16:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034017-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034864-brand-manager</loc>
  <lastmod>2024-12-23T03:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034984-gaojiquyushichangjingli-de-de</loc>
  <lastmod>2024-12-23T04:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034984-gaojiquyushichangjingli</loc>
  <lastmod>2024-12-23T04:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034992-staffing-supporttest</loc>
  <lastmod>2024-12-23T04:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034984-gaojiquyushichangjingli-it-it</loc>
  <lastmod>2024-12-23T04:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034984-gaojiquyushichangjingli-ru-ru</loc>
  <lastmod>2024-12-23T04:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034984-gaojiquyushichangjingli-sl-si</loc>
  <lastmod>2024-12-23T04:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034984-gaojiquyushichangjingli-zh-cn</loc>
  <lastmod>2024-12-23T04:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034955-gsoc-security-systems-lead</loc>
  <lastmod>2024-12-23T08:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033890-global-qms-rdq-specialist</loc>
  <lastmod>2024-12-23T10:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10016178-projektni-inzenir-mzd-project-engineer-ii-mfd</loc>
  <lastmod>2024-12-23T13:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10020289-vodja-investicijskih-projektov-mzd-engineering-project-manager-mfd</loc>
  <lastmod>2024-12-23T13:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034996-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-24T03:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035006-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-24T03:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035022-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-25T10:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035117-medical-advisor-lc-zh-cn</loc>
  <lastmod>2024-12-26T04:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035155-medical-launch-liason-rlt</loc>
  <lastmod>2025-01-15T09:31:19+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032151-sr-manager-retail-national-key-account-zh-cn</loc>
  <lastmod>2025-01-14T07:31:05+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035169-medical-science-liaison-immunology</loc>
  <lastmod>2025-02-11T06:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035171-medical-science-liaison-immunology</loc>
  <lastmod>2024-12-27T04:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035183-gaojidequjingli-zh-cn</loc>
  <lastmod>2024-12-27T04:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035177-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-27T04:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033858-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-27T09:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034315-r2r-senior-specialist-inventory</loc>
  <lastmod>2024-12-27T10:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034862-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2024-12-30T06:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034862-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-30T06:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034862-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2024-12-30T06:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034862-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2024-12-30T06:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034862-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2024-12-30T06:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034862-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-30T06:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035212-medical-science-liaison-immunology-zh-cn</loc>
  <lastmod>2024-12-30T07:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035211-medical-science-liaison-immunology-zh-cn</loc>
  <lastmod>2025-02-11T06:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035216-medical-science-liaison-immunology-zh-cn</loc>
  <lastmod>2025-03-03T08:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035199-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2024-12-30T08:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035199-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2024-12-30T08:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035199-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2024-12-30T08:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035199-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2024-12-30T08:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035199-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2024-12-30T08:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034869-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-30T08:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035199-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-30T08:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035278-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2024-12-30T13:31:03+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035024-gaojidequjingli-zh-cn</loc>
  <lastmod>2024-12-31T04:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10025796-regulatory-affairs-ra-site-head-india</loc>
  <lastmod>2025-01-16T05:31:10+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035308-operation-assistant</loc>
  <lastmod>2025-01-02T04:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032307-l-t-central-services-specialist-mandarin-speaker</loc>
  <lastmod>2025-01-02T07:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035282-medical-information-manager-zh-cn</loc>
  <lastmod>2025-01-02T10:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035358-gaojiquyushichangjingli</loc>
  <lastmod>2025-01-02T12:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035409-radiation-safety-lead</loc>
  <lastmod>2025-01-07T23:31:07+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035386-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-01-03T06:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035340-msl-manager-immu</loc>
  <lastmod>2025-01-03T07:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035265-medical-science-liaison-immunology-zh-cn</loc>
  <lastmod>2025-01-03T07:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035266-medical-science-liaison-immunology-zh-cn</loc>
  <lastmod>2025-01-03T07:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035267-medical-science-liaison-immunology-zh-cn</loc>
  <lastmod>2025-01-03T07:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035268-medical-science-liaison-immunology-zh-cn</loc>
  <lastmod>2025-01-03T07:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035046-expert-scientific-writer</loc>
  <lastmod>2025-01-03T10:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035446-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2025-01-03T11:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033942-buyer-french</loc>
  <lastmod>2025-01-03T14:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035207-gaojidequjingli</loc>
  <lastmod>2025-01-05T03:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10029118-gaojidaqujingli</loc>
  <lastmod>2025-02-26T11:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035476-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-02-24T10:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035509-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-01-06T05:31:05+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035532-area-training-manager</loc>
  <lastmod>2025-01-06T06:31:03+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034012-xianyuzhurenxianyuzhuguan-de-de</loc>
  <lastmod>2025-01-17T03:31:19+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035465-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2025-01-06T07:31:06+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035539-specialist-quality-operations</loc>
  <lastmod>2025-01-10T06:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034012-xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2025-01-17T03:31:19+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035465-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2025-01-06T07:31:06+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034012-xianyuzhurenxianyuzhuguan-it-it</loc>
  <lastmod>2025-01-17T03:31:19+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035465-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2025-01-06T07:31:06+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034012-xianyuzhurenxianyuzhuguan-ru-ru</loc>
  <lastmod>2025-01-17T03:31:19+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035465-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2025-01-06T07:31:06+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034012-xianyuzhurenxianyuzhuguan-sl-si</loc>
  <lastmod>2025-01-17T03:31:19+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035465-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2025-01-06T07:31:06+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034012-xianyuzhurenxianyuzhuguan-zh-cn</loc>
  <lastmod>2025-01-17T03:31:19+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035465-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-01-06T07:31:06+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035508-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035418-xianyuzhurenxianyuzhuguan-de-de</loc>
  <lastmod>2025-01-06T09:31:04+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035418-xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2025-01-06T09:31:04+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035418-xianyuzhurenxianyuzhuguan-it-it</loc>
  <lastmod>2025-01-06T09:31:04+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035418-xianyuzhurenxianyuzhuguan-ru-ru</loc>
  <lastmod>2025-01-06T09:31:04+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035418-xianyuzhurenxianyuzhuguan-sl-si</loc>
  <lastmod>2025-01-06T09:31:04+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035418-xianyuzhurenxianyuzhuguan-zh-cn</loc>
  <lastmod>2025-01-06T09:31:04+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035541-medical-science-liaison-renal-zh-cn</loc>
  <lastmod>2025-01-06T09:31:04+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035545-msl-manager</loc>
  <lastmod>2025-01-06T10:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035522-medical-science-liaison-bc-zh-cn</loc>
  <lastmod>2025-01-15T09:31:19+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035523-medical-science-liaison-bc-zh-cn</loc>
  <lastmod>2025-01-15T09:31:19+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035473-gaojidequjingli-zh-cn</loc>
  <lastmod>2025-01-06T11:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035524-shichangzhunrujingli-zh-cn</loc>
  <lastmod>2025-01-07T12:31:04+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035334-shichangzhunrudaqujingli-zh-cn</loc>
  <lastmod>2025-01-06T12:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033564-snr-specialist-supply-chain-data-analytics</loc>
  <lastmod>2025-02-05T09:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035584-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-01-07T04:31:04+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035604-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-01-07T05:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035482-xianyuzhurenxianyuzhuguan-zh-cn</loc>
  <lastmod>2025-01-07T05:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032460-sr-spec-ddit-isc-gov-digital</loc>
  <lastmod>2025-01-22T05:31:05+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035557-medical-science-liaison-renal-zh-cn</loc>
  <lastmod>2025-01-07T08:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035560-medical-science-liaison-renal-zh-cn</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035561-medical-science-liaison-renal-zh-cn</loc>
  <lastmod>2025-01-07T08:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035563-medical-science-liaison-renal-zh-cn</loc>
  <lastmod>2025-01-07T08:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035559-medical-science-liaison-renal-zh-cn</loc>
  <lastmod>2025-01-07T08:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035564-medical-science-liaison-renal-zh-cn</loc>
  <lastmod>2025-01-07T08:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035562-medical-science-liaison-renal-zh-cn</loc>
  <lastmod>2025-01-07T08:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023256-gcp-bioanalysis-senior-scientist</loc>
  <lastmod>2025-01-07T09:31:05+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10027544-assoc-dir-ddit-isc-secops-vulnsvcs</loc>
  <lastmod>2025-01-16T12:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034539-quality-operations-manager-fmd-kundl-austria-de-de</loc>
  <lastmod>2025-03-06T07:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035594-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-01-07T11:31:03+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034396-manufacturing-data-system-expert</loc>
  <lastmod>2025-03-12T08:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034019-portfolio-manager-qld-sa-nt</loc>
  <lastmod>2025-01-07T13:31:08+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035410-process-engineer</loc>
  <lastmod>2025-01-08T22:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034263-head-engineering</loc>
  <lastmod>2025-01-07T16:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10027368-csr-appendices-oversight-manager</loc>
  <lastmod>2025-01-23T11:31:20+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035704-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-02-24T10:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035789-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-01-08T04:31:04+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035422-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-02-24T10:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035543-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-01-08T04:31:04+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035314-data-steward</loc>
  <lastmod>2025-01-08T05:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035625-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-01-08T06:31:05+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034410-sr-spec-ddit-gf-solution-delivery-time-absence</loc>
  <lastmod>2025-01-08T08:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035166-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-01-08T08:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034872-senior-buyer-japanese-speaker</loc>
  <lastmod>2025-01-08T09:31:06+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033603-key-account-manager-immunology</loc>
  <lastmod>2025-02-07T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032646-tehnolog-proizvodnih-procesov-ii-mzd-process-expert-ii-mfd</loc>
  <lastmod>2025-02-17T08:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028109-external-operations-manager</loc>
  <lastmod>2025-01-23T08:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030736-clinical-label-manager</loc>
  <lastmod>2025-01-08T11:31:05+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035813-expert-data-scientist-digital-finance-hub</loc>
  <lastmod>2025-01-13T14:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035716-assurance-insights-review-senior-consultant</loc>
  <lastmod>2025-01-08T14:31:10+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034455-medical-head-solid-tumors-it-it</loc>
  <lastmod>2025-01-10T11:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034457-medical-head-hematology-it-it</loc>
  <lastmod>2025-01-10T11:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035974-ecompliance-manager</loc>
  <lastmod>2025-01-09T05:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035976-sr-ecompliance-specialist</loc>
  <lastmod>2025-01-09T06:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036131-gsoc-administrator-and-training-manager</loc>
  <lastmod>2025-01-09T08:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035335-value-and-access-specialist</loc>
  <lastmod>2025-02-12T05:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035688-expert-science-technology-iii-process-research-development</loc>
  <lastmod>2025-01-09T10:31:10+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10029229-medical-director-renal-de-de</loc>
  <lastmod>2025-01-09T14:31:03+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034710-qa-operations-project-expert</loc>
  <lastmod>2025-02-03T13:30:52+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035705-director-po-business-partner-international-india</loc>
  <lastmod>2025-01-09T15:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10011953-patient-safety-head-us</loc>
  <lastmod>2025-01-09T18:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036012-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-01-10T05:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036031-fra-head-baltics</loc>
  <lastmod>2025-01-10T07:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036277-xianyuzhurenxianyuzhuguan-de-de</loc>
  <lastmod>2025-01-10T09:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033951-customer-engagement-director</loc>
  <lastmod>2025-01-10T09:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036277-xianyuzhurenxianyuzhuguan</loc>
  <lastmod>2025-01-10T09:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034728-r2r-specialist-gl-reporting</loc>
  <lastmod>2025-01-10T09:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036277-xianyuzhurenxianyuzhuguan-it-it</loc>
  <lastmod>2025-01-10T09:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036277-xianyuzhurenxianyuzhuguan-ru-ru</loc>
  <lastmod>2025-01-10T09:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036277-xianyuzhurenxianyuzhuguan-sl-si</loc>
  <lastmod>2025-01-10T09:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036277-xianyuzhurenxianyuzhuguan-zh-cn</loc>
  <lastmod>2025-01-10T09:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035489-healthcare-manager</loc>
  <lastmod>2025-01-10T10:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036010-tagging-lead-web-and-campaign</loc>
  <lastmod>2025-02-17T09:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036259-key-account-manager</loc>
  <lastmod>2025-01-10T11:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036015-analytics-delivery-leader</loc>
  <lastmod>2025-02-17T09:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036014-analytics-project-manager</loc>
  <lastmod>2025-02-17T09:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036008-technical-lead-marketing-cloud-intelligence</loc>
  <lastmod>2025-02-17T09:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036005-project-manager-marketing-cloud-intelligence</loc>
  <lastmod>2025-02-17T09:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036137-validation-expert-de-de</loc>
  <lastmod>2025-01-10T15:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036348-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-01-13T07:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036567-gaojidaqujingli-zh-cn</loc>
  <lastmod>2025-01-13T09:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036276-key-account-manager-neuroscience-bucharest</loc>
  <lastmod>2025-01-16T07:31:31+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033576-process-expert</loc>
  <lastmod>2025-01-13T13:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036181-associate-director-statistical-programming</loc>
  <lastmod>2025-01-28T12:31:10+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035193-senior-patient-safety-specialist-local-safety-responsible-tunisia</loc>
  <lastmod>2025-01-13T15:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035665-director-product-strategy-counsel</loc>
  <lastmod>2025-01-13T18:31:05+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036230-gaojidequjingli-zh-cn</loc>
  <lastmod>2025-01-14T05:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036590-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2025-01-14T08:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036590-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2025-01-14T08:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036590-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2025-01-14T08:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036590-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2025-01-14T08:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036590-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2025-01-14T08:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036590-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-01-14T08:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034114-clinical-trial-supply-manager</loc>
  <lastmod>2025-01-14T09:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035262-marketing-manager</loc>
  <lastmod>2025-01-14T10:31:27+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034598-sr-spec-ddit-ies-cis-storage-engineering</loc>
  <lastmod>2025-02-21T15:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034656-sr-spec-ddit-ies-cis-backup-engineering</loc>
  <lastmod>2025-01-14T14:31:29+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035994-brand-manager-neuroscience</loc>
  <lastmod>2025-01-14T16:31:33+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036657-sourcing-manager-rd-equipment-maintenance</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033817-ad-performance-excellence-internal-operations</loc>
  <lastmod>2025-01-14T21:31:21+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10027559-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-01-15T03:31:39+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035951-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-02-24T10:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036733-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-01-15T08:31:52+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026895-brand-manager-oncology</loc>
  <lastmod>2025-01-15T09:31:19+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035905-head-content-and-automation-services-data-digital-it</loc>
  <lastmod>2025-01-15T09:31:19+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035902-head-shared-services-data-digital-it</loc>
  <lastmod>2025-01-17T07:31:46+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035961-data-engineering-manager</loc>
  <lastmod>2025-02-12T08:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031117-data-insights-expert-manager</loc>
  <lastmod>2025-02-27T12:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033812-mr-intern-zh-cn</loc>
  <lastmod>2025-01-15T12:31:19+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036743-bidding-strategy-market-access-lead-zh-cn</loc>
  <lastmod>2025-01-15T12:31:19+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10025526-ldc-commercial-reporting-analytics-manager</loc>
  <lastmod>2025-01-15T13:31:21+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036757-bidding-strategy-manager-zh-cn</loc>
  <lastmod>2025-01-15T13:31:21+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10022186-senior-product-operations-manager</loc>
  <lastmod>2025-03-11T16:31:10+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036666-global-category-manager-equipment-and-maintenance</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034299-ei-engineer</loc>
  <lastmod>2025-01-16T06:31:42+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10022259-associate-director-forensics</loc>
  <lastmod>2025-01-16T12:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036793-qc-specialist-i-biochemistry</loc>
  <lastmod>2025-01-16T08:31:22+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10018140-spec-ddit-ies-cloud-engineering</loc>
  <lastmod>2025-01-16T12:31:09+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023832-assoc-dir-ddit-ies-cloud-engineering</loc>
  <lastmod>2025-01-22T13:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036650-grow2glow-rotation-program</loc>
  <lastmod>2025-01-16T11:31:31+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037119-fra-analyst</loc>
  <lastmod>2025-01-16T15:31:29+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036817-global-program-safety-lead-radioligand-therapy</loc>
  <lastmod>2025-01-16T16:31:27+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030741-sr-specialist-ddit-dev-solution-delivery-data-hubs</loc>
  <lastmod>2025-02-25T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036820-associate-director-supply-chain-order-management-operativni-vodja-podrocja-it-oskrba</loc>
  <lastmod>2025-01-17T14:31:47+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036822-ast-qc-specialist</loc>
  <lastmod>2025-01-22T20:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036775-assoc-dir-data-analytics-manufacturing</loc>
  <lastmod>2025-01-17T15:31:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035778-associate-director-business-analyst-po</loc>
  <lastmod>2025-01-17T16:31:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034713-expert-medical-device-testing-laboratory-mfd</loc>
  <lastmod>2025-01-17T17:31:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036242-external-partner-management-senior-expert-trd-rlt</loc>
  <lastmod>2025-01-18T22:31:19+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037181-customer-engagement-partner</loc>
  <lastmod>2025-01-20T02:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037178-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-01-20T05:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037167-sr-sales-executive</loc>
  <lastmod>2025-02-20T04:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037187-sr-ecompliance-specialist</loc>
  <lastmod>2025-01-20T09:31:12+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033863-assoc-dir-ddit-ies-cloud-engg-azure-ai</loc>
  <lastmod>2025-01-20T09:31:12+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023403-senior-specialist-ddit-isc-detection-response</loc>
  <lastmod>2025-01-21T00:31:04+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035770-clinical-trial-supply-manager</loc>
  <lastmod>2025-01-21T07:31:03+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037524-customer-experience-engagement-cee-manager</loc>
  <lastmod>2025-01-21T08:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031381-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-01-21T09:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037516-development-quality-assurance-manager-zh-cn</loc>
  <lastmod>2025-01-21T10:31:05+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033672-senior-manager-patient-advocacy</loc>
  <lastmod>2025-01-21T12:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036670-production-process-support-associate</loc>
  <lastmod>2025-01-21T14:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036668-manufacturing-lead-operator</loc>
  <lastmod>2025-01-21T14:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036606-engineer-process</loc>
  <lastmod>2025-01-21T18:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10013778-sr-spec-cloud-infrastructure-solution-delivery-global-drug-development</loc>
  <lastmod>2025-03-03T20:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037552-qc-analyst-ii-zh-cn</loc>
  <lastmod>2025-01-22T03:31:03+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036742-buyer-japanese-speaker</loc>
  <lastmod>2025-01-23T04:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037720-sr-td-manager-people-analytics-insights-zh-cn</loc>
  <lastmod>2025-01-22T09:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037292-quality-assurance-specialist</loc>
  <lastmod>2025-03-13T09:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037163-sr-bus-analyst-ddit-im-jpapma-analytpt</loc>
  <lastmod>2025-01-22T12:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036470-qc-analyst-ii-chemops-befristet-de-de</loc>
  <lastmod>2025-01-22T13:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034205-assoc-dir-ddit-ies-cloud-engineering</loc>
  <lastmod>2025-01-22T13:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023733-sr-spec-ddit-ies-cloud-engineering</loc>
  <lastmod>2025-01-22T14:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10027990-skladiscnik-mzd</loc>
  <lastmod>2025-01-22T14:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036308-process-expert</loc>
  <lastmod>2025-01-22T15:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037168-regional-sourcing-manager-apac-indirect</loc>
  <lastmod>2025-01-23T04:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026092-program-manager-ddit-ma-usi</loc>
  <lastmod>2025-02-26T16:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037335-medical-representative-cardiovascular</loc>
  <lastmod>2025-01-22T17:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037416-senior-communications-manager-fmd</loc>
  <lastmod>2025-01-22T19:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037539-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-01-23T03:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10022474-business-data-migration-expert-manufacturing</loc>
  <lastmod>2025-01-23T04:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037587-key-account-manager</loc>
  <lastmod>2025-01-23T08:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037588-key-account-manager</loc>
  <lastmod>2025-01-23T09:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037909-gaojidaqujingli</loc>
  <lastmod>2025-01-27T10:31:37+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037580-sr-manager-executive-communications</loc>
  <lastmod>2025-01-23T10:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037581-manager-people-and-culture-communications</loc>
  <lastmod>2025-03-05T01:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037584-sr-manager-growth-strategy-and-policy-communications</loc>
  <lastmod>2025-01-23T10:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10020731-r2r-senior-specialist</loc>
  <lastmod>2025-01-27T09:31:11+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10003489-operater-v-proizvodnji-farmacevtskih-ucinkovin-mzd</loc>
  <lastmod>2025-03-03T09:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037903-sr-channel-operation-specialist</loc>
  <lastmod>2025-03-10T11:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037092-sr-spec-ddit-ies-netsec-extranet-service-manager</loc>
  <lastmod>2025-01-23T17:31:10+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035864-global-program-clinical-head-cardiovascular-early-projects-and-licensing</loc>
  <lastmod>2025-03-04T16:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036570-assoc-dir-security-solutions-architect-mergers-acquisitions</loc>
  <lastmod>2025-01-28T18:31:18+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036969-trd-rlt-senior-expert-isotopes-mfd</loc>
  <lastmod>2025-01-23T22:31:07+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037585-group-manager-brand-and-reputation</loc>
  <lastmod>2025-01-24T02:31:21+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037816-ekspert-upravljanja-kakovosti-skladnost-mzd-regulatory-cmc-facilitator-mfd-menges</loc>
  <lastmod>2025-02-05T08:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10006294-projektni-kontroler-mzd-project-controller-mfd</loc>
  <lastmod>2025-02-28T15:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10001628-ra-cmc-associate-director</loc>
  <lastmod>2025-01-24T16:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037341-global-program-clinical-head-early-projects</loc>
  <lastmod>2025-02-27T08:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038035-assoc-dir-ddit-apd-ce-solution-delivery</loc>
  <lastmod>2025-01-24T20:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037865-lead-qa-operations</loc>
  <lastmod>2025-01-24T22:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037867-qa-operations-specialist</loc>
  <lastmod>2025-01-24T22:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037963-specialist-kontrole-kakovosti-ii-mzd-qc-specialist-ii-mfd-ljubljana</loc>
  <lastmod>2025-02-05T09:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038160-specialist-mst</loc>
  <lastmod>2025-01-27T07:31:06+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037474-senior-specialist-it-ops-manufacturing</loc>
  <lastmod>2025-01-27T08:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032492-associate-director-ddit-usi-analytics-operations-service-delivery</loc>
  <lastmod>2025-01-27T08:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037230-senior-medical-writer-1</loc>
  <lastmod>2025-01-27T08:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037403-senior-medical-writer-2</loc>
  <lastmod>2025-01-27T09:31:11+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037992-digital-manager</loc>
  <lastmod>2025-01-31T12:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036595-spec-ddit-ies-cloud-engineering</loc>
  <lastmod>2025-01-27T10:31:37+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037998-senior-buyer-english</loc>
  <lastmod>2025-01-27T10:31:37+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037756-assoc-dir-ddit-ies-bssol-delivery-gddbr</loc>
  <lastmod>2025-01-29T11:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037361-spec-ddit-ies-cis-security</loc>
  <lastmod>2025-01-27T10:31:37+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037304-assoc-dir-ddit-ies-bssol-delivery-usi</loc>
  <lastmod>2025-01-27T11:31:21+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038177-manufacturing-technician</loc>
  <lastmod>2025-02-28T13:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035395-project-engineer</loc>
  <lastmod>2025-01-27T12:31:19+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038258-atmp-quality-assurance-lead</loc>
  <lastmod>2025-01-27T16:31:23+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035867-global-program-clinical-head-cardiovascular-metabolism</loc>
  <lastmod>2025-02-18T18:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037679-associate-director-commercial-access-integration</loc>
  <lastmod>2025-02-10T17:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10005065-director-enterprise-architect-apd</loc>
  <lastmod>2025-01-28T05:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037399-territory-business-executive</loc>
  <lastmod>2025-03-06T06:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035221-territory-business-executive</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038380-senior-expert-engineering-device-technologymfd</loc>
  <lastmod>2025-01-28T11:31:15+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036667-director-statistical-programming</loc>
  <lastmod>2025-01-28T13:31:23+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10012501-elektrotechniker-schwerpunkt-instrumentierung-mwd</loc>
  <lastmod>2025-03-04T11:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10025703-senior-principal-data-scientist</loc>
  <lastmod>2025-01-28T16:31:20+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037913-product-manager</loc>
  <lastmod>2025-01-28T17:31:17+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037334-associate-director-labor-rights-emea</loc>
  <lastmod>2025-01-28T17:31:17+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037249-pilot-plant-manufacturing-team-head</loc>
  <lastmod>2025-01-28T18:31:18+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038576-qa-manager</loc>
  <lastmod>2025-01-28T18:31:18+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/390301br-medical-science-liaison-onc-prostate-radioligand-therapies-dfw-or-north-tx</loc>
  <lastmod>2025-02-24T19:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038474-cell-processing-specialist-i</loc>
  <lastmod>2025-02-05T23:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036324-principal-scientist-iisenior-principal-scientist-preclinical-statistician</loc>
  <lastmod>2025-02-06T01:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10027884-lead-cx-content-creation</loc>
  <lastmod>2025-02-18T08:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037799-senior-analyst</loc>
  <lastmod>2025-01-29T09:31:31+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037332-associate-director-labor-rights-emea</loc>
  <lastmod>2025-01-29T13:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038376-key-account-manager</loc>
  <lastmod>2025-01-30T13:31:21+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038047-manufacturing-systems-expert</loc>
  <lastmod>2025-02-26T19:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035512-itot-senior-specialist-manufacturing-services-automation-engineer-mfd</loc>
  <lastmod>2025-01-29T16:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034041-associate-director-business-information-security-expert-infrastructure-group</loc>
  <lastmod>2025-01-29T17:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038214-europe-employment-tax-operations-lead</loc>
  <lastmod>2025-01-29T18:31:24+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038489-senior-scientist-iii-vivo-pharmacology-echocardiography-cvm</loc>
  <lastmod>2025-02-07T17:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038072-maintenance-and-calibration-technician-2nd-shift</loc>
  <lastmod>2025-01-30T01:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10022670-container-solutions-senior-engineer</loc>
  <lastmod>2025-03-07T21:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038076-procurement-specialist-medical-affairs</loc>
  <lastmod>2025-01-30T11:31:33+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037556-senior-expert-engineering-risk-management-mfd</loc>
  <lastmod>2025-01-30T16:31:35+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038286-principal-scientist-iisenior-principal-scientist-radioligand-dosimetrist</loc>
  <lastmod>2025-01-30T15:31:22+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037342-global-program-clinical-head-cvm</loc>
  <lastmod>2025-03-04T16:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037567-critical-reagent-manager</loc>
  <lastmod>2025-02-04T05:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038284-principal-scientist-iii-radioligand-modeling-simulation</loc>
  <lastmod>2025-01-30T18:31:19+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038833-production-technician-i-weekend-days</loc>
  <lastmod>2025-01-31T01:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038496-business-partner</loc>
  <lastmod>2025-02-05T08:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038269-associate-expert-medical-device-testing-laboratory-mfd</loc>
  <lastmod>2025-01-31T11:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037170-shift-lead-upstream</loc>
  <lastmod>2025-01-31T10:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038821-qc-technician-fixed-term</loc>
  <lastmod>2025-03-12T18:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10014784-tehnik-za-vzorcenje-mzd</loc>
  <lastmod>2025-01-31T11:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10019457-strategic-design-commercial-contracts-manager-de-de</loc>
  <lastmod>2025-01-31T14:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038196-tehnolog-proizvodnih-procesov-ll-mzd</loc>
  <lastmod>2025-01-31T14:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10024681-inzenir-zagonov-kvalifikacij-mzd-cq-engineer-ii-mfd</loc>
  <lastmod>2025-01-31T15:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038700-medical-science-liaison-msl-onc-prostate-radioligand-therapies-norcal-bakersfield</loc>
  <lastmod>2025-02-24T19:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038410-associate-director-peer-peer-marketing-delivery</loc>
  <lastmod>2025-01-31T21:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038704-senior-manager-design-data-visualization</loc>
  <lastmod>2025-02-03T12:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038621-associate-director-enterprise-data-management</loc>
  <lastmod>2025-02-03T08:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038991-senior-clinical-coding-specialist</loc>
  <lastmod>2025-02-03T09:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038988-clinical-coding-specialist</loc>
  <lastmod>2025-02-03T10:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038990-senior-clinical-coding-specialist</loc>
  <lastmod>2025-02-03T10:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038989-clinical-coding-specialist</loc>
  <lastmod>2025-02-03T10:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037954-senior-specialist-it-information-security-compliance</loc>
  <lastmod>2025-03-06T12:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038806-maintenance-and-automation-lead</loc>
  <lastmod>2025-02-03T11:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038198-tehnolog-proizvodnih-procesov-ll-mzd</loc>
  <lastmod>2025-02-03T11:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038583-associate-director-ddit-gf-finance-solution-delivery-financial-and-management-reporting-enablement</loc>
  <lastmod>2025-02-03T12:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038983-sr-specialist-service-management-data-analytics-operations</loc>
  <lastmod>2025-02-06T09:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038688-senior-automation-engineer</loc>
  <lastmod>2025-02-11T16:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038032-rwe-associate-director</loc>
  <lastmod>2025-02-03T17:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10013121-it-sr-manager-finance-digital-analytics-papm-sap-bw</loc>
  <lastmod>2025-02-13T12:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038107-ad-access-reimbursement-nps-ms-remote-san-diego-ca</loc>
  <lastmod>2025-02-04T21:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038404-qa-operations-specialist-qa-sap-de-de</loc>
  <lastmod>2025-02-03T19:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038405-qa-operations-specialist-qa-sap-part-time-80-de-de</loc>
  <lastmod>2025-02-03T19:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10025511-specialist-upravljanja-kakovosti-za-podrocje-skladnosti-racunalniskih-sistemov-mzd-qa-ecompliance-specialist-mfd-ljubljana</loc>
  <lastmod>2025-02-04T10:31:13+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037847-sample-management-and-logistics-specialist-mfd</loc>
  <lastmod>2025-02-04T11:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037681-cluster-patient-safety-head-uk-ireland</loc>
  <lastmod>2025-02-11T08:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037813-senior-principal-biostatistician</loc>
  <lastmod>2025-02-04T12:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037114-site-maintenance-technician-l-specialist</loc>
  <lastmod>2025-02-04T12:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037030-qa-compliance-lead</loc>
  <lastmod>2025-02-04T12:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/386440br-associate-director-cloud-security-architect-0</loc>
  <lastmod>2025-03-06T15:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10027928-commercial-excellence-manager</loc>
  <lastmod>2025-02-04T13:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039085-portfolio-manager-essential-medicine</loc>
  <lastmod>2025-02-04T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036210-senior-program-head</loc>
  <lastmod>2025-02-04T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10019612-director-enterprise-architecture-iam-ddit-isc</loc>
  <lastmod>2025-03-06T15:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039195-procurement-manager-it</loc>
  <lastmod>2025-02-04T17:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030826-associate-clinical-development-medical-director</loc>
  <lastmod>2025-02-04T18:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037309-associate-director-biologics-project-team-leader-sirna</loc>
  <lastmod>2025-02-04T22:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036714-process-expert</loc>
  <lastmod>2025-02-05T02:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038157-r2r-senior-specialist-statutory</loc>
  <lastmod>2025-02-05T05:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038873-cluster-procurement-category-manager-japanese-speaker</loc>
  <lastmod>2025-02-05T08:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033936-specialist-kontrole-kakovosti-mzd-ljubljana</loc>
  <lastmod>2025-02-05T08:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039521-business-data-migration-expert-manufacturing</loc>
  <lastmod>2025-02-05T09:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038212-payroll-services-senior-expert-hf</loc>
  <lastmod>2025-02-05T09:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038322-dir-ddit-dev-architecture-integration</loc>
  <lastmod>2025-02-05T10:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038146-hire-retire-senior-expert-mandarin-speaker</loc>
  <lastmod>2025-02-05T10:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037204-functional-trainer-operations</loc>
  <lastmod>2025-02-05T11:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037459-ingenieur-exploitation-hf-vivier-talents</loc>
  <lastmod>2025-02-05T11:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037080-regional-procurement-category-manager-api-drug-product-mfd</loc>
  <lastmod>2025-02-26T14:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038839-director-biotherapeutics</loc>
  <lastmod>2025-02-20T19:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039276-tehnolog-proizvodnega-inzeniringa-lokacije-engineer-multidiscipline-ii</loc>
  <lastmod>2025-02-05T17:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039664-manager-managed-care</loc>
  <lastmod>2025-02-05T23:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039183-rlt-hcs-partnerships-head</loc>
  <lastmod>2025-02-06T04:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039397-medical-representative-cardiovascular-cgh</loc>
  <lastmod>2025-02-18T03:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038148-senior-regulatory-affairs-manager</loc>
  <lastmod>2025-02-06T04:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039558-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-02-06T08:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037968-cell-therapy-operations-manager</loc>
  <lastmod>2025-02-06T10:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037902-devops-team-lead-director</loc>
  <lastmod>2025-02-06T10:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039623-senior-specialist-master-batch-record-mbr-designer</loc>
  <lastmod>2025-02-06T10:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039455-global-security-intelligence-intern</loc>
  <lastmod>2025-02-06T12:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038359-assoc-dir-dev-it-data-analytics-dsai</loc>
  <lastmod>2025-02-06T12:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039301-sr-principal-scientist-associate-director-translational-modeling-simulation</loc>
  <lastmod>2025-02-06T17:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037791-director-clinical-development-advanced-methods</loc>
  <lastmod>2025-02-11T08:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037453-gcp-compliance-manager-gco</loc>
  <lastmod>2025-02-11T08:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037887-gcp-compliance-manager-program-study</loc>
  <lastmod>2025-02-11T08:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038664-clinical-innovation-program-management-associate-director</loc>
  <lastmod>2025-02-10T21:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039124-head-quality-control</loc>
  <lastmod>2025-02-07T05:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039553-rd-quality-manager</loc>
  <lastmod>2025-02-14T05:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031988-assocdirddit-usi-mlops-architect</loc>
  <lastmod>2025-02-07T06:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031982-srspecddit-usi-svcmgt-da-operations</loc>
  <lastmod>2025-02-07T06:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039714-xianyuzhurenxianyuzhuguan-zh-cn</loc>
  <lastmod>2025-03-07T09:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037739-customer-service-and-production-planning-manager-mfd-skrbnik-oskrbe-kupcev-planiranja-proizvodnje-mzd</loc>
  <lastmod>2025-02-07T07:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039827-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-02-07T07:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031631-senior-hr-business-partner</loc>
  <lastmod>2025-02-07T09:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10015684-senior-global-program-regulatory-manager</loc>
  <lastmod>2025-02-07T10:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039225-associate-director-aws-architectaws-serverless</loc>
  <lastmod>2025-02-07T11:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023055-country-patient-safety-head-france</loc>
  <lastmod>2025-02-12T18:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037563-director-public-affairs-finland-ad-interim</loc>
  <lastmod>2025-02-07T12:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039616-senior-specialist-master-batch-record-mbr-designer</loc>
  <lastmod>2025-02-07T13:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039811-process-expert</loc>
  <lastmod>2025-02-07T13:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10014994-senior-key-account-manager-northeast-england-dermatology</loc>
  <lastmod>2025-02-12T13:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040017-qc-technician</loc>
  <lastmod>2025-02-07T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035649-delivery-solutions-lead-genaiai-applications</loc>
  <lastmod>2025-02-12T11:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038022-zaposlitvene-priloznosti-v-proizvodnji-inovativnih-zdravil</loc>
  <lastmod>2025-03-06T09:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035641-associate-director-ddit-isc-detection-response</loc>
  <lastmod>2025-02-07T16:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039680-qa-associate</loc>
  <lastmod>2025-02-07T20:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039907-ad-peer-peer-marketing-strategy</loc>
  <lastmod>2025-02-08T17:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035800-es-data-analyst</loc>
  <lastmod>2025-02-09T14:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040084-cell-processing-specialist-i-fri-mon</loc>
  <lastmod>2025-02-10T01:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039761-snr-spec-visualization-platform-delivery-power-bi</loc>
  <lastmod>2025-02-10T05:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039758-payroll-expert</loc>
  <lastmod>2025-02-10T06:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039545-medical-advisor-hematology-and-cell-therapy</loc>
  <lastmod>2025-02-10T08:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038165-customer-engagement-innovation-manager</loc>
  <lastmod>2025-02-11T13:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039574-laboratorijski-analitik-iii-mzd</loc>
  <lastmod>2025-02-10T11:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034729-visji-ekspert-za-oskrbo-zdravil-poudarek-na-strategiji-zagotavljanja-sterilnostiobvladovanja-kontaminacije-mzd-senior-expert-drug-supply-focus-sterility-assurancecontamination-control-strategy-mfd</loc>
  <lastmod>2025-02-10T13:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039389-head-protocol-and-clinical-program-excellence</loc>
  <lastmod>2025-02-10T15:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039669-ad-access-reimbursement-nps-rlt-remote-colorado-springs-co</loc>
  <lastmod>2025-02-10T15:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10021330-novartisov-dvoletni-rotacijski-program-za-financnike-mzd-novartis-two-year-finance-rotation-program-mfd</loc>
  <lastmod>2025-02-10T16:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039942-associate-director-it-dev-clinical-enablement-business-analyst</loc>
  <lastmod>2025-02-10T17:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037543-external-analytical-operations-manager-fmd</loc>
  <lastmod>2025-02-10T17:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039007-renal-rare-disease-territory-account-specialist-minneapolis-remote</loc>
  <lastmod>2025-02-10T21:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037593-shift-lead-ii</loc>
  <lastmod>2025-02-10T21:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039495-learning-solution-partner-associate-director</loc>
  <lastmod>2025-02-10T22:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039684-qa-expert</loc>
  <lastmod>2025-02-11T01:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039911-qa-supervisor</loc>
  <lastmod>2025-02-11T01:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039157-clinical-document-management-business-migrations-manager</loc>
  <lastmod>2025-02-11T06:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10027527-director-portfolio-advocacy-apma</loc>
  <lastmod>2025-02-11T07:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10027609-executive-director-public-affairs-asia-aspiring</loc>
  <lastmod>2025-02-11T07:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039580-tehnolog-proizvodnih-procesov-ii-fmdprocess-expert-ii-fmd</loc>
  <lastmod>2025-02-26T14:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10015799-fra-analyst-treasury-and-cash-management-analitik-specialist</loc>
  <lastmod>2025-02-11T10:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039943-senior-specialist-technical-steward-data-modeling-data-catalog-erwin-or-erstudio</loc>
  <lastmod>2025-02-11T11:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037899-technical-solution-delivery-associate-director</loc>
  <lastmod>2025-02-11T11:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032654-territory-business-executive</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039858-qa-operations-team-leader-qualified-person-mfd-kundl-austria</loc>
  <lastmod>2025-02-11T12:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040183-cdd-analyste-strategique-hf</loc>
  <lastmod>2025-02-11T14:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039851-process-engineer</loc>
  <lastmod>2025-02-11T14:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040392-ethics-risk-and-compliance-manager</loc>
  <lastmod>2025-02-11T15:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039058-quality-operations-manager</loc>
  <lastmod>2025-02-11T17:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039990-vodja-upravljanja-kakovosti-operacije-mzd-qa-operations-lead-mfd</loc>
  <lastmod>2025-02-11T17:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039009-renal-rare-disease-territory-account-specialist-kansas-city-mo-remote</loc>
  <lastmod>2025-02-11T18:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039884-computational-medicinal-chemist-computer-aided-drug-design</loc>
  <lastmod>2025-03-12T22:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031891-data42-medical-affairs-director</loc>
  <lastmod>2025-02-12T00:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040323-gaojiquyushichangjingli-zh-cn</loc>
  <lastmod>2025-02-12T03:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040319-environmental-compliance-manager</loc>
  <lastmod>2025-02-20T06:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040125-assoc-director-workplace-device-provisioning-services</loc>
  <lastmod>2025-02-12T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040346-gaojidequjingli</loc>
  <lastmod>2025-02-12T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040316-artwork-coordinator-packaging-material-planner</loc>
  <lastmod>2025-02-12T08:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039256-trial-vendor-associate-director</loc>
  <lastmod>2025-02-12T09:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038949-trial-vendor-senior-manager</loc>
  <lastmod>2025-02-12T09:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10013446-cdd-data-steward-hf</loc>
  <lastmod>2025-02-12T10:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034150-product-specialist</loc>
  <lastmod>2025-02-12T10:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032653-territory-business-executive</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10027038-territory-business-executive</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034885-territory-business-executive</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10024214-territory-business-executive</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035514-territory-business-executive</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10029446-territory-business-executive</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031401-brand-manager</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032502-assocdirddit-usi-analytics-sol-architecture</loc>
  <lastmod>2025-02-12T12:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032484-analyst-sr-data-analyst-ddit-usi</loc>
  <lastmod>2025-02-12T12:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037901-it-sr-program-manager</loc>
  <lastmod>2025-02-12T12:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040246-instandhaltungsmeister-automatisierungs-steuerungstechnik-mwd-schaftenau-tirol</loc>
  <lastmod>2025-03-05T01:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032537-associate-director-ddit-usi-analytics-products-solutions-delivery</loc>
  <lastmod>2025-02-12T14:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10003822-tehnik-v-proizvodnji-mzd</loc>
  <lastmod>2025-02-12T15:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040265-gcp-compliance-manager-emea-hub</loc>
  <lastmod>2025-02-12T16:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040371-quality-operations-specialist-temporary</loc>
  <lastmod>2025-02-12T18:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037604-country-patient-safety-head-hungary</loc>
  <lastmod>2025-02-21T10:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037655-value-access-head-lacan</loc>
  <lastmod>2025-02-12T19:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040640-clinical-development-medical-director-neuroscience-md-phd</loc>
  <lastmod>2025-02-13T00:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040468-customer-engagement-partner</loc>
  <lastmod>2025-03-13T05:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036602-sr-specialist-ddit-ops-sol-del-sc-planning</loc>
  <lastmod>2025-02-13T07:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10029299-dir-ddit-dev-gco-enterprise-architect</loc>
  <lastmod>2025-02-13T07:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032135-senior-it-project-manager-global-medical-affairs</loc>
  <lastmod>2025-02-13T12:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038916-clinical-development-medical-director-dermatology</loc>
  <lastmod>2025-02-13T12:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039776-payroll-expert</loc>
  <lastmod>2025-02-13T16:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10029773-directorassociate-director-scientific-communications</loc>
  <lastmod>2025-02-13T17:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039485-associate-director-esp-quality-mfd</loc>
  <lastmod>2025-02-13T17:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040259-senior-clinical-development-director-renal</loc>
  <lastmod>2025-02-13T17:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039396-therapeutic-area-strategy-head-neuroscience</loc>
  <lastmod>2025-03-06T16:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039393-therapeutic-area-strategy-head-neuroscience</loc>
  <lastmod>2025-02-18T01:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040679-center-operation-manger</loc>
  <lastmod>2025-02-14T06:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040088-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2025-02-14T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040088-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2025-02-14T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040718-senior-principal-statistical-programmer</loc>
  <lastmod>2025-02-14T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040088-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2025-02-14T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040088-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2025-02-14T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040088-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2025-02-14T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040088-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-02-14T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040688-quality-operations-specialist-shift-specialist-temporary</loc>
  <lastmod>2025-02-14T08:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040720-senior-principal-statistical-programmer-zh-cn</loc>
  <lastmod>2025-02-14T08:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040769-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2025-02-14T09:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040743-assoc-dir-ddit-apd-shared-services</loc>
  <lastmod>2025-02-14T09:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040769-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2025-02-14T09:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040769-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2025-02-14T09:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040769-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2025-02-14T09:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040769-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2025-02-14T09:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040769-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-02-14T09:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040334-medical-engagement-manager</loc>
  <lastmod>2025-03-13T13:31:18+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040434-associate-director-enterprise-architect-network-security</loc>
  <lastmod>2025-03-06T15:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040013-senior-clinical-development-director-renal</loc>
  <lastmod>2025-02-14T13:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030015-equipment-specialist-i</loc>
  <lastmod>2025-02-14T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10014161-financial-it-compliance-senior-specialist</loc>
  <lastmod>2025-02-14T19:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040590-key-account-manager-neuroscience-targu-mures-2-year-contract</loc>
  <lastmod>2025-02-24T14:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040778-mr-intern-zh-cn</loc>
  <lastmod>2025-02-17T03:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040850-mr-intern-zh-cn</loc>
  <lastmod>2025-02-17T03:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040602-sr-spec-ddit-apd-shared-services-sam-aim</loc>
  <lastmod>2025-02-17T04:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040533-specialist-engage-enterprise-services</loc>
  <lastmod>2025-02-17T05:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039705-site-hse-head-commercial-operations-japan</loc>
  <lastmod>2025-02-17T05:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040531-specialist-engage-enterprise-services</loc>
  <lastmod>2025-02-17T05:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040465-senior-access-strategy-manager-zh-cn</loc>
  <lastmod>2025-02-17T07:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040818-brand-manager-zh-cn</loc>
  <lastmod>2025-02-17T07:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033209-director-corporate-communications-china</loc>
  <lastmod>2025-03-05T01:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032789-manager-media-relations-channels</loc>
  <lastmod>2025-03-05T01:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032792-manager-ta-patient-advocacy</loc>
  <lastmod>2025-03-05T01:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032786-associate-director-executive-communications</loc>
  <lastmod>2025-02-17T08:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032791-manager-ta-communications</loc>
  <lastmod>2025-03-05T01:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041038-sales-representative</loc>
  <lastmod>2025-02-17T09:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038415-principal-software-engineer</loc>
  <lastmod>2025-02-17T09:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023228-sr-spec-ddit-ies-o365-sec-compl</loc>
  <lastmod>2025-02-17T10:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040551-director-statistical-programming</loc>
  <lastmod>2025-02-17T10:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040710-tm-academy-fellow-translational-medicine-discovery-profiling</loc>
  <lastmod>2025-02-17T10:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039711-assoc-dir-ddit-dev-td-pspv-rep-dsa</loc>
  <lastmod>2025-02-17T11:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039533-qa-operations-expert</loc>
  <lastmod>2025-03-06T16:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038888-trd-pilot-plant-automation-engineer</loc>
  <lastmod>2025-03-05T01:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038895-trd-pilot-plant-cqv-engineer</loc>
  <lastmod>2025-02-17T12:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041071-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2025-02-17T13:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041070-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2025-02-17T13:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040192-senior-medical-science-liaison-haematology-north-west-and-midlands</loc>
  <lastmod>2025-02-17T13:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041071-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2025-02-17T13:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041070-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2025-02-17T13:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041071-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2025-02-17T13:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041070-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2025-02-17T13:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041071-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2025-02-17T13:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041070-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2025-02-17T13:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041071-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2025-02-17T13:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041070-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2025-02-17T13:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041071-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-02-17T13:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041070-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-02-17T13:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10027886-senior-lead-cx-content-creation</loc>
  <lastmod>2025-02-18T08:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041126-operational-scheduler-temporary-and-part-time-50</loc>
  <lastmod>2025-02-17T18:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039077-equipment-operator-befristet-2-jahre-schichtarbeit-64-schichtmodell</loc>
  <lastmod>2025-02-17T22:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039880-associate-director-forensics-ddit-isc-de-de</loc>
  <lastmod>2025-02-18T03:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040783-senior-patient-safety-specialist</loc>
  <lastmod>2025-02-18T08:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041002-ra-reg-cmc-assoc-director</loc>
  <lastmod>2025-02-18T08:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038440-commercial-excellence-lead</loc>
  <lastmod>2025-02-18T09:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038153-gfmd-specialist</loc>
  <lastmod>2025-03-12T05:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038444-insights-and-analytics-manager</loc>
  <lastmod>2025-02-18T09:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033976-head-gxp-compliance-and-health-authorities-inspection-support</loc>
  <lastmod>2025-02-18T10:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040000-tehnik-vzdrzevanja-ii-zmdmaintenance-technician-ii-fmd</loc>
  <lastmod>2025-02-18T10:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041091-private-market-field-manager</loc>
  <lastmod>2025-02-18T11:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040380-business-excellence-execution-lead-apma</loc>
  <lastmod>2025-02-18T11:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031054-associate-director-people-insights</loc>
  <lastmod>2025-02-18T11:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040271-clinical-trial-contract-budget-manager</loc>
  <lastmod>2025-02-18T12:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040512-value-access-manager</loc>
  <lastmod>2025-02-18T12:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041089-key-account-manager</loc>
  <lastmod>2025-02-19T16:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039440-international-pipeline-and-bdl-ta-crm</loc>
  <lastmod>2025-02-18T13:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038773-reliability-engineer-maint-planning-mwd</loc>
  <lastmod>2025-02-24T11:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039803-organizational-change-manager-fmd</loc>
  <lastmod>2025-02-18T13:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041085-key-account-manager</loc>
  <lastmod>2025-02-18T13:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041037-sr-specialistservicenow-apm-and-cmdb-operations-process-and-governance</loc>
  <lastmod>2025-02-18T14:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040157-medical-science-liaison</loc>
  <lastmod>2025-02-18T14:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10017856-medical-safety-processes-and-projects-manager</loc>
  <lastmod>2025-02-20T20:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039540-campus-management-coordinator-mfd-koordinator-storitvenih-dejavnosti-lokacije-mzd</loc>
  <lastmod>2025-03-07T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041219-senior-study-leader</loc>
  <lastmod>2025-02-18T17:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040933-human-resources-services-expert-slovene</loc>
  <lastmod>2025-02-25T13:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040937-human-resources-trainee</loc>
  <lastmod>2025-02-25T13:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033134-ad-program-launch-and-change-excellence</loc>
  <lastmod>2025-02-18T18:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040762-it-business-partner-director-gco-study-start-operations</loc>
  <lastmod>2025-03-10T14:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037240-biomedical-research-submission-management-associate-director</loc>
  <lastmod>2025-02-18T18:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038818-molecular-pathologist-immunology-80-100</loc>
  <lastmod>2025-03-05T01:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040630-director-channel-operations-strategy-advanced-platforms-remote</loc>
  <lastmod>2025-03-04T19:31:04+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10018094-allergy-territory-account-specialist-albuquerqueel-paso-remote</loc>
  <lastmod>2025-03-13T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041202-sr-spec-ddit-ies-ism-config-mgmt</loc>
  <lastmod>2025-02-19T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041188-mr-intern-zh-cn</loc>
  <lastmod>2025-02-19T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040701-medical-science-liaison-cv-zh-cn</loc>
  <lastmod>2025-02-19T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041127-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2025-02-19T15:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041127-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2025-02-19T16:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041127-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2025-02-19T15:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041127-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2025-02-19T15:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041127-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2025-02-19T15:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041127-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-02-19T15:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041065-field-product-specialist-ha-noi</loc>
  <lastmod>2025-02-26T11:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041179-sr-specialist-mulesoft-application-engineersalesforce-integration-mulesoft</loc>
  <lastmod>2025-02-26T08:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041393-medical-governance-lead</loc>
  <lastmod>2025-02-19T10:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035382-sr-spec-ddit-ies-cis-vmware-engineering</loc>
  <lastmod>2025-02-19T11:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038358-specialist-aws-engineerangular-js-backend-awsazure</loc>
  <lastmod>2025-02-19T12:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040210-assocdir-ddit-apd-special-programs</loc>
  <lastmod>2025-02-19T12:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040772-takticni-planer-mzd-tactical-planner-mfd</loc>
  <lastmod>2025-02-19T12:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037875-intelligence-researcher</loc>
  <lastmod>2025-02-19T15:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041472-global-auditor-clinical-practice-or-pharmacovigilance</loc>
  <lastmod>2025-02-19T15:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041352-manufacturing-operations-facilitator</loc>
  <lastmod>2025-02-19T15:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040542-manufacturing-system-expert-fmd-kundl-austria-temporary</loc>
  <lastmod>2025-02-19T16:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040065-qc-sample-management-technician-wed-sat-am</loc>
  <lastmod>2025-02-19T19:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040211-therapeutic-area-strategy-director-immunology</loc>
  <lastmod>2025-02-19T22:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041344-oncology-sales-specialist-non-malignant-hematology-san-francisco-remote</loc>
  <lastmod>2025-02-19T23:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033993-senior-us-category-manager-patient-support-services</loc>
  <lastmod>2025-02-19T23:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040410-sr-analyst-quality-control-cell-based-methods</loc>
  <lastmod>2025-02-20T00:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041394-qa-batch-release-specialist</loc>
  <lastmod>2025-03-04T03:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040974-manager-process-experts</loc>
  <lastmod>2025-02-20T02:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041354-automation-engineer</loc>
  <lastmod>2025-02-20T02:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041588-regional-hcsp-manager</loc>
  <lastmod>2025-02-20T03:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037728-senior-medical-science-liaison-neuroscience-nsw-based</loc>
  <lastmod>2025-02-20T03:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041590-regional-hcsp-manager</loc>
  <lastmod>2025-02-20T04:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036352-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039800-specialist-ddit-isc-csoc-engineering</loc>
  <lastmod>2025-02-20T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039796-sr-specialist-ddit-isc-csoc-engineering</loc>
  <lastmod>2025-02-20T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041001-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2025-02-20T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040775-buyer-hq-indirect-categories</loc>
  <lastmod>2025-02-20T08:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037808-sr-information-communication-specialist</loc>
  <lastmod>2025-02-20T09:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037805-content-education-specialist</loc>
  <lastmod>2025-02-20T09:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041471-senior-global-auditor-pharmacovigilance</loc>
  <lastmod>2025-03-07T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041621-gaojiquyushichangjingli-zh-cn</loc>
  <lastmod>2025-02-20T11:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035614-director-data-science</loc>
  <lastmod>2025-02-20T12:31:04+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041317-associate-director-hta-biostatistics</loc>
  <lastmod>2025-02-20T13:31:05+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032687-schichtfuhrer-fmd-kundl-tirol-austria-de-de</loc>
  <lastmod>2025-02-20T14:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040408-supervisor-quality-control-cell-based</loc>
  <lastmod>2025-02-20T14:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040745-it-business-partner-external-workforce-management</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039634-country-therapeutic-area-head-im</loc>
  <lastmod>2025-02-20T17:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041242-sr-specialist-salesforce-qa-test-expert</loc>
  <lastmod>2025-02-20T17:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040516-analitik-v-oddelku-racunovodstvo-kupcev-mz-fra-analyst-order-cash-department-mf</loc>
  <lastmod>2025-02-20T18:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039654-expert-technical-development-cell-therapy-process-development</loc>
  <lastmod>2025-02-20T19:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038067-vivo-labs-research-scientist-80-100</loc>
  <lastmod>2025-02-20T22:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038391-principal-scientist-vivo-drug-discovery-pharmacology-80-100</loc>
  <lastmod>2025-02-20T22:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037312-manager-trade-compliance</loc>
  <lastmod>2025-02-24T22:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039889-associate-clinical-research-medical-director-immunology</loc>
  <lastmod>2025-02-20T23:31:03+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041575-principal-scientist-structural-and-biophysical-analytics</loc>
  <lastmod>2025-03-12T22:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041615-gaojiquyushichangjingli-zh-cn</loc>
  <lastmod>2025-02-21T05:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041165-gfmd-senior-specialist</loc>
  <lastmod>2025-02-21T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040680-r2r-senior-specialist-gl-reporting</loc>
  <lastmod>2025-02-21T08:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041438-tehnolog-proizvodnih-procesov-zmdprocess-expert-fmd</loc>
  <lastmod>2025-02-21T09:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040579-associate-director-business-analyst-salesforce-data-cloud</loc>
  <lastmod>2025-03-03T11:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040335-tehnolog-proizvodnih-procesov-ii-process-expert-ii</loc>
  <lastmod>2025-02-21T10:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040734-ekspert-za-kakovost-dobaviteljev-mzd-qa-supplier-specialist-mfd</loc>
  <lastmod>2025-02-21T11:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039749-precision-medicine-director</loc>
  <lastmod>2025-02-21T12:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041097-competitive-intelligence-manager</loc>
  <lastmod>2025-02-21T12:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041073-study-site-operations-feasibility-manager</loc>
  <lastmod>2025-02-21T13:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041420-contract-management-coordinator</loc>
  <lastmod>2025-02-21T13:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040952-associate-director-clinical-qa</loc>
  <lastmod>2025-03-07T13:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033100-associate-dir-itot-integration</loc>
  <lastmod>2025-03-12T16:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038281-director-social-impact-cross-functional-integration-partnerships</loc>
  <lastmod>2025-02-21T16:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041246-associate-director-ddit-isc-vulnerability-response-secops-vulnerability-services</loc>
  <lastmod>2025-02-21T16:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038080-site-engineering-head</loc>
  <lastmod>2025-02-21T16:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037897-it-solution-delivery-director-data-platforms</loc>
  <lastmod>2025-03-07T17:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038285-director-social-impact-business-integration</loc>
  <lastmod>2025-02-21T16:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041782-key-account-manager-haematology-scotland-north-east-england-and-northern-ireland</loc>
  <lastmod>2025-03-10T14:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032241-global-program-head-neuroscience-md-phd</loc>
  <lastmod>2025-02-21T18:31:16+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041733-supply-chain-operations-specialist</loc>
  <lastmod>2025-02-23T04:31:04+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039291-director-heor-international</loc>
  <lastmod>2025-02-23T11:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039111-associate-director-biologics-project-team-leader-biotherapeutics</loc>
  <lastmod>2025-02-23T22:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040024-biotransformation-scientist-combustion-accelerator-mass-spectrometry-cams</loc>
  <lastmod>2025-02-23T22:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041072-qc-analyst-ii</loc>
  <lastmod>2025-02-23T22:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041570-finance-rotation-program</loc>
  <lastmod>2025-02-23T22:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036536-country-head-public-affairs</loc>
  <lastmod>2025-02-26T11:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041589-regional-sales-manager</loc>
  <lastmod>2025-02-24T06:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041223-sr-specialist-salesforce-developer-apex-lightning-web-components</loc>
  <lastmod>2025-02-24T09:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030581-vodja-procesov-upravljanj-tveganj-odpornosti-mzd-risk-resilience-lead-operations-mfd</loc>
  <lastmod>2025-02-24T11:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041946-field-product-specialist-cv-hcm</loc>
  <lastmod>2025-02-26T11:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10022108-ast-expert-micro</loc>
  <lastmod>2025-02-24T13:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041889-global-feasibility-lead-copm</loc>
  <lastmod>2025-02-24T17:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040026-patient-safety-manager</loc>
  <lastmod>2025-02-24T16:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039881-assistente-administrativo-vaga-afirmativa-para-pessoas-com-deficiencia-pcd</loc>
  <lastmod>2025-02-24T16:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041585-business-planning-and-analysis-sr-manager-refs-us</loc>
  <lastmod>2025-02-24T18:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042005-executive-director-decision-science-crm-product-lead-1-3</loc>
  <lastmod>2025-02-28T21:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042028-executive-director-decision-science-oncology-product-lead-1-3</loc>
  <lastmod>2025-02-28T21:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041148-medical-representative-cardiometabolic-12months-contract</loc>
  <lastmod>2025-02-24T23:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042004-executive-director-decision-science-ta-launch-neuroscience</loc>
  <lastmod>2025-02-28T22:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042030-executive-director-decision-science-product-lead-ms</loc>
  <lastmod>2025-02-28T22:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040973-aseptic-manufacturing-manager</loc>
  <lastmod>2025-02-25T00:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042016-executive-director-decision-science-product-lead-rheumatologydermatology</loc>
  <lastmod>2025-02-28T22:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042032-director-decision-science-neuroscience-product-lead-1-2</loc>
  <lastmod>2025-02-25T00:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042011-executive-director-decision-science-product-lead-immunology-1-2</loc>
  <lastmod>2025-02-28T22:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042017-director-decision-science-immunology-product-lead-1-2</loc>
  <lastmod>2025-02-25T00:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042025-director-decision-science-oncology-product-lead-1-3</loc>
  <lastmod>2025-02-25T00:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042009-director-decision-science-renal-product-lead</loc>
  <lastmod>2025-02-25T00:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041149-portfolio-account-specialist-vic-west-immunology</loc>
  <lastmod>2025-02-25T01:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039818-specialist-ddit-isc-detection-response</loc>
  <lastmod>2025-02-25T02:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041840-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2025-02-25T03:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041840-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2025-02-25T03:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039812-senior-specialist-ddit-isc-detection-response</loc>
  <lastmod>2025-02-25T03:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041840-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2025-02-25T03:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041840-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2025-02-25T03:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041840-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2025-02-25T03:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041840-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-02-25T03:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041768-mr-intern-zh-cn</loc>
  <lastmod>2025-02-25T03:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041945-head-new-product-international-china</loc>
  <lastmod>2025-02-25T04:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041624-specialist-qa-ops-manufacturing-mgmt</loc>
  <lastmod>2025-02-25T06:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036523-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-02-25T06:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041633-gaojidequjingli-zh-cn</loc>
  <lastmod>2025-02-25T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041626-specialist-qa-ops-manufacturing-management</loc>
  <lastmod>2025-02-25T09:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041447-vodja-placnega-oddelka-mzd-payroll-services-manager-mfd</loc>
  <lastmod>2025-02-25T09:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10022281-revenue-deduction-accounting-statutory-expert</loc>
  <lastmod>2025-02-25T10:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041863-ekspert-tehnologije-izdelkov-iii-zmdproduct-steward-iii-fmd</loc>
  <lastmod>2025-02-25T10:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037575-srspecddit-dev-td-trd</loc>
  <lastmod>2025-03-12T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039562-sr-spec-ddit-dev-trd</loc>
  <lastmod>2025-02-25T10:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042127-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-02-25T11:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039883-demand-manager-supply-chain-finance-mwd-de-de</loc>
  <lastmod>2025-02-25T13:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041125-bpa-manager</loc>
  <lastmod>2025-02-25T13:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041697-kam-oncology-nw-london-milton-keynes-oxford</loc>
  <lastmod>2025-02-25T13:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038173-administrative-professionalproject-coordinator</loc>
  <lastmod>2025-02-25T14:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042002-vp-ta-launch-decision-science-immunology</loc>
  <lastmod>2025-02-25T16:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040605-senior-principal-scientistassociate-director-oncology-pks</loc>
  <lastmod>2025-02-25T16:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042003-vp-ta-launch-decision-science-oncology</loc>
  <lastmod>2025-02-25T16:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041999-vp-ta-launch-decision-science-crm</loc>
  <lastmod>2025-02-25T16:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040958-associate-director-operations-solution-delivery-supply-chain-logisitics</loc>
  <lastmod>2025-02-25T17:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041735-medical-science-liaison-msl-onc-hematology-pacific-northwest-territory-remote</loc>
  <lastmod>2025-02-25T19:31:03+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041574-associate-director-marketing-strategy-immunology</loc>
  <lastmod>2025-03-13T21:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041117-medical-lead</loc>
  <lastmod>2025-02-26T03:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036526-market-access-manager</loc>
  <lastmod>2025-02-26T04:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042275-strategy-manager</loc>
  <lastmod>2025-02-26T05:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035292-global-category-manager-clinical</loc>
  <lastmod>2025-02-26T07:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042021-techno-functional-specialist-ai-digital-platforms</loc>
  <lastmod>2025-02-26T08:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041776-specialist</loc>
  <lastmod>2025-02-26T09:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041958-p2p-te-ops-specialist-arabic-french-speaker</loc>
  <lastmod>2025-02-26T09:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10024933-senior-analyst-gsoc</loc>
  <lastmod>2025-02-26T10:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040141-director-enterprise-architect-development-trd</loc>
  <lastmod>2025-02-26T10:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041078-omnichannel-engagement-manager</loc>
  <lastmod>2025-02-26T10:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038858-dir-ddit-dev-data-analyt-dsai-ai-architect</loc>
  <lastmod>2025-02-26T10:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040990-it-director-regulatory-affairs-registration-eu</loc>
  <lastmod>2025-02-26T11:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040472-manager-post-merger-integration</loc>
  <lastmod>2025-03-05T16:30:51+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039512-ai-technical-lead-architect</loc>
  <lastmod>2025-02-26T13:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039532-manager-commercial-design-and-advisory</loc>
  <lastmod>2025-02-26T18:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042204-legal-trainee-legal-procurement-datadigital-it</loc>
  <lastmod>2025-02-26T13:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041991-duales-studium-bwl-personalmanagement</loc>
  <lastmod>2025-02-28T16:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031650-regional-category-manager-general</loc>
  <lastmod>2025-02-26T13:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041988-duales-studium-bwl-digital-business-management</loc>
  <lastmod>2025-02-28T15:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041990-duales-studium-bwl-gesundheitsmanagement</loc>
  <lastmod>2025-02-28T15:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035822-therapeutic-area-head</loc>
  <lastmod>2025-02-26T14:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041213-country-medical-affairs-head</loc>
  <lastmod>2025-02-26T16:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10024972-sales-representative-wmd-ta-onkologie-gebiet-westosterreich</loc>
  <lastmod>2025-02-27T09:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037990-ta-coordinator</loc>
  <lastmod>2025-02-26T17:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040285-clinical-development-medical-director-rheumatology</loc>
  <lastmod>2025-02-26T18:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041895-regional-director-health-information-technology-precision-health-west-remote</loc>
  <lastmod>2025-03-06T22:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041897-regional-director-health-information-technology-precision-health-east-remote</loc>
  <lastmod>2025-03-06T23:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041896-regional-director-health-information-technology-precision-health-central-remote</loc>
  <lastmod>2025-03-06T23:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042293-product-executive</loc>
  <lastmod>2025-02-27T02:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041577-medical-science-liaison-msl-allergy-dermatology-co-nm-remote</loc>
  <lastmod>2025-02-28T16:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042329-senior-principal-biostatistician</loc>
  <lastmod>2025-02-27T04:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10029993-senior-clinical-data-scientistmultiple-rolessenior-clinical-data-manager</loc>
  <lastmod>2025-02-27T05:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10029991-clinical-data-scientist-multiple-rolesclinical-data-manager</loc>
  <lastmod>2025-02-27T05:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10029994-clinical-data-scientist-multiple-rolesclinical-data-manager</loc>
  <lastmod>2025-02-27T05:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041227-whatfix-lead</loc>
  <lastmod>2025-02-27T07:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038256-medical-safety-lead-md</loc>
  <lastmod>2025-02-27T07:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035901-manager-medical-oncology</loc>
  <lastmod>2025-02-27T08:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041453-senior-program-head</loc>
  <lastmod>2025-02-27T08:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042117-market-research-manager</loc>
  <lastmod>2025-02-27T08:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039048-global-gmp-senior-quality-auditor</loc>
  <lastmod>2025-02-27T09:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042179-mr-intern-zh-cn</loc>
  <lastmod>2025-02-27T09:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034219-associate-director-ddit-dev-ce-data-engineer</loc>
  <lastmod>2025-02-27T10:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041167-associate-supply-management</loc>
  <lastmod>2025-02-27T10:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041993-tehnolog-proizvodnega-inzeniringa-lokacije-avtomatizacija-mzdengineer-multidiscipline-ii-automation-mfd</loc>
  <lastmod>2025-02-27T11:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10019766-technical-lead</loc>
  <lastmod>2025-02-27T11:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041803-labortechniker-mst-mwd-kundl-tirol-de-de</loc>
  <lastmod>2025-02-27T12:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040329-tehnolog-proizvodnih-procesov-i-process-expert-i</loc>
  <lastmod>2025-02-27T12:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041803-labortechniker-mst-mwd-kundl-tirol</loc>
  <lastmod>2025-02-27T12:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041803-labortechniker-mst-mwd-kundl-tirol-it-it</loc>
  <lastmod>2025-02-27T12:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041803-labortechniker-mst-mwd-kundl-tirol-ru-ru</loc>
  <lastmod>2025-02-27T12:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041803-labortechniker-mst-mwd-kundl-tirol-sl-si</loc>
  <lastmod>2025-02-27T12:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041803-labortechniker-mst-mwd-kundl-tirol-zh-cn</loc>
  <lastmod>2025-02-27T12:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041717-global-program-clinical-head-oncology</loc>
  <lastmod>2025-02-27T13:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042607-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-02-27T13:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10015144-rlt-formulation-project-leader</loc>
  <lastmod>2025-02-27T14:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041989-vendor-alliance-lead-associate-director</loc>
  <lastmod>2025-02-27T15:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042140-warehouse-operator</loc>
  <lastmod>2025-02-27T15:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037876-time-service-delivery-expert-temporary-role-12-months</loc>
  <lastmod>2025-02-27T17:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041406-it-sr-specialist-project-gco</loc>
  <lastmod>2025-02-27T17:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041949-sr-specialist-aimlmlops-gen-ai-azure</loc>
  <lastmod>2025-03-04T07:30:52+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041553-patent-attorney-ii-biologics</loc>
  <lastmod>2025-02-27T18:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10020329-rotkreuz-product-solutions-partner-oncology-east-80-de-de</loc>
  <lastmod>2025-02-27T20:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032483-project-managerscrum-master-ddit-usi-americas</loc>
  <lastmod>2025-02-28T01:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037541-expert-science-technology-ii</loc>
  <lastmod>2025-02-28T04:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042710-gaojidequjingli-zh-cn</loc>
  <lastmod>2025-02-28T05:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042294-senior-legal-counsel</loc>
  <lastmod>2025-02-28T06:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037374-principal-statistical-programmer</loc>
  <lastmod>2025-02-28T07:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042583-mr-intern-zh-cn</loc>
  <lastmod>2025-02-28T07:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036557-assoc-dir-ddit-ops-soldel-sc-d365</loc>
  <lastmod>2025-02-28T08:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038856-territory-business-executive</loc>
  <lastmod>2025-02-28T09:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040247-automatisierungsingennieur-mwd</loc>
  <lastmod>2025-02-28T09:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040869-principal-biostatistician</loc>
  <lastmod>2025-02-28T10:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041135-sr-ekspert-procesne-tehnologije-za-pakiranje-zmdsenior-technical-manager-fmd</loc>
  <lastmod>2025-02-28T10:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10025513-manager-data-privacy-review-and-remediation</loc>
  <lastmod>2025-02-28T11:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042156-senior-clinical-project-manager</loc>
  <lastmod>2025-02-28T12:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038899-skladiscnik-mzd</loc>
  <lastmod>2025-02-28T12:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042195-medical-science-liaison-manager-hamatologie-wmd-nordrhein-westfalen-de-de</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042435-medical-science-liaison-manager-hamatologie-wmd-gebiet-westfalen-lippe-de-de</loc>
  <lastmod>2025-02-28T14:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031122-analytics-architect</loc>
  <lastmod>2025-03-10T09:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042622-principal-infrastructure-and-utilities-engineer-mfd-vodilni-inz-za-infr-opremo-mzd</loc>
  <lastmod>2025-03-04T13:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042577-community-key-account-manager-cvd-bucks-frimley</loc>
  <lastmod>2025-02-28T14:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042589-tehnolog-proizvodnega-inzeniringa-lokacije-ekspert-avtomatizacija-mzdengineer-multidiscipline-i-automation-mfd</loc>
  <lastmod>2025-02-28T14:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031827-tagging-lead-web-and-campaign</loc>
  <lastmod>2025-03-10T09:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042641-qc-supervisor</loc>
  <lastmod>2025-02-28T15:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10022538-it-strategic-business-partner-usi-salesforce-0</loc>
  <lastmod>2025-02-28T16:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041301-production-support-engineer</loc>
  <lastmod>2025-03-12T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041699-procurement-specialist-marketing</loc>
  <lastmod>2025-03-03T15:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034833-cell-management-specialist</loc>
  <lastmod>2025-02-28T17:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039245-solution-design-director</loc>
  <lastmod>2025-02-28T18:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041389-external-animal-activities-managersenior-manager</loc>
  <lastmod>2025-03-01T13:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039727-senior-clinical-research-associate-remote-position</loc>
  <lastmod>2025-03-01T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040901-formulation-scientist-oral-dosage-forms-labormitarbeiter-galenische-entwicklung-mfd-de-de</loc>
  <lastmod>2025-03-02T22:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035215-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-03T03:30:51+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033022-health-data-insights-manager</loc>
  <lastmod>2025-03-03T05:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042269-oncology-disease-area-lead-non-malignant-hematology-los-angeles-remote</loc>
  <lastmod>2025-03-03T06:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041461-drug-substance-project-manager-e2e</loc>
  <lastmod>2025-03-03T09:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042711-mr-intern-zh-cn</loc>
  <lastmod>2025-03-03T09:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030588-laboratorijski-analitik-mzd</loc>
  <lastmod>2025-03-03T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041276-rotkreuz-value-demonstration-heor-manager-80-100</loc>
  <lastmod>2025-03-03T11:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042926-china-dei-culture-lead</loc>
  <lastmod>2025-03-03T12:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042686-qa-batch-release-specialist</loc>
  <lastmod>2025-03-04T03:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042401-technicien-support-maintenance-hf-cdd</loc>
  <lastmod>2025-03-10T14:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042963-medical-leadmedical-science-liaison</loc>
  <lastmod>2025-03-03T15:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10027702-principal-clinical-data-standards-specialists</loc>
  <lastmod>2025-03-03T15:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042804-oncology-area-business-leader-hematology-alexandria-remote</loc>
  <lastmod>2025-03-03T15:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10022081-associate-director-clinical-data-standards</loc>
  <lastmod>2025-03-03T16:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040190-external-drug-discovery-transaction-sourcing-coordinator</loc>
  <lastmod>2025-03-12T22:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042928-clinical-trial-vendor-senior-manager</loc>
  <lastmod>2025-03-03T16:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042927-clinical-trial-vendor-associate-director</loc>
  <lastmod>2025-03-03T16:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042906-territory-sales-manager-oncology-moravia</loc>
  <lastmod>2025-03-03T17:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041277-head-public-affairs-fmd</loc>
  <lastmod>2025-03-03T17:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042957-international-ethics-risk-compliance-operations-director</loc>
  <lastmod>2025-03-03T18:30:51+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042500-medical-science-liaison-msl-cardiometabolic-nebraska-iowa-remote</loc>
  <lastmod>2025-03-03T20:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038841-medical-director-rheumatology-sjogrens-disease-lupus</loc>
  <lastmod>2025-03-03T20:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041200-sr-specialist-it-solution-delivery</loc>
  <lastmod>2025-03-03T20:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040412-us-director-procurement-category-head-market-insights-patient-services-and-sales-effectiveness</loc>
  <lastmod>2025-03-03T21:30:52+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040765-specialty-sales-consultant-ottawa-gatineau</loc>
  <lastmod>2025-03-03T21:30:52+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040425-shift-lead-ii-shift-lead-ii-sol-preprosol-compweegdienst</loc>
  <lastmod>2025-03-03T21:30:52+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037238-biomedical-research-submission-management-associate-director</loc>
  <lastmod>2025-03-03T22:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032872-global-head-lab-solutions-scientific-services</loc>
  <lastmod>2025-03-03T22:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041876-global-program-head-neuroscience-drug-development-md-phd</loc>
  <lastmod>2025-03-04T00:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038086-global-program-head-gene-therapy-drug-development-mdphd</loc>
  <lastmod>2025-03-04T00:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042706-senior-scientist-vitro-pharmacology-gene-therapy</loc>
  <lastmod>2025-03-04T00:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032148-global-program-clinical-head-neuroscience-md-phd</loc>
  <lastmod>2025-03-04T00:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042772-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-05T06:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042619-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2025-03-04T03:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042414-key-account-manager-quebec</loc>
  <lastmod>2025-03-04T03:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042087-qc-microbiologist</loc>
  <lastmod>2025-03-04T03:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038491-atlantic-specialty-sales-consultant</loc>
  <lastmod>2025-03-04T03:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042619-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2025-03-04T03:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042619-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2025-03-04T03:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042619-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2025-03-04T03:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042619-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2025-03-04T03:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042619-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-04T03:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042617-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2025-03-04T04:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042617-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2025-03-04T04:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042617-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2025-03-04T04:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042617-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2025-03-04T04:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042617-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2025-03-04T04:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042617-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-04T04:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042907-xianyuzhurenxianyuzhuguan-zh-cn</loc>
  <lastmod>2025-03-04T04:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042892-medical-science-liaison-hematology-zh-cn</loc>
  <lastmod>2025-03-04T04:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040476-director-gen-ai-applications</loc>
  <lastmod>2025-03-04T05:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042987-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2025-03-04T05:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042908-xianyuzhurenxianyuzhuguan-zh-cn</loc>
  <lastmod>2025-03-04T05:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037111-assistant-manager-erp-assurance</loc>
  <lastmod>2025-03-04T06:30:52+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042621-senior-analyst-patient-support-analytics</loc>
  <lastmod>2025-03-04T06:30:52+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040049-manager-corporate-insurance</loc>
  <lastmod>2025-03-04T07:30:52+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040711-assistant-legal-and-erc-teams</loc>
  <lastmod>2025-03-04T07:30:52+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039380-customer-engagement-lead</loc>
  <lastmod>2025-03-04T09:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10008279-laboratorijski-analitik-mzd-qc-analyst-mfd</loc>
  <lastmod>2025-03-04T10:30:52+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042905-data-analyst</loc>
  <lastmod>2025-03-04T10:30:52+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032691-clinical-data-mapper</loc>
  <lastmod>2025-03-04T10:30:52+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042941-projektni-vodja-upravljanja-zivljenjske-krivulje-izdelka-mzd-life-cycle-manager-mfd</loc>
  <lastmod>2025-03-04T10:30:52+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041937-digital-lead-temporary-maternity-cover-role</loc>
  <lastmod>2025-03-04T10:30:52+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032362-senior-clinical-data-mapper</loc>
  <lastmod>2025-03-04T10:30:52+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031507-schichtfuhrer-fmd-schaftenau-tirol-austria-de-de</loc>
  <lastmod>2025-03-04T11:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042707-strokovni-sodelavec-za-oskrbo-zdravil-mzd-associate-expert-drug-supply-mfd-de-de</loc>
  <lastmod>2025-03-04T11:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041926-director-global-functions-solution-delivery-hcm</loc>
  <lastmod>2025-03-04T11:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10027999-backbone-messaging-support-senior-specialist</loc>
  <lastmod>2025-03-04T15:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042919-internship-bachelormaster-students-br-gdc-computational-drug-design</loc>
  <lastmod>2025-03-04T15:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042119-ekspert-za-upravljanje-podatkov-na-podrocju-nabave-mzd-procurement-data-management-specialist-mfd</loc>
  <lastmod>2025-03-10T17:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042760-clinical-development-postgraduate-fellow</loc>
  <lastmod>2025-03-04T16:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040556-exec-director-tppm-ta-head-immunology-nce</loc>
  <lastmod>2025-03-04T22:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042261-pilot-plant-supply-chain-lead</loc>
  <lastmod>2025-03-04T16:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042001-senior-scientist-synthetic-chemistry-bs-or-ms</loc>
  <lastmod>2025-03-12T22:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038175-manager-us-reporting</loc>
  <lastmod>2025-03-04T16:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042359-associate-director-solution-architect-marketing-automation</loc>
  <lastmod>2025-03-04T17:31:03+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10027392-medical-director-prostate-cancergu-rlt-us-medical-affairs</loc>
  <lastmod>2025-03-04T17:31:03+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035929-comptable-generale-experimentee-hf</loc>
  <lastmod>2025-03-04T19:31:04+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042829-procurement-performance-analyst</loc>
  <lastmod>2025-03-04T20:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037195-program-manager-ai-and-genai</loc>
  <lastmod>2025-03-04T22:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043015-rltzhongxinyewujingli</loc>
  <lastmod>2025-03-05T02:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043127-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-05T03:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043095-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-05T04:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036908-head-medical-excellence-and-operation</loc>
  <lastmod>2025-03-05T07:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043029-mr-intern-zh-cn</loc>
  <lastmod>2025-03-05T07:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041811-laboratorijski-analitik-v-bioanalitskem-laboratoriju-mzd</loc>
  <lastmod>2025-03-05T09:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042370-job-title-risk-response-insights-director</loc>
  <lastmod>2025-03-05T11:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10013965-senior-regulatory-affairs-manager</loc>
  <lastmod>2025-03-05T11:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043249-laboratorijski-analitik-mzd</loc>
  <lastmod>2025-03-05T11:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041940-team-lead-patent-support-europe</loc>
  <lastmod>2025-03-05T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040975-senior-patent-paralegal</loc>
  <lastmod>2025-03-05T12:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042529-corporate-communications-lead</loc>
  <lastmod>2025-03-05T12:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040922-regional-data-payroll-lead-my-total-rewards-project</loc>
  <lastmod>2025-03-05T13:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10021760-lehrling-chemieverfahrenstechnik-de-de</loc>
  <lastmod>2025-03-05T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042936-principal-people-services-solutions</loc>
  <lastmod>2025-03-05T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040758-priloznosti-za-iskalce-prve-zaposlitve-v-novartisu-slovenija</loc>
  <lastmod>2025-03-05T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034766-expert-science-technology</loc>
  <lastmod>2025-03-05T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10021773-lehrling-elektrotechnik</loc>
  <lastmod>2025-03-05T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10021766-lehre-labortechnik</loc>
  <lastmod>2025-03-05T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10021772-lehrling-mechatronik</loc>
  <lastmod>2025-03-05T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10014299-global-head-learning-production-studio</loc>
  <lastmod>2025-03-05T15:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042198-qc-analyst</loc>
  <lastmod>2025-03-05T15:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032566-associate-director-business-analyst-scientific-products</loc>
  <lastmod>2025-03-12T13:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034469-talent-acquisition-strategy-operations-lead-compliance-and-knowledge-management</loc>
  <lastmod>2025-03-05T16:30:51+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043311-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-05T16:30:51+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042399-global-clinical-operations-budget-associate-director-de-de</loc>
  <lastmod>2025-03-05T17:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042265-senior-study-leader</loc>
  <lastmod>2025-03-05T17:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042418-allergy-area-business-leader-arizona-remote</loc>
  <lastmod>2025-03-05T18:30:52+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042415-allergy-area-business-leader-kansas-remote</loc>
  <lastmod>2025-03-05T18:30:52+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042419-allergy-area-business-leader-new-york-city-remote</loc>
  <lastmod>2025-03-05T18:30:52+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042420-allergy-area-business-leader-upstate-new-york-remote</loc>
  <lastmod>2025-03-05T18:30:52+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042247-quality-assurance-operations-specialist</loc>
  <lastmod>2025-03-05T18:30:52+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031374-director-cell-and-gene-therapy-analytical-operations</loc>
  <lastmod>2025-03-12T20:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042931-healthcare-manager</loc>
  <lastmod>2025-03-05T18:30:52+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028370-director-product-sciences-cell-therapy-analytical-development</loc>
  <lastmod>2025-03-12T20:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042416-allergy-area-business-leader-rocky-mountain-remote</loc>
  <lastmod>2025-03-05T18:30:52+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041998-research-scientist-synthetic-chemistry-bs-or-ms</loc>
  <lastmod>2025-03-12T22:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040592-senior-specialist-lab-operations</loc>
  <lastmod>2025-03-12T22:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042425-allergy-territory-account-specialist-fort-wayneindianapolis-remote</loc>
  <lastmod>2025-03-05T21:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042462-allergy-territory-account-specialist-medinatoledo-oh-remote</loc>
  <lastmod>2025-03-05T21:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042469-pathologist-senior-principal-scientist-multiple-positions</loc>
  <lastmod>2025-03-05T21:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030495-technical-trainer</loc>
  <lastmod>2025-03-05T21:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042459-allergy-territory-account-specialist-medina-oh-remote</loc>
  <lastmod>2025-03-05T21:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042424-allergy-territory-account-specialist-louisvillelexington-ky-remote</loc>
  <lastmod>2025-03-05T21:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042460-allergy-territory-account-specialist-flintgrand-rapids-mi-remote</loc>
  <lastmod>2025-03-05T21:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042447-allergy-territory-account-specialist-harrisburgpittsburgh-remote</loc>
  <lastmod>2025-03-05T22:30:51+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043011-associate-director-manufacturing-operations</loc>
  <lastmod>2025-03-05T23:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042272-director-us-forecasting</loc>
  <lastmod>2025-03-07T21:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042451-allergy-territory-account-specialist-new-orleans-shreveport-remote</loc>
  <lastmod>2025-03-06T00:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042472-allergy-territory-account-specialist-jersey-city-edison-remote</loc>
  <lastmod>2025-03-05T23:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042450-allergy-territory-account-specialist-nashville-little-rock-remote</loc>
  <lastmod>2025-03-05T23:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042453-allergy-territory-account-specialist-des-moines-lincoln-remote</loc>
  <lastmod>2025-03-05T23:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042454-allergy-territory-account-specialist-kansas-city-wichita-remote</loc>
  <lastmod>2025-03-05T23:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042433-allergy-territory-account-specialist-riverside-pasadena-remote</loc>
  <lastmod>2025-03-06T01:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042473-allergy-territory-account-specialist-morristown-allentown-remote</loc>
  <lastmod>2025-03-05T23:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042463-allergy-territory-account-specialist-baltimore-bethesda-remote</loc>
  <lastmod>2025-03-05T23:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042464-allergy-territory-account-specialist-washington-dc-arlington-remote</loc>
  <lastmod>2025-03-05T23:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042498-associate-clinical-research-medical-director-immunology</loc>
  <lastmod>2025-03-06T00:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042437-allergy-territory-account-specialist-san-diego-orange-county-remote</loc>
  <lastmod>2025-03-06T00:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042448-allergy-territory-account-specialist-akroncleveland-remote</loc>
  <lastmod>2025-03-06T00:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042444-allergy-territory-account-specialist-manchesterworcester-remote</loc>
  <lastmod>2025-03-06T00:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042432-allergy-territory-account-specialist-seattle-remote</loc>
  <lastmod>2025-03-06T01:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042427-allergy-territory-account-specialist-portlandsacramento-remote</loc>
  <lastmod>2025-03-06T01:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042446-allergy-territory-account-specialist-hartfordnew-haven-remote</loc>
  <lastmod>2025-03-06T01:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042428-allergy-territory-account-specialist-san-franciscosan-jose-remote</loc>
  <lastmod>2025-03-06T01:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042455-allergy-territory-account-specialist-gainesvillechattanooga-remote</loc>
  <lastmod>2025-03-06T01:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042429-allergy-territory-account-specialist-fort-collinsdenver-remote</loc>
  <lastmod>2025-03-06T01:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042476-allergy-territory-account-specialist-albanywhite-plains-remote</loc>
  <lastmod>2025-03-06T01:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042430-allergy-territory-account-specialist-spokanesalt-lake-city-remote</loc>
  <lastmod>2025-03-06T01:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042456-allergy-territory-account-specialist-atlantamacon-remote</loc>
  <lastmod>2025-03-06T01:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042426-allergy-territory-account-specialist-ashevillecharlotte-remote</loc>
  <lastmod>2025-03-06T01:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042467-allergy-territory-account-specialist-oklahoma-cityfort-worth-remote</loc>
  <lastmod>2025-03-06T01:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042465-allergy-territory-account-specialist-tampasarasota-remote</loc>
  <lastmod>2025-03-06T02:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042479-allergy-territory-account-specialist-manhattanbrooklyn-remote</loc>
  <lastmod>2025-03-06T02:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042477-allergy-territory-account-specialist-long-islandqueens-remote</loc>
  <lastmod>2025-03-06T02:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042468-allergy-territory-account-specialist-dallas-remote</loc>
  <lastmod>2025-03-06T02:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042470-allergy-territory-account-specialist-houston-remote</loc>
  <lastmod>2025-03-06T02:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042471-allergy-territory-account-specialist-austin-remote</loc>
  <lastmod>2025-03-06T02:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042466-allergy-territory-account-specialist-palm-beachmiami-remote</loc>
  <lastmod>2025-03-06T02:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033700-clinical-scientific-expert-i</loc>
  <lastmod>2025-03-06T06:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028703-manager-trade-sales</loc>
  <lastmod>2025-03-06T07:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10015326-medical-science-liaison</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041470-customer-insights-and-engagement-manager</loc>
  <lastmod>2025-03-06T15:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042150-compliance-coordinator</loc>
  <lastmod>2025-03-06T11:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040177-senior-expert-science-technology</loc>
  <lastmod>2025-03-06T11:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043339-people-partner-team-lead-development-international-br</loc>
  <lastmod>2025-03-06T11:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043313-site-operations-lead</loc>
  <lastmod>2025-03-10T17:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034297-tax-manager</loc>
  <lastmod>2025-03-06T12:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043320-field-product-specialist-medical-representative-oncology-hcm</loc>
  <lastmod>2025-03-06T12:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043086-senior-principal-product-operations-manager-applied-gen-ai</loc>
  <lastmod>2025-03-06T12:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042178-labortechniker-qc-analyst-ii-mwd-kundl-tirol-de-de</loc>
  <lastmod>2025-03-06T14:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042076-associate-director-product-management-platform-strategy-operations</loc>
  <lastmod>2025-03-06T14:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043211-elektrotechniker-wmd-schaftenau-tirol-de-de</loc>
  <lastmod>2025-03-06T15:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042790-techniker-mwd-kundl-tirol-de-de</loc>
  <lastmod>2025-03-06T15:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031424-gco-budget-manager-de-de</loc>
  <lastmod>2025-03-06T15:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041543-access-reimbursement-manager-nps-cv-thousand-oaks-ca-remote</loc>
  <lastmod>2025-03-06T15:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041481-health-intelligence-specialist</loc>
  <lastmod>2025-03-06T15:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042727-associate-dir-servicenow-delivery</loc>
  <lastmod>2025-03-06T15:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028003-medical-science-liaison-manager-rlt-radioligandentherapie-mwd-gebiet-nordrhein-de-de</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042999-associate-director-ma-it-project-manager</loc>
  <lastmod>2025-03-06T16:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043201-associate-director-gen-aimlmlops-gen-ai-azure</loc>
  <lastmod>2025-03-06T16:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042013-pharmacovigilance-managercountry-rmp-manager</loc>
  <lastmod>2025-03-06T17:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043089-research-scientist-ii-radiochemist-80-100</loc>
  <lastmod>2025-03-07T13:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042367-risk-response-insights-director</loc>
  <lastmod>2025-03-06T18:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043382-customer-support-coordinator-radioligand-therapies</loc>
  <lastmod>2025-03-06T21:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041288-principal-scientist-medicinal-chemistry</loc>
  <lastmod>2025-03-12T22:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040716-senior-expert-engineering-automation-mfd</loc>
  <lastmod>2025-03-06T22:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043370-director-operational-excellence</loc>
  <lastmod>2025-03-06T23:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040991-production-technician-i-weekend-nights</loc>
  <lastmod>2025-03-07T00:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040992-production-technician-i-weekday-nights</loc>
  <lastmod>2025-03-07T00:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043406-medical-lead-cml</loc>
  <lastmod>2025-03-07T02:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037787-medical-science-liaison</loc>
  <lastmod>2025-03-07T03:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043232-regional-hospital-access-manager-zh-cn</loc>
  <lastmod>2025-03-07T04:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043017-sr-specialist-ddit-ops-site-it-expert</loc>
  <lastmod>2025-03-07T06:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041021-regulatory-affairs-specialistsrregulatory-affairs-specialist</loc>
  <lastmod>2025-03-07T06:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043196-country-dpdai-manager-south-korea</loc>
  <lastmod>2025-03-07T06:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043018-sr-specialist-ddit-ops-site-automation-expert</loc>
  <lastmod>2025-03-07T06:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038965-manager-patient-support-analysis</loc>
  <lastmod>2025-03-07T07:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038063-senior-analyst</loc>
  <lastmod>2025-03-07T07:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039857-senior-analyst</loc>
  <lastmod>2025-03-07T07:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037747-manager</loc>
  <lastmod>2025-03-07T07:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039150-territory-business-executive</loc>
  <lastmod>2025-03-07T07:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037914-manager</loc>
  <lastmod>2025-03-07T07:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043243-validation-lead</loc>
  <lastmod>2025-03-07T08:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042949-analyst-digital</loc>
  <lastmod>2025-03-07T09:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042954-senior-analyst-digital-analytics</loc>
  <lastmod>2025-03-07T09:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10024232-territory-business-executive</loc>
  <lastmod>2025-03-07T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030564-zaposlitvene-priloznosti-novartis</loc>
  <lastmod>2025-03-07T11:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043564-specialist-mst-zmdmst-specialist-fmd</loc>
  <lastmod>2025-03-07T11:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043123-globalni-vodja-kakovosti-qc-ast-small-molecules-mzd-global-head-qcast-small-molecules-mfd</loc>
  <lastmod>2025-03-07T12:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042846-research-scientist-ii-vivo-pharmacologist-cvm</loc>
  <lastmod>2025-03-07T12:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041608-medical-scientific-liaison-fmd-region-west-switzerland</loc>
  <lastmod>2025-03-13T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043200-qa-manager-eso</loc>
  <lastmod>2025-03-07T13:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042989-medical-science-liaison-manager-kardiologie-wmd-gebiet-hessen-rheinland-pfalz-und-saarland-de-de</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042084-qc-chemist</loc>
  <lastmod>2025-03-07T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043092-senior-scientist-mst</loc>
  <lastmod>2025-03-07T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042442-allergy-territory-account-specialist-san-antonio-corpus-christi-remote</loc>
  <lastmod>2025-03-12T22:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039683-qa-specialist</loc>
  <lastmod>2025-03-07T16:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032722-product-specialist</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035320-senior-administrative-assistant</loc>
  <lastmod>2025-03-07T16:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041890-ethics-risk-compliance-manager-erc</loc>
  <lastmod>2025-03-12T18:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042379-executive-assistant-digital-data-it</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042260-ad-thought-leader-liaison-renal-pacific-nw-remote</loc>
  <lastmod>2025-03-07T17:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040262-automation-engineer</loc>
  <lastmod>2025-03-07T18:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042874-head-data-science-and-ai</loc>
  <lastmod>2025-03-07T18:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042882-head-ai-products-and-innovation</loc>
  <lastmod>2025-03-07T18:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042886-ai-and-innovation-product-manager</loc>
  <lastmod>2025-03-07T18:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037824-brand-associate-oncology</loc>
  <lastmod>2025-03-07T19:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034573-head-pss-india</loc>
  <lastmod>2025-03-07T19:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042505-cardiovascular-territory-account-specialist-portland-me-remote</loc>
  <lastmod>2025-03-07T20:30:53+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033827-manager-performance-excellence-processes</loc>
  <lastmod>2025-03-07T21:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043551-key-account-manager</loc>
  <lastmod>2025-03-07T22:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042490-production-technician-i</loc>
  <lastmod>2025-03-07T22:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042994-us-head-strategy-operational-excellence-procurement</loc>
  <lastmod>2025-03-07T22:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042407-director-us-heor-product-lead-non-malignant-hematology</loc>
  <lastmod>2025-03-07T22:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043546-supervisor-cell-processing-team</loc>
  <lastmod>2025-03-07T23:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042687-medical-science-liaison-msl-cardiometabolic-centralsouth-arizona-nm-and-city-el-paso-tx-remote</loc>
  <lastmod>2025-03-07T23:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10025437-automatiker-im-schichtbetrieb-novartis-stein-galenic-de-ch</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041211-equipment-specialist-de-ch</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/395252br-analyst-sfe-products-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10004925-qa-specialist-apqr-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10014560-sales-value-associate-cdmx-privado-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10021228-record-report-specialist-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10022233-buyer-lacan-temporary-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10022053-sales-value-associate-cdmx-virtual-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023267-sales-value-associate-oncologiahematologia-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10024901-general-accounting-manager-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023658-quality-control-staff-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10015658-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023471-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023664-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026865-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028158-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028262-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031384-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031928-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032125-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032713-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032299-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032849-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032851-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032586-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032428-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032426-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034511-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031941-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032427-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034984-gaojiquyushichangjingli-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034862-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035199-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034012-xianyuzhurenxianyuzhuguan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035465-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035418-xianyuzhurenxianyuzhuguan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036277-xianyuzhurenxianyuzhuguan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036590-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034289-ldc-americas-adopt-lead-taxes-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034290-ldc-americas-adopt-lead-direct-tax-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038849-sales-value-associate-cardiology-estado-de-mexico-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040088-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040769-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041071-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041070-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037891-sales-value-associate-institucional-monterrey-nl-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041127-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041134-manager-public-affairs-policy-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041840-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041377-evidence-generation-manager-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040961-sales-value-associate-toluca-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041803-labortechniker-mst-mwd-kundl-tirol-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041379-governance-excellence-specialist-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041557-product-security-engineer-es-es</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042020-legal-advisor-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036828-msl-oncology-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041883-health-economics-heor-manager-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042617-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042619-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042601-tecnico-de-produccion-mhd-es-es</loc>
  <lastmod>2025-03-12T17:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042602-tecnico-de-produccion-mhd-temporal-es-es</loc>
  <lastmod>2025-03-12T17:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042414-responsable-des-comptes-cles-fr-ca</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041890-chef-ethique-risque-et-conformite-fr-ca</loc>
  <lastmod>2025-03-12T18:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10003203-msl-tumeurs-solides-nord-est-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10005103-alternant-market-acces-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10004844-alternant-market-acces-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10005104-alternant-market-acces-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10007713-alternant-controle-de-gestion-bpa-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/395252br-analyst-sfe-products-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10007364-alternant-expert-en-developpement-des-competences-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10007745-alternant-ingenieur-data-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10008546-alternant-chef-de-projet-maladie-de-verneuilurticaire-chronique-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10003184-apprentie-coordinateur-formation-hf-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10007888-apprentie-animateur-sse-hf-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10017484-analyst-strategique-hf-en-stage-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10021368-cisr-committee-lead-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023658-quality-control-staff-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026779-app-business-planning-analyst-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028996-supply-chain-project-manager-en-stage-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10030400-stagiaire-chef-de-produit-neurosciences-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10015658-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023471-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023664-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026865-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028158-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028262-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031384-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031928-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032125-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032713-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032299-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032849-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032851-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032586-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032428-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032426-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034511-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031941-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032427-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034984-gaojiquyushichangjingli-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034862-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035199-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034012-xianyuzhurenxianyuzhuguan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035465-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035418-xianyuzhurenxianyuzhuguan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036277-xianyuzhurenxianyuzhuguan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036590-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035764-associate-director-research-quality-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023079-technicien-services-techniques-hf-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038778-senior-manager-plain-language-trial-summary-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040088-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040769-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041071-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041070-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041127-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037509-risk-surveillance-lead-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041840-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041803-labortechniker-mst-mwd-kundl-tirol-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040543-bon-usage-du-medicament-hf-en-alternance-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042617-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042619-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/395252br-analyst-sfe-products-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10010893-clinical-biospecimen-senior-scientist-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10014193-lead-medical-excellence-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10016310-senior-specialist-ddit-ops-mfg-site-it-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10006743-ta-strategy-lead-genmed-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10025068-head-regulatory-writing-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023658-quality-control-staff-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10027187-associate-or-manager-phad-japan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10020222-customer-engagement-lead-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10015658-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023471-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023664-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026865-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028158-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028262-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031384-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031928-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032125-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032713-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032299-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032849-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032851-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032586-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032428-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032426-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10025572-investigation-expert-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034511-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031941-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032427-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034984-gaojiquyushichangjingli-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034862-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035199-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034012-xianyuzhurenxianyuzhuguan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035465-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035418-xianyuzhurenxianyuzhuguan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035100-japan-program-manager-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031779-senior-lead-ta-medical-hematology-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036277-xianyuzhurenxianyuzhuguan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036590-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037007-clinical-research-associate-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035502-manager-product-brand-comms-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037562-lead-pricing-public-policy-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037192-manager-ddit-strategic-business-partner-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040088-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040769-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041071-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041070-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041127-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10014731-associate-automation-engineer-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041840-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041803-labortechniker-mst-mwd-kundl-tirol-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042617-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042619-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10002702-lead-rwe-and-evidence-excellence-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043209-senior-lead-new-product-planning-launch-excellence-ja-jp</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/395252br-analyst-sfe-products-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023658-quality-control-staff-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10015658-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023471-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023664-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026865-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028158-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028262-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031384-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031928-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032125-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032713-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032299-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032849-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032851-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032586-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032428-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032426-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034511-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031941-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032427-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034984-gaojiquyushichangjingli-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034862-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035199-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034012-xianyuzhurenxianyuzhuguan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035465-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035418-xianyuzhurenxianyuzhuguan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036277-xianyuzhurenxianyuzhuguan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036590-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10025478-account-manager-dermatology-south-netherlands-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040088-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040769-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041071-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041070-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041127-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041840-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041803-labortechniker-mst-mwd-kundl-tirol-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042617-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042619-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040207-validation-expert-externe-sterilisaties-eto-gamma-nl-nl</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040588-generic-role-profile-interns-pt-br</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/395252br-analyst-sfe-products-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023658-quality-control-staff-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10015658-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023471-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10023664-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026865-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028158-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10028262-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031384-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031928-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032125-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032713-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032299-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032849-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032851-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032586-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032428-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032426-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034511-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031941-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032427-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034984-gaojiquyushichangjingli-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034862-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035199-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034012-xianyuzhurenxianyuzhuguan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035465-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035418-xianyuzhurenxianyuzhuguan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036277-xianyuzhurenxianyuzhuguan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036590-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040088-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040769-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041071-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041070-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041127-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041840-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041803-labortechniker-mst-mwd-kundl-tirol-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042617-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042619-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-09T04:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043548-director-priority-accounts-san-franciscoseattle-remote</loc>
  <lastmod>2025-03-09T05:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035699-medical-representative-field-product-specialist-specialty-ho-chi-minh</loc>
  <lastmod>2025-03-09T05:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042743-expert-science-technology-parenteral-formulation-and-process-development-de-de</loc>
  <lastmod>2025-03-09T22:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041641-regional-access-lead</loc>
  <lastmod>2025-03-10T06:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043020-regional-access-lead</loc>
  <lastmod>2025-03-10T06:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043021-regional-access-lead</loc>
  <lastmod>2025-03-10T06:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043607-head-key-account-management</loc>
  <lastmod>2025-03-10T06:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043399-territory-business-executive</loc>
  <lastmod>2025-03-10T06:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042894-semantic-technologies-lead</loc>
  <lastmod>2025-03-10T06:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043022-regional-access-lead</loc>
  <lastmod>2025-03-10T06:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041659-ast-specialist-mzd</loc>
  <lastmod>2025-03-10T06:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043026-regional-access-lead</loc>
  <lastmod>2025-03-10T06:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041780-laboratorijski-analitik-mzd</loc>
  <lastmod>2025-03-10T06:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043789-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-10T07:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043565-senior-innovative-strategy-manager</loc>
  <lastmod>2025-03-10T09:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040555-project-coordinator-innovation-business-excellence-execution</loc>
  <lastmod>2025-03-10T09:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043683-senior-talent-acquisition-business-partner</loc>
  <lastmod>2025-03-10T09:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043566-alliance-project-manager-zh-cn</loc>
  <lastmod>2025-03-10T09:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043631-medical-launch-liason-rlt</loc>
  <lastmod>2025-03-10T10:30:54+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033021-senior-ddit-isc-governance-specialist</loc>
  <lastmod>2025-03-10T11:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043179-specialist-resource-management-pmo</loc>
  <lastmod>2025-03-10T11:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035977-spec-sol-delivery-gdo</loc>
  <lastmod>2025-03-10T11:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10035344-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-10T11:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043602-znanstveni-svetovalec-v-tehnicnem-razvoju-mzd-senior-expert-science-technology-mfd</loc>
  <lastmod>2025-03-10T12:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041824-associate-director-senior-study-leader</loc>
  <lastmod>2025-03-10T14:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042398-study-director</loc>
  <lastmod>2025-03-10T14:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043463-specialist-kontrole-kakovosti-mzd</loc>
  <lastmod>2025-03-10T12:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043604-raziskovalec-expert-v-tehnicnem-razvoju-mzd-expert-science-technology-mfd</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043485-associate-director-solution-design-architecturesalesforce-functional-architect</loc>
  <lastmod>2025-03-10T12:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043555-associate-director-technical-design-architecturesalesforce-technical-architect</loc>
  <lastmod>2025-03-10T13:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043479-global-program-clinical-head-cvm</loc>
  <lastmod>2025-03-10T13:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043678-gmp-specialist-ru-ru</loc>
  <lastmod>2025-03-10T13:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043459-assoc-dir-functional-security-architect-novartis-biomedical-research</loc>
  <lastmod>2025-03-10T14:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040927-specialist-ddit-ies-conferencing-engineering-ar-vr</loc>
  <lastmod>2025-03-10T14:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043321-senior-legal-counsel</loc>
  <lastmod>2025-03-11T16:31:10+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037701-oncology-disease-area-lead-bwc-st-louis-remote</loc>
  <lastmod>2025-03-10T16:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042694-patent-practitionerattorney-ii</loc>
  <lastmod>2025-03-10T16:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033989-director-applied-ai-research-data-science-drug-discovery-chemistry</loc>
  <lastmod>2025-03-10T18:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042668-medical-science-liaison-manager-kardiologie-wmd-gebiet-baden-wurttemberg</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042243-estagio-processos-operacionais-pt-br</loc>
  <lastmod>2025-03-10T19:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043820-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043498-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043496-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043497-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039754-territory-business-executive-de-de</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043723-hit-discoveryhit-finding-lead</loc>
  <lastmod>2025-03-12T22:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031531-associate-director-bioanalytics-cell-and-gene-therapy-analytical-operations</loc>
  <lastmod>2025-03-12T20:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042616-business-information-security-expert-sr-spec-ddit-isc-usi</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043481-global-program-clinical-head-cvm</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043372-global-program-clinical-head-hematology-md</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042520-clinical-research-medical-advisor</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042337-medical-scientific-liaison-cardiometabolic-vic</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042486-senior-scientist-iii-comparative-medicine</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039248-global-idt-wht-system-assurance-and-performance-lead</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043792-director-public-affairs-policy</loc>
  <lastmod>2025-03-13T09:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043777-specialist-ddit-ops-mfg-site-it-engineer</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043820-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043716-fra-head-nocc-hyderabad</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043793-director-public-affairs</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043498-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040926-it-director-open-source-clinical-enablement</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031674-zonal-business-manager</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034875-territory-business-executive-guwahati</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043776-specialist-ddit-ops-mfg-site-ot-engineer</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043058-laboratorijski-tehnik-mst-specialist-zmdlab-technician-mst-senior-fmd</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043496-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043794-director-public-affairs-north-region</loc>
  <lastmod>2025-03-13T08:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043033-associate-director-technology-scientific-computing</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10009243-product-manager</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041731-operations-lead-data42</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043497-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10024036-zonal-business-manager</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042720-program-execution-lead-data42</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10032521-territory-business-executive</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039754-territory-business-executive</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034402-assoc-dir-ddit-gf-soldel-hcm</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10025928-territory-business-executive</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036517-territory-business-executive</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043151-medical-lead-breast-cancer</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10014388-specialist-mobile-device-management-mdm-engineer</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043855-medical-science-liaison</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042069-global-clinical-operations-pricing-resource-associate-director</loc>
  <lastmod>2025-03-13T16:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040648-sample-data-associate</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042564-administrateur-outils-et-canaux-hf-en-alternance</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041951-gen-ai-business-analyst-lifesciences</loc>
  <lastmod>2025-03-13T13:31:18+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042193-health-insights-manager</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042704-bi-lead-es-es</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042705-crm-incentives-expert-es-es</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043820-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043498-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043496-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043497-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039754-territory-business-executive-es-es</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043820-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043498-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043496-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043497-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039754-territory-business-executive-fr-fr</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043820-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043498-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043496-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043497-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039754-territory-business-executive-it-it</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043820-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043498-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043496-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043497-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039754-territory-business-executive-ja-jp</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043820-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043498-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043496-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043497-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039754-territory-business-executive-nl-nl</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043514-consultor-tecnico-especialidades-onco-hematologia-pt-br</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043512-consultor-tecnico-especialidades-sr-onco-hematologia-pt-br</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043511-consultor-tecnico-especialidades-onco-hematologia-pt-br</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043820-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043498-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043496-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043497-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039754-territory-business-executive-ru-ru</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043820-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043498-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043496-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043497-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039754-territory-business-executive-sl-si</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043820-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043498-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043496-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043497-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039754-territory-business-executive-tr-tr</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043826-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043820-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043498-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043496-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044014-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043497-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043815-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039754-territory-business-executive-zh-cn</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044066-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-11T15:31:30+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031312-hr-people-partner</loc>
  <lastmod>2025-03-11T16:31:10+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041378-associate-director-access-reimbursement-nps-cv-cleveland-oh-remote</loc>
  <lastmod>2025-03-11T16:31:10+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043455-medical-affairs-director</loc>
  <lastmod>2025-03-11T16:31:10+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031517-associate-director-biostatistics</loc>
  <lastmod>2025-03-11T17:31:08+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043474-regulatory-affairs-cmc-senior-manager</loc>
  <lastmod>2025-03-11T17:31:08+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041380-associate-director-access-reimbursement-nps-cv-charleston-wv-remote</loc>
  <lastmod>2025-03-11T17:31:08+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039587-refs-lacan-capital-program-manager</loc>
  <lastmod>2025-03-11T22:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042558-responsable-strategie-data-hf</loc>
  <lastmod>2025-03-11T17:31:08+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041523-access-reimbursement-manager-arm-detroit-mi-remote</loc>
  <lastmod>2025-03-11T17:31:08+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041520-access-reimbursement-manager-arm-charleston-wv-remote</loc>
  <lastmod>2025-03-11T17:31:08+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043473-regulatory-affairs-cmc-manager</loc>
  <lastmod>2025-03-11T17:31:08+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042683-cardiovascular-territory-account-specialist-las-vegas-remote</loc>
  <lastmod>2025-03-11T18:31:16+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043714-procurement-manager-latam-temporary</loc>
  <lastmod>2025-03-11T18:31:16+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042676-cardiovascular-territory-account-specialist-prescott-az-remote</loc>
  <lastmod>2025-03-12T18:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042675-cardiovascular-territory-account-specialist-las-vegas-north-remote</loc>
  <lastmod>2025-03-11T18:31:16+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033404-us-category-manager-market-insights</loc>
  <lastmod>2025-03-11T19:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042039-expert-science-technology-quality-control-information-technology</loc>
  <lastmod>2025-03-13T18:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042677-cardiovascular-territory-account-specialist-bakersfield-remote</loc>
  <lastmod>2025-03-11T20:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031499-analytical-project-leader-trd-mfd</loc>
  <lastmod>2025-03-11T21:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041906-technician-science-technology-analytical-development</loc>
  <lastmod>2025-03-13T18:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042629-patient-coordinator-2-multiple-positions-tempe-az</loc>
  <lastmod>2025-03-11T21:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042948-sso-site-partnership-manager</loc>
  <lastmod>2025-03-11T22:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042449-allergy-territory-account-specialist-knoxville-murfreesboro-remote</loc>
  <lastmod>2025-03-11T22:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042948-chef-partenariat-des-centres-sso-fr-ca</loc>
  <lastmod>2025-03-11T22:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043648-field-solution-manager-gene-therapy-pt-br</loc>
  <lastmod>2025-03-12T00:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043790-mr-intern-zh-cn</loc>
  <lastmod>2025-03-12T03:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044057-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-12T05:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041256-sr-financial-analyst</loc>
  <lastmod>2025-03-12T06:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043435-clinical-research-medical-advisor</loc>
  <lastmod>2025-03-12T06:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043912-rlt-zhongxinyewujingli-de-de</loc>
  <lastmod>2025-03-12T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043583-senior-analyst-digital</loc>
  <lastmod>2025-03-12T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043912-rlt-zhongxinyewujingli</loc>
  <lastmod>2025-03-12T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043912-rlt-zhongxinyewujingli-es-es</loc>
  <lastmod>2025-03-12T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043912-rlt-zhongxinyewujingli-fr-fr</loc>
  <lastmod>2025-03-12T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043912-rlt-zhongxinyewujingli-it-it</loc>
  <lastmod>2025-03-12T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043912-rlt-zhongxinyewujingli-ja-jp</loc>
  <lastmod>2025-03-12T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043912-rlt-zhongxinyewujingli-nl-nl</loc>
  <lastmod>2025-03-12T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043912-rlt-zhongxinyewujingli-ru-ru</loc>
  <lastmod>2025-03-12T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043912-rlt-zhongxinyewujingli-sl-si</loc>
  <lastmod>2025-03-12T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043912-rlt-zhongxinyewujingli-tr-tr</loc>
  <lastmod>2025-03-12T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043912-rlt-zhongxinyewujingli-zh-cn</loc>
  <lastmod>2025-03-12T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044045-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-12T07:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037994-finance-manager-techops-austria-fmd</loc>
  <lastmod>2025-03-12T08:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033444-business-data-analyst-i</loc>
  <lastmod>2025-03-12T08:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042592-commercial-head-cmo-mfd</loc>
  <lastmod>2025-03-12T08:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043447-medical-science-liaison-manager-dermatologie-wmd-gebiet-niedersachsen-bremen-hamburg-de-de</loc>
  <lastmod>2025-03-12T09:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043487-medical-science-liaison-manager-dermatologie-wmd-gebiet-sachsen-de-de</loc>
  <lastmod>2025-03-12T09:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043658-medical-science-liaison-manager-dermatologie-wmd-gebiet-nordrhein-westfalen-de-de</loc>
  <lastmod>2025-03-12T09:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043491-medical-science-liaison-manager-dermatologie-wmd-gebiet-hessen-rheinland-pfalz-und-saarland-de-de</loc>
  <lastmod>2025-03-12T09:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040917-global-payroll-time-subject-matter-expert</loc>
  <lastmod>2025-03-12T09:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043679-medical-science-liaison-manager-dermatologie-wmd-gebiet-berlin</loc>
  <lastmod>2025-03-13T15:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038569-direktor-komercialne-odlicnosti-izvedbe-mzd-business-excellence-execution-head-mfd</loc>
  <lastmod>2025-03-12T09:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044041-country-head-quality-japan-de-de</loc>
  <lastmod>2025-03-12T11:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042400-data-quality-manager</loc>
  <lastmod>2025-03-12T10:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042055-data-steward</loc>
  <lastmod>2025-03-12T10:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044048-tehnolog-podpornih-sistemov-zmdmanufacturing-systems-expert-fmd</loc>
  <lastmod>2025-03-12T10:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043121-global-mobility-specialist</loc>
  <lastmod>2025-03-12T10:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044178-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-12T10:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043149-snr-specialist-ddit-global-clinical-operations-business-analyst</loc>
  <lastmod>2025-03-12T11:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044232-sr-strategy-manager</loc>
  <lastmod>2025-03-13T02:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043919-senior-global-project-manager</loc>
  <lastmod>2025-03-12T13:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041593-dir-ddit-dev-architecture-integration</loc>
  <lastmod>2025-03-12T11:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043635-specialist-mst</loc>
  <lastmod>2025-03-12T12:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041700-ast-expert-de-de</loc>
  <lastmod>2025-03-12T13:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042190-knowledge-management-km-strategist</loc>
  <lastmod>2025-03-12T13:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043545-associate-director-retirement-plans</loc>
  <lastmod>2025-03-12T13:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043444-clinical-research-medical-advisor-crma</loc>
  <lastmod>2025-03-12T13:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043034-regulatory-affairs-associate-capability-director</loc>
  <lastmod>2025-03-13T11:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037703-vendor-start-manager</loc>
  <lastmod>2025-03-12T14:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044149-psp-analyst</loc>
  <lastmod>2025-03-12T14:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043522-recent-bachelormaster-graduate-novartis-compound-management</loc>
  <lastmod>2025-03-12T15:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036478-maintenance-technician-2-cdd-hf-fr-fr</loc>
  <lastmod>2025-03-12T15:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040913-customer-care-coordinator</loc>
  <lastmod>2025-03-12T16:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042552-medical-lead-cardiology</loc>
  <lastmod>2025-03-12T16:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042267-qc-investigations-expert</loc>
  <lastmod>2025-03-12T17:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042264-qc-sr-investigations-expert</loc>
  <lastmod>2025-03-12T17:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10038663-application-support-manager-ddit-usi-service-management-medical</loc>
  <lastmod>2025-03-12T17:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042514-cardiovascular-territory-account-specialist-prescott-az-remote</loc>
  <lastmod>2025-03-12T17:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043146-medical-director-prostate-cancergu-rlt-dirsr-dir</loc>
  <lastmod>2025-03-12T17:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039685-solution-architect</loc>
  <lastmod>2025-03-12T17:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041761-assoc-dir-ddit-apd-ce-integration-architect</loc>
  <lastmod>2025-03-12T17:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042673-cardiovascular-territory-account-specialist-knoxville-s-tn-remote</loc>
  <lastmod>2025-03-12T17:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043710-order-management-specialist-temporary-es-es</loc>
  <lastmod>2025-03-12T17:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044124-strategic-assistant-global-head-corporate-and-business-development-de-de</loc>
  <lastmod>2025-03-13T11:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10039697-people-services-solutions-engagement-services-expert-hr</loc>
  <lastmod>2025-03-12T18:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042220-bioprocess-engineer-downstreamfill-finish</loc>
  <lastmod>2025-03-12T18:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043446-o2c-specialist</loc>
  <lastmod>2025-03-12T18:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042102-associate-director-rapid-sterility</loc>
  <lastmod>2025-03-12T22:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043965-qc-microbiologist</loc>
  <lastmod>2025-03-12T20:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036382-global-feasibility-lead-copm</loc>
  <lastmod>2025-03-12T21:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041231-security-automation-engineering</loc>
  <lastmod>2025-03-12T22:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043529-senior-expert-science-technology-downstream-process-development</loc>
  <lastmod>2025-03-12T22:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043393-sales-manager</loc>
  <lastmod>2025-03-13T00:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043147-msl-oncology-es-es</loc>
  <lastmod>2025-03-13T00:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043890-sales-representative-solid-tumor-taoyuan</loc>
  <lastmod>2025-03-13T01:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044175-sale-representative</loc>
  <lastmod>2025-03-13T02:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044177-strategic-access-partnership-lead</loc>
  <lastmod>2025-03-13T02:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10040635-associate-director-early-strategic-partnerships</loc>
  <lastmod>2025-03-13T02:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10026253-japan-program-head-neuroscience-gtx-ja-jp</loc>
  <lastmod>2025-03-13T02:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042309-km-process-manager</loc>
  <lastmod>2025-03-13T03:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044198-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2025-03-13T04:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044198-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2025-03-13T04:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044183-business-excellence-execution-head</loc>
  <lastmod>2025-03-13T04:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044231-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2025-03-13T04:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044204-rltzhongxinyewujingli</loc>
  <lastmod>2025-03-13T04:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044200-rltzhongxinyewujingli</loc>
  <lastmod>2025-03-13T04:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044198-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-13T04:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044198-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-13T04:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044198-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2025-03-13T04:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044198-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-13T04:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044198-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-13T04:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044198-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2025-03-13T04:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044198-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2025-03-13T04:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044198-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-13T04:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044198-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-13T04:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044208-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-de-de</loc>
  <lastmod>2025-03-13T05:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044203-rltzhongxinyewujingli</loc>
  <lastmod>2025-03-13T05:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044208-gaojiyiyaodaibiao-zishenchanpinzhuanyuan</loc>
  <lastmod>2025-03-13T05:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044208-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-es-es</loc>
  <lastmod>2025-03-13T05:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044208-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-fr-fr</loc>
  <lastmod>2025-03-13T05:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044208-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-it-it</loc>
  <lastmod>2025-03-13T05:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044208-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ja-jp</loc>
  <lastmod>2025-03-13T05:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044208-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-nl-nl</loc>
  <lastmod>2025-03-13T05:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044208-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-ru-ru</loc>
  <lastmod>2025-03-13T05:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044208-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-sl-si</loc>
  <lastmod>2025-03-13T05:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044208-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-tr-tr</loc>
  <lastmod>2025-03-13T05:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044269-gaojidequjingli-zh-cn</loc>
  <lastmod>2025-03-13T05:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044208-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-13T05:30:57+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044352-marketing-director</loc>
  <lastmod>2025-03-13T08:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10034300-ei-technician</loc>
  <lastmod>2025-03-13T08:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043822-trainee-engineer</loc>
  <lastmod>2025-03-13T08:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043788-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-13T08:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043704-quality-assurance-officer-jr</loc>
  <lastmod>2025-03-13T09:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044134-qualified-person-it-it</loc>
  <lastmod>2025-03-13T09:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044271-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-13T09:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043345-contract-administrator-mwd</loc>
  <lastmod>2025-03-13T10:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043802-people-partner-team-lead</loc>
  <lastmod>2025-03-13T10:31:02+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041857-vodja-proizvodnih-znanosti-tehnologij-mzd-site-head-mst-mfd</loc>
  <lastmod>2025-03-13T16:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044377-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-13T11:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043408-senior-qa-operations-specialist-zh-cn</loc>
  <lastmod>2025-03-13T11:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044303-qc-analyst-ii</loc>
  <lastmod>2025-03-13T13:31:18+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042938-p-r-heor-manager-tempo-determinato</loc>
  <lastmod>2025-03-13T13:31:18+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10020367-regional-business-manager</loc>
  <lastmod>2025-03-13T13:31:18+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10024187-territory-business-executive</loc>
  <lastmod>2025-03-13T13:31:18+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044026-release-and-deployment-expert</loc>
  <lastmod>2025-03-13T13:31:18+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044190-associate-director-apex-lightning-web-components</loc>
  <lastmod>2025-03-13T13:31:18+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044380-gaojidequjingli-zh-cn</loc>
  <lastmod>2025-03-13T13:31:18+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042441-allergy-territory-account-specialist-colorado-springs-albuquerque-remote</loc>
  <lastmod>2025-03-13T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043263-head-medical-affairs</loc>
  <lastmod>2025-03-13T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042300-rotkreuz-medical-scientific-liaison-fmd-region-east-switzerland</loc>
  <lastmod>2025-03-13T14:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043517-medical-alliance-lead-mwd-immunologie-einsatzgebiet-bundesweit-de-de</loc>
  <lastmod>2025-03-13T15:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044022-ai-and-innovation-portfolio-manager</loc>
  <lastmod>2025-03-13T15:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042884-ai-and-innovation-change-lead</loc>
  <lastmod>2025-03-13T15:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044404-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-13T15:30:55+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10036180-clinical-research-associate</loc>
  <lastmod>2025-03-13T16:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10042241-buyer</loc>
  <lastmod>2025-03-13T16:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043450-sap-service-manager</loc>
  <lastmod>2025-03-13T16:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10041765-sr-global-program-safety-team-lead-immunology</loc>
  <lastmod>2025-03-13T17:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044052-specialiste-qualification-hf-cdd-fr-fr</loc>
  <lastmod>2025-03-13T17:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037855-medical-science-liaison-radioligand-therapy</loc>
  <lastmod>2025-03-13T18:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10033828-associate-director-product-line-operations-management-data-core-product-line</loc>
  <lastmod>2025-03-13T18:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10037855-liaison-en-sciences-medicales-cancer-de-la-prostate-fr-ca</loc>
  <lastmod>2025-03-13T18:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044098-global-program-regulatory-manager-immunology</loc>
  <lastmod>2025-03-13T19:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044291-senior-manager-internal-audit</loc>
  <lastmod>2025-03-13T19:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043940-global-program-regulatory-manager-cardio-renal-metabolic</loc>
  <lastmod>2025-03-13T19:30:58+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10013017-risk-management-manager</loc>
  <lastmod>2025-03-13T22:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043386-executive-director-creative-excellence-and-effectiveness</loc>
  <lastmod>2025-03-13T23:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044114-allergy-territory-account-specialist-toms-river-philadelphia-remote</loc>
  <lastmod>2025-03-13T23:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043407-director-biostatistics-fr-fr</loc>
  <lastmod>2025-03-14T01:30:59+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044463-field-product-specialist-hematology-hcm</loc>
  <lastmod>2025-03-14T02:30:56+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044340-supply-demand-planner</loc>
  <lastmod>2025-03-14T04:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10043173-medical-science-liaison-msl-onc-solid-tumor-miami-region-remote</loc>
  <lastmod>2025-03-14T04:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10031483-manager-ra-cmc-manager-japan-ja-jp</loc>
  <lastmod>2025-03-14T04:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10017545-japan-program-head-immunology-ja-jp</loc>
  <lastmod>2025-03-14T04:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10019692-japan-program-clinical-head-ja-jp</loc>
  <lastmod>2025-03-14T04:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044338-gaojiyiyaodaibiao-zishenchanpinzhuanyuan-zh-cn</loc>
  <lastmod>2025-03-14T04:31:01+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
 <url>
  <loc>https://www.novartis.com/careers/career-search/job/details/req-10044049-mr-intern-zh-cn</loc>
  <lastmod>2025-03-14T05:31:00+00:00</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.5</priority>
 </url>
</urlset>
